PUSHING

BOUNDARIES
STAYING AHEAD
Abbott India Limited | Annual Report 2017-18

Scan the QR code or download

“Abbott India Ltd Annual Report”
(AR app)* from Playstore to view
the augmented 3D experience on
this page

*The AR app shall go live on July 18, 2018.

CORPORATE INFORMATION TABLE OF CONTENTS
BOARD OF DIRECTORS
Munir Shaikh - Chairman
REGISTERED OFFICE
3, Corporate Park
02
ABBOTT INDIA
Ambati Venu - Managing Director Sion - Trombay Road
R A Shah - Independent Director
Krishna Mohan Sahni - Independent Director
Mumbai - 400 071
Tel No: +91-22-6797 8888 05
Anisha Motwani - Independent Director Fax: +91-22-6797 8727 CHAIRMAN’S MESSAGE
Jawed Zia - Non-Executive Director Email: investorrelations.india@abbott.com
Kaiyomarz Marfatia - Non-Executive Director 09
Rajiv Sonalker - CFO and Whole-time Director CORPORATE OFFICE MANAGING DIRECTOR’S MESSAGE

12
16th Floor, Godrej BKC
KEY MANAGEMENT TEAM
Plot C- 68, “G” Block
Ambati Venu - Managing Director Bandra-Kurla Complex PUSHING BOUNDARIES, STAYING AHEAD
Rajiv Sonalker - CFO and Whole-time Director Bandra (East), Mumbai 400 051 13 | Accelerated Growth Delivers Business Performance
Sandeep Khandelwal - Commercial Director Tel No: +91-22-3816 2000 22 | Future-Focused
Milind Tendulkar - Commercial Director Fax: +91-22-3816 2400 32 | Culture of Collaboration
Ramanathan V - Commercial Director
Burjor Dadachanji - Commercial Director
Nitu Bhushan - Director - Human Resources
FACTORY 42
L-18/19, Verna Industrial Estate, Goa AWARDS
Mahadeo Karnik - Director - Finance
Dr Srirupa Das - Director - Medical Affairs
Dr Vijay Patil - Associate Director - NPI and TAS REGISTRAR & SHARE TRANSFER AGENT 44
Karvy Computershare Private Limited
STATUTORY REPORTS
COMPANY SECRETARY 44 | Board of Directors Report and Management
Karvy Selenium Tower B
Discussion And Analysis
Krupa Anandpara Plot 31-32, Gachibowli 72 | Business Responsibility Report
Financial District 84 | Corporate Governance Report
Nanakramguda
STATUTORY AUDITORS
96
Hyderabad - 500 032
S R B C & CO LLP, Chartered Accountants Tel No: +91-40-6716 2222
Fax No: +91-40-2344 0674 FINANCIAL REPORTS
INTERNAL AUDITORS 96 | Independent Auditor's Report
102 | Balance Sheet
M/s KPMG, Chartered Accountants ANNUAL GENERAL MEETING f=^K^OWOX^YP:\Y ^KXN6Y]]
Date: July 18, 2018, Wednesday 104 | Statement of Changes in Equity
COST AUDITORS 105 | Statement of Cash Flow
Time: 3:30 p.m.
M/s Kishore Bhatia & Associates, Cost Accountants Venue: RAMA WATUMULL AUDITORIUM 107 | Notes to the Financial Statements

146
K C College, 124, Dinshaw Wachha Road
SECRETARIAL AUDITOR Vidyasagar Prin. K. M. Kundnani Chowk
Ms Neena Bhatia, Practicing Company Secretary
Churchgate, Mumbai - 400 020 NOTICE

FORWARD - LOOKING STATEMENT

In this Annual Report, we might have disclosed forward-looking statements that set out anticipated results based on the management’s
plans and assumptions. We cannot guarantee that these forward–looking statements will be realised, although we believe we have been
prudent in our assumptions. The achievements of results are subject to risks, uncertainties, and even inaccurate assumptions. We undertake
no obligation to publicly update any forward–looking statements, whether as a result of new information, future events or otherwise.
References to “Abbott India” in this Annual Report shall mean “Abbott India Limited”.
ON THE COVER - FEEL THE EXPERIENCE
Digital is at the heart of most innovations at Abbott India. The cover provides an augmented 3D experience, which would
allow you to step inside our journey, feel the exuberance and get a glimpse of how we push boundaries and stay ahead.
Every Single Day.
Download the App “Abbott India Ltd Annual Report” (AR app) from Google Playstore.
The AR app shall go live on the date of Annual General Meeting - July 18, 2018.
ABBOTT INDIA

HELPING PEOPLE LEAD THE BEST

LIFE THROUGH GOOD HEALTH
Abbott India, part of Abbott’s Global
Pharmaceutical business, is one of India’s
most admired and fastest-growing
pharmaceutical companies.

We, at Abbott India, provide consumers

with market-leading, trusted, global and
local products across various therapeutic
categories such as Women’s Health,
Gastroenterology, CNS, Metabolics,
General Care, Vitamins, Vaccines, etc.

WHAT MAKES US UNIQUE?

IN INDIA, FOR INDIA
Our products are manufactured in
India and also sourced from local
third-party manufacturers in India.
We have a manufacturing facility at
Goa and are engaged with over 40
third-party manufacturers in India.
LOCAL R&D FOR LOCALIZED
SOLUTIONS
Our in-house development and medical
teams work passionately to advance
health by addressing the country’s
unique challenges. We launched over
XOaZ\YN_M^]N_\SXQ^ROVK]^ `O
years for meeting the increasing
healthcare needs of society.
EXPANSIVE HEALTH NETWORK
Our mission to enhance the health and
well-being of Indians extends beyond our
products to innovative methodologies
and platforms across distribution
channels. Through the distribution
network of over 25 carrying and
forwarding service providers and hubs,
we reach out to millions of Indians.
A LEGACY OF EXCELLENCE
From creating an excellent workplace
to making a positive impact on the
health of people, we are proud of the
work we do in India with the help of
over 3,300 talented people.

2 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 3
 CHAIRMAN’S
Try the augmented
experience on this page
through the AR app.

MESSAGE
A HOLISTIC APPROACH TOWARDS
GROWTH, DEVELOPMENT, HEALTH
AND WELLNESS

We, at Abbott India, are

redoubling our efforts to make
quality branded pharmaceutical

THIS IS
products accessible to more
people in the country. We
launched 21 new products

ABBOTT INDIA
this year and are gearing up to
introduce over 100 new products
SX^ROXOb^ `OcOK\]9_\
efforts to spread education and
awareness about various diseases
are also intensifying. Our
knowledge sharing initiatives
WE PROVIDE TOMORROW’S with Healthcare Professionals -
doctors, medical fraternities and
HEALTHCARE SOLUTIONS TODAY pharmacists - are also expanding.
AND CONTINUE TO OUTPERFORM Our commitment to helping
people unlock life’s possibilities
through the power of health
\O
OM^ONSX630/>9>2/
0?66/=>S]KMYWWS^WOX^^RK^
is intrinsically aligned with a
prosperous and healthy India.

MUNIR SHAIKH
Chairman

Abbott India Limited | Annual Report 2017-18 | 5

Dear Shareholders,
We, at Abbott India, have always worked with a
N_KVPYM_]x>RO \]^S]Y_\WS]]SYX^YROVZZOYZVO
lead healthier and better lives and the second is to
continuously reward our shareholders by excelling
SXY_\ XKXMSKVKXNL_]SXO]]ZO\PY\WKXMOCY_\
Company successfully accomplished both these
objectives. Once again, we achieved a remarkable
Sales growth of 12.8% over the prior year, which
was 1.6 times# the market growth.
As I look back, this was a landmark year for
economies across the globe and India. As per
the IMF, the world economy posted a growth
of 3.8% in 2017, with a notable rebound in global
trade. At US $2.6 trillion, the Indian economy
became the sixth largest in the world. The
country is well positioned to accelerate its growth
^Y!SX^ROM_\\OX^ ]MKVKXN^Y!"XOb^
year, as it recovers from the twin impacts of
demonetisation and GST roll out.
The Indian Pharmaceutical Market is estimated
to be about 3.3% of the global Pharmaceutical
Industry in value and 10% in volume. This
is expected to grow to US $55 billion by
2020, thereby emerging as the sixth largest
pharmaceutical market globally.
TOTAL REVENUE
(` IN CRORES)
OM^ONSX630/>9>2/ high-potential therapy areas while maintaining
3,424
2,996
2,696
2016 2017 2018
6 | Abbott India Limited | Annual Report 2017-18
>RO1Y`O\XWOX^YP3XNSKRK]^KUOX]SQXS MKX^
steps towards the promotion of this industry in
India. ‘Pharma Vision 2020’ aims at making India
a global leader in end-to-end drug manufacture.
Approval time for new facilities has been reduced
to boost investments. The single-window facility
has been announced to expedite new drug
approvals and is expected to give a push to the
“Make in India” initiative.
During the year, all our business units performed
well and contributed to the overall success of the
Company. Eight out of our top ten products
remained at No 1* in their respective therapy
segments and these ten products contributed to
over 70% of the core business.
CY_\.S\OM^Y\]RK`OZ\YZY]ONK XKVNS`SNOXNYP
`50 and special dividend of `5 per equity share of
`10 each for the year ended March 31, 2018.
We, at Abbott India, are redoubling our efforts to
make quality branded pharmaceutical products
accessible to more people in the country. We
launched 21 new products this year and are
gearing up to introduce over 100 new products
SX^ROXOb^ `OcOK\]9_\OPPY\^]^Y]Z\OKN
education and awareness about various diseases
are also intensifying. Our knowledge sharing
initiatives with Healthcare Professionals -
doctors, medical fraternities and pharmacists -
are also expanding. Our commitment to helping
people unlock life’s possibilities through the
ZYaO\YPROKV^R\O
Chairman
FULLEST. - is a commitment that is intrinsically
aligned with a prosperous and healthy India.
In order to deepen our patient commitment,
we are foraying into sub-therapies within our
established therapeutic domains. Our beyond-the-
pill orientation is aimed at giving much more than
just medicine to our customers.
Our emphasis is on creating a sustainable growth
blueprint, which is futuristic and viable. Our
constant focus on innovation, diversifying the
product portfolio, maintaining brand excellence,
technology driven initiatives and value-added
#
core business
* Source: IMS Health
knowledge sharing initiatives will further
strengthen your Company’s positioning as a
committed, capable and compassionate organisation.
` 3,424
crores
` 401
crores
CY_\-YWZKXc^\_Vc`KV_O]S^]OWZVYcOO]AO
TOTAL PROFIT
have an employee pool of over 3,300 talented
REVENUE AFTER TAX
and committed workforce, which is one of our
most valuable assets. Their hard work and
commitment has helped the Company to push
all boundaries and stay ahead of the curve, even
in a very volatile and competitive environment.
Altogether, we have a holistic approach towards 11.7% 26.1%
growth, development, health and wellness. PAT (% OF RETURN ON
REVENUES) AVG CAPITAL
EMPLOYED
I am proud to announce that your Company
also won several prestigious awards this year
including the most prestigious “Best Companies
To Work For” by Business Today.
On behalf of the entire Board, I thank all our valued
We sincerely recognise the contributions of our
partners – our bankers, doctors, pharmacists and
business partners and continue rewarding them
vendors who have always been very supportive and
SX`K\SY_]aKc]0Y\SX]^KXMOaOaO\O^RO \]^
important contributors to our success.
company to compensate our stockists to cover their
losses on account of transition to GST, thereby also
I am also thankful to all members of the Abbott
ensuring continuous availability of medicines at
family - our customers, employees and above all,
the market place. Such initiatives help us build long
our shareholders who have continued to place
lasting relationships with our business partners.
faith in the Management of the Company.
Next year will mark the completion of 75 years
of your Company in India - another landmark in
our history. We have once again developed strong
strategies to ensure our business continues to
outperform. Our focus remains on entering new, MUNIR SHAIKH
leadership in the areas we dominate. We will
continue to push in under leveraged geographies
and rural markets and remain committed to be
responsive and agile.
With deep regret, we inform you about the
untimely demise of Mr Ranjan Kapur. We
]SXMO\OVcKZZ\OMSK^ORSWPY\RS]]SQXS MKX^
contributions. Mr Bhasker Iyer and Ms Nancy
Berce resigned as Directors upon their
retirement from Abbott. We thank them for their
contributions and wish them good health and
success in their future endeavours. We welcome
Ms Anisha Motwani and Mr Jawed Zia, who
have recently joined the Board.
Abbott India Limited | Annual Report 2017-18 | 7
 MANAGING
Try the augmented
experience on this page
through the AR app.

DIRECTOR’S
MESSAGE
PLAYING ON A STRONG WICKET

PUSHING
BOUNDARIES,
STAYING AHEAD Our Sales growth of 12.8% was driven by multiple
L_]SXO]]SWZO\K^S`O]>RO \]^KXNPY\OWY]^aK]
restructuring our product portfolio into key
business areas – Women’s Health, Gastroenterology,
Consumer Care, CNS, Metabolics, General Care and
Vaccines. Among these, Women’s Health grew by
19.1%, Vaccines grew by 59.7% and Metabolics grew
by 15.3%.

AMBATI VENU
Managing Director

8 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 9
Dear Shareholders,
OM^ONKQ\Ya^RYPKLY_^Y`O\^RO As we set our eye on the future, rapid inroads into
The promise of enabling fuller, healthier lives
is worth pursuing in every possible way, every
single day. At Abbott India, we continue to
SX^OX]SPcY_\MYWWS^WOX^^YP_V V^ROZ\YWS]OYP
human potential by helping people achieve their
best health at every stage of their life. We have
had yet another year of excellent performance
and I am happy to share the highlights with you
through this Annual Report 2017-18.
Powerful business performance
We know how to deliver high-quality healthcare,
and our heritage is proof that we are committed
for the long-term. Our Sales growth of 12.8% was
driven by multiple business imperatives. The
\]^KXNPY\OWY]^aK]\O]^\_M^_\SXQY_\Z\YN_M^
portfolio into key business areas – Women’s Health,
Gastroenterology, Consumer Care, CNS, Metabolics,
General Care and Vaccines. Among these, Women’s
Health grew by 19.1%, Vaccines grew by 59.7% and
Metabolics grew by 15.3%. Clearly, the foundation of
our business, is our brands and our people.
Our brands are trusted by millions of patients
and doctors across therapies. All our key brands
have shown strong growth during the year and
continue to lead in the market place.
BUSINESS DIVISIONS*
_OXdK7+3MKWZKSQX
Women's Health & Gastrointestine (WH & GI),
Gastroenterology, GI Prospera and GI Advance
Specialty Care (Metabolics and
Central Nervous System)
_`KM 9_\ZYaO\P_V^OKW]LY^RSX^RO OVNKXNhead
GenNext and
Vaccines
Consumer Care
*The Company operates in a single reportable segment i.e. Pharmaceuticals.
10 | Abbott India Limited | Annual Report 2017-18
Relentless drive
We continued to take on the mantle of launching
market shaping initiatives in collaboration
with cross-industry players and technology
partners, even when we encountered challenging
circumstances on a few fronts.
In less than 8 months, the Indian economy
encountered two powerful disruptors, both of
which would go on to become positive enablers
of economic growth and formalization, but we
emerged stronger with renewed focus on core
operational excellence. We introduced multiple
\]^SXSXN_]^\cWY`O]KXNMY_X^O\WY`O]^RK^
ensured that economic changes did not come in
the way of expectations.
We have an endless drive to bring meaningful
innovation to our markets – in both medicines
and the services that go along with them – to help
people live healthier, fuller lives. We give people
a reason to choose our medicines, and this model
has led to consistent, exceptional growth.
At Abbott India, our 360 degree efforts to further
and fortify our brand leadership in the chosen
therapies helped us deliver another market
beating performance in the year gone by. At
`3,424 Crores, our Total Revenues grew by 14.3%.
Key Brands
Duphaston | Udiliv
Cremaffin | Duphalac |
Creon | Heptral
Thyronorm | Vertin
Prothiaden
DYVP\O]Rf3X
Enteroshield | Brufen
Arachitol Nano
Digene | Citrosoda |
Rashfree
+8O^:\Y ^YP`401 Crores, our highest ever Future-Focused
Z\Y ^\O
previous year. With our relentless efforts and
sub-therapies, accelerated new product launches,
differentiated approach, we consistently remain
innovative marketing and deployment of digital
ahead of the market.
tools, steady deepening of relationships with
the doctor, pharmacist, patient trio, continued
/X\SMRSXQ^ROVS`O]YPY_\ZK^SOX^] strengthening and expansion of our brand
We continued our engagement with patients. portfolio, and the collective living of a shared
During the last year, we were able to vaccinate vision by an over 3,300 strong employee pool,
over 20 Lakh people against Swine Flu and will continue to be the central levers of our
conducted Thyroid screening for over 21 Lakh growth momentum.
people pan-India.
I thank you for your continued trust and
Real Film. Real Heroes MYX NOXMOSXY_\KLSVS^SO]3MYXQ\K^_VK^OY_\
Abbott India family on scripting another stellar
We also continued to strengthen our brand identity,
ZO\PY\WKXMOSX0C!"KXN^RKXUWcPOVVYa
through our much appreciated campaign “Real
board members for their valuable guidance
Film. Real Heroes”, depicting how breakthrough
and contributions. The future looks even more
innovations from Abbott have helped people
exciting and promising to me and I seek your
live fuller and healthier lives. The campaign,
support to co-create a healthier India and a
coupled with our value-added knowledge sharing
value-creating company.
initiatives, has ensured that the Company
remains at the forefront with consumers and
Healthcare Professionals.
Beyond Pills
We are here to help people lead fuller, healthier AMBATI VENU
lives. And in this mission, it is imperative for us to Managing Director
gain patient insights. We also leverage technology
to connect and engage with various stakeholders.
Notable initiatives include Thyroweight, the
country’s largest Thyroid Awareness program
where we reached 3.5 Crore people this year and
^RO7Y^RO\]KQKSX]^3X
that aimed at increasing awareness about the need
for vaccination. Another high impact campaign in
the year was breaking taboos with #Constipation
Conversations.
Strong and motivated workforce
YP MORK`OMYX^\SL_^ON]SQXS MKX^Vc^Y^RO
Company’s success. During the year, we
introduced various talent management and
leadership initiatives aimed at attracting and
retaining top talent and empowering them
through several development programs.
* Source: IMS Health
Abbott India Limited | Annual Report 2017-18 | 11
PUSHING
BOUNDARIES, 1
STAYING
ACCELERATED GROWTH DELIVERS
BUSINESS PERFORMANCE

AHEAD
Continuing tradition,
Abbott India has delivered
yet another strong business
ZO\PY\WKXMOSX0C!"
Total While overall revenue grew by 14.3% to `3,424 Crores in
Revenue 0C!", Z\Y ^Q\OaLcAORK`OLOOXKLVO^Y
` 3,424 grow at 1.6 times# the market, 8* of our top 10 brands are
Crores market leaders in their respective segments.

2
FUTURE-FOCUSED
We realise that the business OX`S\YXWOX^S]MRKXQSXQ\KZSNVcKXN^OMRXYVYQcS]\ONO XSXQRYa
we interact with people around us. Abbott India took an important step this year of ensuring a
technologically connected organisation with a plan to launch

iPADS Over
2,500 FIELD FORCE
FOR

Also, we facilitated better engagement with doctors and patients through technology-led innovative
solutions in the form of augmented reality and virtual reality.

We, at Abbott India, have always
challenged the limits of what is possible
and offered value through our products
and services. Our commitment remains
to help Indians lead healthier lives.
3
CULTURE OF COLLABORATION
Employees play a vital role in building an inclusive culture across our business operations. Various
training and leadership development programs were conducted during the year to help them maximise
their potential. The Company reached out to help the broader community through programs such
as the iCARE Road Safety Drive, Nirmal Dhara Dairy Project and SEWA, an initiative for creating a
Sustainable Healthcare Delivery Model through Livelihoods.
#
core business
* Source: IMS Health

12 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 13
 1
Accelerated Growth Delivers Business Performance

10 Year Financial Highlights All amounts in ` Lakhs, unless otherwise stated

PREVIOUS GAAP IND AS @

OPERATING RESULTS 2008 2009 2010(13M) 2011* 2012 2014 (15M) 2015 2016 2017 2018
TOTAL REVENUE# 701,21 795,93 1031,97 1528,07 1696,93 2358,39 2364,56 2696,23 2996,33 3424,11
MATERIAL COST 454,62 504,17 647,30 861,21 971,65 1297,41 1311,96 1492,03 1712,06 1904,74
EMPLOYEE BENEFIT EXPENSE 48,92 62,37 111,20 167,35 206,20 299,74 305,40 341,09 345,27 393,69
OTHER EXPENSES# 96,32 102,80 168,03 304,32 294,97 444,68 387,40 448,14 484,04 484,19
DEPRECIATION AND AMORTISATION 6,98 9,01 11,25 15,00 19,49 21,93 14,94 14,44 16,43 16,19
FINANCE COST 2 20 4 3 2 8 50 2,52 2,04 3,82
PROFIT BEFORE TAX AND EXCEPTIONAL ITEMS 94,35 117,38 94,15 180,16 204,60 294,55 344,36 398,01 436,49 621,48
EXCEPTIONAL ITEMS - - - - 10,39 - - - - -
PROVISION FOR TAXATION 31,49 39,87 33,21 59,77 70,29 96,10 115,40 142,76 159,84 220,26
PROFIT AFTER TAX AND EXCEPTIONAL ITEMS 62,86 77,51 60,94 120,39 144,70 198,45 228,96 255,25 276,65 401,22
EARNING PER SHARE - BASIC & DILUTED (`) 43.62 56.68 44.56 56.66 68.10 93.39 107.75 120.12 130.19 188.81
DIVIDEND PER SHARE (`) 14.00 17.00 17.00 17.00 17.00 23.00 31.00 35.00 40.00 55.00**

ASSETS EMPLOYED
FIXED ASSETS (NET) 50,63 49,15 50,57 80,02 109,18 99,52 99,95 111,29 115,88 83,55
OTHER ASSETS (NET) 171,38 222,41 254,82 464,12 537,68 688,33 837,58 1084,31 1271,06 1609,21
TOTAL ASSETS 222,01 271,56 305,39 544,14 646,86 787,85 937,53 1195,60 1386,94 1692,76
FINANCED BY
SHARE CAPITAL 13,68 13,68 13,68 21,25 21,25 21,25 21,25 21,25 21,25 21,25
OTHER EQUITY 207,57 257,88 291,71 522,89 625,61 766,60 916,28 1174,35 1365,69 1671,51
TOTAL EQUITY 221,25 271,56 305,39 544,14 646,86 787,85 937,53 1195,60 1386,94 1692,76
BORROWINGS 76 - - - - - - - - -
NUMBER OF SHAREHOLDERS 13,689 13,422 14,461 19,354 20,826 18,270 19,407 21,250 23,004 22,583
NUMBER OF EMPLOYEES 1,150 1,308 1,767 2,425 2,667 2,766 2,867 2,956 3,083 3,322
**Includes special dividend of `5/- per share.
* Post Merger with Solvay Pharma India Limited.
# Inclusive of Excise duty on sales / net of GST.
@
The Company transitioned into IND AS from April 1, 2015, hence these numbers are not comparable with previous years.

14 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 15
 1 DIVIDEND PER SHARE EMPLOYEE COST (` IN LAKHS)
Accelerated Growth Delivers Business Performance `55* ` 393,69
EARNING PER SHARE (`) EMPLOYEES (NOS)
55.00*
393,69

Key 35.00
40.00
341,09
345,27

Performance 31.00

188.81
305,40

Indicators

3,322
23.00

130.19

3,083
120.12

2,956
299,74

107.75

2,867
93.39

2,766
2014 2015 2016 2017 2018
(15M) 2014 2015 2016 2017 2018
*Includes special dividend of ` 5/- per share (15M)

RESERVES AND SURPLUS CONTRIBUTION TO

REVENUE GROWTH EBITDA MARGINS GROWTH# EXCHEQUER (` IN LAKHS)
14.3% 18.7% 22.4% ` 644,65
REVENUE (` IN LAKHS) EBITDA (` IN LAKHS) RESERVES AND SURPLUS (` IN LAKHS)
14.3% 18.7% 22.4%
11.1%
16.4%
14.0% 15.2%
15.4% 28.3%

25.3%* 15.2% 19.5%

1675,46
3424,11

641,49

644,65
2996,33

1368,57
11.2%* 13.4%
2696,23

454,96

499,81
1175,35
414,97
22.5%

437,23
2364,56

916,28
359,80

372,40
2358,39

316,56

766,60

350,25
2014 2015 2016 2017 2018 2014 2015 2016 2017 2018 2014 2015 2016 2017 2018
2014 2015 2016 2017 2018
(15M) (15M) (15M) (15M)
* Annualised percentage #Excluding Other Comprehensive Income (OCI)
RETURN ON AVG. CAPITAL
PAT MARGINS EMPLOYED BOOK VALUE GROWTH SHARE PRICE (AS AT MARCH 31)
11.7% 26.1% 22.1% `5,449
PAT (` IN LAKHS) AVG. CAPITAL EMPLOYED (` IN LAKHS) BOOK VALUE PER SHARE (`) MARKET CAPITALISATION ( ` IN LAKHS)
11.7% 22.1% 5,449
26.1%

16.0% 4,708
9.2% 21.4%
4,639
9.5% 27.7%
23.9%
9.7% 18.9% 3,948
26.5%

11578,96
401,22

1539,85

797

10003,11
1291,27
276,65

8.4%

653

9857,23
27.7%
255,25

1066,57

563
22.0% 1,753

8390,07
228,96

441
862,69
198,45

717,36

3724,47
371
2014 2015 2016 2017 2018 2014 2015 2016 2017 2018 2014 2015 2016 2017 2018
2014 2015 2016 2017 2018
(15M) (15M) (15M)
(15M)

16 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 17
 1
Accelerated Growth Delivers Business Performance VALUE ADDED STATEMENT FY 2017-18
@KV_OKNNONS]NO XONK]^RO`KV_OM\OK^ONLc^ROKM^S`S^SO]YPKL_]SXO]]KXNS^]OWZVYcOO]
(` in Lakhs)

Revenue STAKEHOLDERS 2017-18 2016-17

Distribution (%) Payment to Exchequer 644,65 499,81

Payment to Employees 393,69 345,27

Payment to Shareholders* 116,87 85,00

FY 2017-18
Total Revenue `3424,11 Lakhs Contribution to Society 9,12 7,14
RETAINED EARNINGS & OCI*
7.6 % Towards replacement and expansion# 275,43 188,90
TAX
6.4 %
DIVIDEND
Total Value Added 1439,76 1126,12
OTHER EXPENSES (Includes Dividend Distribution Tax)
14.0 % 4.1 %
*Dividend excluding Dividend Distribution Tax
#Replacement and expansion is Retained earnings + Depreciation
DEPRECIATION
0.5 % EMPLOYEE COST
11.5 %

MATERIAL COST
ENVIRONMENT CSR PEOPLE
55.6 %

EXCISE DUTY ON SALES

0.3 %

Goa Plant – Zero Waste Spend of Over

^Y6KXN VVSXZ_\`SOa
of waste disposal ` 9,12 6KUR] 3,300
FY 2016-17 employees
Total Revenue `2996,33 Lakhs
RETAINED EARNINGS & OCI*
Goa Plant received
u,O]^/X`S\YXWOX^KV
115.9%
of mandatory spend
Awarded ‘Best
6.0 % Companies to work for’
TAX Practices Award”
5.3 %
by Business Today
OTHER EXPENSES DIVIDEND Collaborated with 17
15.0 %
(Includes Dividend Distribution Tax)
3.4 %
Waste Management schools covering 18,823 <YL_]^ OVN^\KSXSXQKXN
DEPRECIATION
0.5 % EMPLOYEE COST
11.5 %
50%
Reduction in total waste
students, Over 15 Lakh
people connected through
iCARE Road Safety Drive
Leadership development
programs

MATERIAL COST
Various initiatives on
57.1 % Over 1,500 smallholder diversity and inclusion
Water Usage NKS\cPK\WO\]LOXO ^^ON such as Women Leaders

30%
EXCISE DUTY ON SALES
1.2 % through Nirmal Dhara of Abbott (WLA)
Dairy Program
Reduction in total 0VObSLVO,OXO ^]
water intake Program for Abbott
Employees
*Other Comprehensive Income (OCI)

18 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 19
 1
Accelerated Growth Delivers Business Performance PERFORMANCE OF TOP 10 BRANDS @

Therapy-leading BRAND MARKET SHARE (%)# RANK#

products 24.3 1

Abbott India stands for quality, trust and partnership. We deliver quality healthcare
through high-quality products. Our top 10 brands are leaders (at number 1 or
51.7 1
2 position* ) in their respective segments. Our relentless pursuit of invention is
delivering an unprecedented number of advances that will extend our impact and
sustain our growth for years to come.
15.1 2

29.8 1

9.5 2

13.7 1

##
14.4 1

51.4 1

34.8 1

7.3 1

@
Source : IMS Health
#In Respective Participated Market
##Digene Range

Disclaimer: All products displayed/mentioned on this page are for illustration purpose only. Consult your doctor for
*Source: IMS Health professional medical advice.

20 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 21
 2
Future-Focused
NEW PRODUCTS
PRODUCT THERAPY AREA BUSINESS UNIT
6K_XMRSXQXOaZ\YN_M^]^Y Polycystic Ovary Syndrome Women's Health

address unmet patient needs Ovulation Women's Health

Gut Health Gastroenterology

New products have not only been a source of growth for the business but have
addressed medical gaps in multiple therapy areas. In FY 2017-18 we launched Constipation Gastroenterology
21 new products / product extensions. This shows our commitment to expanding
our portfolios. We aim to continue this pace of growth in the future as well. NAFLD Gastroenterology

Lemon Flavour Laxative Gastroenterology

Diaper Rash Cream Consumer Care

Paan Flavour Antacid Consumer Care

Digestive Consumer Care

Laxative Consumer Care

Pain Relief Consumer Care

Constipation GI Advance

Irritable Bowel Syndrome GI Advance

Diarrhoea / Hepatic Encephalopathy GI Advance

ALD/NALD GI Advance

Hepatitis C GI Prospera

Pain Management in Chronic Pancreatitis GI Prospera

ALD/NAFLD GI Prospera

Probiotic (Bacterial Vaginosis) Metabolics

20 Migraine CNS

Stroke / Brain Injury CNS

Above new product launches also include line extensions. In addition to our new product launches,
we also upgraded the packaging for Creamaffin, Udiliv and Duphaston.

Disclaimer: All products displayed/mentioned on this page are for illustration purpose only. Consult your doctor for
professional medical advice.
22 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 23
 2
Future-Focused
SERVICE OPERATIONS
The plant continues to operate at a high service A number of operational improvements were

A safe, green and level. The Key Performance Indicator for service
is measured in terms of 'On Time In Full', which
undertaken at the plant to enhance productivity
KXNMY]^\ON_M^SYX0Y\^RO-\OWKP X\KXQO^RO

MY]^OP MSOX^ S]#"8Oa=5?]SX-\OWKP X?NSVS`KXN

Duphalac were launched. A key project underway
batch size was increased from 5.5KL to 10KL to
KMRSO`OYZO\K^SYXKVKXNMY]^OP MSOXMSO]AOKV]Y

manufacturing facility is to bring all tablet production in-house from

third party manufacturers.
SX]^KVVONXOa`YV_WO^\SMVS[_SN VVSXQWKMRSXO]
to improve performance and yields.

+LLY^^3XNSKt]1YKZVKX^\OMOS`ONK]SQXS MKX^_ZQ\KNOSX0C!">ROZVKX^S]M\S^SMKV Manufacturing facility at Goa

SXWKX_PKM^_\SXQYPUOcZ\YN_M^]]_MRK]-\OWKP X._ZRKVKM,\_POXKXN.SQOXO

TABLET
VOLUME
1,250 million
DOSAGE
FORMS
Tablets and
liquids

LIQUIDS
VOLUME
3,900 56
NUMBER
OF EMPLOYEES
171

WE FOCUSED ON FOUR CRITICAL AREAS FOR IMPROVEMENT –

SAFETY, QUALITY, SERVICE AND OPERATIONS

SAFETY
A number of safety initiatives such as disposal
of hazardous waste and sludge to Ultratech
cement factories for co-processing, a successful
Factory Mutual global inspection of safety
procedures and launch of ‘Stop for Safety’
program for creating awareness of safety among
employees were completed. The Goa plant is a
MO\^S ON]KPOaY\UZVKMOKXNRKNXY\OZY\^KLVO
or loss time incident during last 5 years.
QUALITY
The plant continuously strives to improve the
quality of products manufactured. A number
of licenses were renewed as well as audits by
WHO and Abbott Quality and Regulatory teams
aO\OMYXN_M^ON6S[_SN^KXU]aO\OWYNS ON
for better product management and skilled staff
were recruited for critical production equipment.
Lastly, a number of engineering updates were also
made to improve hygiene and work environment.

24 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 25
 2
Future-Focused
THYROWEIGHT
This campaign aims to increase awareness

Creating value through among women (in the age group of 25-40)
around the correlation between weight

differentiated services gain and thyroid disorders. A persona-led

integrated marketing communication plan
was deployed that aimed at easy and early
diagnosis for clinicians and patients and to
Abbott India has taken a leadership role in the industry in implementing patient
create more awareness amongst patients
awareness and doctor engagement programs. We use the latest technology tools
living with hypothyroidism.
and adopt innovative, integrated, omni-channel marketing strategies. These efforts
help our sales force create a unique positioning for Abbott India in the minds of our
stakeholders. Some of our notable projects in FY 2017-18 were:

GUTFIT

1_^0S^S]3XNSKt] \]^SX^OQ\K^ONVSPO]^cVO PARTNERSHIP

WYNS MK^SYXZ\YQ\KWKNN\O]]SXQQKZ]SX
WITH KEY OPINION
Gastrointestinal disease management.
6SPO]^cVOS]^RO \]^VSXOYP^\OK^WOX^PY\
13NS]Y\NO\]KXNROXMOaOSXNOX^S ON^RS]
LEADERS 500
framework. A comprehensive program was
ASSISTED
created, which enrolled high-risk patients
and provided them with virtual counseling,
wearable devices for tracking health metrics
PATIENTS 5.4
6KUR]
and customised diet plans.

TELEVISION
REACH
130 6KUR]

15
THERAPIES COVERED
PUBLIC RELATIONS
CONNECT 6KUR]

HEALTHCARE
PROFESSIONAL
REACH
0.26KUR]

TWITTER
VISITORS
120 6KUR]
CONSTIPATION FATTY LIVER ACIDITY IBS PANCREATITIS

AWARENESS | DIAGNOSIS | TREATMENT | COMPLIANCE

26 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 27
 2
Future-Focused
EXPERIENTIAL MARKETING
FOR DUPHASTON
NO. OF DOCTORS
REACHED
3
6KUR]

#MOMVSFLU
0.6
The complex process of manufacturing
PHYSICIAN
MOTHERS AGAINST Duphaston came alive through experimental
^OMRXYVYQcAO]O^_ZQKWS MK^SYXKXN`S\^_KV ENGAGEMENT
INFLUENZA CAMPAIGN reality experience zones at key conferences to
6KUR]

to allow participants to create the Duphaston

>RO7Y^RO\]+QKSX]^3X
_OXdK7+3MKWZKSQX molecule through the gaming console. We
was launched to make mothers aware of the also conceptualised an immersive story telling
need for vaccination, in order to protect the fetus experience using advanced mixed reality
and the new born till the age of 3 years against to travel through time and experience the
SX
_OXdK+]KZK\^YP^RS]MKWZKSQXSX
_OXMO\ invention process of Duphaston.
led (mother bloggers, women twitterati)
conversations, with information shared by
doctors, were started on digital media. We also
M\OK^ON]RY\^ VW]^RK^RSQRVSQR^^ROOPPOM^]YP

_SXMRSVN\OX

VERTIN HEAD
Vertin is our 50-year-old brand and is a
therapy leader in Vertigo management.
We designed Vertin Head, which is a pioneer
initiative, by using 3D Printing Technologies
TWITTER
IMPRESSIONS
510 6KUR]
to impart knowledge among patients about
various vestibular habituation therapy exercises
for better management of vertigo. The Vertin
Head helped doctors demonstrate detailed

46
information on how to perform various
UNIQUE PEOPLE excercises to patients in clinic.
REACH 6KUR]

28 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 29
 2
Future-Focused
LIGHT DELIGHTS –
CELEBRATING LOVE FOR FOOD
Choosing a healthy diet, especially low in lipids,
is essential for certain patients (such as IBS
patients) to ensure a healthy lifestyle. With tasty
_OXMO\VON
food playing a major role in diet decisions, we
reached out to help these patients by providing
SXOMKWZKSQXN\S`OXLc^ROMYWZKXc
them healthy low-lipid recipes. For this, we tied
up with a Michelin star chef, Vikas Khanna, who
penned a book with over 20 healthy low-lipid
food recipes from across India. This book, Light
Delights, was shared with over 2.7 Lakh patients.
#CONSTIPATION
CONVERSATIONS
Considering the need to make people feel
MYX NOX^KXNMYWPY\^KLVOKLY_^RK`SXQ
#ConstipationConversations, we engaged with
consumers through an omni-channel (print,
digital, mobile, onground) approach. We also
conducted an on-ground event and bloggers
meet, around #ConstipationConversations with
the celebrity therapy ambassador and women
LVYQQO\]%^RS]aK]PYVVYaONLcKXSX
(mom blogger) Tweet chat conversation, and
KXYP
A #FirstinPharma social experiment was
also created.

PANCRECARE
This is a Mobile App based interactive platform
to support patients who suffer from Pancreatic
/bYM\SXO3X]_P MSOXMc2OKV^RMK\O:\YPO]]SYXKV]
through this app, have access to monitor real
time patient health outcomes. Patients can get
counseling on diet and pain management.

FACEBOOK
IMPRESSIONS
15
6KUR]

TWITTER
IMPRESSIONS
350 6KUR]

TWITTER
VISITORS
32
6KUR]

30 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 31
 3
Culture of Collaboration
Creating a best-in-class
work environment
ONE ABBOTT WORKPLACE
Abbott employees spread across different
locations in Mumbai came under one roof in
^RO \]^[_K\^O\YP^ROcOK\>ROYP MORK]LOOX
coined as the One Abbott Workplace, with
OWZVYcOO]KM\Y]]KVVNS`S]SYX]KXNYP MO]SX
Mumbai now being able to collaborate closely
with each other. This initiative is viewed as a
]SQXS MKX^Z\YN_M^S`S^cOXRKXMOWOX^WY`O
32 | Abbott India Limited | Annual Report 2017-18
FLEXIBLE BENEFITS PROGRAM
Abbott India provides a wider bouquet YPLOXO ^]
for employees. Employees have the choice to
NOMSNO^ROS\YaXLOXO ^]P\YWKWK]^O\VS]^
according to their needs at their life stages, and
L_c^RO]OLOXO ^]aS^RZYSX^]Y\^YZ_Z
with cash.
Abbott India instituted multiple initiatives to improve the work environment and
provide a better workplace for employees. Our goal is to enhance workplace productivity
and provide adequate motivation to employees to excel in their day-to-day activities.
WOMEN LEADERS OF ABBOTT BETTER DETAILING AND
(WLA) CONNECTIVITY
Abbott India's WLA employee network helps Another key initiative and investment made by
female employees to : Abbott India has been the launch of the iPad
Z\YQ\KWaRO\O OVNOWZVYcOO]aSVVLOO[_SZZON
INSPIRE with 6th generation iPads. This technological
Meaningful and enabling work advancement ensures that our employees are
environment better connected with one another and can
use some of the latest tools to engage with our
customers. This also enables us to move to a
CONNECT paper-free doctor detailing model with enhanced
That is all about creating engaged and
interactivity for better communication.
inclusive work culture
GROW
Enriching the gender
diversity ratio
Abbott India Limited | Annual Report 2017-18 | 33
 3
Culture of Collaboration

At Abbott India, we believe that the driving force of our business is its people.

Shaping future >RO2_WKX<O]Y_\MO2<^OKWRK]L_SV^]ZOMS MZ\YQ\KW]aRSMROXMYWZK]]^ROOX^S\O

employee lifecycle; attracting best talent and retention via career management, rewards

leaders and development across all cadres. Some of the initiatives undertaken in FY 2017-18 include:

IN-STRIDE MANAGEMENT TRAINING /bOM_^S`O:\YQ\KWSX=KVO]7K\UO^SXQ TRACKS

The In-Stride program is aimed at strengthening
the leadership pipeline towards senior leadership
positions (quality and quantity). This ensures
business continuity for high potential talent
through simulations, e-Learning, group
mentoring, individual stretch assignments
and mentorship.
LEADERSHIP
PROGRAMS
CREATING LEARNING
OPPORTUNITES
IN COLLABORATION WITH
IIM-CALCUTTA
8Ob^1OX6OKNO\]RSZ:\YQ\KW816:
In line with our Employee Value Proposition
(EVP) of providing best-in-class exposure,
access and accelerated development for high
performers, we launched a Professional
Development Program in Sales & Marketing
for our First Line Managers called
Next Generation Leadership Program.
This included a tie up with IIM-Calcutta,
one of India’s Best B-Schools, for a 9-month
MO\^S MK^SYXZ\YQ\KWSX=KVO]KXN7K\UO^SXQ
3^S]^RO \]^YPS^]USXNZ\YQ\KWSX^RO
healthcare industry in India.
/:=7
We also launched an Executive Program in Tracks is a sales force career development
Sales and Marketing from IIM Calcutta for high framework to source talent internally and establish
potential Second Line Managers. This is an open a career path for key functions/roles. It provides a
program and mode of delivery is through an
clear and objective guideline for career movements
interactive online learning platform.
along with cross-functional exposure to build
leadership skills.
MANAGEMENT TRAINEE
PROGRAM
At Abbott India, our emphasis on building a key
differentiator via our marketing practices and
OPPY\^]S]YP]SQXS MKX^`KV_OAS^R^ROSX^OX^YP
building a future-ready talent pool of marketers
we have redesigned the ‘Management Trainee
Program’ targeting the premier MBA colleges
in India.

34 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 35
 3
Culture of Collaboration

Board of Directors
MUNIR SHAIKH AMBATI VENU JAWED ZIA KAIYOMARZ MARFATIA
Chairman Managing Director 8YX/bOM_^S`O.S\OM^Y\ 8YX/bOM_^S`O.S\OM^Y\

ANISHA MOTWANI R A SHAH KRISHNA MOHAN SAHNI RAJIV SONALKER

Independent Director Independent Director Independent Director CFO and Whole-time Director

Ranjan Kapur, Independent Director

With deep regret and profound grief, we report the sad and untimely demise of
Mr Ranjan Kapur. The Company places on record its sincere appreciation for the invaluable
contributions and guidance received from him towards the progress of the Company.

36 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 37
 3
Culture of Collaboration
Key
Management
Team
Left to Right :
Milind Tendulkar,
Ramanathan V,
Dr Sripupa Das,
Rajiv Sonalker,
Sandeep Khandelwal,
Nitu Bhushan,
Mahadeo Karnik,
Ambati Venu,
Burjor Dadachanji,
Krupa Anandpara,
Dr Vijay Patil
AMBATI VENU
Managing Director
Venu comes with over
25 years of experience in
GlaxoSmithKline Consumer
Healthcare (GSK Consumer)
in various leadership positions
across the Indian sub-continent,
Middle East, North Africa and
Asia. His last role till September
2015 was Regional Vice
President & General Manager –
Asia, GSK Consumer.
MILIND TENDULKAR SANDEEP
Commercial Director - KHANDELWAL
GenNext and Vaccines
Milind has over 27 years
of experience in Sales and
Marketing. Prior to joining
Abbott India, he was associated
with Abbott Healthcare, Zydus
Cadila, Emcure and Ipca Labs.
38 | Abbott India Limited | Annual Report 2017-18
RAJIV SONALKER
CFO and Whole-time
Director
Rajiv has over 29 years
of experience in the
Pharmaceutical, FMCG and
Engineering industries. Prior to
joining Abbott India, he worked
with Bristol-Myers Squibb as
Director – Finance. He was also
associated with Voltas, Johnson
4YRX]YX=KXY +`OX^S]SX
India and Germany.
Commercial Director
- Women’s Health,
Gastroenterology,
GI Prospera, GI Advance
and Consumer Care
Sandeep has over 14 years of
experience in the Consumer
Products Industry. Prior to
joining Abbott India, he worked
with Marico as Head-Sales for
Nature and Personal Care.
RAMANATHAN V
Commercial Director -
Specialty Care
Ramanathan has over 21 years
of experience in Sales and
Marketing in companies such
as Dr. Reddy’s Laboratories,
Ranbaxy and Zydus Cadila.
Prior to joining Abbott India,
he worked with Zydus Cadila
as Vice President – Sales and
Marketing of the Cardiva
division.
BURJOR
DADACHANJI
Commercial Director -
-YWWO\MSKV/bMOVVOXMOKXN Nitu has over 14 years of
International Business experience in human resources
Burjor has over 14 years of
diverse experience across
pharma, management
consulting, banking and
operations. Prior to joining
Abbott India, he was associated
with Abbott Healthcare,
The Boston Consulting Group
and JPMorgan Chase.
KRUPA ANANDPARA
Associate Director -
Secretarial & Company
Secretary
Krupa has over 16 years of
experience and expertise in
handling company secretarial
compliance streams. Prior
to joining Abbott India, she
worked with Borosil Glass
Works and Wimco.
NITU BHUSHAN
Director - Human
Resources
across organisations such
as Asian Paints, HSBC and
Mondelez International
(formerly Cadbury India). In her
last role, she worked as Head
– Talent Acquisition, India,
Indonesia, Philippines, Japan
and ANZ with Mondelez.
MAHADEO KARNIK
Director - Finance
Mahadeo has over 20 years of
experience, in Finance. Prior
to joining Abbott India, he
was associated with Roche
Diagnostics, Unilever and
United Phosphorus.
Abbott India Limited | Annual Report 2017-18 | 39
DR SRIRUPA DAS
Director – Medical Affairs
Dr Das has over 15 years of
experience in Medical Research,
Clinical Research and Drug
Development. Prior to joining
Abbott India, she was associated
with Fresenius Kabi, Lupin and
Sun Pharma.
DR VIJAY PATIL
Associate Director – New
Product Introductions and
Therapy Area Strategy
Dr Patil has over 34 years of
experience in Pharmaceuticals
KXN>OMRXSMKV OVN:\SY\^Y
joining Abbott India, he was
associated with Schering Plough,
Fulford, Aventis, German
Remedies and Novartis.
 3
Culture of Collaboration NIRMAL DHARA DAIRY In 2017, iCARE Road Safety Drive also extended
PROGRAM its reach by collaborating with 17 schools to
educate 18,823 students on pedestrian safety and

Working with India is the world’s largest producer of milk,

and nearly half of rural households depend on
road safety awareness.

communities to build dairy farming for at least part of their income.

a better India
Abbott India is engaged with multiple community support programs. Right from
helping farmers earn a better livelihood to imparting road safety awareness and
helping Indians lead safe lives.
Despite this, many dairy farmers continue to be
marginalized, limited by middlemen and lack
of technology and methods to produce higher
quality milk for a better price.
Working with Prabhat, a local dairy supplier, and
>OMRXY=O\`OKXYXZ\Y ^Y\QKXSdK^SYXaORK`O
directly reached out to nearly 1,500 smallholder
dairy farmers, half of whom are women, in
Maharashtra and Gujarat. We developed the
infrastructure required to expand capacity for
milk production and delivered robust training on
topics ranging from the basics of ensuring high-
quality milk to technical dairying skills.
AOKV]Y\_X^\KSXSXQ]]ZOMS MKVVcPY\aYWOX
farmers and have established transparent
pricing mechanisms.
iCARE ROAD SAFETY DRIVE
India has one of the worst records of road
safety in the world. Road Safety has been a part
of Abbott’s global focus, targeted at avoiding
accidents and improving lives. Abbott’s iCARE
Road Safety Drive is geared towards spreading
awareness about road safety measures to prevent
road accidents and save lives.
IMPROVING ACCESS TO
QUALITY AND AFFORDABLE
HEALTHCARE
Abbott India has initiated a project in partnership
with SEWA (Self-Employed Women’s Association)
to improve access to quality healthcare in
India. This program aims to improve health
outcomes, generate livelihoods and create an
ecosystem with all stakeholders and key partners
(Doctors, Pharmacies, Labs), while ensuring both
affordability of services for SEWA members,
K]aOVVK]K XKXMSKVVc]_]^KSXKLVOROKV^RMK\O
ecosystem.
The program will educate SEWA members
on various health conditions while training
community healthcare workers on providing
consistent, community-based care. It will
KV]YSWZ\Y`OKMMO]]^Y[_KVS ONNYM^Y\]KXN
pharmacies in order to develop a healthcare
ecosystem to provide quality and affordable
healthcare facilities and eventually improve
health-seeking behaviour in communities.

Over the years, we have reached more than

15 Lakh people through this initiative. In 2017,
more than 3,000 members of our workforce
educated people they met in medical clinics,
hospitals and schools about safe driving practices.
They used this opportunity to share simple,
actionable steps for reducing road accidents and
injuries, like wearing a helmet and a seat belt,
staying alert, obeying speed limits and avoiding
mobile phone use while driving.

40 | Abbott India Limited | Annual Report 2017-18 Abbott India Limited | Annual Report 2017-18 | 41
 3
Culture of Collaboration

Awards &
Recognition
Abbott India continues to receive recognition from multiple industry bodies and leading
media organisations. We also received multiple awards for excellence at a brand level. AWACS AWARDS IN
BUSINESS TODAY MARKETING EXCELLENCE
‘Best Companies to Work For’
NO.1 BRAND OF THE YEAR
(GOLD)
Udiliv

FIRST RUNNER UP (SILVER)

Duphaston

BEST USE OF TECHNOLOGY

for Training Excellence in The Production
of Learning Content

SILVER FOR DIGITAL

MARKETING EXCELLENCE
for Abbott India Radio

GOA STATE POLLUTION

BEST MARKETING CONTROL BOARD
CAMPAIGN
#Constipation Conversations Goa Plant - “Best Environmental
Practices Award”

Abbott India Limited | Annual Report 2017-18 | 43

ABBOTT
ABBOTT INDIA
INDIA LIMITED
LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

BOARD OF DIRECTORS REPORT

AND MANAGEMENT DISCUSSION AND ANALYSIS
TO THE MEMBERS MANAGEMENT DISCUSSION AND ANALYSIS OPPORTUNITIES AND THREATS REVIEW OF OPERATIONS
Your Directors have pleasure in presenting their Seventy-fourth ECONOMIC OVERVIEW >RO PYVVYaSXQ PKM^Y\] K\O VSUOVc ^Y SWZKM^ ^RO 3:7 SX ^RO XOb^ Financial Performance
Annual Report and the Audited Financial Statements of the
-YWZKXcPY\^RO XKXMSKVcOK\!" IX ^RO 3X^O\XK^SYXKV 7YXO^K\c 0_XNt] 370 +Z\SV " AY\VN POacOK\]$
Total Revenue
/MYXYWSM9_^VYYU3XNSKt]Q\Ya^R\K^OS]Z\YTOM^ON^YLO!SX
FINANCIAL HIGHLIGHTS " KXN !" SX # >RO VK^O]^ O]^SWK^O ]OO] 3XNSK \OOWO\QO w Draft Pharmaceutical Policy, 2017 - >RO +_Q_]^ ! >Y^KV<O`OX_OPY\^ROcOK\OXNON7K\MR"S]` "#
(` in Lakhs) K] ^RO PK]^O]^ Q\YaSXQ OMYXYWc Y_^ZO\PY\WSXQ Y^RO\ OWO\QSXQ \OVOK]O YP ^RO N\KP^ ZYVSMc Z\OZK\ON Lc ^RO .OZK\^WOX^ YP 6KUR] `S]K`S] ` ##  6KUR] VK]^ cOK\ \OMY\NSXQ K \YL_]^
Particulars For the year ended For the year ended WK\UO^]]_MRK]-RSXK<_]]SKKXN,\KdSV :RK\WKMO_^SMKV] ]O^] Y_^ UOc YLTOM^S`O] ]_MR K] SXM\OK]SXQ Q\Ya^RYPY`O\^ROZ\O`SY_] XKXMSKVcOK\
March 31, 2018 7K\MR! 3XNSKt] Q\Ya^R RK] \OMY`O\ON P\YW ^RO ^OWZY\K\c NSZ ZY]^ ^RO KMMO]] K^ KPPY\NKLVO Z\SMO] PY\ O]]OX^SKV N\_Q] WKXNK^Y\c
Net Sales 3273,90.01 #! ! SWZVOWOX^K^SYX YP ^RO 1YYN] KXN =O\`SMO] >Kb 1=> VK]^ 4_Vc 8O^ =KVO] PY\ ^RO XKXMSKV cOK\ !" Q\Oa Lc " Y`O\ ^RO
,SY+`KSVKLSVS^c KXN ,SY/[_S`KVOXMO ,+,/ ^O]^] PY\ KVV
Other Operating Income 33,22.16   KMRKXQO^RK^S]ObZOM^ON^YVOKN^YOK]OSXNYSXQL_]SXO]]KXN Z\O`SY_] cOK\ ^Y ` !# 6KUR] KX SXM\OK]O YP ` !
N\_QWKX_PKM^_\SXQZO\WS]]SYX]LcMOX^\KVY\]^K^O\OQ_VK^Y\]
Other Income L\YKNOXSXQYP^RO^KbLK]O^R\Y_QRMYX`O\]SYXYP3XNSKSX^YYXO 6KUR]N\S`OXWKSXVcLc`YV_WO]
116,98.72 ! " KXNOX]_\SXQ^RK^KVVWKX_PKM^_\SXQ_XS^]KNYZ^A2917:
Total Income 3424,10.89 ##  MYWWYXWK\UO^
KXN16:]^KXNK\N] Other Income
:\Y ^,OPY\O>Kb 621,48.26  #! >RO37=2OKV^R7K\UO^:\YQXY]S]<OZY\^RSQRVSQR^ON^RK^\S]SXQ
:\Y ^+P^O\>Kb 401,21.78 !  "" Z\S`K^OMYX]_WZ^SYXPY\OMK]^ON^YQ\YaK^"aSVVLO^ROQ\OK^O]^ w Price Controls - :\SMO] aSVV \OWKSX _XNO\ Z\O]]_\O K] ^RO >RO]SQXS MKX^SXM\OK]OSX9^RO\3XMYWOS]WKSXVcYXKMMY_X^YP
MYX^\SL_^SYX^YQ\Ya^R7Y\OY`O\K]^RO#OVOM^SYXKZZ\YKMRO] scope of price controls increased under the Drug Price Control SXMYWOQOXO\K^ONP\YWK]]SQXWOX^YP^\KNOWK\U]KWY_X^SXQ^Y
Retained Earnings and
Other Comprehensive 1Y`O\XWOX^]ZOXNSXQS]ObZOM^ON^YSXM\OK]O ` 6KUR]
+WOXNWOX^ 9\NO\ .:-9 PYVVYaSXQ ^RO _ZNK^O YP ^RO
Income (OCI) 3XNSKt] ZYZ_VK^SYX Q\Ya^R \K^O S] ObZOM^ON ^Y ]VYa KV^RY_QR ^RO 8K^SYXKV 6S]^ YP /]]OX^SKV 7ONSMSXO] 86/7 -_\\OX^Vc # 3X^O\O]^YXSX^O\MYWZKXcVYKX^Y+VO\O7ONSMKV:\S`K^O6SWS^ON
,KVKXMOL\Y_QR^PY\aK\N 1047,45.13 ""#" X_WLO\] aSVV ]^SVV Q\Ya Lc KVWY]^ !! WSVVSYX Lc  ^Y \OKMR
^RO\KZO_^SMMVK]]O]K\OMY`O\ONLc^ROVS]^3^S]ObZOM^ON^RK^ 3XNSK KWY_X^SXQ ^Y `  6KUR] S] KV]Y SXMV_NON SX 9^RO\
:\Y ^+P^O\>Kb 401,21.78 !  "" LSVVSYX
P_^_\O \O`S]SYX] YP 86/7 aSVV OX]_\O Z\SMO MYX^\YV] K\O XY^ 3XMYWO
OCI arising from
INDIAN HEALTHCARE ENVIORNMENT NSV_^ON>RO.OZK\^WOX^YP:RK\WKMO_^SMKV]S]KV]YKWOXNSXQ
re-measurement of (1,07.64) "!  >RO -YWZKXc MYX^SX_ON ^Y SX`O]^ SX bON NOZY]S^] aS^R ,KXU]
OWZVYcOOLOXO ^] IX3XNSKKV^RY_QRROKV^RMK\OS]Z\Y`SNONLcKWSbYPLY^RZ_LVSM ^RO.:-93^S]VSUOVc^RK^]YWOYP^ROKWOXNWOX^]aSVVZY]O
KXN Z\S`K^O PKMSVS^SO] S^ S] ^RO Z\S`K^O ]OM^Y\ ^RK^ KMMY_X^] PY\ RK`SXQ RSQR M\ONS^ \K^SXQ] aS^R K `SOa ^Y ]KPOQ_K\NSXQ ^RO
.S`SNOXN0C ! (84,99.72) - P_\^RO\MRKVVOXQO]^Y^ROSXN_]^\c Z\SXMSZKV KXN WKSX^KSXSXQ VS[_SNS^c 3XMYWO P\YW ,KXU .OZY]S^]
!" YP Y_^ZK^SOX^ MK\O KXN   YP SXZK^SOX^ MK\O
.S`SNOXN0C - !!  >RO PONO\KV 7SXS]^\c YP 2OKV^R KXN 0KWSVc AOVPK\O 7920A Q\OaLc"3X`O]^WOX^]^\K^OQcS]\O`SOaONZO\SYNSMKVVcLc^RO
-Y\ZY\K^O.S`SNOXN>Kb (17,30.34) 
w National Health Protection Scheme - +c_]RWKX ,RK\K^
S] \O]ZYX]SLVO PY\ P\KWSXQ KXN MYY\NSXK^SXQ ROKV^RMK\O ZYVSMc 0SXKXMO-YWWS^^OO>RO-YWZKXcRK]KXSX`O]^WOX^ZY\^PYVSYYP
>\KX]PO\^Y<O]O\`O] aRSVO ]^K^O KXN NS]^\SM^ K_^RY\S^SO] Y`O\]OO ^RO KNWSXS]^\K^SYX S] 8K^SYXKV 2OKV^R :\Y^OM^SYX =MROWO aRSMR S] KWLS^SY_]Vc
(40,12.18) ! # ` #"!6KUR]K]K^7K\MR"
Balance carried forward 1305,17.03 ! KXNNOVS`O\cYP]O\`SMO]^Y^ROS\ZK^SOX^ZYZ_VK^SYX].OZK\^WOX^ KSWSXQ^YOb^OXNROKV^RSX]_\KXMOMY`O\KQOYP_Z^Y`6KUR
YP:RK\WKMO_^SMKV]7SXS]^\cYP-ROWSMKV]KXN0O\^SVSdO\]P\KWO] ZO\ PKWSVc ZO\ KXX_W ^Y Y`O\  -\Y\O PKWSVSO] P\YW ^RO Material Cost
INDIAN ACCOUNTING STANDARDS (IND AS) KXNSWZVOWOX^]\OQ_VK^SYX]PY\3XNSKX:RK\WKMO_^SMKV]3XN_]^\c `_VXO\KLVOKXN_XNO\Z\S`SVOQON]OM^SYX]YP]YMSO^cO[_K^SXQ
EPPOM^S`O +Z\SV    ^RO -YWZKXc RK] KNYZ^ON KVV ^RO 3XN += +XOa8K^SYXKV2OKV^R:YVSMcZ_LVS]RONSX7K\MR!MKVV]PY\KX >ROSWZ\Y`ON]KVO]WSbKXNWK\QSXKVQ\Ya^RSX]KVO]Z\SMO\OKVS]K^SYX
^Y K\Y_XN  -\Y\O LOXO MSK\SO] O[_S`KVOX^ ^Y  YP ^RO
=^KXNK\N] KXN ^RO KNYZ^SYX aK] MK\\SON Y_^ SX KMMY\NKXMO aS^R SXM\OK]OSXQY`O\XWOX^]ZOXNSXQYXZ_LVSMROKV^RObZOXNS^_\O^Y resulted in decrease in Material Cost as a percentage of Sales from
ZYZ_VK^SYX
3XN+=s0S\]^^SWOKNYZ^SYXYP3XNSKX+MMY_X^SXQ=^KXNK\N]t YP^RO1.:SXK^SWOLY_XNWKXXO\3^KV]YKSW]K^OX]_\SXQ #SX XKXMSKVcOK\ !^Y"SX^ROM_\\OX^cOK\
aS^R+Z\SVK]^RO^\KX]S^SYXNK^O>RO^\KX]S^SYXaK]MK\\SON SWZ\Y`ONKMMO]]KXNKPPY\NKLSVS^cYP[_KVS^c]OMYXNK\cKXN^O\^SK\c
out from Indian Accounting Principles generally accepted in India MK\O ]O\`SMO] >RO :YVSMc] _V^SWK^O VYXQ^O\W QYKV S] KMRSO`SXQ
w Uniform Code of Pharmaceuticals Marketing Practices
Employee Cost
K] Z\O]M\SLON _XNO\ =OM^SYX  YP ^RO +M^ \OKN aS^R <_VO ! YP _XS`O\]KV ROKV^R MY`O\KQO KXN S] `SOaON K] ^RO aY\VNt] VK\QO]^ (UCPMP) - ?-:7: M_\\OX^Vc `YV_X^K\c S] ObZOM^ON ^Y
^RO -YWZKXSO] +MMY_X^] <_VO]  31++: aRSMR aK] ^RO ROKV^RMK\OSXS^SK^S`OLc^RO]ROO\X_WLO\YPZY^OX^SKVLOXO MSK\SO] LOMYWOWKXNK^Y\c]RY\^Vc+WKXNK^Y\c-YNOS]ObZOM^ON^Y ARSVO ^RO -YWZKXc SXM\OK]ON S^] OWZVYcOO ]^\OXQ^R Lc !" ^Y
Z\O`SY_]1++: >RO 8K^SYXKV 6S]^ YP /]]OX^SKV 7ONSMSXO] 86/7 aRSMR aK] Z\Y`SNO K VO`OV ZVKcSXQ OVN KXN O^RSMKV WK\UO^SXQ Z\KM^SMO] ^RO/WZVYcOO-Y]^K]KZO\MOX^KQO^Y=KVO]RK]WK\QSXKVVc
\O`S]ONSX.OMOWLO\LcKNNSXQWY\ON\_Q]S]ObZOM^ON^Y]OO aY_VNLOPYVVYaONLcKVVMYWZKXSO] SXM\OK]ON P\YW # SX XKXMSKV cOK\  ! ^Y  SX ^RO
DIVIDEND
WY\OP\O[_OX^\O`S]SYX]KXNKNNS^SYX] M_\\OX^cOK\
CY_\.S\OM^Y\]\OMYWWOXNK XKVNS`SNOXNYP` KXN]ZOMSKV
w Increasing Digital Penetration - >RO ObZYXOX^SKV Q\Ya^R
dividend of ` ZO\/[_S^c=RK\OPY\^ROcOK\OXNON7K\MR INDUSTRY STRUCTURE AND DEVELOPMENT >RO SXM\OK]O SX /WZVYcOO -Y]^ Lc  Y`O\ ^RO VK]^ cOK\ S]
" YX # P_VVc ZKSN_Z /[_S^c =RK\O] YP `  OKMR SX^ROKNYZ^SYXYPWYLSVOKXNNSQS^KVWONSKaSVVMYX^SX_O^Y
>RO 3XNSKX :RK\WKMO_^SMKV 7K\UO^ 3:7 aK] O]^SWK^ON ^Y LO mainly due to merit increases and impact of change in monetary
>RO Z\YZY]ON NS`SNOXN SP KZZ\Y`ON K^ ^RO +XX_KV 1OXO\KV LOKXSWZY\^KX^^YYVPY\ZK^SOX^OXQKQOWOX^KXNKWONS_W^Y
` LSVVSYXSX!aS^RKQ\Ya^RYP,c3XNSKS]VSUOVc MOSVSXQPY\1\K^_S^c
7OO^SXQ aSVV KL]Y\L K ]_W YP `  "! 6KUR] :\O`SY_] cOK\ $ \KS]ONS]OK]OKaK\OXO]]AOObZOM^^RS]^\OXN^YMYX^SX_OKXN
^YLOKWYXQ^RO^YZ^R\OOZRK\WKMO_^SMKVWK\UO^]LcSXM\OWOX^KV
` "##!6KUR]KXN-Y\ZY\K^O.S`SNOXN>KbYP` 6KUR]
Q\Ya^RKXN^RO ^RVK\QO]^WK\UO^QVYLKVVcSXKL]YV_^O]SdO QKSXSWZY\^KXMO
:\O`SY_]cOK\$` !6KUR]>RO-Y\ZY\K^O.S`SNOXN>KbS] Other Expenses
Z\Y`SNONK^^RO\K^OKZZVSMKLVOYX^RONKcYXaRSMR^ROKMMY_X^] 3XM\OK]OSX^ROX_WLO\YPWSNNVOMVK]]RY_]ORYVN]MY_ZVONaS^R
aO\OKZZ\Y`ONLc^RO,YK\NYP.S\OM^Y\] SWZ\Y`OWOX^ SX WONSMKV SXP\K]^\_M^_\O \S]SXQ KaK\OXO]] KXN w Regulation of OTC Drugs - >RO 9>- WK\UO^ S] Q\YaSXQ 9^RO\/bZOX]O]SXMV_NSXQObMS]ON_^cYX=KVO].OZ\OMSK^SYXKXN
SXM\OK]OSXZOXO^\K^SYXYPROKV^RSX]_\KXMOSX^ROMY_X^\caSVVKV]Y ]^\YXQVc K^  KXN aS^R Q\OK^O\ aSVVSXQXO]] ^Y 0SXKXMO -Y]^ SXM\OK]ON Lc  Y`O\ ^RO VK]^ cOK\ >RO SXM\OK]O
DIVIDEND DISTRIBUTION POLICY SX
_OXMO^ROQ\Ya^RYPZRK\WKMO_^SMKV]]OM^Y\ ]OVPWONSMK^O ^RO \OQ_VK^Y\c K_^RY\S^SO] K\O VYYUSXQ K^ YXKMMY_X^YPYP MOVOK]O\OX^KV]PY\9XO+LLY^^YP MOS]ZK\^SKVVc
>RO-YWZKXcRK]PY\W_VK^ON.S`SNOXN.S]^\SL_^SYX:YVSMcSX^O\W] >ROWK\UO^S]RSQRVcP\KQWOX^ONaS^R^RO^YZMYWZKXSO]MYX]^S^_^SXQ M\OK^SXQ K Z\YZO\Vc NO XON 9>- ]OM^Y\ >RO M\OK^SYX YP K YPP]O^LcNOM\OK]OSXObMS]ON_^cYX=KVO]ZY]^SWZVOWOX^K^SYXYP
YP\O[_S\OWOX^]_XNO\^RO=OM_\S^SO]KXN/bMRKXQO,YK\NYP3XNSK ]RK\OYP^RO3:7KXN^RO^YZMYWZKXSO]KMMY_X^SXQPY\#! aOVVNO XONKXN\OQ_VK^ON9>-WK\UO^MY_ZVONaS^R]^\SM^O\ 1=> 9^RO\ /bZOX]O] K] K ZO\MOX^KQO ^Y =KVO] \ON_MON ^Y 
6S]^SXQ 9LVSQK^SYX] KXN .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX] YP^RO3:7>RO3:7S]Z\SWK\SVcWKNO_ZYP3XNSKXMYWZKXSO]aS^RK ^RS]cOK\MYWZK\ON^Y!PY\^RO XKXMSKVcOK\ !YaSXQ^Y
OXPY\MOWOX^ YP Z\O]M\SLSXQ KXN NS]ZOX]SXQ \OQ_VK^SYX] aSVV
 >RO ]KSN :YVSMc S] K`KSVKLVO YX ^RO -YWZKXct] aOL]S^O K^ ]RK\OYP!#YP^ROWK\UO^aRSVOKM_^O^RO\KZSO]MYX^SX_O^YNYWSXK^O
R^^Z$aaaKLLY^^MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV N\S`OQ\Ya^RYP^RO9>-WK\UO^ RSQRO\=KVO]SX^ROM_\\OX^cOK\
^ROWK\UO^MYX]^S^_^SXQ YP^RO3:7

44 ANNUAL REPORT 2017-18 45

 ABBOTT INDIA LIMITED
:\Y ^,OPY\O>Kb
:\Y ^ ,OPY\O >Kb PY\ ^RO cOK\ OXNON 7K\MR  " K^ ` " 
6KUR]Q\Oa^Y#YP=KVO]K]MYWZK\ON^YSX^ROZ\O`SY_]cOK\
Goods and Services Tax (GST)
_`KM ;_KN\S`KVOX^ @KMMSXO
1=> ^RO LSQQO]^ SXNS\OM^ ^Kb \OPY\W YP 3XNSK aK] \YVVONY_^
OPPOM^S`O 4_Vc  ! >RS] ^\KX]PY\WK^SYXKV \OPY\W ]SQXS MKX^Vc
SWZKM^ON KVV K\OK] YP L_]SXO]]O] KM\Y]] `K\SY_] ]OM^Y\] SXMV_NSXQ
^RO ZRK\WKMO_^SMKV SXN_]^\c >RO KZZVSMKLVO \K^O YP 1=> YX N\_Q]
SX QOXO\KV S]  KXN PY\ VSPO ]K`SXQ N\_Q] S]  /K\Vc KXKVc]S] YP
_`KM SX
_OXdK
ZY^OX^SKV 1=> SWZKM^ YX L_]SXO]] Z\YKM^S`O Z\OZK\ONXO]] SX ^RO
3> ]c]^OW OXRKXMOWOX^] KXN =_ZZVc -RKSX YZO\K^SYX] ROVZON ^RO
-YWZKXc ^Y LO 1=> MYWZVSKX^ \SQR^ P\YW ^RO 1=> \YVVY_^ NK^O
>RO-YWZKXc_]ON^RS]WOQK\OPY\WK]KXYZZY\^_XS^c^Y_ZQ\KNO
the systems and also launched many initiatives such as providing
^\KSXSXQ] ^Y ^\KNO ZK\^XO\] KXN Y^RO\ ]^KUORYVNO\] ^R_] OXQKQSXQ
aS^R ^ROW ^Y ]OM_\O KX OPPOM^S`O 1=> MYWZVSKX^ OX`S\YXWOX^
>RO -YWZKXc RK] ^KUOX K VOKN SX WKUSXQ ]O`O\KV \OZ\O]OX^K^SYX]
^Y ^RO 1Y`O\XWOX^ K_^RY\S^SO] YX ^RO UOc MYXMO\X K\OK]
MRKVVOXQO]PKMONLc^ROZRK\WKMO_^SMKVSXN_]^\cKXNWKNOMO\^KSX
\OMYWWOXNK^SYX]^YOK]OMYWZVSKXMO
Division-wise Performance
_`KMKMRSO`ON8YZY]S^SYXSXS^]
>RO -YWZKXc YZO\K^O] SX K ]SXQVO \OZY\^KLVO L_]SXO]] ]OQWOX^
SOu:RK\WKMO_^SMKV]v
>RO-YWZKXct]L_]SXO]]YZO\K^SYX]K\ONS`SNONSX^YPY_\NS`S]SYX]
SO S AYWOXt] 2OKV^R  1K]^\YSX^O]^SXO 1K]^\YOX^O\YVYQc
13:\Y]ZO\KKXN13+N`KXMOSS=ZOMSKV^c-K\OSSS1OX8Ob^KXN
@KMMSXO]KXNS`-YX]_WO\-K\O
K^_VOX^x^KLVO^]VS[_SN]KXNZYaNO\] - Provide services that go beyond just the pill :
>RO UOc ZO\PY\WKXMO RSQRVSQR^] YP OKMR ,_]SXO]] .S`S]SYX PY\
^RO XKXMSKVcOK\!"K\OK]PYVVYa]$
(i) Women’s Health & Gastrointestine, Gastroenterology,
GI Prospera and GI Advance Division
>RS].S`S]SYXYPPO\]KWSbYPY_\QVYLKVKXN3XNSK]ZOMS ML\KXN]
KM\Y]] Z\OQXKXMc MYX]^SZK^SYX KXN VS`O\ NS]OK]O] ]OQWOX^]
KQ]RSZZY]S^SYX Rash Cream), Digene Paan Flavour (Antacid), Digene Pudina Pearls
=O`O\KV YP ^RO -YWZKXct] VK\QO]^ L\KXN] ]_MR K] ._ZRK]^YX
AYWOXt]2OKV^R2Y\WYXO._ZRKVKM6KbK^S`O?NSVS`2OZK^SM
:\Y^OM^S`O -\OWKP X 6KbK^S`O -\OWKP X :V_] 6KbK^S`O
-\OYX.SQO]^S`O/XdcWO]2OZ^\KV+VMYRYVSMVS`O\NS]OK]OKXN
<YaK]K3X
KWWK^Y\c,YaOV=cXN\YWOPY\WZK\^YP^RS]NS`S]SYX
- Women’s Health & Gastrointestine
>RS] ,_]SXO]] ?XS^ ZY]^ON K ]^\YXQ Q\Ya^R YP # N_\SXQ
^RO cOK\ ._ZRK]^YX ?NSVS` KXN ._ZRKVKM RK`O MYX^\SL_^ON
]SQXS MKX^Vc^YY`O\KVVQ\Ya^R
._\SXQ ^RO cOK\  XOa Z\YN_M^]  Cystofert (Polycystic Ovary
=cXN\YWOKXN6O^\YVSPO9`_VK^SYXaO\OVK_XMRON
46 ANNUAL REPORT 2017-18
- Gastroenterology
>RS],_]SXO]]?XS^ZY]^ONK]^\YXQQ\Ya^RYPN_\SXQ^RO
cOK\ WKSXVc N\S`OX Lc L\KXN] -\OWKP X -\OWKP X :V_] KXN
6SL\Kb
._\SXQ^ROcOK\XOaZ\YN_M^]._ZRKVKM,_VU1_^2OKV^R
._ZRKZ\Y -YX]^SZK^SYX ?NSVS`  8+06. KXN ._ZRKVKM
6OWYX0VK`Y\6KbK^S`OaO\OVK_XMRON
- GI Prospera
>RS],_]SXO]]?XS^Q\OaLc#N_\SXQ^ROcOK\>ROQ\Ya^RaK]
WKTY\VcN\S`OXLcL\KXN]-\OYX2OZ^\KVKXN<YaK]K
._\SXQ ^RO cOK\  XOa Z\YN_M^]  @OVZKMVOK\ 2OZK^S^S] -
+X^YbSZKX :KSX 7KXKQOWOX^ SX MR\YXSM ZKXM\OK^S^S] KXN
2OZ^\KV>+6.8+06.aO\OVK_XMRON
- GI Advance
>RS] ,_]SXO]] ?XS^ aK] PY\WON SX 4KX_K\c " ^Y L_SVN XOa
Z\YN_M^]YXKL_SVNYZO\K^O^\KX]PO\WYNOV+]YP7K\MR"
 XOa Z\YN_M^]  -YX XOb -YX]^SZK^SYX -\OWKZOQ 3\\S^KLVO
,YaOV =cXN\YWO .S\SPK .SK\\RYOK2OZK^SM /XMOZRKVYZK^Rc
KXN1B +6.8+6.aO\OVK_XMRON
(ii) Specialty Care Division
>RS] .S`S]SYX MYX]S]^] YP K MYWZ\OROX]S`O \KXQO YP Z\YN_M^] PY\
^\OK^WOX^ YP WO^KLYVSM NS]Y\NO\] KXN MOX^\KV XO\`Y_] ]c]^OW
SVVXO]]O] KXN MY`O\] ^RO\KZc K\OK] VSUO RcZY^Rc\YSNS]W `O\^SQY
NOZ\O]]SYX KXN WSQ\KSXO >RO UOc L\KXN] SX ^RS] NS`S]SYX
K\O >Rc\YXY\W ^Rc\YSN Z\OZK\K^SYX] @O\^SX KX^S`O\^SQY
:\Y^RSKNOXKX^SNOZ\O]]KX^KXN3XNO\KVWSQ\KSXOZ\YZRcVKbS]
=YWO YP ^RO]O OXTYc WK\UO^ VOKNO\]RSZ ZY]S^SYX] SX ^ROS\
\O]ZOM^S`O^RO\KZO_^SMK\OK]
- Metabolics
>RS] ,_]SXO]] ?XS^ Q\Oa Lc  N_\SXQ ^RO cOK\ >RO Q\Ya^R
aK]WKSXVcN\S`OXLc>Rc\YXY\WaRSMR\O^KSX]
products in our existing therapy areas :
SXS^]]OQWOX^
During the year  XOa Z\YN_M^  -YWLSXY\W :\YLSY^SM x
,KM^O\SKV@KQSXY]S]aK]VK_XMRON
INITIATIVES
- Central Nervous System
>RS] ,_]SXO]] ?XS^ Q\Oa Lc "" N_\SXQ ^RO cOK\ @O\^SX KXN
:\Y^RSKNOX MYX^SX_O] K] ^RO WK\UO^ VOKNO\ KXN RK] ]RYaX
NY_LVONSQS^Q\Ya^R
._\SXQ ^RO cOK\  XOa Z\YN_M^]  3XNO\KV  7SQ\KXO KXN
-O\OLSYX=^\YUO,\KSX3XT_\caO\OVK_XMRON
 *
=Y_\MO]$37=2OKV^R
CORPORATE OVERVIEW
(iii) GenNext and Vaccines Division
This Division includes the therapy areas of Pain Management and
Vitamins. It comprises multi-specialty drugs and applications, and
is primarily aimed at general physicians. The key brands include
Brufen (pain killer), Duvadilan (peripheral vasodilator), Zolfresh
(sleep management), Arachitol Nano (Vitamin D preparations)
and Digecaine (antacid anaesthetic).
The Company has a licensing arrangement with Bharat Biotech
India Limited to market vaccines in immunology segment.
>RO UOc L\KXN] SX `KMMSXO ZY\^PYVSY K\O 3X
vaccine), Enteroshield (typhoid vaccine) and Rotasure (rotavirus
diarrhea vaccine).
- GenNext
This Buisness Unit has shown a negative growth of 2.6%;
however, Arachitol Nano and Duvadilan have shown positive
growth. Zolfresh retains number 1* position in its participated
market.
- Vaccines
This Business Unit showed growth of 59.7% and contributed
3.4% of Sales for the year. The double digit growth was driven by
KVVUOcL\KXN]SX^RS]_XS^3X
participated market this year.
(iv) Consumer Care Division
This Division is present in the Over The Counter (OTC) antacid
segment and mainly promotes all variants of Digene (antacid –
KX^S
The Division focuses on connecting with patients through
positioning of its products mainly through mass media, social
media and point of sale promotion. New advertisement and
marketing strategies will help sustaining the growth of this
portfolio. The Division showed growth of 10.6% over the previous
year.
During the year, 5 new products - Rashfree Natural Cream (Diaper
.SQO]^S`O -\OWKP X 0\O]R 6KbK^S`O KXN ,\_POX +M^S`O :KSX
Relief Ointment) were launched.
MEDICAL RESEARCH AND KNOWLEDGE SHARING
>RO-YWZKXc]SQXS MKX^Vc]_ZZY\^]<OKVAY\VN/`SNOXMOE<A/G
Generation Studies and Registration Studies for innovative
products developed by Innovation and Development (I&D) teams,
aRSMR ROVZ SX K^^KSXSXQ S^] MYWWS^WOX^ PY\ ZY\^PYVSY ObZKX]SYX
In addition, training imparted to Healthcare professionals (HCPs)
during clinical studies via Good Clinical Practice (GCP), drives the
-YWZKXct]]^KXNSXQK]K]MSOX^S MMYWZKXc
STATUTORY REPORT FINANCIAL STATEMENTS
._\SXQ^ROcOK\^RO-YWZKXcObOM_^ONXOa]^_NSO]Z_LVS]RON
Z_LVSMK^SYX]SXWKTY\SXNObONTY_\XKV]KXNWKNO!SX^O\XK^SYXKV
congress presentations. The health authority of India approved
3 studies submitted and presented by the Company. The Company
received approvals to conduct phase 3 studies in adults/elderly
KXN ZONSK^\SM] SX ZK\KVVOV PY\ S^] 3X
;3@:\YQ\KW>RO-YWZKXcKV]YMYXN_M^ON 1-:aY\U]RYZ]
to raise awareness on clinical trials.
Some of the notable studies are in therapy segments of Migraine,
Metabolic Syndrome, Constipation, Insomnia and Preterm which
were presented/published at different national/international
congresses during the year under review.
OUTLOOK
IMS Health has forecasted the Indian Pharmaceutical Market to
grow at a compounded annual growth rate of 9.7% between 2017
KXN\OKMRSXQKZZ\YbSWK^OVc` 2000 billion by 2022.
For the near future, after an in-depth overview of our strength and
Y_\WK\UO^VOKNSXQZY]S^SYXaO SNOX^S ON]ZOMS MYZZY\^_XS^SO]
to leverage for growth. Some of these are :
- Shape therapies to accelerate existing key brands :
  MMOVO\K^O Q\Ya^R YP ObS]^SXQ L\KXN] ^R\Y_QR PYM_]ON
+
brand building, innovative marketing campaigns and
partnerships to help patients and physicians. This will
ensure we continue growing faster than the market and
drive our therapy leadership.
  O RK`O ^K\QO^ON SX^O\`OX^SYX] K^ OKMR ]^KQO KVYXQ ^RO
A
sMYX^SX__W YP MK\Ot PY\ ZK^SOX^] 0Y\ ObKWZVO aO RK`O
developed a holistic end-to-end solution in the gut space
MKVVON s1_^ ^t aRSMR SX`YV`O] ]YV_^SYX] ]_MR K] MY_X]OVVSXQ
and nutrition advice for patients.
- Increase portfolio depth through the launch of new
During the year, we have launched 21 new products and have a
robust plan for future launches.
- Focus on internal talent development, engagement,
retention and capability building :
  O \_X ]_MMO]]P_V WKXKQOWOX^ ^\KSXOO Z\YQ\KW] MYXN_M^
A
_XSPY\W K]]O]]WOX^] PY\ \]^ VSXO KXN ]OMYXN VSXO WKXKQO\
\YVO]KXNRK`O^ROSXN_]^\c]YXVc^SO\MO\^S MK^SYXZ\YQ\KW
PY\Y_\ OVNPY\MO>RS]cOK\aOVK_XMRON^ROAYWOX6OKNO\]
YP+LLY^^A6+SXS^SK^S`O^YROVZPOWKVOOWZVYcOO]K^+LLY^^
3XNSKWKbSWSdO^ROS\ZY^OX^SKV
Sources : IMS Health
47
 ABBOTT INDIA LIMITED
- Digital differentiation and use of technology :
3 ^ MYWZVOWOX^ Y_\ Z\YN_M^] ^Y N\S`O OXQKQOWOX^ aS^R
5Oc 9ZSXSYX 6OKNO\] KXN ZK^SOX^] PY\ ObKWZVO SXMVSXSM
engagement through augmented and virtual reality interfaces
]_MRK]^RO@O\^S1Y+ZZ>R\Y_QR^RO\YVVY_^YPS:KN]^Y OVN
PY\MOYP^R\OOYPY_\,_]SXO]]?XS^]aORK`OWY\OOXQKQSXQ
KXNNSPPO\OX^SK^ONMYX^OX^^Y]RYaMK]O^YNYM^Y\]
RISKS AND CONCERNS
>ROSWZVSMK^SYXYP\S]URK]]^OKNSVcSX^OX]S ONQS`OX^RO`YV_WO
KXNMYWZVObS^cYPMRKXQO^ROZRK\WKMO_^SMKVSXN_]^\cMYX^SX_O]
^Y PKMO LY^R SX 3XNSK KXN ^RO aY\VN <OQ_VK^Y\c MRKVVOXQO] K\O
MYWZY_XNON Lc O`YV`SXQ \OQ_VK^SYX] KXN XOa VOQS]VK^SYX]
ARSVO \OQ_VK^Y\] K\O MYWWS^^ON ^Y M\OK^O KX OX`S\YXWOX^
MYXN_MS`O PY\ ZRK\WKMO_^SMKV MYWZKXSO] ^Y NY L_]SXO]] ]cXM
LO^aOOXZYVSMcKXNYZO\K^SYX]aSVVLOKXK\OK^YaK^MR
>RO 8K^SYXKV :RK\WKMO_^SMKV :\SMSXQ +_^RY\S^c 8::+ aSVV
continue to play an active role of regulator for drug prices and
P_\^RO\ MRKXQO] K\O ObZOM^ON ^Y LO SX^\YN_MON ^Y ^RO Z\SMSXQ
]c]^OW7Y\OP\O[_OX^\O`S]SYX]^Y^RO8K^SYXKV6S]^YP/]]OX^SKV
7ONSMSXO]86/7K\OObZOM^ON
Although no concrete proposals to introduce direct controls on
ZK^OX^ONZ\YN_M^Z\SMO]RKNLOOXWKNOZ_LVSMK]YPOK\Vc"S^
S]ZY]]SLVO^RK^KZK^OX^ONN\_QZ\SMOZYVSMcMY_VNLOSX^\YN_MON
8_WO\Y_] Z\YPO]]SYXKV Y\QKXS]K^SYX] KXN QY`O\XWOX^ LYNSO]
RK`O \OZOK^ONVc MKVVON PY\ NYM^Y\] ^Y Z\O]M\SLO VYa MY]^ QOXO\SM
WONSMSXO] ^Y ZK^SOX^] >RS] S] YXO KWYXQ K ]O\SO] YP WOK]_\O]
ZVKXXONLc^ROROKV^RWSXS]^\c^Y\OQ_VK^O^ROMY]^YPWONSMKVMK\O
KXNWKUOROKV^RMK\OWY\OKPPY\NKLVOSX3XNSK>ROSX^\YN_M^SYX
YPQOXO\SMZ\O]M\SLSXQ\OQ_VK^SYX]S]YX^ROQY`O\XWOX^t]KQOXNK
INTERNAL CONTROL SYSTEM AND ITS ADEQUACY
>RO -YWZKXc RK] Z_^ SX ZVKMO KX SX^O\XKV MYX^\YV WOMRKXS]W
^RK^ S] MYWWOX]_\K^O aS^R S^] ]SdO KXN XK^_\O YP L_]SXO]]
>RO]O ]c]^OW] Z\Y`SNO K \OK]YXKLVO K]]_\KXMO YX KMRSO`OWOX^
YPS^]YZO\K^SYXKVMYWZVSKXMOKXN\OZY\^SXQYLTOM^S`O]SXMV_NSXQ
]KPOQ_K\NSXQYPK]]O^]YP^RO-YWZKXcZ\O`OX^SYXKXNNO^OM^SYX
YP P\K_N] KMM_\KMc KXN MYWZVO^OXO]] YP KMMY_X^SXQ \OMY\N] KXN
OX]_\SXQMYWZVSKXMOaS^R^ROMY\ZY\K^OZYVSMSO]
>RS] WOMRKXS]W S] ]Y_XN SX NO]SQX KXN ^RO P\KWOaY\U S]
MYX^SX_Y_]Vc O`KV_K^ON PY\ OPPOM^S`OXO]] KXN KNO[_KMc
>RO WOMRKXS]W YZO\K^O] ^R\Y_QR aOVVNYM_WOX^ON ]^KXNK\N
YZO\K^SXQZ\YMON_\O]ZYVSMSO]KXNZ\YMO]]Q_SNOVSXO]
>RO3X^O\XKV+_NS^ZVKXS] XKVS]ONLK]ONYXM_\\OX^ZO\MOZ^SYXYP
SX^O\XKVMYX^\YV\S]UKXNMYWZVSKXMO\O[_S\OWOX^SXMYX]_V^K^SYX
aS^RYZO\K^SXQNS`S]SYX]>RO3X^O\XKV+_NS^Y\]K]KZK\^YP^ROS\
K_NS^] \O`SOa ^RO NO]SQX YP UOc Z\YMO]]O] P\YW KX KNO[_KMc YP
MYX^\YV]ZYSX^YP`SOa
48 ANNUAL REPORT 2017-18
+NNS^SYXKVVc ]SQXS MKX^ SX^O\XKV K_NS^ YL]O\`K^SYX] KXN
WKXKQOWOX^KM^SYX]^RO\OYXK\O\OZY\^ON^Y^RO+_NS^-YWWS^^OO
YX K [_K\^O\Vc LK]S] +X SXNOZOXNOX^ KXN OWZYaO\ON +_NS^
-YWWS^^OO \O`SOa] ^RO YL]O\`K^SYX] KXN K]]O]]O] ^RO KNO[_KMc
YP^ROKM^SYX]Z\YZY]ONK]aOVVK]WYXS^Y\]^ROS\SWZVOWOX^K^SYX
ARSVO ^RO 3X^O\XKV +_NS^Y\] MYXN_M^ K [_K\^O\Vc PYVVYa _Z PY\
SWZVOWOX^K^SYX\OWONSK^SYX YP KVV K_NS^ \OMYWWOXNK^SYX] KXN
^RO]^K^_]\OZY\^S]Z\O]OX^ON^Y^RO+_NS^-YWWS^^OO\OQ_VK\Vc
>RO-YWZKXcRK]SWZVOWOX^ONLY^RZ\O`OX^K^S`OKXNNO^OM^SYX
MYX^\YV] KXN KZZ\YZ\SK^O MY\\OM^S`O KM^SYX] ^Y \ON_MO ^RO \S]U]
SXMV_NSXQ$
w  LLY^^ -YNO YP ,_]SXO]] -YXN_M^ -9,- \O[_S\O] KXX_KV
+ WK\UO^]aOYZO\K^OSXKXNNOVS`O\Z\ONSM^KLVOZO\PY\WKXMO
MO\^S MK^SYXLcKVVOWZVYcOO]%
w  YWZVSKXMO-YWWS^^OOS]PY\WONaS^R\OZ\O]OX^K^S`O]P\YW
- ^R\Y_QR]RK\ONQYKV]MKZKLSVS^cL_SVNSXQSXS^SK^S`O]MK\OO\Q\Ya^R
KVV^ROYZO\K^SXQQ\Y_Z]%
w Senior Management have oversight of the compliance
Z\YQ\KW]%
w  _]SXO]] -YWZVSKXMO -OVV S] K]]SQXON aS^R \O]ZYX]SLSVS^c
, 2OVZSXQ aYWOX K^ +LLY^^ WKbSWSdO ^ROS\ ZY^OX^SKV KXN \OKVS]O
YP ^\KSXSXQ WYXS^Y\SXQ KXN OX]_\SXQ MYWZVSKXMO YP ^RO
-YWZKXc]:YVSMSO]KXN:\YMON_\O]Lc OVNOWZVYcOO]%
w >RO-YWZKXcRK]KARS]^VO,VYaO\WOMRKXS]WSXZVKMO%
w  _]SXO]] .S`S]SYX] RK`O K [_K\^O\Vc WOO^SXQ aS^R .S\OM^Y\ 
, MK\OO\]K^+LLY^^
9P MOYP/^RSM]KXN-YWZVSKXMO^YWYXS^Y\KXNNS]M_]]^RO
MYWZVSKXMOaS^R`K\SY_]L_]SXO]]Z\YMO]]O]
>RO -YWZKXc 7KXKQOWOX^ RK] K]]O]]ON ^RO OPPOM^S`OXO]] YP
SX^O\XKV MYX^\YV] Y`O\ XKXMSKV \OZY\^SXQ PY\ ^RO cOK\ OXNON
7K\MR  " KXN LK]ON YX ^RO K]]O]]WOX^ LOVSO`O ^RK^ ^RO
]KWOK\OKNO[_K^OKXNaY\USXQOPPOM^S`OVc
>RO=^K^_^Y\c+_NS^Y\]RK`OS]]_ONKXK_NS^\OZY\^YX^ROKNO[_KMc
KXN OPPOM^S`OXO]] YP ^RO SX^O\XKV XKXMSKV MYX^\YV ]c]^OW] Y`O\
XKXMSKV\OZY\^SXQ
HUMAN RESOURCES
>RO-YWZKXc \WVcLOVSO`O]^RK^R_WKXMKZS^KVMYX^SX_O]^YLO
^RON\S`SXQPY\MOYPY_\L_]SXO]]AOOXNOK`Y\^YK^^\KM^\O^KSX
NO`OVYZKXNNOZVYc^ROLO]^K`KSVKLVO^KVOX^KM\Y]]^ROP_XM^SYX]
KXN RSO\K\MRc YP ^RO -YWZKXc :\Y`SNSXQ KX OWZYaO\SXQ aY\U
OX`S\YXWOX^^RK^S]L_SV^_ZYXYZOXXO]]KXN^\KX]ZK\OXMcPY]^O\]
MYVVKLY\K^S`O ZK\^SMSZK^SYX YP Y`O\  MYWWS^^ON ZOYZVO
^YaK\N] KNN\O]]SXQ ^RO _XWO^ ROKV^RMK\O XOON] YP S^] M_]^YWO\
_XS`O\]O
9_\ 2_WKX <O]Y_\MO ^OKW RK] NO`OVYZON KXN NOZVYcON KX
SX^OQ\K^ON ^KVOX^ WKXKQOWOX^ WOMRKXS]W aRSMR OXMYWZK]]O]
^RO OX^S\O OWZVYcOO VSPOMcMVO x \OM\_S^WOX^ MK\OO\ Z\YQ\O]]SYX
\OaK\N]KXN\OMYQXS^SYX]
CORPORATE OVERVIEW
India Talent Strategy
Pursuing an integrated approach to talent management helps us to
K^^\KM^^ROLO]^^KVOX^KXNKV]YNO`OVYZP_^_\OVOKNO\]P\YWaS^RSX
^RO Y\QKXS]K^SYX AO VO`O\KQO NSPPO\OX^SK^ON ^KVOX^ RS\SXQ _]SXQ
W_V^SZVOMRKXXOV]SXMV_NSXQZ\OWSO\L_]SXO]]]MRYYV]SX3XNSKKXN
KL\YKN3XS^]PY_\^RcOK\YPObOM_^SYXY_\3XNSK>KVOX^=^\K^OQc
KSW]$
w ^ YLO^ROOWZVYcO\YPMRYSMOSX^RO3XNSKX2OKV^RMK\O3XN_]^\c
SX ^O\W] YP K^^\KM^SXQ KXN \O^KSXSXQ ^RO \SQR^ [_KX^S^c KXN
[_KVS^c^KVOX^%
w ^ YKMRSO`OY_\K]ZS\K^SYX^YMYX^SX_O^YQ\YaPK]^O\^RKX^RO
>RO -YWZKXc LOVSO`O] SX WY^S`K^SXQ KXN OXQKQSXQ OWZVYcOO]
YZZY\^_XS^SO]KXNKXOX`S\YXWOX^YP^\KX]ZK\OXMcKMMY_X^KLSVS^c
KXNZY]S^S`O\OSXPY\MOWOX^
Women Leaders of Abbott
greater achievement and advancement throughout their careers is
^ROWS]]SYXYPAYWOX6OKNO\]YP+LLY^^A6+>R\Y_QR`K\SY_]
Z\YQ\KW] SXS^SK^S`O] KXN ]ZOKUO\ ]O\SO] A6+ MYXXOM^] aYWOX
OWZVYcOO]KXNYPPO\]^YYV]KXN^YZSM]^YROVZ^ROWWKbSWSdO^ROS\
>ROYLTOM^S`OYP^RS]SXS^SK^S`OS]^YM\OK^OKZVK^PY\WPY\K^^\KM^SXQ
retaining and advancing female talent in the organisation
KXN ^RO\OLc LOMYWSXQ ^RO /WZVYcO\ YP -RYSMO PY\ POWKVO
OWZVYcOO]KXNMYX^\SL_^SXQZY]S^S`OVc^YL_]SXO]]]_MMO]]
Leadership Programs
=O`O\KV VOKNO\]RSZ Z\YQ\KW] ]_MR K] 3X]^\SNO 1VYLKV -S^SdOX
.O`OVYZWOX^ :\YQ\KW /WO\QSXQ 6OKNO\] :\YQ\KW O^M aO\O
MYXN_M^ONN_\SXQ^ROcOK\
=YWO YP ^RO Y^RO\ XY^KLVO SXS^SK^S`O] SXMV_NO $ Feeder Pool
Development Program KSWON K^ KMMOVO\K^SXQ Z\YQ\O]] YP Y_\
UOc ^KVOX^ ^YaK\N] VOKNO\]RSZ \YVO] K^ WSNWKXKQOWOX^ VO`OV%
Differential Hiring Strategy KSWON K^ SXP_]SXQ NSPPO\OX^SKV
^KVOX^ KXN NS`O\]S^c% Sales Management Trainee Program
KSWON K^ L_SVNSXQ K NS`O\]O KXN ]_ZO\SY\ ^KVOX^ ZYYV PY\ \]^
VSXO WKXKQO\]% Sales Leadership Development Program
an internal career development program designed to source
^KVOX^ SX^O\XKVVc KXN O]^KLVS]R K MK\OO\ ZK^R PY\ UOc P_XM^SYX]
\YVO]% Uniform Assessments for First Line and Second Line
Manager roles KSWON K^ M\OK^SXQ ]_MMO]]SYX ZSZOVSXO PY\ 0S\]^
6SXOKXN=OMYXN6SXORSQRZO\PY\WSXQ OVNWKXKQO\]%Executive
Program in Sales & MarketingKX/bOM_^S`O:\YQ\KWSX=KVO]
KXN7K\UO^SXQP\YW337-KVM_^^KPY\RSQRZY^OX^SKV=OMYXN6SXO
7KXKQO\]
STATUTORY REPORT FINANCIAL STATEMENTS
Coaching Culture
>RO -YWZKXc MYX]^KX^Vc PYM_]O] YX Z\YZKQK^SXQ K MYKMRSXQ
M_V^_\O KM\Y]] ]KVO] RSO\K\MRc 9XTYLMYKMRSXQ S] YXO YP ^RO
SWZY\^KX^ VO`O\] YP L_SVNSXQ SXNS`SN_KV MKZKLSVS^SO] KXN N\S`O
OWZVYcOO WY^S`K^SYX KXN OXQKQOWOX^ u-YKMRSXQ 9VcWZSKNv S]
a very innovative initiative aimed at identifying and recognising
u,O]^-YKMRO]vSX^RO]KVO]^OKW]+^Y^KVYPLO]^MYKMRO]aO\O
\OMYQXS]ONN_\SXQ^ROLSQQO]^KXX_KV]KVO]MYXPO\OXMOK \]^SX
SXN_]^\cSXS^SK^S`O
Prevention of Sexual Harassment at Workplace
>RO -YWZKXc RK] KX 3X^O\XKV -YWZVKSX^] -YWWS^^OO 3--
SX ZVKMO K] \O[_S\ON _XNO\ ^RO =Ob_KV 2K\K]]WOX^ YP AYWOX K^
AY\UZVKMO :\O`OX^SYX :\YRSLS^SYX KXN <ON\O]]KV +M^ 
+ZZ\YZ\SK^O^\KSXSXQS]SWZK\^ON^YOWZVYcOO]>RS]^\KSXSXQKV]Y
PY\W]KZK\^YP8Oa/WZVYcOO9\SOX^K^SYX:\YQ\KW>RO\OaO\O
XY MYWZVKSX^] \OMOS`ON Lc ^RO -YWZKXc3-- N_\SXQ ^RO cOK\
_XNO\^ROKPY\O]KSN+M^
>Y^KVX_WLO\YPOWZVYcOO]K]YX7K\MR"S]
DIRECTORS’ RESPONSIBILITY STATEMENT
:_\]_KX^ ^Y =OM^SYX  YP ^RO -YWZKXSO] +M^  cY_\
.S\OM^Y\]]^K^O^RK^$
K S X^ROZ\OZK\K^SYXYP^RO+XX_KV+MMY_X^]PY\^ROcOK\OXNON
7K\MR"^ROKZZVSMKLVOKMMY_X^SXQ]^KXNK\N]RK`OLOOX
PYVVYaONKXN^RO\OK\OXYWK^O\SKVNOZK\^_\O]P\YW^RO]KWO%
L ^ ROcRK`O]OVOM^ON]_MRKMMY_X^SXQZYVSMSO]KXNKZZVSON^ROW
MYX]S]^OX^Vc KXN WKNO T_NQWOX^] KXN O]^SWK^O] ^RK^ K\O
\OK]YXKLVOKXNZ\_NOX^]YK]^YQS`OK^\_OKXNPKS\`SOaYP^RO
]^K^OYPKPPKS\]YP^RO-YWZKXcK]K^7K\MR"KXNYP^RO
Z\Y ^]YP^RO-YWZKXcPY\^RK^cOK\%
M ^ ROcRK`O^KUOXZ\YZO\KXN]_P MSOX^MK\OPY\^ROWKSX^OXKXMO
YP KNO[_K^O KMMY_X^SXQ \OMY\N] SX KMMY\NKXMO aS^R ^RO
Z\Y`S]SYX] YP ^RO -YWZKXSO] +M^  PY\ ]KPOQ_K\NSXQ ^RO
assets of the Company and for preventing and detecting fraud
KXNY^RO\S\\OQ_VK\S^SO]%
N ^ ROcRK`OZ\OZK\ON^RO+XX_KV+MMY_X^]YP^RO-YWZKXcYX
KQYSXQMYXMO\XLK]S]%
O ^ ROcRK`OVKSNNYaXKNO[_K^O3X^O\XKV0SXKXMSKV-YX^\YV]
^Y LO PYVVYaON Lc ^RO -YWZKXc KXN ^RK^ ]_MR 3X^O\XKV
0SXKXMSKV -YX^\YV] K\O KNO[_K^O KXN K\O YZO\K^SXQ
OPPOM^S`OVc%
P  ^ ROcRK`ONO`S]ONZ\YZO\]c]^OW]^YOX]_\OMYWZVSKXMOaS^R
^ROZ\Y`S]SYX]YPKVVKZZVSMKLVOVKa]KXN^RK^]_MR]c]^OW]K\O
KNO[_K^OKXNYZO\K^SXQOPPOM^S`OVc
49
 ABBOTT INDIA LIMITED
RELATED PARTY TRANSACTIONS
Policy on dealing with Related Party Transactions and
Materiality
>RO -YWZKXc RK] PY\W_VK^ON K :YVSMc YX NOKVSXQ aS^R <OVK^ON
:K\^c>\KX]KM^SYX]KXN7K^O\SKVS^cSX^O\W]YP\O[_S\OWOX^]YP^RO
-YWZKXSO]+M^KXN^RO=OM_\S^SO]KXN/bMRKXQO,YK\NYP3XNSK
6S]^SXQ 9LVSQK^SYX] KXN .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX]
 >RO ]KSN :YVSMc S] K`KSVKLVO YX ^RO -YWZKXct] aOL]S^O K^
R^^Z$aaaKLLY^^MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV
+] ZO\ ^RO ]KSN :YVSMc KVV <OVK^ON :K\^c >\KX]KM^SYX] K\O
Z\OKZZ\Y`ON Lc ^RO +_NS^ -YWWS^^OO KXN ,YK\N K] KXN aROX
\O[_S\ON >RO NO^KSV] YP ]_MR ^\KX]KM^SYX] K\O KV]Y \O`SOaON
Lc ^RO +_NS^ -YWWS^^OO YX K [_K\^O\VcKXX_KV LK]S] 7K^O\SKV
>\KX]KM^SYX]^\KX]KM^SYXObMOONSXQYP^ROKXX_KV^_\XY`O\K]
ZO\^ROVK]^K_NS^ON XKXMSKV]^K^OWOX^]SPKXcaS^RKXc<OVK^ON
:K\^SO]K\OZ\OKZZ\Y`ONLc^RO=RK\ORYVNO\]
Details of Related Party Transactions
+VV ^RO <OVK^ON :K\^c >\KX]KM^SYX] SXMV_NSXQ ^RO 7K^O\SKV
>\KX]KM^SYX]OX^O\ONSX^YLc^RO-YWZKXcN_\SXQ^ROcOK\!"
u]KSN>\KX]KM^SYX]vaO\OSX^ROY\NSXK\cMY_\]OYPL_]SXO]]KXN
YXK\Wt]VOXQ^RLK]S]>RO]KSN>\KX]KM^SYX]aO\OZ\OKZZ\Y`ON
Lc ^RO +_NS^ -YWWS^^OO ,YK\N KXN =RK\ORYVNO\] aRO\O`O\
XOMO]]K\c
.O^KSV] YP ^RO ]KSN >\KX]KM^SYX] K\O Z\Y`SNON SX 8Y^O  ^Y ^RO
0SXKXMSKV=^K^OWOX^]
CORPORATE SOCIAL RESPONSIBILITY
Corporate Social Responsibility (CSR) Policy
>RO -=< :YVSMc S] K`KSVKLVO YX ^RO -YWZKXct] aOL]S^O K^
R^^Z$aaaKLLY^^MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV
-=<SXS^SK^S`O]_XNO\^KUOXN_\SXQ^RO XKXMSKVcOK\!"
>RO-YWZKXcSXM_\\ONKXKWY_X^YP ` #6KUR]YX`K\SY_]
-=<KM^S`S^SO]N_\SXQ^RO XKXMSKVcOK\!"
>RO+XX_KV<OZY\^YP-=<KM^S`S^SO]_XNO\^KUOXLc^RO-YWZKXc
N_\SXQ^RO XKXMSKVcOK\!"S]KXXObONK]u+XXOb_\O3vKXN
PY\W]ZK\^YP^RS]<OZY\^
RISK MANAGEMENT FRAMEWORK
>RO -YWZKXc \OMYQXS]O] <S]U 7KXKQOWOX^ K] KX SX^OQ\K^ON
PY\aK\NVYYUSXQKXNZ\YMO]]Y\SOX^ONKZZ\YKMR3^RK]NO`OVYZON
K <S]U 0\KWOaY\U aRSMR S] NS\OM^ON ^Y OXKLVO WKXKQOWOX^
^Y OPPOM^S`OVc NOKV aS^R _XMO\^KSX^c KXN K]]YMSK^ON \S]U KXN
YZZY\^_XS^c OXRKXMSXQ ^RO MKZKMS^c ^Y L_SVN `KV_O 3^ OXKLVO] ^Y
K`YSNZS^PKVV]KXN]_\Z\S]O]KVYXQ^ROaKc,\YKNVc^RO0\KWOaY\U
OXMYWZK]]O]$
w  VSQXSXQ\S]UKZZO^S^OKXN]^\K^OQcx>RO-YWZKXcMYX]SNO\]
+ K] +NNS^SYXKV KXN ARYVO^SWO .S\OM^Y\ YP ^RO -YWZKXc PY\
S^] \S]U KZZO^S^O SX O`KV_K^SXQ ]^\K^OQSM KV^O\XK^S`O] ]O^^SXQ
\OVK^ON YLTOM^S`O] KXN NO`OVYZSXQ WOMRKXS]W] ^Y WKXKQO
\OVK^ON\S]U]
50 ANNUAL REPORT 2017-18
w  XRKXMSXQ \S]U \O]ZYX]O NOMS]SYX] x <S]U 7KXKQOWOX^
/  7
Z\Y`SNO]^RO\SQY\^YSNOX^SPcKXN]OVOM^KWYXQKV^O\XK^S`O\S]U
\O]ZYX]O]x\S]UK`YSNKXMO\ON_M^SYX]RK\SXQKXNKMMOZ^KXMO
w  ON_MSXQ YZO\K^SYXKV ]_\Z\S]O] KXN VY]]O] x >RO -YWZKXc
<
]^\S`O]^YQKSXOXRKXMONMKZKLSVS^c^YSNOX^SPcZY^OX^SKVO`OX^]
KXN O]^KLVS]R \O]ZYX]O] \ON_MSXQ ]_\Z\S]O] KXN K]]YMSK^ON
MY]^]Y\VY]]O]
w 3 NOX^SPcSXQKXNWKXKQSXQW_V^SZVOKXNM\Y]]OX^O\Z\S]O\S]U]
x>RO-YWZKXcPKMO]K`K\SO^cYP\S]U]KPPOM^SXQNSPPO\OX^ZK\^]
YP^ROY\QKXS]K^SYXKXN\S]UWKXKQOWOX^PKMSVS^K^O]OPPOM^S`O
\O]ZYX]O^Y^ROSX^O\\OVK^ONSWZKM^]KXNSX^OQ\K^ON\O]ZYX]O]
^YW_V^SZVO\S]U]
w  OSdSXQYZZY\^_XS^SO]x,cMYX]SNO\SXQKP_VV\KXQOYPZY^OX^SKV
= \OKZZYSX^WOX^YP7\7_XS\=RKSURaRYRK]K^^KSXON^ROKQOYP
O`OX^]^RO-YWZKXcS]ZY]S^SYXON^YSNOX^SPcKXNZ\YKM^S`OVc
\OKVS]OYZZY\^_XS^SO]
w 3 WZ\Y`SXQ NOZVYcWOX^ YP MKZS^KV x 9L^KSXSXQ \YL_]^ \S]U
SXPY\WK^SYX KVVYa] WKXKQOWOX^ ^Y OPPOM^S`OVc K]]O]] Y`O\KVV
MKZS^KVXOON]KXNOXRKXMOMKZS^KVKVVYMK^SYX
>RO]O MKZKLSVS^SO] SXRO\OX^ SX ^RS] 0\KWOaY\U OXKLVO ^RO
-YWZKXcKMRSO`SXQ^ROZO\PY\WKXMOKXNZ\Y ^KLSVS^c^K\QO^]KXN
Q_K\N KQKSX]^ VY]] YP \O]Y_\MO] 3^ S] KV]Y NS\OM^ON ^Y ROVZ OX]_\O
OPPOM^S`O\OZY\^SXQKXNMYWZVSKXMOaS^RVKa]KXN\OQ_VK^SYX]K`YSN
NKWKQO^Y^ROOX^S^ct]\OZ_^K^SYXKXNK]]YMSK^ONMYX]O[_OXMO]
>RO-YWZKXcYZO\K^SYX]KXNS^],_]SXO]].S`S]SYX]K\OSXMV_NON
SX^RO]MYZOYP^RO<S]U7KXKQOWOX^0\KWOaY\U
._\SXQ ^RO cOK\ <S]U 7KXKQOWOX^ -Y\O >OKW MYWZ\S]SXQ YP
\OZ\O]OX^K^S`O] YP `K\SY_] P_XM^SYX] KXN L_]SXO]]O] MK\\SON Y_^
\S]U K]]O]]WOX^ ObO\MS]O ^Y SNOX^SPc `K\SY_] ]SQXS MKX^ \S]U]
K]]YMSK^ONaS^R^ROL_]SXO]]YZO\K^SYX]KXNWS^SQK^SYXZVKX]^Y
KNN\O]] ]_MR \S]U] 7K^O\SKV \S]U] SNOX^S ON K\O O`KV_K^ON YX K
MYX^SX_SXQLK]S]
7K^O\SKV \S]U] KXN WS^SQK^SYX ZVKX] aO\O \O`SOaON Lc ^RO <S]U
7KXKQOWOX^ -YWWS^^OO KXN ^ROX Z\O]OX^ON ^Y ^RO ,YK\N KXN
+_NS^-YWWS^^OO
DIRECTORS
AO \OZY\^ aS^R Z\YPY_XN Q\SOP ^RO ]KN KXN _X^SWOVc NOWS]O
YP 7\ <KXTKX 5KZ_\ aRY ZK]]ON KaKc YX 4KX_K\c ! "
>RO ,YK\N ZVKMO] YX \OMY\N S^] ]SXMO\O KZZ\OMSK^SYX PY\ ^RO
SX`KV_KLVO MYX^\SL_^SYX] KXN Q_SNKXMO \OMOS`ON P\YW 7\ 5KZ_\
^YaK\N]^ROZ\YQ\O]]YP^RO-YWZKXc
>RO,YK\NLK]ONYX^RO\OMYWWOXNK^SYXYP^RO8YWSXK^SYXKXN
<OW_XO\K^SYX -YWWS^^OO KZZYSX^ON ^RO PYVVYaSXQ .S\OM^Y\] YX
^RO,YK\NYP^RO-YWZKXc_Z^Y^RONK^OYP^RS]<OZY\^
  \ <KTS` =YXKVUO\ .38 $ !#!" RK] LOOX KZZYSX^ON
7 <OQ_VK^SYX]  ^RO -YWZKXc RK] PY\W_VK^ON :O\PY\WKXMO
K ZO\SYN YP  ^aY cOK\] OPPOM^S`O +_Q_]^ " ! ]_LTOM^ ^Y
^ROKZZ\Y`KVYP^RO7OWLO\]K^^ROOX]_SXQ+XX_KV1OXO\KV
7OO^SXQ%
CORPORATE OVERVIEW
 ]+XS]RK7Y^aKXS.38$ ##RK]LOOXKZZYSX^ONK]
+NNS^SYXKVKXN3XNOZOXNOX^.S\OM^Y\PY\KZO\SYNYP^R\OO
cOK\] OPPOM^S`O +Z\SV  " ]_LTOM^ ^Y ^RO KZZ\Y`KV YP ^RO
7OWLO\]K^^ROOX]_SXQ+XX_KV1OXO\KV7OO^SXQ
3X MYWZVSKXMO aS^R =OM^SYX  YP ^RO -YWZKXSO] +M^ 
7\7_XS\=RKSUR.38$# !KXN7\5KScYWK\d7K\PK^SK
.38$# !\O^S\OLc\Y^K^SYXK^^ROOX]_SXQ+XX_KV1OXO\KV
7OO^SXQKXNLOSXQOVSQSLVOYPPO\^ROW]OV`O]PY\\OKZZYSX^WOX^
3XKMMY\NKXMOaS^R^ROZ\Y`S]SYX]YP^RO=OM_\S^SO]KXN/bMRKXQO
,YK\NYP3XNSK6S]^SXQ9LVSQK^SYX]KXN.S]MVY]_\O<O[_S\OWOX^]
+WOXNWOX^ <OQ_VK^SYX] " OPPOM^S`O +Z\SV  #
KZZ\Y`KV YP 7OWLO\] S] ]Y_QR^ ^R\Y_QR =ZOMSKV <O]YV_^SYX PY\
=O`OX^c `OcOK\]
,K]ONYX\OMYWWOXNK^SYXYP^RO8YWSXK^SYXKXN<OW_XO\K^SYX
-YWWS^^OO cY_\ .S\OM^Y\] \OMYWWOXN KZZYSX^WOX^
\OKZZYSX^WOX^ YP 7\ <KTS` =YXKVUO\ 7] +XS]RK 7Y^aKXS
7\7_XS\=RKSURKXN7\5KScYWK\d7K\PK^SK
Declaration of Independence
>RO -YWZKXc RK] \OMOS`ON NOMVK\K^SYX] P\YW KVV ^RO 3XNOZOXNOX^
.S\OM^Y\] MYX \WSXQ ^RK^ ^ROc WOO^ aS^R ^RO M\S^O\SK YP
SXNOZOXNOXMO Z\O]M\SLON _XNO\ ]_L]OM^SYX   YP =OM^SYX #
YP ^RO -YWZKXSO] +M^  KXN ^RO =OM_\S^SO] KXN /bMRKXQO
,YK\N YP 3XNSK 6S]^SXQ 9LVSQK^SYX] KXN .S]MVY]_\O <O[_S\OWOX^]
<OQ_VK^SYX]K]KWOXNONP\YW^SWO^Y^SWO
Number of Meetings of the Board
=O`OX,YK\N7OO^SXQ]aO\OROVNN_\SXQ^ROcOK\YX7Kc#!%
4_Vc " !% +_Q_]^ " !% 8Y`OWLO\  !% .OMOWLO\ #
!%0OL\_K\c"KXN7K\MR!"
Policy on Nomination and Appointment of Directors/ Criteria
for appointment of Senior Management and Remuneration
Policy
:YVSMcYX8YWSXK^SYXKXN+ZZYSX^WOX^YP.S\OM^Y\]-\S^O\SKPY\
appointment of Senior Management and Remuneration Policy as
PY\W_VK^ON _XNO\ =OM^SYX !" YP ^RO -YWZKXSO] +M^  S]
KXXObONK]u+XXOb_\O33vKXNPY\W]ZK\^YP^RS]<OZY\^
Performance Evaluation of the Board, Board Committees
and Directors
:_\]_KX^ ^Y ^RO \O[_S\OWOX^] YP ^RO -YWZKXSO] +M^  \OKN
aS^R <_VO] P\KWON ^RO\O_XNO\ KXN ^RO =OM_\S^SO] KXN /bMRKXQO
,YK\NYP3XNSK6S]^SXQ9LVSQK^SYX]KXN.S]MVY]_\O<O[_S\OWOX^]
/`KV_K^SYX 0\KWOaY\U KXN :YVSMc aRSMR ]O^] K WOMRKXS]W PY\
^RO O`KV_K^SYX YP ^RO ,YK\N ,YK\N -YWWS^^OO] KXN .S\OM^Y\]
>RO ]KSN :YVSMc S] K`KSVKLle at R^^Z$aaaKLLY^^MYSXSX`O]^Y\
\OVK^SYX]ZYVSMSO]R^WV
STATUTORY REPORT FINANCIAL STATEMENTS
?XNO\^ROKPY\OWOX^SYXON0\KWOaY\UKXN:YVSMc^ROZO\PY\WKXMO
O`KV_K^SYX YP ^RO ,YK\N -YWWS^^OO] KXN SXNS`SN_KV .S\OM^Y\]
S] MYXN_M^ON ^R\Y_QR ]OVPK]]O]]WOX^ KXN Q\Y_Z NS]M_]]SYX
>RO,YK\NWKc\OPO\^YK]_QQO]^ON]O^YP[_O]^SYX]ZK\KWO^O\]^Y
Q_SNO^ROS\NS]M_]]SYX]>RO-RKS\WKXYP^RO,YK\N8YWSXK^SYX
and Remuneration Committee meet the individual Directors to
Z\Y`SNOPOONLKMUSPKXc
._\SXQ^ROcOK\^RO,YK\N^RO8YWSXK^SYXKXN<OW_XO\K^SYX
Committee conducted performance evaluation of each
SXNS`SN_KV NS\OM^Y\ KXN ^RO ,YK\N MYXN_M^ON ZO\PY\WKXMO
O`KV_K^SYX YP ^RO ,YK\N KXN -YWWS^^OO] ^R\Y_QR ]OVP
K]]O]]WOX^KXNQ\Y_ZNS]M_]]SYX]/`KV_K^SYXaK]NYXOLK]ON
YX ^RO ZK\KWO^O\] ]^K^ON _XNO\ ^RO KPY\O]KSN 0\KWOaY\U
3XNOZOXNOX^ .S\OM^Y\] K^ ^ROS\ ]OZK\K^O WOO^SXQ O`KV_K^ON
ZO\PY\WKXMO YP 8YX3XNOZOXNOX^ .S\OM^Y\] ^RO ,YK\N K] K
aRYVO KXN ^RO -RKS\WKX +ZZ\YZ\SK^O POONLKMU aK] Z\Y`SNON
^Y^RO-RKS\WKXKXN7KXKQSXQ.S\OM^Y\
KEY MANAGERIAL PERSONNEL
7\ +WLK^S @OX_ 7KXKQSXQ .S\OM^Y\ 7\ <KTS` =YXKVUO\ -RSOP
0SXKXMSKV9P MO\KXN7]5\_ZK+XKXNZK\K-YWZKXc=OM\O^K\c
K\O^RO5Oc7KXKQO\SKV:O\]YXXOVYP^RO-YWZKXc
AUDIT COMMITTEE
>RO +_NS^ -YWWS^^OO MYWZ\S]O] 7\ < + =RKR -RKS\WKX
7\5\S]RXK7YRKX=KRXS7\7_XS\=RKSURKXN7]+XS]RK7Y^aKXS
Role of the Committee is provided in detail in the Corporate
1Y`O\XKXMO <OZY\^ PY\WSXQ ZK\^ YP ^RS] <OZY\^ +VV ^RO
\OMYWWOXNK^SYX]WKNOLc^RO+_NS^-YWWS^^OON_\SXQ^ROcOK\
aO\OKMMOZ^ONLc^RO,YK\N
VIGIL MECHANISM/WHISTLE BLOWER POLICY
>RO@SQSV7OMRKXS]WARS]^VO,VYaO\:YVSMcMKVVONu+LLY^^3XNSK
6SWS^ON x :\YMON_\O PY\ 3X^O\XKV 3X`O]^SQK^SYX]v VKc] NYaX K
WOMRKXS]WPY\\OZY\^SXQKXNSX`O]^SQK^SYXYPKVV_XO^RSMKVLORK`SY\
KVVOQON `SYVK^SYX] Y\ ZY^OX^SKV `SYVK^SYX] YP VKa] \OQ_VK^SYX] Y\
+LLY^^ -YNO YP ,_]SXO]] -YXN_M^ ZYVSMSO] Z\YMON_\O] Y\ Y^RO\
]^KXNK\N]
>RO ]KSN :YVSMc S] K`KSVKLVO YX ^RO aOL]S^O YP ^RO -YWZKXc K^
R^^Z$aaaKLLY^^MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV
/WZVYcOO] RK`O X_WO\Y_] aKc] ^Y `YSMO MYXMO\X] KXN K\O
OXMY_\KQON^Y\OZY\^^RO]KWOSX^O\XKVVcPY\\O]YV_^SYX>RO]KSN
:YVSMc Z\Y`SNO] PY\ KNO[_K^O ]KPOQ_K\N] KQKSX]^ \O^KVSK^SYX KXN
KMMO]]^Y^RO-RKS\WKXYP^RO+_NS^-YWWS^^OO
+Xc MYXMO\X]Q\SO`KXMO MKX LO MYWW_XSMK^ON ^R\Y_QR `K\SY_]
]Y_\MO]K]Z\Y`SNON_XNO\^RO]KSN:YVSMcY\`SK^YVVP\OOX_WLO\
""Y\YXVSXOK^R^^Z$]ZOKU_ZKLLY^^MYW
51
 ABBOTT INDIA LIMITED
STATUTORY AUDITORS
=<,--966:-RK\^O\ON+MMY_X^KX^]3-+30S\W<OQS]^\K^SYX
8Y#"//aO\OKZZYSX^ONK]^RO=^K^_^Y\c+_NS^Y\]
K^^RO=O`OX^SO^R+XX_KV1OXO\KV7OO^SXQYP^RO-YWZKXcROVNYX
+_Q_]^PY\K^O\WYPcOK\]SOP\YW XKXMSKVcOK\
^Y^RO XKXMSKVcOK\"#^YRYVNYP MO^SVV^ROMYXMV_]SYXYP^RO
=O`OX^c P^R+XX_KV1OXO\KV7OO^SXQYP^RO-YWZKXc]_LTOM^^Y
\K^S MK^SYXK^OKMR+XX_KV1OXO\KV7OO^SXQ
3X ^O\W] YP =OM^SYX  YP ^RO -YWZKXSO] +WOXNWOX^ +M^
! XY^S ON YX 7Kc ! " ^RO \O[_S\OWOX^ PY\ \K^S MK^SYX YP
KZZYSX^WOX^ YP =^K^_^Y\c +_NS^Y\] Lc 7OWLO\] K^ O`O\c +XX_KV
1OXO\KV 7OO^SXQ RK] LOOX YWS^^ON KXN KMMY\NSXQVc 7OWLO\]
KZZ\Y`KV S] XY^ \O[_S\ON PY\ \K^S MK^SYX YP ^ROS\ KZZYSX^WOX^
KXX_KVVc
AUDITORS’ REPORT
>RO+_NS^Y\]t<OZY\^PY\^RO XKXMSKVcOK\!"NYO]XY^MYX^KSX
KXcKN`O\]O\OWK\U][_KVS MK^SYX]Y\\O]O\`K^SYX]Y\NS]MVKSWO\]
_SN LON N\cO\
aRSMR\O[_S\OObZVKXK^SYXMYWWOX^]Lc^RO,YK\N
COST AUDITORS
7]5S]RY\O,RK^SK+]]YMSK^O]-Y]^+MMY_X^KX^]<OQS]^\K^SYX
8Y # K\O KZZYSX^ON K] ^RO -Y]^ +_NS^Y\] YP ^RO
-YWZKXc PY\ ^RO XKXMSKV cOK\ "# K^ K \OW_XO\K^SYX YP
_OX^ ^\OK^WOX^ ZVKX^ K^
`   6KUR] ZV_] ^KbO] K] KZZVSMKLVO KXN \OSWL_\]OWOX^ YP
_OX^] aOVV LOVYa ^RO VSWS^ DISCLOSURE UNDER SECTION 197(12) OF THE
Y_^YPZYMUO^ObZOX]O]
>RO ]KSN \OW_XO\K^SYX ^Y ^RO -Y]^ +_NS^Y\] ]RKVV LO ]_LTOM^
^Y \K^S MK^SYX Lc ^RO 7OWLO\] K^ ^RO OX]_SXQ +XX_KV 1OXO\KV
7OO^SXQ
-Y]^ +_NS^ <OZY\^ KVYXQ aS^R ^RO -YWZVSKXMO <OZY\^ PY\ ^RO
XKXMSKV cOK\  ! S]]_ON Lc 7] 8 3 7OR^K KXN +]]YMSK^O]
^ROX-Y]^K_NS^Y\]aK] VONYX+_Q_]^!N_ONK^OYP VSXQ
aK]=OZ^OWLO\!!
INTERNAL AUDITORS
7] 5:71 -RK\^O\ON +MMY_X^KX^] 3-+3 0S\W <OQS]^\K^SYX
8Y,+ K\O^RO3X^O\XKV+_NS^Y\]YP^RO-YWZKXc3X^O\XKV
+_NS^ <OZY\^ ^ROS\ ]SQXS MKX^ XNSXQ] KXN PYVVYa _Z KM^SYX]
^KUOXLc^RO7KXKQOWOX^S]\O`SOaONLc^RO+_NS^-YWWS^^OOYX
K[_K\^O\VcLK]S]
SECRETARIAL AUDIT REPORT
>RO =OM\O^K\SKV +_NS^ <OZY\^ S]]_ON Lc 7] 8OOXK ,RK^SK
:\KM^S]SXQ -YWZKXc =OM\O^K\c 7OWLO\]RSZ 8Y$ 0-= ## KXN
-O\^S MK^O YP :\KM^SMO 8Y   PY\ ^RO XKXMSKV cOK\ OXNON
7K\MR"NYO]XY^MYX^KSXKXcKN`O\]O\OWK\U[_KVS MK^SYX]
Y\ \O]O\`K^SYX] Y\ NOMVKSWO\ aRSMR \O[_S\O] KXc ObZVKXK^SYX
MYWWOX^] Lc ^RO ,YK\N >RO ]KSN <OZY\^ S] KXXObON K]
u+XXOb_\O333vKXNPY\W]ZK\^YP^RS]<OZY\^
52 ANNUAL REPORT 2017-18
HEALTH, SAFETY AND ENVIRONMENT
Health and Safety :
:\Y`SNSXQ K ]KPO aY\UZVKMO KXN UOOZSXQ ^RO OWZVYcOO] ROKV^Rc
S] ^RO -YWZKXct] ^YZ Z\SY\S^c AO K\O MYWWS^^ON ^Y UOOZSXQ
KVV ^RY]O aRY aY\U PY\ ^RO -YWZKXc ]KPO Lc Z\O`OX^SXQ
NKXQO\Y_] SXMSNOX^] SX KXN K\Y_XN ^RO aY\UZVKMO 9_\ /2=
strategy aims to develop a standardised approach to foster
MYX^SX_Y_]SWZ\Y`OWOX^KXNOX]_\OK]KPOKXNOP MSOX^aY\USXQ
OX`S\YXWOX^^RK^WSXSWS]O]KXcKN`O\]OOX`S\YXWOX^KVSWZKM^
3XON_MK^SXQY_\OWZVYcOO]aOKV]YOWZYaO\^ROW^YZ\YWY^O
]KPO\ KXN ROKV^RSO\ VS`O] SX ^ROS\ aSNO\ MYWW_XS^SO] AO ]^\S`O
^Y WKSX^KSX ^RO RSQRO]^ ]^KXNK\N] YP /X`S\YXWOX^ 2OKV^R KXN
=KPO^c/2=Z\KM^SMO]
>RO /WZVYcOO 2OKV^R KXN =KPO^c /2= :YVSMc RK] LOOX
SWZVOWOX^ON ^R\Y_QR Y_\ 1VYLKV /2= =^KXNK\N] ]_ZZY\^ON
Lc K aOVVNO XON /2= Y\QKXS]K^SYXKV ]^\_M^_\O /2= =^KXNK\N
9ZO\K^SXQ:\YMON_\O]KXN/2=]ZOMS MZ\YQ\KW]KVVOX]_\SXQaO
WOO^KVV^ROVYMKV\OQ_VK^Y\c\O[_S\OWOX^]
=_QQO]^SYX] P\YW ^RO =KPO^c -YWWS^^OO MYWZ\S]SXQ
\OZ\O]OX^K^S`O] P\YW ^RO aY\UPY\MO KXN WKXKQOWOX^ K\O
implemented promptly to resolve issues impacting Plant safety
KXN OWZVYcOO ROKV^R <Y_^SXO ]OVPK_NS^] KXN ^RS\N ZK\^c
]KPO^c K_NS^] K\O MYXN_M^ON ^Y `O\SPc MYWZVSKXMO aS^R ^RO
\OQ_VK^Y\cKXNSX^O\XKV]KPO^c\O[_S\OWOX^]
._\SXQ ^RO cOK\ Z_WZ] aS^RSX ^RO ObS]^SXQ \O RcN\KX^ ]c]^OW
aO\O_ZQ\KNON^YMY`O\KNNS^SYXKVObZKX]SYXK\OK^YWS^SQK^O^RO
\S]UYP \OK^^RO1YK:VKX^>RO]S^OS]QOK\ON^YRKXNVOKXc^cZO
YP \O]S^_K^SYX
>\KSXSXQ Z\YQ\KW] K\O MYXN_M^ON K^ ^RO :VKX^ YX ROKV^R KXN
]KPO^c S]]_O] ^Y L_SVN ^OMRXSMKV MKZKLSVS^SO] /WZVYcOO] K\O KV]Y
OXMY_\KQON^YK^^OXNOb^O\XKV^\KSXSXQZ\YQ\KW]YX`K\SY_]^YZSM]
]_MRK]\OQ_VK^Y\c\O[_S\OWOX^]O\QYXYWSM]WKMRSXOQ_K\NSXQ
RY^aY\U]KPO^c\YKN]KPO^cSXN_]^\SKVRcQSOXOSXN_]^\SKV]KPO^c
KXN]YYX+M\Y]]P_XM^SYXKV^OKW]PY\OWO\QOXMc\O]ZYX]OKXN
\O QR^SXQ S] SX ZVKMO 7YMU N\SVV] PY\ \O QR^SXQ KXN \O]M_O
YZO\K^SYX] K\O MYXN_M^ON SX K]]YMSK^SYX aS^R VYMKV \O L\SQKNO
^YUOOZ^RO]^KPPSXK]^K^OYPZ\OZK\ONXO]]PY\KXcOWO\QOXMSO]
>RO -YWZKXc RK] K NO^KSVON ,_]SXO]] -YX^SX_S^c :VKX SX ZVKMO
AO K\O MYX^SX_Y_]Vc SWZ\Y`SXQ YX ^RO ,ORK`SY\ ,K]ON =KPO^c
,,= Z\YQ\KW KXN `S]SLVO SWZ\Y`OWOX^ SX ]KPO^c M_V^_\O S]
YL]O\`ON =^YZ PY\ =KPO^c SXS^SK^S`O aK] SXS^SK^ON ^RS] cOK\ ^Y
]_ZZY\^ ^RO ,,= Z\YQ\KW >RO :VKX^ RKN XY \OZY\^KLVO Y\ VY]]
^SWOSXMSNOX^N_\SXQVK]^cOK\]
>RO:VKX^RK]KaOVVKZZYSX^ON \]^KSN\YYWaS^RKP_VV^SWOX_\]O
KXN 9MM_ZK^SYXKV 2OKV^R :Rc]SMSKX MK^O\SXQ ^Y OWZVYcOO XOON]
>RO:VKX^S]KV]YK\WONaS^RKXYX]S^OP_VVcO[_SZZONKWL_VKXMO
`KX 3^ S] WKXNK^Y\c PY\ KVV ZVKX^ OWZVYcOO] ^Y _XNO\QY \OQ_VK\
WONSMKVMROMU_ZK]Z\O]M\SLON_XNO\^RO-YWZKXct]:YVSMSO]
CORPORATE OVERVIEW
Introduction of closed loop system for Chloroform handling
aK] K WKTY\ SXS^SK^S`O _XNO\^KUOX K^ ^RO :VKX^ ^RS] cOK\
>RS]aSVV\ON_MOOWZVYcOOObZY]_\OKXNKMMSNOX^KVSXRKVK^SYX
+NNS^SYXKVVcaORK`OSX`O]^ONSX]O`O\KVOWZVYcOOOXQKQOWOX^
Z\YQ\KW] VSUO MOVOL\K^SYX YP 8K^SYXKV =KPO^c aOOU AY\VN
/X`S\YXWOX^NKcKXN+LLY^^/2=WYX^R^RK^aSVVROVZL_SVNK
]_]^KSXKLVO/2=M_V^_\O
Environment :
+ \O]ZYX]SLSVS^c ^YaK\N] ^RO OX`S\YXWOX^ S] ZK\^ YP +LLY^^t]
WKXNK^O AO MYX^SX_Y_]Vc OXNOK`Y\ ^Y WSXSWSdO ^RO _]O YP
\OXOaKLVO \O]Y_\MO] KXN M_^ NYaX YX MK\LYX OWS]]SYX 3X KVV
Y_\ SXS^SK^S`O] aO KNYZ^ K RYVS]^SM KZZ\YKMR KXN WKUO OPPY\^]^Y
M_\^KSV ^RO KN`O\]O OX`S\YXWOX^KV SWZKM^ SP ^RO\O S] KXc N_\SXQ
Z\YN_M^WKX_PKM^_\SXQKXNS^]NS]ZY]KVOS^RO\Lc_]Y_\`OXNY\]
Y\ M_]^YWO\] >RO ]S^O MYX^SX_ON ^Y SWZVOWOX^ W_V^SZVO aK^O\
MYX]O\`K^SYX Z\YTOM^] ^Y ]K`O aK^O\ /bKWZVO]SXMV_NO SWZ\Y`ON
MYXNOX]K^O \OMY`O\c P\YW LYSVO\] SX]^KVVK^SYX YP
V^O\ LKQ aK]RSXQ KXN N\cSXQ WKMRSXO ^Y ]K`O  VS^O\] YP aK^O\
ZO\ aK]RSXQ McMVO KXN SX^O\WONSK^O Z\YN_M^ MYX^KSXO\ MVOKXSXQ
WKMRSXO SX]^KVVON ^Y ]K`O  VS^O\] YP aK^O\ ZO\ MYX^KSXO\
>RO^\OK^ONaK^O\P\YWY_\aK]^OaK^O\^\OK^WOX^ZVKX^S]\OMcMVON
PY\RY\^SM_V^_\OaS^RSX^RO]S^O
>RO -YWZKXc RK] K ]^K^OYP^ROK\^ OP
1YK aS^R ZK\KWO^O\] YP ^\OK^ON OP
]O^Lc^ROVYMKV=^K^O:YVV_^SYX-YX^\YV,YK\N9_\1YKZVKX^S]K
uD/<9vNS]MRK\QOZVKX^
9`O\^ROZO\SYNYPVK]^cOK\]^RO]S^ORK]KMRSO`ONWY\O^RKX
 KL]YV_^O aK^O\ \ON_M^SYX SX _]KQO KXN ^RO \KSX aK^O\
RK\`O]^SXQ Z\YTOM^ aK] OPPOM^S`OVc MYX^SX_ON K^ ^RO :VKX^ ^RS]
cOK\ aRSMR \O]_V^ON SX  56 YP aK^O\ ]^Y\KQO N_\SXQ ^RO
WYX]YYX]OK]YX
7KTY\ PYM_] N_\SXQ ^RO cOK\ aK] cSOVN SWZ\Y`OWOX^
+VYXQ aS^R SXM\OK]SXQ Z\YN_M^S`S^c ^RS] SXS^SK^S`O RK] ROVZON
]K`O ^RO NS]MRK\QO YP \Ka WK^O\SKV] KXN ]YV`OX^] SX^Y ^RO
OX`S\YXWOX^
1YKZVKX^RK]\OMOS`ON^ROu,O]^/X`S\YXWOX^KV:\KM^SMO]+aK\Nv
P\YW1YK=^K^O:YVV_^SYX-YX^\YV,YK\N^Y\OMYQXS]O^ROOPPY\^]PY\
\OMcMVSXQ^RO_]ONaK^O\P\YWVS[_SNLY^^VOMVOKXSXQWKMRSXO]SX
MYYVSXQaK^O\^YaO\]SX_^SVS^c]OM^SYX
F_\^RO\WY\O QK] OWS]]SYX] P\YW ^RO LYSVO\ KXN QOXO\K^Y\
]^KMU]K]aOVVK]^ROKWLSOX^KS\[_KVS^cK\OWYXS^Y\ON\OQ_VK\Vc
Lc_]KXN^ROcK\OaOVVLOVYa^ROVSWS^]]O^Lc^RO=^K^O:YVV_^SYX
-YX^\YV,YK\N>RO\OS]KV]YK`O\WSMYWZY]^SXQ_XS^SXZVKMO
^Y MYX`O\^ MKX^OOX aK]^O SX^Y Y\QKXSM WKX_\O aRSMR S] _]ON
SX^ROVKaX]KXNYX^ROZVKX^K^SYXSX]SNO^ROPKM^Y\cZ\OWS]O]
>RO ]S^O \O^KSX] S^] DO\Y AK]^O ^Y VKXN VV MO\^S MK^SYX SX ^RO
STATUTORY REPORT FINANCIAL STATEMENTS
Z_\`SOaYPaK]^ONS]ZY]KV3X! YP^ROaK]^OaK]]OX^
PY\ \OMcMVSXQ   PY\ SXMSXO\K^SYXMYZ\YMO]]SXQ KXN  PY\
MYWZY]^SXQ9XOYPY_\]SQXS MKX^KMRSO`OWOX^]RK]LOOX^RO
MRKXQSXQ PK^O YP RKdK\NY_] aK]^O ^R\Y_QR Y_\ SXS^SK^S`O] ^RK^
MRKXQONP\YW3XMSXO\K^SYX^Y-YZ\YMO]]SXQAS^R^RS]MRKXQO
aO RK`O OX]_\ON ^RK^ ^RO OXO\Qc P\YW ^RO aK]^O S] \OMY`O\ON
^R_]MYX^\SL_^SXQ^Y^RO\ON_M^SYXYP-9OWS]]SYXKXNQVYLKV
aK\WSXQ   YP ]S^O aK]^O aK] SXMSXO\K^ON aS^R OXO\Qc
\OMY`O\c
CONSERVATION OF ENERGY, TECHNOLOGY
ABSORPTION AND FOREIGN EXCHANGE EARNINGS
AND OUTGO
>RO ZK\^SM_VK\] K] \O[_S\ON _XNO\ ^RO Z\Y`S]SYX] YP =OM^SYX
 W YP ^RO -YWZKXSO] +M^  \OKN aS^R <_VO " YP ^RO
-YWZKXSO]+MMY_X^]<_VO]SX\O]ZOM^YP-YX]O\`K^SYXYP
/XO\Qc>OMRXYVYQc+L]Y\Z^SYX0Y\OSQX/bMRKXQO/K\XSXQ]KXN
9_^QYO^MK\OKXXObONK]u+XXOb_\O3@vKXNPY\W]ZK\^YP^RS]
<OZY\^
EXTRACT OF ANNUAL RETURN
/b^\KM^ YP +XX_KV <O^_\X K] Z\Y`SNON _XNO\ ]_L]OM^SYX  YP
=OM^SYX#YP^RO-YWZKXSO]+M^KXN<_VO]P\KWON^RO\O_XNO\
S]KXXObONK]u+XXOb_\O@vKXNPY\W]ZK\^YP^RS]<OZY\^
COMPANIES ACT, 2013 AND OTHER DISCLOSURES
AS PER RULE 5 OF THE COMPANIES (APPOINTMENT
AND REMUNERATION OF MANAGERIAL PERSONNEL)
RULES, 2014
.S]MVY]_\O] \O[_S\ON SX KMMY\NKXMO aS^R ^RO Z\Y`S]SYX] YP
=OM^SYX #! YP ^RO -YWZKXSO] +M^  \OKN aS^R <_VO 
of the Companies (Appointment and Remuneration of Managerial
:O\]YXXOV <_VO]  S] KXXObON K] u+XXOb_\O @3v KXN PY\W]
ZK\^YP^RS]<OZY\^
Statement containing Particulars of Employees pursuant
^Y =OM^SYX #! YP ^RO -YWZKXSO] +M^  \OKN aS^R
<_VO  YP ^RO -YWZKXSO] +ZZYSX^WOX^ KXN <OW_XO\K^SYX
YP7KXKQO\SKV:O\]YXXOV<_VO]PY\W]ZK\^YP^RS]<OZY\^
2YaO`O\ K] ZO\ ^RO Z\Y`S]SYX] YP =OM^SYX]  KXN   YP ^RO
-YWZKXSO] +M^  ^RO <OZY\^ KXN 0SXKXMSKV =^K^OWOX^] K\O
LOSXQ]OX^^Y^RO7OWLO\]KXNY^RO\]OX^S^VON^RO\O^YObMV_NSXQ
^RO =^K^OWOX^ MYX^KSXSXQ :K\^SM_VK\] YP /WZVYcOO] aRSMR S]
K`KSVKLVOPY\SX]ZOM^SYXLc^RO7OWLO\]K^^RO<OQS]^O\ON9P MO
YP ^RO -YWZKXc N_\SXQ L_]SXO]] RY_\] YX KVV aY\USXQ NKc]
ObMOZ^ =K^_\NKc] _Z ^Y ^RO NK^O YP OX]_SXQ +XX_KV 1OXO\KV
7OO^SXQ +Xc 7OWLO\ SX^O\O]^ON SX YL^KSXSXQ K MYZc YP ]_MR
=^K^OWOX^WKca\S^O^Y^RO-YWZKXc=OM\O^K\cK^^RO<OQS]^O\ON
9P MOYP^RO-YWZKXc
53
 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

CORPORATE GOVERNANCE REPORT GENERAL ANNEXURE I

+XX_KV<OZY\^YP-=<+M^S`S^SO]PY\^RO XKXMSKVcOK\!"
-Y\ZY\K^O 1Y`O\XKXMO <OZY\^ KVYXQ aS^R K -O\^S MK^O P\YW ^RO 8YNS]MVY]_\OY\\OZY\^SXQS]\O[_S\ONSX\O]ZOM^YP^ROPYVVYaSXQ E3XMYWZVSKXMOaS^R=OM^SYXYP^RO-YWZKXSO]+M^KXN-YWZKXSO]-Y\ZY\K^O=YMSKV<O]ZYX]SLSVS^c<_VO]G
=^K^_^Y\c +_NS^Y\] YP ^RO -YWZKXc aS^R \OQK\N ^Y MYWZVSKXMO S^OW]K]^RO\OaO\OXY^\KX]KM^SYX]\OVK^SXQ^Y^RO]OS^OW]N_\SXQ
1. Brief outline of the Company’s CSR Policy w =_MR Y^RO\ Z\YTOM^] ^RK^ PKVV aS^RSX ^RO Z_\`SOa YP ^RO
YP ^RO MYXNS^SYX] YP -Y\ZY\K^O 1Y`O\XKXMO Z_\]_KX^ ^Y ^RO ^ROcOK\_XNO\\O`SOa$ KM^S`S^SO]SXMV_NONSX=MRON_VO@33YP^RO-YWZKXSO]+M^
Policy Statement :
\O[_S\OWOX^] YP ^RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK  3 ]]_OYPO[_S^c]RK\O]aS^RNSPPO\OX^SKV\SQR^]K]^YNS`SNOXN KXN<_VO]P\KWON^RO\O_XNO\K]KWOXNONP\YW^SWO
`Y^SXQY\Y^RO\aS]O% +^ +LLY^^ aO LOVSO`O ^RK^ SXXY`K^S`O \O]ZYX]SLVO KXN ^Y^SWO
6S]^SXQ 9LVSQK^SYX] KXN .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX]
]_]^KSXKLVO L_]SXO]] ZVKc] KX SWZY\^KX^ \YVO SX L_SVNSXQ K  >RO -=< ZYVSMc S] K`KSVKLVO YX ^RO -YWZKXct] aOL]S^O K^
PY\W]ZK\^YP^RS]<OZY\^  3 ]]_OYP]RK\O]SXMV_NSXQ]aOK^O[_S^c]RK\O]^YOWZVYcOO] ROKV^Rc ^R\S`SXQ ]YMSO^c >RO -=< ZYVSMc YP +LLY^^ 3XNSK R^^Z$aaaKLLY^^MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV
YP^RO-YWZKXc_XNO\KXc]MROWO% 6SWS^ONS]PYM_]ONYXPY]^O\SXQOMYXYWSMOX`S\YXWOX^KVKXN
BUSINESS RESPONSIBILITY REPORT ]YMSKV aOVVLOSXQ >R\Y_QR Y_\ -=< SXS^SK^S`O] aO ]^\S`O ^Y 2. Composition of CSR Committee :
 >RO -YWZKXc NYO] XY^ RK`O KXc TYSX^ `OX^_\O OXRKXMO ZOYZVOt] ROKV^R KXN aOVVLOSXQ KXN Z\Y`SNO VK]^SXQ 
,_]SXO]] <O]ZYX]SLSVS^c <OZY\^ K] \O[_S\ON _XNO\ <OQ_VK^SYX >RO-=<-YWWS^^OOK]YX^RONK^OYP^RS]<OZY\^S]MYWZ\S]ON
 Y\]_L]SNSK\SO] ]YV_^SYX]^YNO`OVYZWOX^MRKVVOXQO]
YP^RO=OM_\S^SO]KXN/bMRKXQO,YK\NYP3XNSK6S]^SXQ9LVSQK^SYX] YP^ROPYVVYaSXQ.S\OM^Y\]$
AWARDS AND RECOGNITIONS -Y\O-=<K\OK]SNOX^S ONLc^RO-YWZKXc$
KXN .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX]  PY\W] ZK\^ YP Sr. Name of Member Category
3X KMMY\NKXMO aS^R ^RO ]^K^_^Y\c \O[_S\OWOX^] KXN UOOZSXQ No.
this Report ._\SXQ ^RO cOK\ ^RO -YWZKXc aYX ]O`O\KV Z\O]^SQSY_] KaK\N] ^RO -YWZKXc ZRSVY]YZRc K^ Z\SY\S^c ^RO -=< -YWWS^^OO  7\7_XS\=RKSUR-RKS\WKX 8YX/bOM_^S`O.S\OM^Y\
KXN \OMYQXS^SYX] SXMV_NSXQ u,O]^ -YWZKXSO] ^Y AY\U 0Y\v Lc SNOX^S ON ^RO PYVVYaSXQ ^R\_]^ K\OK] SX VSXO aS^R Y_\ -=<
DISCLOSURES OF ORDERS PASSED BY REGULATORS QYKV]$
 Mr Krishna Mohan Sahni Independent Director
,_]SXO]] >YNKc% ,O]^ 7K\UO^SXQ -KWZKSQX PY\ u-YX]^SZK^SYX
OR COURTS OR TRIBUNAL 3 7\+WLK^S@OX_ Managing Director
-YX`O\]K^SYX]v Lc 2OKV^RMK\O 6OKNO\]RSZ +aK\N]% ,O]^ _]O YP  w Enhancing access to healthcare across the country for a
8YY\NO\]RK`OLOOXZK]]ONLcKXc<OQ_VK^Y\Y\-Y_\^Y\>\SL_XKV >OMRXYVYQc PY\ >\KSXSXQ KXN /bMOVVOXMO SX ^RO :\YN_M^SYX YP ROKV^Rc]YMSO^c%MYXN_M^SXQaOVVXO]]MKWZ]PY\SWZ\Y`SXQ  +`O\KQO8O^:\Y ^YP^RO-YWZKXcPY\VK]^^R\OO XKXMSKV
6OK\XSXQ-YX^OX^Lc^RAY\VN>\KSXSXQ.O`OVYZWOX^-YXQ\O]]% VS`O]YP^RO_XNO\Z\S`SVOQONMYWW_XS^c% years* :
aRSMR MKX RK`O SWZKM^ YX ^RO QYSXQ MYXMO\X ]^K^_] KXN ^RO
=SV`O\PY\.SQS^KV7K\UO^SXQ/bMOVVOXMOPY\+LLY^^3XNSK<KNSYLc  w -RK\S^KLVONYXK^SYX]KXNON_MK^SYXKVQ\KX^]PY\]O\`SXQ `#  6KUR]
-YWZKXct]YZO\K^SYX]SXP_^_\O ^RO_XNO\]O\`ON]OM^SYX]YP]YMSO^c%
.313BB  MKVM_VK^ONYX^ROLK]S]YP8O^:\Y ^]PY\^RO XKXMSKVcOK\]
FIXED DEPOSITS  w <OKMRSXQ Y_^ ^Y 1Y`O\XWOX^ ^Y KN`KXMO ]Y_XN Z_LVSM  KXN !
EMPLOYEES ZYVSMcKXNObZKXNZK^SOX^KMMO]]^YROKV^RMK\O%
8Y bONNOZY]S^]aO\OKMMOZ^ONN_\SXQ^ROcOK\  w .S]OK]O KaK\OXO]] Z\YTOM^]KM^S`S^SO] ^RK^ ]_ZZY\^ 4. Prescribed CSR Expenditure (two percent of the amount
CY_\ ,YK\N \OMYQXS]O] ^RO Ob^OX]S`O MYX^\SL_^SYX WKNO Lc KVV ]_L]SNS]ON]M\OOXSXQKXN^\OK^WOX^% as in item 3 above) :
PARTICULARS OF LOANS, INVESTMENTS AND OWZVYcOO] ^YaK\N] ^RO Q\Ya^R YP ^RO -YWZKXc cOK\KP^O\cOK\  w :\YN_M^NYXK^SYX]^R\Y_QR^\_]^ONZK\^XO\]SX^ROMYX^Ob^ `!"!6KUR]
GUARANTEES KXNZVKMO]YX\OMY\NS^]]SXMO\OKZZ\OMSK^SYXPY\^RO]KWO YP+LLY^^t]QVYLKVZYVSMSO]KXNSX^O\XK^SYXKV]^KXNK\N]%  .O^KSV]YP-=<]ZOX^N_\SXQ^RO XKXMSKVcOK\$
 w /b^OXNSXQ ]_ZZY\^ ^Y `K\SY_] 819] ^R\Y_QR WYXO^K\c
._\SXQ^ROcOK\^RO-YWZKXcQ\KX^ONKVYKXYP` 6KUR] ACKNOWLEDGEMENT grants for education healthcare and livelihood of  K >Y^KVKWY_X^]ZOX^N_\SXQ^RO XKXMSKVcOK\x` #
_XNO\Z\S`SVOQONMRSVN\OXKXNaYWOX% 6KUR]
^Y+VO\O7ONSMKV:\S`K^O6SWS^ON3XNSKK<OVK^ON:K\^cK]ZO\^RO CY_\ ,YK\N S] ]SXMO\OVc ^RKXUP_V ^Y KVV L_]SXO]] ZK\^XO\]
Z\Y`S]SYX]YP^RO=OM_\S^SO]KXN/bMRKXQO,YK\NYP3XNSK6S]^SXQ  w /X`S\YXWOX^Z\Y^OM^SYXWOK]_\O]%  L +WY_X^_X]ZOX^SPKXc8SV
SX]^S^_^SYX] LKXU] KXN SX ZK\^SM_VK\ ^RO 7OWLO\] PY\ ^ROS\
9LVSQK^SYX]KXN.S]MVY]_\O<O[_S\OWOX^]<OQ_VK^SYX]PY\ YXQYSXQ]_ZZY\^KXN^\_]^SX^RO-YWZKXc  M 7KXXO\SXaRSMR^ROKWY_X^aK]]ZOX^N_\SXQ^RO XKXMSKVcOK\S]NO^KSVONLOVYa
(` in Lakhs)
KZO\SYNYP]SbWYX^R]YX.OMOWLO\ !K^KXSX^O\O]^\K^O
For and on behalf of the Board Sr. CSR Project Name Schedule VII Location Amount Amount spent on the Cumulative Amount Spent :
YPZO\KXX_WZ_\]_KX^^Y^ROZ\Y`S]SYX]YP=OM^SYX" YP^RO
No. Category Outlay projects or programs Expenditure Direct or through
-YWZKXSO]+M^KXN<_VO]P\KWON^RO\O_XNO\^YZKcYPPS^] (Budget) 1) Direct Implementing
Munir Shaikh R A Shah 2) Overheads Agency
ObS]^SXQSX^O\MYWZKXc^\KNOVSKLSVS^c>RO]KSNVYKXS]Q_K\KX^OON Chairman Director  2OKV^R-VSXSM] :\YWY^SXQ2OKV^RMK\O Pan-India    Direct
Lc+LLY^^6KLY\K^Y\SO]?=+SO^RO_V^SWK^ORYVNSXQMYWZKXc .38$# !       .38$#" Implementation
 8S\WKV.RK\K.KS\c:\YTOM^ <_\KV.O`OVYZWOX^ +RWONXKQK\ #" #" #" Direct
:\YWY^SXQ1OXNO\ Maharashtra Implementation
/[_KVS^c3WZ\Y`SXQ
6S`OVSRYYN]
3 =/A+x-\OK^SXQK :\YWY^SXQ2OKV^RMK\O Pan-India       Direct
=_]^KSXKLVO2OKV^RMK\O :\YWY^SXQ1OXNO\ Implementation
Delivery Model through /[_KVS^cKXN
6S`OVSRYYN] /OWZYaO\SXQAYWOX
 iCARE Road Safety Drive Promoting Education Pan-India ""  "" "" Direct
Implementation
 +NWSXS]^\K^S`O/bZOX]O]   
Total 9,12.22 9,12.22 9,12.22
The Responsibility Statement of the CSR Committee of the Board of Directors –
u>ROSWZVOWOX^K^SYXKXNWYXS^Y\SXQYP-=<:YVSMcK\OSXMYWZVSKXMOaS^R-=<9LTOM^S`O]KXN:YVSMcYP^RO-YWZKXcv

Munir Shaikh Krishna Mohan Sahni

           -RKS\WKX-=<-YWWS^^OO   7OWLO\-=<-YWWS^^OO
           .38$# !    .38$"

54 ANNUAL REPORT 2017-18 55

 ABBOTT INDIA LIMITED
ANNEXURE II
Policy on Nomination and Appointment of Directors/Criteria for Appointment of Senior Management
E3XMYWZVSKXMOaS^R^ROZ\Y`S]SYX]YP=OM^SYX!"YP^RO-YWZKXSO]+M^KXN<OQ_VK^SYX#\OKNaS^R=MRON_VO33:K\^.+
YP^RO=OM_\S^SO]KXN/bMRKXQO,YK\NYP3XNSK6S]^SXQ9LVSQK^SYX]KXN.S]MVY]_\O<O[_S\OWOX^]<OQ_VK^SYX]G
1. Purpose :   9 ^RO\ K\OK] YP ObZO\SOXMO aRSMR K\O NO]S\KLVO PY\
\OZ\O]OX^K^SYXYX^RO+LLY^^LYK\NSXMV_NOL_^K\OXY^
  3 X ^O\W] YP ^RO Z\Y`S]SYX] YP =OM^SYX !" YP ^RO
VSWS^ON^Y$
-YWZKXSO] +M^  <_VO] WKNO ^RO\O_XNO\ KXN
^RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK 6S]^SXQ    7ONSMSXO
9LVSQK^SYX] KXN .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX]    7K\UO^SXQ
 ^RO 8YWSXK^SYX KXN <OW_XO\K^SYX -YWWS^^OO    7ONSMKV KXN =MSOX^S M <O]OK\MR KXN
S] SX^O\ KVSK \O[_S\ON ^Y NO^O\WSXO ^RO KZZ\YZ\SK^O
Development
]SdO KXN MYWZY]S^SYX YP ^RO ,YK\N PY\W_VK^O M\S^O\SK
PY\ SNOX^SPcSXQ ]_S^KLVO MKXNSNK^O] PY\ ^RO ZY]S^SYX YP    0SXKXMO
Directors and Senior Management and criteria for    3X^O\XK^SYXKV,_]SXO]]
NO^O\WSXSXQ ^RO [_KVS MK^SYX] ZY]S^S`O K^^\SL_^O] KXN   9^RO\[_KVS MK^SYX]^RK^aY_VNLOROVZP_VSXKNNS^SYX^Y
SXNOZOXNOXMO YP NS\OM^Y\ NO`S]O ]_MMO]]SYX ZVKX KXN ^ROKLY`OSXMV_NOL_^K\OXY^VSWS^ON^Y$
\OMYWWOXN ^Y ^RO ,YK\N KZZYSX^WOX^ KXN \OWY`KV YP    =OXSY\VO`OVQY`O\XWOX^ObZO\SOXMO
,YK\NWOWLO\]KXN=OXSY\7KXKQOWOX^ZO\]YXXOV
   +MKNOWSMKNWSXS]^\K^SYX
  >
 RS] :YVSMc ]RKVV KM^ K] K Q_SNOVSXO PY\ NO^O\WSXSXQ
   >RO,YK\N]RKVVSXMV_NOK\KXQOYPKQO]KXNKNS`O\]S^cYP
[_KVS MK^SYX] ZY]S^S`O K^^\SL_^O] KXN SXNOZOXNOXMO YP
O^RXSMS^cQOXNO\KXNQOYQ\KZRc
a Director and matters related to the appointment and
\OWY`KVYP.S\OM^Y\]KXN=OXSY\7KXKQOWOX^  ! :\SWK\cMRK\KM^O\S]^SM]\O[_S\ONSXXOaLYK\NMKXNSNK^O]$
2. Objective :   ! >ROcW_]^LO \]^KXNPY\OWY]^KLVOKXNaSVVSXQ
^Y \OZ\O]OX^ ^RO ]RK\ORYVNO\]t ]RY\^^O\W KXN
  >
 RS] :YVSMc aY_VN VKc NYaX M\S^O\SK KXN ^O\W] KXN VYXQ^O\WOMYXYWSMSX^O\O]^]
MYXNS^SYX] aS^R \OQK\N ^Y SNOX^SPcSXQ ZO\]YX] aRY K\O
  ! >ROcW_]^LOKLVO^YMYX^\SL_^O^Y^ROO`KV_K^SYX
[_KVS ON^YLOMYWO.S\OM^Y\]/bOM_^S`O8YXObOM_^S`O
YP^ROObS]^SXQWKXKQOWOX^YP^RO-YWZKXc
KXN 3XNOZOXNOX^ KXN =OXSY\ 7KXKQOWOX^ SXMV_NSXQ
^ROS\[_KVS MK^SYX]ZY]S^S`OK^^\SL_^O]KXNSXNOZOXNOXMO   ! >ROc W_]^ KV]Y LO MYQXSdKX^ YP ^RO
\O]ZYX]SLSVS^SO]YP^RO-YWZKXc^Y$
3. Criteria for appointment of Directors :
Its employees
  >
 RO PYVVYaSXQ MRK\KM^O\S]^SM] ]RKVV LO ^KUOX SX^Y
Its customers
MYX]SNO\K^SYXaROX]OVOM^SXQXYWSXOO]PY\^RO,YK\NYP
Social issues
.S\OM^Y\]3XNS`SN_KVXYWSXOO]NYXY^XOON^Y]K^S]PcKVV
^RO[_KVS MK^SYX]VS]^ONLOVYaKXN^RO\OS]XY\O[_S\OWOX^ Regulatory authorities
  ! >ROcW_]^LOaSVVSXQ^Y^KUO^ROXOMO]]K\c^SWO
^RK^KVV[_KVS MK^SYX]LO\OZ\O]OX^ONYX^ROLYK\N
^Y Z\YZO\Vc Z\OZK\O PY\ LYK\N KXN MYWWS^^OO
  3 XKNNS^SYX^Y^RO]ZOMS MMRK\KM^O\S]^SM]]O^PY\^RLOVYa WOO^SXQ] K^ K WSXSW_W LK]ON YX K ^RY\Y_QR
LYK\NWOWLO\]]RY_VNK^KWSXSW_WRK`OLKMUQ\Y_XN] \O`SOa YP ^RO WK^O\SKV ]_ZZVSON LOPY\O OKMR
^RK^ aROX MYWLSXON Z\Y`SNO K ZY\^PYVSY YP ObZO\SOXMO
LYK\NWOO^SXQ
KXN UXYaVONQO ^RK^ aSVV ]O\`O +LLY^^t] QY`O\XKXMO KXN
]^\K^OQSM XOON] ,YK\N MKXNSNK^O] aSVV LO MYX]SNO\ON YX  " :\SWK\c MRK\KM^O\S]^SM] \O[_S\ON PY\ \OXYWSXK^SYX YP
SXM_WLOX^NS\OM^Y\]$
^RO LK]S] YP K \KXQO YP M\S^O\SK SXMV_NSXQ L\YKNLK]ON
L_]SXO]] UXYaVONQO KXN \OVK^SYX]RSZ] Z\YWSXOXMO KXN   " 3XM_WLOX^ NS\OM^Y\] ]RY_VN MYX^SX_O ^Y WOO^
ObMOVVOX^\OZ_^K^SYX]SX^ROS\Z\SWK\c OVN]YPOXNOK`Y\ ^ROQOXO\KV[_KVS MK^SYX]Y_^VSXONKLY`OKXNSX
K]aOVVK]KL\YKNL_]SXO]]ZO\]ZOM^S`OKXNMYWWS^WOX^ KNNS^SYX]RY_VNKLSNOLc^ROPYVVYaSXQM\S^O\SK$
^Y QYYN MY\ZY\K^O MS^SdOX]RSZ .S\OM^Y\] ]RY_VN RK`O     " +NO[_K^O Z\OZK\K^SYX PY\ LYK\N KXN
NOWYX]^\K^ON ObZO\SOXMO KXN KLSVS^c ^RK^ S] \OVO`KX^ ^Y MYWWS^^OO WOO^SXQ] SXMV_NSXQ K
^RO ,YK\N YP .S\OM^Y\]t Y`O\]SQR^ \YVO aS^R \O]ZOM^ ^Y ^RY\Y_QR\O`SOaYPKXNPKWSVSK\S^caS^R
+LLY^^t]L_]SXO]]KXNKPPKS\] ^RO a\S^^OX WK^O\SKV] ]_ZZVSON LOPY\O
  =
 ^\YXQWKXKQOWOX^ObZO\SOXMOSNOKVVcaS^RWKTY\Z_LVSM each meeting
MYWZKXSO] aS^R ]_MMO]]P_V W_V^SXK^SYXKV YZO\K^SYX]     " :K\^SMSZK^SYX SX KXN MYX^\SL_^SYX]
^Y LYK\N KXN MYWWS^^OO NS]M_]]SYX]
SXMV_NSXQL_^XY^VSWS^ON^Y$
through useful and pertinent
 Active or recently retired Chairman and Chief
]_QQO]^SYX][_O]^SYX]KXNMYWWOX^]
/bOM_^S`O9P MO\]
    " :\Y`SNSXQYXQYSXQKN`SMOKXNMY_X]OV
:\O]SNOX^]KXN-RSOP9ZO\K^SXQ9P MO\]
^Y WKXKQOWOX^ YX ^RO NS\OM^Y\t] YaX
/bOM_^S`OY\1\Y_Z@SMO:\O]SNOX^]aS^R]RY\^^O\W SXS^SK^S`O KXN aROX \O[_O]^ON Lc
ZY^OX^SKVPY\WY`OWOX^^YS^OWY\KLY`O management
56 ANNUAL REPORT 2017-18
CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS
" <OQ_VK\ K^^OXNKXMO K^ LYK\N KXN  ! >
 RO 7KXKQSXQ .S\OM^Y\/bOM_^S`O .S\OM^Y\]8YX
committee meetings /bOM_^S`O .S\OM^Y\]5Oc 7KXKQO\SKV :O\]YXXOV K\O
    " 7KSX^KSXSXQKXSXNOZOXNOX^PKWSVSK\S^c KZZYSX^ONLc^RO,YK\NYP.S\OM^Y\]_ZYX\OMYWWOXNK^SYX
P\YW^RO8YWSXK^SYXKXN<OW_XO\K^SYX-YWWS^^OO
aS^R ^RO Ob^O\XKV OX`S\YXWOX^] SX
aRSMR ^RO -Y\ZY\K^SYX YZO\K^O]  ! =
 OXSY\7KXKQOWOX^:O\]YXXOV]RKVVLOKZZYSX^ONLc^RO
KXN O]ZOMSKVVc SX ^RO NS\OM^Y\t] YaX -YWZKXcK]ZO\-YWZKXcZYVSMSO]
ZK\^SM_VK\ OVN]YPObZO\^S]O 8. Term/Tenure :
4. Other Positive Attributes for Directors :  "  7KXKQSXQ.S\OM^Y\/bOM_^S`O.S\OM^Y\]$
  3 ^S]NO]S\KLVO^RK^MKXNSNK^O]Z\YZY]ONPY\.S\OM^Y\]RSZ   " 7KXKQSXQ .S\OM^Y\/bOM_^S`O .S\OM^Y\] ]RKVV
ZY]]O]]^ROPYVVYaSXQZY]S^S`OK^^\SL_^O]$ \O^S\O K] ZO\ ^RO KZZVSMKLVO Z\Y`S]SYX] YP ^RO
   +XcZY]^Q\KN_K^SYX[_KVS MK^SYX]P\YW\OZ_^ON -YWZKXSO]+M^Y\<_VO]WKNO^RO\O_XNO\
L_]SXO]]]MRYYV]_XS`O\]S^SO]SX3XNSKY\KL\YKN% Y\^ROZ\O`KSVSXQ+LLY^^3XNSK6SWS^ONQ_SNOVSXO]
YX\O^S\OWOX^YP.S\OM^Y\]aRSMRO`O\S]OK\VSO\
   /bZO\SOXMO KXN ObZO\^S]O SX NOKVSXQ aS^R
]^\K^OQSMS]]_O]KXNVYXQ^O\WZO\]ZOM^S`O]%   " >RO,YK\NaSVVRK`O^RONS]M\O^SYX^Y\O^KSX^RO
   =^\YXQ VOKNO\]RSZ ObZO\SOXMO K ]_ZO\SY\ retiring Director in the same position even after
UXYaVONQO YP L_]SXO]] Z\SXMSZVO] KXN MKZKMS^c K^^KSXSXQ ^RO \O^S\OWOX^ KQO PY\ ^RO LOXO ^ YP
PY\ SXNOZOXNOX^ ^RY_QR^ KXN ObO\MS]SXQ ^RO-YWZKXc
SXNOZOXNOX^T_NQWOX^%
  " =ZOMSKV \O]YV_^SYX XOON] ^Y LO ZK]]ON PY\
   +LSVS^c ^Y ZK\^SMSZK^O MYX]^\_M^S`OVc SX KZZYSX^WOX^ \OKZZYSX^WOX^ YP .S\OM^Y\ SX
NOVSLO\K^SYX]K^LYK\NWOO^SXQ]% ^RO ZY]S^SYX YP 7KXKQSXQ .S\OM^Y\/bOM_^S`O
.S\OM^Y\]aRYRK`OK^^KSXONKQOYP!cOK\]
   ASVVSXQXO]]^YObO\MS]OK_^RY\S^cSXKMYVVOM^S`O
WKXXO\% 9. Independent Director :
    3X[_S]S^S`O KXN YLTOM^S`O ZO\]ZOM^S`O Z\KM^SMKV  # +
 X3XNOZOXNOX^.S\OM^Y\]RKVVRYVNYP MOPY\K^O\WYP_Z
aS]NYWKXNWK^_\OT_NQWOX^% ^Y `OMYX]OM_^S`OcOK\]YX^RO,YK\NYP^RO-YWZKXcKXN
  ! =OVPMYX NOXMO ^Y MYX^\SL_^O ^Y LYK\N aSVVLOOVSQSLVOPY\\OKZZYSX^WOX^PY\KXY^RO\^O\WYP_Z
NOVSLO\K^SYX]KXN]^K^_\O]_MR^RK^Y^RO\LYK\N ^YMYX]OM_^S`OcOK\]YXZK]]SXQYPK]ZOMSKV\O]YV_^SYX
WOWLO\]aSVV\O]ZOM^RS]Y\RO\`SOa% Lc ^RO -YWZKXc KXN NS]MVY]_\O YP ]_MR KZZYSX^WOX^ SX
  " -KZKLVOYPNO`Y^SXQ]_P MSOX^^SWOKXNK^^OX^SYX ^RO,YK\Nt]<OZY\^
^YRS]RO\Z\YPO]]SYXKVYLVSQK^SYX]PY\SXPY\WON  # 8
 Y3XNOZOXNOX^.S\OM^Y\]RKVVRYVNYP MOPY\WY\O^RKX
KXNLKVKXMONNOMS]SYXWKUSXQ% ^aY MYX]OM_^S`O ^O\W] L_^ ]_MR 3XNOZOXNOX^ .S\OM^Y\
  # 0YM_]ON ^YaK\N] ^RO -YWZKXc KXN QOXO\Y_] ]RKVV LO OVSQSLVO PY\ KZZYSX^WOX^ KP^O\ ObZS\c YP ^R\OO
cOK\] YP MOK]SXQ ^Y LOMYWO KX 3XNOZOXNOX^ .S\OM^Y\
YZOXWSXNON^YaK\N]^RO^OKW%
:\Y`SNON^RK^KX3XNOZOXNOX^.S\OM^Y\]RKVVXY^N_\SXQ
   0S^ KXN Z\YZO\ ZO\]YX YP SWZOMMKLVO SX^OQ\S^c ^RO ]KSN ZO\SYN YP ^R\OO cOK\] LO KZZYSX^ON SX Y\ LO
\OZ_^K^SYXKXNMRK\KM^O\%KL]OXMOYPMYX`SM^SYX]
K]]YMSK^ONaS^R^RO-YWZKXcSXKXcY^RO\MKZKMS^cOS^RO\
KXN\O]^\KSX^Y\NO\]%KXNMYWZO^OXMOSXMV_NSXQ NS\OM^VcY\SXNS\OM^Vc
XKXMSKV]YV`OXMcKXNXO^aY\^R
10. Non- Executive Director (other than Independent
5. Independence :
Director) :
  3 X MK]O YP KZZYSX^WOX^ YP 3XNOZOXNOX^ .S\OM^Y\ ^RO
  9^RO\XYXObOM_^S`O.S\OM^Y\]]RKVV\O^S\OLc\Y^K^SYXK]
candidate shall meet the criteria of Independence as set ZO\^ROKZZVSMKLVOZ\Y`S]SYX]YP^RO-YWZKXSO]+M^
Y_^SX+XXOb_\O3 Y\<_VO]WKNO^RO\O_XNO\K]KWOXNONP\YW^SWO^Y^SWO
6. Criteria for Appointment of Senior Management : 11. Key Managerial Personnel and Senior Management :
  3 XNS`SN_KV] YP RSQR SX^OQ\S^c aRY RK`O K ]YVSN \OMY\N YP  Key Managerial Personnel and Senior Management shall
KMMYWZVS]RWOX^SX^ROS\MRY]OX OVN]KXNaRYZY]]O]]^RO retire as per the Company policy or their employment
[_KVS MK^SYX][_KVS^SO]KXN]USVV]^YOPPOM^S`OVc\OZ\O]OX^ ^O\W]
^ROLO]^SX^O\O]^]YPKVV]^KUORYVNO\]-KXNSNK^O]aSVVLO
]OVOM^ONPY\^ROS\KLSVS^c^YObO\MS]OQYYNT_NQWOX^KXN^Y 12. Removal :
Z\Y`SNOZ\KM^SMKVSX]SQR^]KXNNS`O\]OZO\]ZOM^S`O]  >RO -YWWS^^OO WKc \OMYWWOXN ^Y ^RO ,YK\N aS^R
7. Appointment Mechanism : \OK]YX]\OMY\NONSXa\S^SXQ\OWY`KVYPKX3XNOZOXNOX^
.S\OM^Y\ KXN 5Oc 7KXKQO\SKV :O\]YXXOV ]_LTOM^ ^Y ^RO
 ! >
 RO8YWSXK^SYXKXN<OW_XO\K^SYX-YWWS^^OO]RKVVZVKc Z\Y`S]SYX] KXN MYWZVSKXMO YP ^RO -YWZKXSO] +M^ 
KMYX]_V^K^S`O\YVOPY\KXcKZZYSX^WOX^\O[_S\SXQ,YK\N
<_VO]WKNO^RO\O_XNO\KXNY^RO\KZZVSMKLVO\OQ_VK^SYX]
KZZ\Y`KVK]]^SZ_VK^ONLcVKaY\\OQ_VK^SYXPY\.S\OM^Y\] KXNKZZVSMKLVOZYVSMSO]YP^RO-YWZKXc
Key Managerial Personnel and Senior Management
YP MSKV]3^]RKVVZ\Y`SNOS^]KN`SMOKXN\OMYWWOXNK^SYX]  >RO=OXSY\7KXKQOWOX^:O\]YXXOV]RKVVLO\OWY`ONLc
^Y^RO,YK\N ^RO-YWZKXcK]ZO\-YWZKXcZYVSMSO]
57
 ABBOTT INDIA LIMITED
13. Succession Planning :
  =_MMO]]SYX ZVKXXSXQ PY\ +LLY^^t] ]OXSY\ WKXKQOWOX^
ZY]S^SYX] S] M\S^SMKV ^Y +LLY^^t] VYXQ^O\W ]_MMO]]
>RO 8YWSXK^SYX KXN <OW_XO\K^SYX -YWWS^^OO ]RKVV
KXX_KVVc\O`SOaKXNMYXPO\aS^R^RO7KXKQSXQ.S\OM^Y\
KXN^RO2<.S\OM^Y\\OQK\NSXQ+LLY^^t]]_MMO]]SYXZVKX]
KXN \OZY\^ KXN WKUO \OMYWWOXNK^SYX] YX ^ROW ^Y ^RO
,YK\NYP.S\OM^Y\]
14. Review of the Policy :
  >RS]:YVSMc]RKVVLO]_LTOM^^Y\O`SOaLc^RO-YWWS^^OO
OM^SXQ ]RY\^ KXN VYXQ ^O\W ZO\PY\WKXMO   u=OXSY\7KXKQOWOX^vWOKX]ZO\]YXXOVYP^ROMYWZKXc
K^ ]_MR SX^O\`KV] K] WKc LO NOOWON XOMO]]K\c -RKXQO]
SPKXc\OMYWWOXNONLc^RO-YWWS^^OO]RKVVLOZVKMON
LOPY\O^RO,YK\NPY\S^]KZZ\Y`KV
ANNEXURE
1. Criteria for Independence :
  +
 .S\OM^Y\S]MYX]SNO\ON3XNOZOXNOX^SP^RO,YK\NWKUO]
KXKP \WK^S`ONO^O\WSXK^SYXKP^O\K\O`SOaYPKVV\OVO`KX^
SXPY\WK^SYX 3X Y\NO\ PY\ K .S\OM^Y\ ^Y LO MYX]SNO\ON
3XNOZOXNOX^^RO.S\OM^Y\$
   =RKVVXY^LO7KXKQSXQ.S\OM^Y\Y\KARYVO^SWO
.S\OM^Y\Y\K8YWSXOO.S\OM^Y\
    RKVV LO K ZO\]YX YP SX^OQ\S^c KXN ]RKVV ZY]]O]]
= 
\OVO`KX^ObZO\^S]OKXNObZO\SOXMO
   =RKVV XY^ LO K Z\YWY^O\ YP ^RO -YWZKXc Y\ S^]
RYVNSXQ]_L]SNSK\cY\K]]YMSK^O-YWZKXc
   =RKVVXY^LO\OVK^ON^YZ\YWY^O\]Y\.S\OM^Y\]SX
^RO-YWZKXcS^]RYVNSXQ]_L]SNSK\cY\K]]YMSK^O
-YWZKXc
    ZK\^ P\YW \OMOS`SXQ .S\OM^Y\t] \OW_XO\K^SYX
+ YP ZO\PY\WKXMO OWZVYcOO ZKc K^ ^RO -YWZKXc S] YX
]RKVVXY^RK`OKXcZOM_XSK\c\OVK^SYX]RSZ]aS^R
^RO -YWZKXc S^] RYVNSXQ S^] ]_L]SNSK\c S^]
K]]YMSK^OMYWZKXSO]S^]Z\YWY^O\]Y\.S\OM^Y\]
N_\SXQ^ROM_\\OX^ XKXMSKVcOK\Y\SWWONSK^OVc
Z\OMONSXQ^aY XKXMSKVcOK\]
     OVK^S`O] ]RY_VN XY^ RK`O Y\ RKN ZOM_XSK\c
< WKXXO\ XKWOVc x 0K^RO\ SXMV_NO] ]^OZPK^RO\ 7Y^RO\
\OVK^SYX]RSZ]Y\^\KX]KM^SYX]aS^R^RO-YWZKXc
S^]RYVNSXQ]_L]SNSK\cY\K]]YMSK^O-YWZKXcY\
^ROS\Z\YWY^O\]Y\.S\OM^Y\]KWY_X^SXQ^Y
or more of its gross turnover or total income or
38<6KUR]Y\]_MRKWY_X^K]^RO-YWZKXc
WKc Z\O]M\SLO aRSMRO`O\ S] VYaO\ N_\SXQ ^RO
^aY SWWONSK^OVc Z\OMONSXQ XKXMSKV cOK\] Y\
N_\SXQ^ROM_\\OX^ XKXMSKVcOK\
  !  OS^RO\ RSW]OVPRO\]OVP XY\ KXc YP RS]RO\
8 .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX]  \O[_S\O]
relatives shall hold or has held the position of a Key
7KXKQO\SKV:O\]YXXOVY\S]Y\RK]LOOXOWZVYcOO
YP ^RO -YWZKXc Y\ S^] RYVNSXQ ]_L]SNSK\c Y\
K]]YMSK^O MYWZKXc SX KXc YP ^RO ^R\OO XKXMSKV
cOK\]SWWONSK^OVcZ\OMONSXQ^RO XKXMSKVcOK\SX
aRSMRROS]Z\YZY]ON^YLOKZZYSX^ON
 " 8OS^RO\ RSW]OVPRO\]OVP XY\ KXc YP RS]RO\
\OVK^S`O]S]Y\RK]LOOXKXOWZVYcOOY\Z\YZ\SO^Y\
Y\ K ZK\^XO\ SX KXc YP ^RO  XKXMSKV cOK\]
SWWONSK^OVcZ\OMONSXQ^RO XKXMSKVcOK\YP$
58 ANNUAL REPORT 2017-18
" + \W YP K_NS^Y\] 3X^O\XKV=^K^_^Y\c Y\
company secretaries in practice or cost
K_NS^Y\] YP ^RO -YWZKXc Y\ S^] RYVNSXQ
]_L]SNSK\cY\K]]YMSK^OMYWZKXc%
   "  XcVOQKVY\KMYX]_V^SXQ \W^RK^RK]Y\RKN
+ 
KXc^\KX]KM^SYXaS^R^RO-YWZKXcS^]RYVNSXQ
]_L]SNSK\cY\K]]YMSK^O-YWZKXcKWY_X^SXQ^Y
Y\WY\OYP^ROQ\Y]]^_\XY`O\YP]_MR \W%
   " 2YVN]^YQO^RO\aS^RRS]\OVK^S`O]Y\WY\O
YP^RO^Y^KV`Y^SXQZYaO\YP^RO-YWZKXc%
   " K-RSOP/bOM_^S`OY\.S\OM^Y\LcaRK^O`O\
XKWOMKVVONYPKXcXYXZ\Y ^Y\QKXSdK^SYX
^RK^ \OMOS`O]  Y\ WY\O YP S^] \OMOSZ^]
P\YW ^RO -YWZKXc KXc YP S^] Z\YWY^O\]
.S\OM^Y\] Y\ S^] RYVNSXQ ]_L]SNSK\c Y\
K]]YMSK^O-YWZKXcY\^RK^RYVN]Y\WY\O
YP^RO^Y^KV`Y^SXQZYaO\YP^RO-YWZKXc
  # 2K]XY^ROVNYP MOPY\WY\O^RKXMYX]OM_^S`O
^O\W]YX^RO,YK\NYP^RO-YWZKXc
   RY_VNXY^LOKWK^O\SKV]_ZZVSO\]O\`SMOZ\Y`SNO\
= 5.
Y\M_]^YWO\Y\KVO]]Y\Y\VO]]OOYP^RO-YWZKXc
   =RKVVXY^LOVO]]^RKXcOK\]YPKQO
 .O XS^SYXPY\^RO]KSNZ_\ZY]O$
  u 8YWSXOO .S\OM^Y\v SWZVSO] K .S\OM^Y\ XYWSXK^ON Lc
KXc XKXMSKVSX]^S^_^SYXSXZ_\]_KXMOYP^ROZ\Y`S]SYX]YP
KXcVKaPY\^RO^SWOLOSXQSXPY\MOY\YPKXcKQ\OOWOX^
Y\KZZYSX^ONLcKXcQY`O\XWOX^Y\KXcY^RO\ZO\]YX^Y
\OZ\O]OX^S^]SX^O\O]^]
  u +]]YMSK^O -YWZKXcv SWZVSO] K -YWZKXc aRSMR S] KX
uK]]YMSK^Ov K] NO XON SX 3XN += " u3X`O]^WOX^] SX
+]]YMSK^O]KXN4YSX^@OX^_\O]vS]]_ONLc^RO3X]^S^_^OYP
-RK\^O\ON+MMY_X^KX^]YP3XNSK
  u <OVK^S`OvSWZVSO]KXcYXOaRYS]\OVK^ON^YKXY^RO\SP^ROc
K\OWOWLO\]YP2?0%SP^ROcK\OR_]LKXNKXNaSPO%Y\SP
one person is related to the other in such manner as may
LOZ\O]M\SLON+ZO\]YX]RKVVLONOOWON^YLO^RO\OVK^S`O
YPKXY^RO\SPROY\]ROS]\OVK^ON^YKXY^RO\SX^ROPYVVYaSXQ
SXMV_NO] ]^OZWY^RO\ =YX SXMV_NO] ]^OZ]YX =YXt]
aSPO .K_QR^O\ .K_QR^O\t] R_]LKXN ,\Y^RO\ SXMV_NO]
]^OZL\Y^RO\=S]^O\SXMV_NO]]^OZ]S]^O\
Remuneration Policy
1. Purpose :
  =
 OM^SYX!"YP^RO-YWZKXSO]+M^KXN=OM_\S^SO]
KXN /bMRKXQO ,YK\N YP 3XNSK 6S]^SXQ 9LVSQK^SYX] KXN
every Nomination and Remuneration Committee
8<-^YNO`S]OK:YVSMcYX\OW_XO\K^SYXYP.S\OM^Y\]
5Oc7KXKQO\SKV:O\]YXXOV57:KXNY^RO\OWZVYcOO]
  >
 RO8<-S]\O]ZYX]SLVOPY\\OMYWWOXNSXQ^Y^RO,YK\N
K :YVSMc \OVK^SXQ ^Y ^RO \OW_XO\K^SYX YP .S\OM^Y\] 5Oc
7KXKQO\SKV:O\]YXXOVKXNY^RO\OWZVYcOO]
2. Overview :
  8
 <- RK] VKSN NYaX ^RS] :YVSMc ^Y OX]_\O MYWZVSKXMO
aS^R =OM^SYX !"  YP ^RO -YWZKXSO] +M^  aRSMR
]^K^O]^RK^$
CORPORATE OVERVIEW
   ^RO VO`OV KXN MYWZY]S^SYX YP \OW_XO\K^SYX S]
\OK]YXKLVO KXN ]_P MSOX^ ^Y K^^\KM^ \O^KSX KXN
WY^S`K^O.S\OM^Y\]YP^RO[_KVS^c\O[_S\ON^Y\_X
^ROMYWZKXc]_MMO]]P_VVc%
  \OVK^SYX]RSZ YP \OW_XO\K^SYX ^Y ZO\PY\WKXMO
is clear and meets appropriate performance
LOXMRWK\U]%KXN
   <OW_XO\K^SYX ^Y ARYVO^SWO .S\OM^Y\] 57:
and Senior Management Personnel involves
K LKVKXMO LO^aOOX bON KXN SXMOX^S`O ZKc
\O
YLTOM^S`O] KZZ\YZ\SK^O ^Y ^RO aY\USXQ YP ^RO
-YWZKXcKXNS^]QYKV]
3. Company Philosophy :
  >RO -YWZKXct] MYWZOX]K^SYX ZRSVY]YZRc S] LK]ON YX
^R\OOZ\SWK\cPKM^Y\]$
   ,OSXQ MYWZO^S^S`O aS^R ZOO\Q\Y_Z MYWZKXSO]
LY^R aS^RSX KXN Y_^]SNO YP ROKV^RMK\O aS^R
XKXMSKVZO\PY\WKXMO]SWSVK\^Y^RO-YWZKXc%
   7KUSXQ SXNS`SN_KV ZO\PY\WKXMO ^RO Z\SWK\c
N\S`O\YP^Y^KVZKc%
   6SXUSXQ ZKc ^Y KMRSO`OWOX^ YP ^RO -YWZKXct]
L_]SXO]]QYKV]
 =SWZVc]^K^ON^RO-YWZKXct]MYWZOX]K^SYXS]SX^OXNON
^Y MYWZK\O PK`Y\KLVc aS^R ^RO ZKc Z\YQ\KW] YP Y^RO\
VOKNSXQ ROKV^RMK\O MYWZKXSO] K] aOVV K] Y^RO\ RSQR
performing companies outside of the healthcare arena
^RK^RK`OK]SWSVK\]SdO]MYZOKXN XKXMSKVZO\PY\WKXMO
^Y ^RO -YWZKXc KXN YZO\K^O SX WK\UO^] aRO\O aO
MYWZO^OPY\^KVOX^
  ARSVOOWZVYcOO]K\OZKSNLK]ONYX^ROS\]USVV]KXNVO`OV]
K`O\KQO^K\QO^ON^YLOMYWZO^S^S`OK^^ROWONSKXZKcYP
Y^RO\VOKNSXQMYWZKXSO]
  >RO-YWZKXcS]NONSMK^ON^YZ\Y`SNSXQK]YVSNPY_XNK^SYX
YP OWZVYcOO LOXO ^] ^RK^ aSVV KVVYa OWZVYcOO] ^Y WOO^
^ROS\ ZO\]YXKV KXN PKWSVc XOON] AO \OMYQXSdO ^RO
SWZY\^KXMO YP XKXMSKV ]OM_\S^c PY\ ^RSXQ] ^RK^ WK^^O\
WY]^ ^Y ^RO OWZVYcOO KXN ^ROS\ PKWSVc 9_\ LOXO ^]
ZRSVY]YZRcS]LK]ONYX^R\OOZ\SWK\cMY\O`KV_O]$
   >RO -YWZKXc MK\O] KXN S] MYXMO\XON PY\ ^RO
ROKV^R aOVPK\O KXN XKXMSKV aOVVLOSXQ YP S^]
OWZVYcOO]aY\VNaSNO
   >RO -YWZKXc RK] O]^KLVS]RON MYWZO^S^S`O
LOXO ^]K]ZK\^YP^RO>Y^KV<OaK\N]YPPO\ON^Y
S^]OWZVYcOO]
  >RO -YWZKXc RK] NO`OVYZON ]^KXNK\N] PY\
OPPOM^S`O WKXKQOWOX^ YP OWZVYcOO LOXO ^
Z\YQ\KW]
  >RO -YWZKXc S] MYWWS^^ON ^Y YPPO\SXQ MYWZ\OROX]S`O
KXN MYWZO^S^S`O LOXO ^ ZKMUKQO] NO]SQXON ^Y WOO^
the changing needs of our employees and our diverse
L_]SXO]]O]
 .O XS^SYX]$
  u +M^vWOKX]^RO-YWZKXSO]+M^KXN<_VO]P\KWON
^RO\O_XNO\K]KWOXNONP\YW^SWO^Y^SWO
STATUTORY REPORT FINANCIAL STATEMENTS
 u5Oc7KXKQO\SKV:O\]YXXOVvWOKX]
  w  RSOP/bOM_^S`O9P MO\Y\^RO7KXKQSXQ.S\OM^Y\Y\
-
^RO7KXKQO\%
  w -YWZKXc=OM\O^K\c%
w ARYVO^SWO.S\OM^Y\%
  w -RSOP0SXKXMSKV9P MO\%KXN
  w  _MR Y^RO\ YP MO\ K] WKc LO Z\O]M\SLON _XNO\ ^RO
=
+M^
aRYK\OWOWLO\]YPS^]MY\OWKXKQOWOX^^OKWObMV_NSXQ
^RO ,YK\N YP .S\OM^Y\] MYWZ\S]SXQ KVV WOWLO\] YP
WKXKQOWOX^ YXO VO`OV LOVYa ^RO /bOM_^S`O .S\OM^Y\]
SXMV_NSXQ^ROP_XM^SYXKVROKN]
 u 9^RO\ /WZVYcOO]v WOKX] KVV Y^RO\ OWZVYcOO] YP
+LLY^^ 3XNSK 6SWS^ON L_^ NY XY^ SXMV_NO OWZVYcOO]
aRY RK`O ]SQXON MYVVOM^S`O Y\ _XSYX KQ\OOWOX^] Y\ YX
MYX^\KM^_KVLK]S]
Remuneration for Non-Executive Directors (Independent
& Non- Independent Directors) :
 =S^^SXQ0OO]
   8YX/bOM_^S`O .S\OM^Y\] 8/.] Y^RO\
^RKX ^RY]O OWZVYcON aS^R KXc +LLY^^ Q\Y_Z
MYWZKXcaSVVLOZKSN]S^^SXQPOO]PY\K^^OXNSXQ
OKMR WOO^SXQ YP ^RO ,YK\N KXN S^] -YWWS^^OO]
K]NO^O\WSXONLc^RO,YK\NP\YW^SWO^Y^SWOSX
KMMY\NKXMOaS^R^ROZ\Y`S]SYX]YP^RO+M^>RO
]S^^SXQPOO]ZKcKLVO^Y^RO8/.]PY\K^^OXNSXQ^RO
WOO^SXQ]YP^RO,YK\NKXN`K\SY_]-YWWS^^OO]S]
QS`OXSX^RO+XXOb_\OK^^KMRONK^^ROOXNYP^RS]
:YVSMc;_KX^_WYP]S^^SXQPOO]WKcLO]_LTOM^^Y
\O`SOaYXKZO\SYNSMLK]S]K]KXNaROX\O[_S\ON
]_LTOM^^Y^ROKZZVSMKLVO]^K^_^Y\cZ\Y`S]SYX]YP
^RO+M^K]KWOXNONP\YW^SWO^Y^SWO
  <OSWL_\]OWOX^YP\OK]YXKLVOObZOX]O]
   >RO -YWZKXc WKc ZKc Y\ \OSWL_\]O ^Y ^RO
8/.] ]_MR ObZOXNS^_\O K] WKc RK`O LOOX
SXM_\\ON Lc ^ROW PY\ K^^OXNSXQ ^RO ,YK\N
-YWWS^^OO WOO^SXQ] >RS] WKc SXMV_NO
\OSWL_\]OWOX^YPObZOXNS^_\OSXM_\\ONLc^ROW
PY\KMMYWWYNK^SYX^\K`OVKXNKXcY_^YPZYMUO^
ObZOX]O] PY\ K^^OXNSXQ ,YK\N-YWWS^^OO
WOO^SXQ] 1OXO\KV WOO^SXQ] -Y_\^ MYX`OXON
WOO^SXQ]7OO^SXQ]aS^R]RK\ORYVNO\]M\ONS^Y\]
WKXKQOWOX^]S^O`S]S^]SXN_M^SYXKXN^\KSXSXQ
Y\QKXSdONLc^RO-YWZKXcPY\.S\OM^Y\]
   3X ^RO MK]O YP 3XNOZOXNOX^ .S\OM^Y\] ^RO
-YWZKXc WKc ZKc\OSWL_\]O KXc ObZOX]O]
SXM_\\ON ]_LTOM^ ^Y \OK]YXKLVO VSWS^] Lc ^RO
independent Director for professional advice
from Independent advisors in the furtherance of
^ROS\N_^SO]K]3XNOZOXNOX^.S\OM^Y\]
  =^YMU9Z^SYX]
   3XNOZOXNOX^ .S\OM^Y\] ]RKVV XY^ LO OX^S^VON ^Y
KXc]^YMUYZ^SYX]YP^RO-YWZKXc
59
 ABBOTT INDIA LIMITED
  3X]_\KXMOZYVSMcPY\8YX/bOM_^S`O.S\OM^Y\]
   ARO\O KXc SX]_\KXMO S] ^KUOX Lc ^RO -YWZKXc
YX LORKVP YP S^] 8/.] PY\ SXNOWXSPcSXQ ^ROW
OM^TYLaY\^RLK]ONYX E:_\]_KX^^Y=OM^SYXYP^RO-YWZKXSO]+M^KXN<_VO#YP^RO-YWZKXSO]+ZZYSX^WOX^KXN<OW_XO\K^SYXYP:O\]YXXOV
KQKSX]^KXc]^K^_^Y\cVSKLSVS^c^ROZ\OWS_WZKSN
YX]_MRSX]_\KXMOaY_VNXY^MYX]^S^_^OZK\^YP
^ROS\\OW_XO\K^SYX
6. Remuneration for Managing Director (“MD”), Executive
Directors (“ED”) :
  > RO \OW_XO\K^SYX ^Y 7./. KXN KXc MRKXQO ^RO\OYP
]RKVVLOKZZ\Y`ONLc^RO,YK\NYX^RO\OMYWWOXNK^SYX
YP^RO8<-]_LTOM^^YKZZ\Y`KVLc^RO]RK\ORYVNO\]YP
^RO-YWZKXcaS^RSX^ROVSWS^]Z\O]M\SLON_XNO\^RO+M^
KXN-OX^\KV1Y`O\XWOX^KZZ\Y`KVaRO\O`O\\O[_S\ON
  0SbON \OW_XO\K^SYX S] ZKcKLVO Lc ^RO aKc YP ]KVK\c
ZO\[_S]S^O]KXNKVVYaKXMO]>RO8<-]RKVV\OMYWWOXN
^Y ^RO ,YK\N KXX_KV SXM\OWOX^] SX ]KVK\c OPPOM^S`O ]^
+Z\SVOKMRcOK\
  +ZK\^ P\YW ^RO bON \OW_XO\K^SYX ^RO\O S] K `K\SKLVO
MYWZYXOX^ YP K ZO\PY\WKXMO VSXUON SXMOX^S`O
MYWWS]]SYX aRSMR S] ZKcKLVO YX KX KXX_KV LK]S]
>ROKWY_X^YPZO\PY\WKXMOLYX_]MYWWS]]SYX]RKVVLO
NO^O\WSXONLc^RO,YK\NLK]ONYX^RO\OMYWWOXNK^SYX
YP ^RO 8<- KXN SX KVSQXWOX^ aS^R -YWZKXc ZYVSMc
>RO\OMKXLOMYWZYXOX^]YPYXO^SWOSXMOX^S`OY\]ZOMSKV
SXMOX^S`O]LK]S]RS]KQ\OONMYWZOX]K^SYX]^\_M^_\OaS^R
^RO RY]^ MY_X^\SO] SX MK]O YP ObZK^\SK^O] >RO ]KWO aSVV
LO K] \OMYWWOXNON Lc ^RO 8<- KXN KZZ\Y`ON Lc ^RO
,YK\NYP.S\OM^Y\]
  >RO -YWZKXc ]RKVV Z\Y`SNO \O^S\OWOX^ LOXO ^] K] ZO\
]^K^_^Y\c\O[_S\OWOX^]+NNS^SYXKVVc^RO\OWKcLOMO\^KSX
Y^RO\ \O^S\OWOX^ LOXO ^] ^RK^ WKc LO Z\Y`SNON ^Y 7.
/.]_MRK]ZOX]SYXQ\K^_S^c]_ZO\KXX_K^SYXO^M
  7./.K\OKV]YOVSQSLVOPY\6YXQ>O\W3XMOX^S`O]Q\KX^ON
Lc^RO:K\OX^-YWZKXc+LLY^^6KLY\K^Y\SO]?=+SX^RO
PY\WYP=^YMU9Z^SYX]KXNY\<O]^\SM^ON=^YMU?XS^]
7. Minimum Remuneration :
 ! 3 P SX KXc XKXMSKV cOK\ ^RO -YWZKXc RK] XY Z\Y ^]
Y\ S^] Z\Y ^] K\O SXKNO[_K^O ^RO -YWZKXc ]RKVV ZKc
\OW_XO\K^SYX ^Y S^] 7.  /.] SX KMMY\NKXMO aS^R ^RO
Z\Y`S]SYX]YP=MRON_VO@YP^RO+M^
8. Provisions for excess Remuneration :
 " 3 P7./.N\Ka]Y\\OMOS`O]NS\OM^VcY\SXNS\OM^VcLcaKc
YP \OW_XO\K^SYX KXc ]_MR ]_W] SX ObMO]] YP ^RO VSWS^]
Z\O]M\SLON _XNO\ ^RO +M^ Y\ aS^RY_^ ^RO Z\SY\ ]KXM^SYX
YP^RO-OX^\KV1Y`O\XWOX^aRO\O\O[_S\ONRO]RO]RKVV
refund such sums to the Company and until such sum is
\OP_XNONRYVNS^SX^\_]^PY\^RO-YWZKXc>RO-YWZKXc
]RKVV XY^ aKS`O \OMY`O\c YP ]_MR ]_W \OP_XNKLVO ^Y S^
_XVO]]ZO\WS^^ONLc^RO-OX^\KV1Y`O\XWOX^
9. Key Managerial Personnel (“KMP”), Senior Management
and Other Employees :
 # ,K]O=KVK\c
  # =KVK\SO] ^Y 57: =OXSY\ 7KXKQOWOX^ KXN
Y^RO\ OWZVYcOO] K\O NOMSNON LK]S] ^RO VO`OV YP
\O]ZYX]SLSVS^cKXNSXNS`SN_KVZO\PY\WKXMO,K]O
ZKc]^\_M^_\OaY_VNNOZOXN_ZYX$
   w :Y]S^SYXO`KV_K^SYX]%
60 ANNUAL REPORT 2017-18
CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS
   w Periodic surveys of appropriate comparison ANNEXURE III
MYWZKXSO]% =OM\O^K\SKV+_NS^<OZY\^PY\^RO XKXMSKVcOK\OXNON7K\MR"
   w =KVK\c\KXQO]aRSMR\O
MYWZO^S^S`OMYWZK\S]YX] <_VO]G
 # ,YX_]:O\[_S]S^O]+VVYaKXMO]KXN,OXO ^]
  # 3X KNNS^SYX ^Y ^RO bON ]KVK\c MO\^KSX >Y 3 RK`OKV]YObKWSXONMYWZVSKXMOaS^R^ROKZZVSMKLVOMVK_]O]YP^RO
PYVVYaSXQ$
ZO\[_S]S^O] KVVYaKXMO] KXN LOXO ^] K\O >RO7OWLO\]
Z\Y`SNON^Y^RO57:]=OXSY\7KXKQOWOX^KXN  S =
 OM\O^K\SKV=^KXNK\N]S]]_ONLc>RO3X]^S^_^OYP-YWZKXc
+LLY^^3XNSK6SWS^ON
Y^RO\OWZVYcOO] =OM\O^K\SO]YP3XNSKK]KWOXNONP\YW^SWO^Y^SWO%
  # >RO-YWZKXcM_\\OX^VcZ\Y`SNO]KVVOWZVYcOO] 3 8OOXK ,RK^SK KZZYSX^ON K] ^RO =OM\O^K\SKV +_NS^Y\ YP ^RO
aS^R ]YMSKV ]OM_\S^c SX ^O\W] YP SX]_\KXMO -YWZKXcLc^RO,YK\NYP.S\OM^Y\]RK`OMYXN_M^ON^RO=OM\O^K\SKV  SS >
 RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK 6S]^SXQ
^YaK\N]RY]ZS^KVSdK^SYX7ONSMVKSWSX]_\KXMO +_NS^ YP ^RO MYWZVSKXMO aS^R KZZVSMKLVO ]^K^_^Y\c Z\Y`S]SYX] 9LVSQK^SYX] KXN .S]MVY]_\O <O[_S\OWOX^] <OQ_VK^SYX]
KMMSNOX^KVNOK^RKXNNS]WOWLO\WOX^ZO\]YXKV KXN ^RO KNRO\OXMO ^Y QYYN MY\ZY\K^O Z\KM^SMO] Lc +LLY^^ 3XNSK 
KMMSNOX^SX]_\KXMO 6SWS^ON RO\OSXKP^O\ MKVVON u^RO -YWZKXcv =OM\O^K\SKV +_NS^  YLO]^YPWc_XNO\]^KXNSXQ3KWYP^RO`SOa^RK^N_\SXQ^ROZO\SYN
>
  # >RO -YWZKXc Z\Y`SNO] \O^S\OWOX^ LOXO ^] K] aK]MYXN_M^ONSXKWKXXO\^RK^Z\Y`SNONWOK\OK]YXKLVOLK]S] _XNO\ \O`SOa ^RO -YWZKXc RK] MYWZVSON aS^R ^RO Z\Y`S]SYX]
ZO\]^K^_^Y\c\O[_S\OWOX^] PY\O`KV_K^SXQ^ROMY\ZY\K^OMYXN_M^]]^K^_^Y\cMYWZVSKXMO]KXN
YP ^RO +M^ <_VO] <OQ_VK^SYX] KXN 1_SNOVSXO] =^KXNK\N] O^M
  # >RO -YWZKXc Z\Y`SNO] K ZO\PY\WKXMO ObZ\O]]SXQWcYZSXSYX^RO\OYX WOX^SYXONKLY`O
VSXUON MK]R LYX_] ^Y KVV OWZVYcOO] LK]ON YX
,K]ONYXWc`O\S MK^SYXYP^RO-YWZKXct]LYYU]ZKZO\]WSX_^O I further report that :
performance of the Company in general and LYYU PY\W] KXN \O^_\X] VON KXN Y^RO\ \OMY\N] WKSX^KSXON Lc
^RO SXNS`SN_KVt] ZO\PY\WKXMO PY\ ^RO \OVO`KX^
^RO -YWZKXc KXN KV]Y SXPY\WK^SYX Z\Y`SNON Lc ^RO -YWZKXc 2K`SXQ \OQK\N ^Y ^RO MYWZVSKXMO ]c]^OW Z\O`KSVSXQ SX ^RO
XKXMSKV cOK\ WOK]_\ON KQKSX]^ ]ZOMS M 5Oc
S^] YP MO\] KQOX^] KXN K_^RY\SdON \OZ\O]OX^K^S`O] N_\SXQ ^RO -YWZKXc KXN YX ObKWSXK^SYX YP ^RO \OVO`KX^ NYM_WOX^] KXN
<O]_V^+\OK]aRSMRK\OKVSQXON^Y^RO-YWZKXct] \OMY\N]SXZ_\]_KXMO^RO\OYPYX^O]^MROMULK]S]^RO-YWZKXc
YLTOM^S`O]KXNZYVSMSO] MYXN_M^YP=OM\O^K\SKV+_NS^3RO\OLc\OZY\^^RK^SXWcYZSXSYX
^RO-YWZKXcRK]N_\SXQ^ROK_NS^ZO\SYNMY`O\SXQ^RO XKXMSKV RK]MYWZVSONaS^R^ROPYVVYaSXQVKa]KZZVSMKLVO]ZOMS MKVVc^Y^RO
  # 57:=OXSY\ 7KXKQOWOX^ :O\]YXXOVY^RO\ -YWZKXc$
OWZVYcOO] K] ZO\ ^ROS\ Q\KNO K\O KV]Y OVSQSLVO cOK\ OXNON YX 7K\MR  " MYWZVSON aS^R ^RO ]^K^_^Y\c
provisions listed hereunder and also that the Company has
PY\6YXQ>O\W3XMOX^S`O]Q\KX^ONLc^RO:K\OX^  K .
 \_Q] KXN -Y]WO^SM] +M^ # KXN .\_Q] KXN -Y]WO^SM]
-YWZKXc+LLY^^6KLY\K^Y\SO]?=+SX^ROPY\W Z\YZO\ ,YK\N Z\YMO]]O] KXN MYWZVSKXMO WOMRKXS]W SX ZVKMO <_VO#%
YP=^YMU9Z^SYX]KXNY\<O]^\SM^ON=^YMU?XS^] ^Y^ROOb^OX^SX^ROWKXXO\KXN]_LTOM^^Y^RO\OZY\^SXQWKNO
 L .
 \_Q]KXN7KQSM<OWONSO]9LTOM^SYXKLVO+N`O\^S]OWOX^
10. Merit Pay : RO\OSXKP^O\$
+M^#%
  >ROMYWWYXOPPOM^S`ONK^OPY\WO\S^ZKcSXM\OK]OS]YX 3 RK`O ObKWSXON ^RO LYYU] ZKZO\] WSX_^O LYYU PY\W] KXN
 M .\_Q]:\SMO-YX^\YV9\NO\%
]^ +Z\SV YP ^RO MKVOXNK\ cOK\ 7O\S^ ZKc S] SX^OXNON ^Y \O^_\X] VONKXNY^RO\\OMY\N]WKSX^KSXONLc^RO-YWZKXcPY\^RO
focus solely on individual performance against goals and XKXMSKVcOK\OXNONYX7K\MR"KMMY\NSXQ^Y^ROZ\Y`S]SYX] I further report that :
ObZOM^K^SYX] NO^O\WSXON PY\ KX SXNS`SN_KV N_\SXQ ^RO YP$ >RO,YK\NYP.S\OM^Y\]YP^RO-YWZKXcS]N_VcMYX]^S^_^ONaS^R
:O\PY\WKXMO/bMOVVOXMO\O`SOaZ\YMO]]    RO-YWZKXSO]+M^KXN^RO<_VO]WKNO^RO\O_XNO\
> Z\YZO\ LKVKXMO YP /bOM_^S`O .S\OM^Y\] 8YX/bOM_^S`O .S\OM^Y\]
11. Policy Implementation : K]KWOXNONP\YW^SWO^Y^SWO^RO+M^% KXN3XNOZOXNOX^.S\OM^Y\]
  >RO 8<- S] \O]ZYX]SLVO PY\ \OMYWWOXNSXQ ^RS]   >
 RO =OM_\S^SO] -YX^\KM^] <OQ_VK^SYX +M^ #  =-<+ +NO[_K^O XY^SMO S] QS`OX ^Y KVV .S\OM^Y\] ^Y ]MRON_VO ^RO ,YK\N
<OW_XO\K^SYX:YVSMc^Y^RO,YK\N KXN^RO<_VO]WKNO^RO\O_XNO\% 7OO^SXQ]+QOXNKKXNNO^KSVONXY^O]YXKQOXNKaO\O]OX^K^VOK]^
 >RO ,YK\N S] \O]ZYX]SLVO PY\ KZZ\Y`SXQ KXN Y`O\]OOSXQ ]O`OXNKc]SXKN`KXMOKXNK]c]^OWObS]^]PY\]OOUSXQKXNYL^KSXSXQ
  >
 RO.OZY]S^Y\SO]+M^## KXN^RO<OQ_VK^SYX]KXN,cO
SWZVOWOX^K^SYXYP^RS]:YVSMcaS^R^RO]_ZZY\^YP^RO8<- P_\^RO\SXPY\WK^SYXKXNMVK\S MK^SYX]YX^ROKQOXNKS^OW]LOPY\O
VKa]P\KWON^RO\O_XNO\%
12. Review of this Policy : ^ROWOO^SXQKXNPY\WOKXSXQP_VZK\^SMSZK^SYXK^^ROWOO^SXQ
  0
 Y\OSQX/bMRKXQO7KXKQOWOX^+M^###KXN^RO<_VO]
  >RS] :YVSMc ]RKVV LO ]_LTOM^ ^Y \O`SOa Lc ^RO 8<- K^ .OMS]SYX S] MK\\SON ^R\Y_QR 7KTY\S^c aRSVO ^RO NS]]OX^SXQ
KXN<OQ_VK^SYX]WKNO^RO\O_XNO\^Y^ROOb^OX^YP0Y\OSQX
]_MR SX^O\`KV] K] WKc LO NOOWON XOMO]]K\c -RKXQO] .S\OM^3X`O]^WOX^% WOWLO\t] `SOa] SP KXc K\O MKZ^_\ON KXN \OMY\NON K] ZK\^ YP ^RO
SPKXc\OMYWWOXNONLc^RO8<-]RKVVLOZVKMONLOPY\O WSX_^O]
^RO,YK\NPY\S^]KZZ\Y`KV   >
 RO PYVVYaSXQ <OQ_VK^SYX] KXN 1_SNOVSXO] Z\O]M\SLON
_XNO\ ^RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK +M^ 3P_\^RO\\OZY\^^RK^^RO\OK\OKNO[_K^O]c]^OW]KXNZ\YMO]]O]SX
ANNEXURE TO THE POLICY ##s=/,3+M^t`Sd$ ^RO-YWZKXcMYWWOX]_\K^OaS^R^RO]SdOKXNYZO\K^SYX]YP^RO
Sr. Board/Committee Meeting Amount per Meeting -YWZKXc^YWYXS^Y\KXNOX]_\OMYWZVSKXMOaS^RKZZVSMKLVOVKa]
No. per Director (`)   K >
 RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK \_VO]\OQ_VK^SYX]KXNQ_SNOVSXO]
 ,YK\NYP.S\OM^Y\]SXMV_NSXQ7OO^SXQ]YP  =_L]^KX^SKV +M[_S]S^SYX YP =RK\O] KXN >KUOY`O\
<OQ_VK^SYX]K]KWOXNONP\YW^SWO^Y^SWO% >RS] \OZY\^ S] ^Y LO \OKN aS^R Wc VO^^O\ YP O`OX NK^O aRSMR S]
3XNOZOXNOX^.S\OM^Y\]
KXXObONK]+XXOb_\OKXNPY\W]SX^OQ\KVZK\^YP^RS]\OZY\^
 Audit Committee    L >
 RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK
3 8YWSXK^SYX<OW_XO\K^SYX-YWWS^^OO  :\YRSLS^SYXYP3X]SNO\>\KNSXQ<OQ_VK^SYX]%
 =^KUORYVNO\]<OVK^SYX]RSZ-YWWS^^OO 
  M >
 RO =OM_\S^SO] KXN /bMRKXQO ,YK\N YP 3XNSK Neena Bhatia
 -Y\ZY\K^O=YMSKV<O]ZYX]SLSVS^c 
<OQS]^\K\] ^Y KX 3]]_O KXN =RK\O >\KX]PO\ +QOX^] Practicing Company Secretary
Committee :VKMO$7_WLKS    7OWLO\]RSZ8Y$0-=##
<OQ_VK^SYX]##\OQK\NSXQ^RO-YWZKXSO]+M^KXN
<S]U7KXKQOWOX^-YWWS^^OO  .K^O$7Kc"   -O\^S MK^OYP:\KM^SMO8Y$ 
NOKVSXQaS^RMVSOX^
61
 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

+XXOb_\O^Y^RO=OM\O^K\SKV+_NS^<OZY\^YP+LLY^^3XNSK6SWS^ONPY\ XKXMSKVcOK\OXNON7K\MR" ANNEXURE IV

Conservation of Energy, Technology Absorption and Foreign Exchange Earnings and Outgo
>Y E3XMYWZVSKXMOaS^R^ROZ\Y`S]SYX]YP=OM^SYXWYP^RO-YWZKXSO]+M^\OKNaS^R<_VO"YP^RO-YWZKXSO]+MMY_X^]<_VO]G
>RO7OWLO\]
A. Conservation of Energy w  Oa`YV_WO^\SMVS[_SN VVSXQVSXOSXM\OK]ON^ROcSOVN]
8
+LLY^^3XNSK6SWS^ON YP -\OWKP X KXN ._ZRKVKM Lc  KXN SWZ\Y`ON
i. The Energy conservation measures taken
7c<OZY\^YPO`OXNK^OS]^YLO\OKNKVYXQaS^R^RS]VO^^O\    /bS]^SXQ 0V_Y\O]MOX^ >_LO 6SQR^ RSQR ZYaO\ 0>6 Y`O\KVVO[_SZWOX^OP MSOXMcLc 
MYX]_WSXQVSQR^]\OZVKMONaS^ROXO\Qc]K`SXQ6SQR^   w  OL\KZ\SX^O\]SX]^KVVONPY\Z\SX^SXQYP]RSZZO\VKLOV]
D
  KSX^OXKXMOYP]OM\O^K\SKV\OMY\NS]^RO\O]ZYX]SLSVS^cYP^RO7KXKQOWOX^YP^RO-YWZKXc7c\O]ZYX]SLSVS^cS]^YObZ\O]]KXYZSXSYX
7 /WS^^SXQ.SYNO6/.VSQR^]SX;_KVS^c-YX^\YVK\OK] SX^KLVO^KXNVS[_SN]OMYXNK\cZKMUSXQK\OK^Y\OZVKMO
YX^RO]O]OM\O^K\SKV\OMY\N]LK]ONYXWcK_NS^ WKX_KVY`O\Z\SX^SXQYP]RSZZO\VKLOV]KVYXQaS^R^aY
   8OaMYXNOX]K^O\OMY`O\cZ_WZSX]^KVVON^YSWZ\Y`O
 3  RK`O PYVVYaON ^RO K_NS^ Z\KM^SMO] KXN Z\YMO]]O] K] aO\O KZZ\YZ\SK^O ^Y YL^KSX \OK]YXKLVO K]]_\KXMO KLY_^ ^RO MY\\OM^XO]] ^ROMYXNOX]K^O\OMY`O\cP\YW^Y" WKXZYaO\]K`SXQ]ZO\]RSP^
YP ^RO MYX^OX^] YP ^RO ]OM\O^K\SKV \OMY\N] >RO `O\S MK^SYX aK] NYXO YX ^O]^ LK]S] ^Y OX]_\O ^RK^ MY\\OM^ PKM^] K\O \O
OM^ON SX   0YVVYaSXQ WOK]_\O] RK`O LOOX ^KUOX K^ ^RO 1YK ZVKX^   w  \OWKP X LK^MR ]SdO SXM\OK]ON P\YW  56 ^Y
-
]OM\O^K\SKV\OMY\N]3LOVSO`O^RK^^ROZ\YMO]]O]KXNZ\KM^SMO]3PYVVYaONZ\Y`SNOK\OK]YXKLVOLK]S]PY\WcYZSXSYX N_\SXQ^ROcOK\!"PY\MYX]O\`K^SYXYPaK^O\x  56 ^Y MYZO _Z aS^R SXM\OK]SXQ WK\UO^ NOWKXN
   /P
_OX^ >\OK^WOX^ :VKX^ ^\OK^ON aK^O\ _]ON PY\ >RS] SXS^SK^S`O \O]_V^ON SX KZZ\YbSWK^OVc  
 3RK`OXY^`O\S ON^ROMY\\OM^XO]]KXNKZZ\YZ\SK^OXO]]YP XKXMSKV\OMY\N]KXNLYYU]YPKMMY_X^]YP^RO-YWZKXc ^YSVO^
_]RSXQSXMRKXQO\YYW] \ON_M^SYXSXVSXOMVOK\KXMO]^SWO\ON_M^SYXSX
   0V_SNLONN\cO\ V^O\LKQaK]RSXQKXNN\cSXQWKMRSXO LK^MR ^O]^SXQ KXN  SXM\OK]O SX VS[_SN VVSXQ VSXO
 A
 RO\O`O\ \O[_S\ON 3 RK`O YL^KSXON ^RO 7KXKQOWOX^ <OZ\O]OX^K^SYX KLY_^ ^RO MYWZVSKXMO YP VKa] \_VO] KXN \OQ_VK^SYX] KXN
RKZZOXSXQYPO`OX^]O^M SX]^KVVON^Y]K`OVS^O\]YPaK^O\ZO\aK]RSXQMcMVO OP MSOXMc
- Intermediate product container cleaning machine   w  K_XMR YP XOa =5?] -\OWKP X  WV ?NSVS` t]
6
 >
 RO MYWZVSKXMO YP ^RO Z\Y`S]SYX] YP -Y\ZY\K^O KXN Y^RO\ KZZVSMKLVO VKa] \_VO] \OQ_VK^SYX] ]^KXNK\N] S] ^RO \O]ZYX]SLSVS^c YP SX]^KVVON^Y]K`OVS^O\]YPaK^O\ZO\MYX^KSXO\ XOaZKMU._ZRKVKM6OWYX
K`Y\
7KXKQOWOX^7cObKWSXK^SYXaK]VSWS^ON^Y^RO`O\S MK^SYXYPZ\YMON_\O]YX^O]^LK]S] ii. The steps taken by the Company for utilizing iii. In case of imported technology (imported during the
alternate sources of energy last three years reckoned from the beginning of the
 >
 RO=OM\O^K\SKV+_NS^<OZY\^S]XOS^RO\KXK]]_\KXMOK]^Y^ROP_^_\O`SKLSVS^cYP^RO-YWZKXcXY\YP^ROOP MKMcY\OPPOM^S`OXO]]
aS^RaRSMR^RO7KXKQOWOX^RK]MYXN_M^ON^ROKPPKS\]YP^RO-YWZKXc Nil XKXMSKVcOK\
iii. The Capital Investment on Energy Conservation   K ^RONO^KSV]YP^OMRXYVYQcSWZY\^ON$8SV
Equipment
Neena Bhatia   L ^ROcOK\YPSWZY\^$8SV
` !6KUR]
Practicing Company Secretary   M aRO^RO\^RO^OMRXYVYQcLOOXP_VVcKL]Y\LON$8+
:VKMO$7_WLKS    7OWLO\]RSZ8Y$0-=## B. Technology Absorption
  N S PXY^P_VVcKN]Y\LONK\OK]aRO\OKN]Y\Z^SYXRK]XY^
.K^O$7Kc"   -O\^S MK^OYP:\KM^SMO8Y$  i. The efforts made towards Technology Absorption ^KUOXZVKMOKXN^RO\OK]YX]^RO\OYP$8+
  w 2SQR ]ZOON RKWWO\ WSVV SX]^KVVON ^Y SWZ\Y`O iv. Expenditure on Research & Development
^RO OP MSOXMc YP ]_QK\ WSVVSXQ Z\YMO]] ^Y \ON_MO
O\QYXYWSM\S]UaRSVOWKX_KVRKXNVSXQYP]_QK\KXN Sr. No. Particulars ` in Lakhs
^Y\ON_MO^ROVKLY\RY_\]ZO\LK^MR
K Capital !
  w ,_MUO^ ^cZO ]OVPMVOKXSXQ V^O\ SX]^KVVON SX VS[_SN
WKX_PKM^_\SXQK\OK^Y\ON_MOYZOXRKXNSXQYPVS[_SN L Recurring "!
WK^O\SKV]N_\SXQLK^MRWKX_PKM^_\SXQ M >Y^KV !
  w Pneumatic pumps installed for paste charging in N >Y^KV<.ObZOXNS^_\OK]K:O\MOX^KQO 
VS[_SNWKX_PKM^_\SXQK\OK^Y\ON_MOO\QYXYWSM\S]U YP>Y^KV>_\XY`O\
aRSVO WKX_KV VYKNSXQ YP ZK]^O] SX]SNO ^RO ^KXU]
^R\Y_QRRYZZO\ C. Foreign Exchange Earnings and Outgo
  w Closed loop system installed for chloroform transfer Particulars ` in Lakhs
P\YWYXO^KXU^YKXY^RO\^KXU^Y\ON_MO^RO\S]UYP
WKX_KVRKXNVSXQKXNSXRKVK^SYXYPMRVY\YPY\W A. Total Foreign Exchange used
  w >\KMU^\KMO]c]^OWPY\^O\^SK\cZKMUSXQSX]^KVVON^Y K 9XSWZY\^YP\KaWK^O\SKV] XS]RONQYYN]  
MYWZVcaS^RM_\\OX^\OQ_VK^SYX] MYX]_WKLVO]^Y\O]KXNMKZS^KVQYYN]
w 9XVSXOSX]ZOM^SYX]c]^OWSX]^KVVONYXLVS]^O\ZKMUSXQ L 9XZ\YPO]]SYXKVMRK\QO]]KVO]Z\YWY^SYX !
WKMRSXO]^Y\OTOM^XYX VVONLVS]^O\]YXVSXO ObZOX]O]MYWWS]]SYXYXObZY\^]KVO]
  w 3X]^KVVK^SYXYPNcXKWSM]^K^SMZK]]LYbPY\Z\YZO\ \OQS]^\K^SYXPOO]L_]SXO]]^\K`OV]YP^aK\OO^M
WK^O\SKV
Ya M 9XZ_\MRK]OYP>\KNOWK\U] !!#
 SS >RO LOXO ^] NO\S`ON VSUO Z\YN_M^ SWZ\Y`OWOX^ N For dividend remittance ! 
cost reduction, product development or import B. Total Foreign Exchange earned
substitution
K /bZY\^]YPQYYN] #!
  w 8Oa @SNOYTO^ Z\SX^O\] SX]^KVVON YX VS[_SN KXN ^KLVO^
]OMYXNK\cZKMUSXQVSXO]SXY\NO\^Y\ON_MO^ROZKMUSXQ L Service income  
VSXO]^YZZKQO]YXKMMY_X^YPYVNZ\SX^O\L\OKUNYaX] M <OMY`O\cYPObZOX]O] 
\O]_V^SXQSXSXM\OK]ONOP MSOXMcYPZKMUSXQVSXO]KXN
\ON_M^SYXSX^ROaK]^KQOYPZKMUSXQWK^O\SKV] N Other earnings  

62 ANNUAL REPORT 2017-18 63

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

ANNEXURE V Category of No. of Shares held at the beginning of the year No. of Shares held at the end of the year %
/b^\KM^YP+XX_KV<O^_\XK]YX XKXMSKVcOK\OXNON7K\MR" Shareholders Demat Physical Total % of Total Demat Physical Total % of Total Change
Share Shares during
FORM NO. MGT 9 the year
:_\]_KX^^Y=OM^SYX#YP^RO-YWZKXSO]+M^KXN<_VOYP^RO-YWZKXSO]7KXKQOWOX^+NWSXS]^\K^SYX<_VO] B. Public Shareholding
 Institutions
i. REGISTRATION AND OTHER DETAILS
K Mutual Funds #  #   "    
CIN $ 6#72#:6-! L ,KXU]03  " " !!   ## " !  !
Registration Date $ +_Q_]^# M -OX^\KV1Y`^ - - - - - - - - -
Name of the Company $ +LLY^^3XNSK6SWS^ON N =^K^O1Y`^] - - - - - - - - -
-K^OQY\c=_L-K^OQY\cYP^RO-YWZKXc $ -YWZKXc6SWS^ON,c=RK\O]3XNSKX8YX1Y`O\XWOX^-YWZKXc O Venture Capital Funds - - - - - - - - -
+NN\O]]YP^RO<OQS]^O\ONYP MOKXNMYX^KM^NO^KSV] $ -Y\ZY\K^O:K\U=SYX>\YWLKc<YKN7_WLKSx! P  Insurance Companies #  - #  #  -   !
>OVOZRYXO8Y$# !#!""""#" # Q FIIs   !    -    
0Kb$# !#!"!!#"  R Foreign Venture
- - - - - - - - -
ARO^RO\VS]^ONMYWZKXc $ Yes Capital Investors
S ;_KVS ON0Y\OSQX
8KWO+NN\O]]KXN-YX^KM^NO^KSV]YP^RO<OQS]^\K\KXN $ 5K\`c-YWZ_^O\]RK\O:\S`K^O6SWS^ON - - - - - - - - -
Investor
=RK\O>\KX]PO\+QOX^$ ?XS^x+LLY^^3XNSK6SWS^ON
+NN\O]]5K\`c=OVOXS_W>YaO\,:VY^1KMRSLYaVS T 9^RO\]]ZOMSPc
0SXKXMSKV.S]^\SM^8KXKU\KWQ_NK2cNO\KLKNx 0Y\OSQX:Y\^PYVSYx-Y\Z #!# - #!# " #"# - #"# " 
>OV8Y$# ! 0Kb8Y$# ! Sub-total (B)(1) : 1887110 708 1887818 8.88 1901062 458 1901520 8.95 +0.07%
 Non-Institutions
ii. PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY
K ,YNSO]-Y\Z
 +VV^ROL_]SXO]]KM^S`S^SO]MYX^\SL_^SXQY\WY\OYP^RO^Y^KV^_\XY`O\YP^RO-YWZKXc]RKVVLO]^K^ON$ S Indian  ! #  "  !"    #   
Sr. Name and Description of main Products/ NIC Code of the Product/Service % to total turnover of the Company SS Overseas - - - - - - - - -
No. Services L Individuals
 Pharmaceuticals   S Individual
shareholders
iii. PARTICULARS OF HOLDING, SUBSIDIARY AND ASSOCIATE COMPANIES holding nominal  #!  #!# #"  ! ! " #   
share capital
Sr. Name and address of the Company CIN/GLN Holding/Subsidiary/ % of shares Applicable section
upto `6KUR
No. Associate held
SS Individual
 +LLY^^-KZS^KV3XNSK6SWS^ON NA 2YVNSXQ   YP^RO-YWZKXSO] shareholders
+NN\O]]$+LLY^^2Y_]O@KX`KVV,_]SXO]]:K\U +M^ holding nominal   ! #"    #! # #" !" " !
7KSNOXROKN,O\U]RS\O=6 B/ share capital in
ObMO]]YP`6KUR
IV. SHARE HOLDING PATTERN (Equity Share Capital Breakup as percentage of Total Equity)
M 9^RO\]]ZOMSPc
i Category-wise Share Holding Alternative
- - - - "! - "! # #
Category of No. of Shares held at the beginning of the year No. of Shares held at the end of the year % Investment Fund
Shareholders Demat Physical Total % of Total Demat Physical Total % of Total Change >\_]^ ! - ! -   -   - -
Share Shares during 8<3<OZ   #  ! #     !  -
the year -VOK\SXQ7OWLO\  -   " - "  
A. Promoters
8<38YX<OZ "  # !   # #  
 Indian
0Y\OSQX-Y\Z,YNSO] - ! ! - - ! ! - -
K 3XNS`SN_KV2?0 - - - - - - - -- -
L -OX^\KV1Y`^ - - - - - - - -- - Investor Education
and Protection Fund - - - - "# - "#  
M =^K^O1Y`^] - - - - - - - -- -
Authority
N ,YNSO]-Y\Z - - - - - - - -- -
- - - - - - - -- - Unclaimed Suspense
O ,KXU]03 - - - -  ! -  !  
Account
P  Any other - - - - - - - -- -
8,0- - - - -  " -  "  
Sub-total (A)(1) : - - - - - - - -- -
 Foreign 0Y\OSQX8K^SYXKV
- - - - - - - - -
K 8<3]x3XNS`SN_KV] - - - - - - - - - ,YNSO]9-,
L 9^RO\x3XNS`SN_KV] - - - - - - - - - 8=.6SX^\KX]S^ - - - - - - - - -
M ,YNSO]-Y\Z #" - #" !## #" - #" !## - Sub-total (B)(2) : 2816856 610580 3427436 16.13 2885628 528106 3413734 16.07 -0.06%
N ,KXU]03 - - - - - - - - - Total Public Shareholding
4703966 611288 5315254 25.01 4786690 528564 5315254 25.01 -
O Any other - - - - - - - - - (B)=(B)(1)+(B)(2)
Sub-total (A)(2) : #" - #" !## #" - #" !## - C. Shares held by Custodian for
- - - - - - - - -
Total shareholding of GDRs & ADRs
15934048 - 15934048 74.99 15934048 - 15934048 74.99 -
Promoter (A) = (A)(1)+(A)(2) Grand Total (A+B+C) 20638014 611288 21249302 100.00 20720738 528564 21249302 100.00 -

64 ANNUAL REPORT 2017-18 65

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

ii. Shareholding of Promoters Sr. Name Shareholding Cumulative shareholding

No during the year (1/04/2017
Sr. Shareholder’s Shareholding at the beginning of the year Shareholding at the end of the Year % change
to 31/03/2018)
No. Name in share
No. of % of total % of Shares No. of % of total % of Shares No. of Shares at % of total Date Increase / Reason No. of % of total
holding
Shares Shares Pledged / Shares Shares of the Pledged / the beginning shares Decrease in Shares shares
during
of the encumbered to Company encumbered of the year of the shareholding of the
the year
Company total shares to total shares (1/04/2017) company company
 +LLY^^-KZS^KV3XNSK6SWS^ON?5 !##!  - !##!  - -
 196.7+8=+-2=38.3+ !# " ! - - !# "
 +LLY^^2OKV^RMK\O:\YN_M^] !# !  - !# !  - - 6373>/. !! !# >\KX]PO\ "#"! "!
6SWS^ON?5
" - - "#"! "!
 ,\S^S]R-YVVYSN]6SWS^ON?5 !  # - !  # - -
 </63+8-/-+:3>+6 !  # ! - - !  #
Total 15934048 74.99 - 15934048 74.99 - -
><?=>//-97:+8C !!  >\KX]PO\  ! !#
iii. No Change in the shareholding of the Promoters during the year. 6373</.+-
!!  >\KX]PO\  # "
</63+8-/73.=7+66
iv. SHAREHOLDING PATTERN OF TOP TEN SHAREHOLDERS (OTHER THAN DIRECTORS, PROMOTERS AND HOLDERS " - -  # "
CAP FUND
OF GDRS AND ADRS)
 =>/38,/<1 ##! " ! - ##! "
Sr. Name Shareholding Cumulative shareholding 38.3+/7/<1381
No during the year (1/04/2017 "! ! >\KX]PO\ ! 
9::9<>?83>3/=0?8.
to 31/03/2018) "! !! >\KX]PO\ !!! !
6373>/.
No. of Shares at % of total Date Increase / Reason No. of % of total "#!  >\KX]PO\ " "
the beginning shares Decrease in Shares shares #! ! >\KX]PO\ "! "
of the year of the shareholding of the
(1/04/2017) company company ##!  ! >\KX]PO\ #" 
 ! !# >\KX]PO\ #!  
 0<+85638>/7:6/>98   ! - -  
7?>?+60?8.+- "!  >\KX]PO\  # !! # >\KX]PO\ #"#  
0<+8563838.3+2312 ! ! >\KX]PO\ ! # !  >\KX]PO\ ## " !
1<9A>2-97:+83/=
#! """ >\KX]PO\   #  ! !#! >\KX]PO\  "
FUND
 ! #" >\KX]PO\  #" !  >\KX]PO\   
 !  >\KX]PO\  ##
!  >\KX]PO\  
# ! #" >\KX]PO\ # 
! - -  
 ! !  >\KX]PO\  
#!  >\KX]PO\     38.3+A23D.970?8. - - ! - - - -
 ! "! >\KX]PO\   "  >\KX]PO\  "
!!  # >\KX]PO\ !# ## "  >\KX]PO\   "
"! "# >\KX]PO\ # # #" "" >\KX]PO\ #"  
!  >\KX]PO\ #"" #
 " # >\KX]PO\ ##! !
! # >\KX]PO\  ! #
" !# >\KX]PO\  "
#!  ! >\KX]PO\  #
" - -  # " " >\KX]PO\ "! #

 </63+8-/-+:3>+6 !"! ! ! - - !"! ! " - - "! #

><?=>//-97:+8C ! " >\KX]PO\ ! ! ! 630/38=?<+8-/  ! ! - -  !
6373>/.+-</63+8-/  !  >\KX]PO\ ! ! -9<:9<+>3989038.3+ ! "! >\KX]PO\  !
:2+<7+0?8.
 ! !! >\KX]PO\ "!"  " - -  !
!! " >\KX]PO\ #  !
" </63+8-/-+:3>+6 - - ! - - - -
!! #" >\KX]PO\ #! #
><?=>//-97:+8C #!   >\KX]PO\   
"!! " >\KX]PO\ ## !  6373>/.+-</63+8-/
"!  " >\KX]PO\ ##  ##! # >\KX]PO\  
1<9A>20?8.
"! " >\KX]PO\ #   !!  >\KX]PO\  
""! "" >\KX]PO\    !  >\KX]PO\ ! 
"!  >\KX]PO\   # " - - ! 
#! # >\KX]PO\ " 
# 3-3-3:<?./8>3+6 !##  ! - - !## 
!!  >\KX]PO\ " 
,+6+8-/.+.@+8>+1/  "  >\KX]PO\ !  
!!  >\KX]PO\ "   FUND
"  >\KX]PO\ "   " !  >\KX]PO\ - -
" - - "   " - - - -

66 ANNUAL REPORT 2017-18 67

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

vi. INDEBTEDNESS
Sr. Name Shareholding Cumulative shareholding
No during the year (1/04/2017 3XNOL^ONXO]]YP^RO-YWZKXcSXMV_NSXQSX^O\O]^Y_^]^KXNSXQKMM\_ONL_^XY^N_OPY\ZKcWOX^
to 31/03/2018) Secured Loans Unsecured Deposits Total
No. of Shares at % of total Date Increase / Reason No. of % of total excluding deposits Loans Indebtedness
the beginning shares Decrease in Shares shares 3XNOL^ONXO]]K^^ROLOQSXXSXQYP^RO XKXMSKVcOK\
of the year of the shareholding of the S :\SXMSZKV+WY_X^
(1/04/2017) company company
SS 3X^O\O]^N_OL_^XY^ZKSN
 196.7+8=+-2=  # ! - -  # SSS 3X^O\O]^KMM\_ONL_^XY^N_O
0?8.=196.7+8 " - -  # Total (i+ii+iii)
=+-2=1<9A>2 -RKXQOSX3XNOL^ONXO]]N_\SXQ^RO XKXMSKVcOK\
/7/<13817+<5/>=
,<9+./;?3>C
Addition
Reduction 836
:9<>09639
Net Change
 @+81?+<./7/<1381 ## " ! - - ## "
3XNOL^ONXO]]K^^ROOXNYP^RO XKXMSKVcOK\
7+<5/>==>9-5 ! # >\KX]PO\ # "
38./B0?8.+=/<3/= S :\SXMSZKV+WY_X^
90@+81?+<. ! # >\KX]PO\ " ! SS 3X^O\O]^N_OL_^XY^ZKSN
38>/<8+>398+6  !  ! >\KX]PO\ !! ! SSS 3X^O\O]^KMM\_ONL_^XY^N_O
/;?3>C38./B0?8.   !  >\KX]PO\ !! ! Total (i+ii+iii)
 ! ! >\KX]PO\  !  
vii. REMUNERATION OF DIRECTORS AND KEY MANAGERIAL PERSONNEL
!! " >\KX]PO\  
A. Remuneration to Managing Director, Whole-time Directors and/or Manager
#! "" >\KX]PO\ !   (` in Lakhs)
##! !  >\KX]PO\ - -
Sr. Particulars of Remuneration Name of MD/WTD Total
" - - - - No. Amount
Ambati Venu Rajiv Sonalker
 38@/=>9</.?-+>398 - - ! - - - - Managing Director Whole-time Director
+8.:<9>/->3980?8. ! !## >\KX]PO\ !##  (w.e.f. August 8, 2017)
+?>29<3>C7383=><C
90-9<:9<+>/+00+3<= "!  >\KX]PO\ "#   1\Y]]=KVK\c
" - - "#  K =KVK\cK]ZO\Z\Y`S]SYX]MYX^KSXONSX=OM^SYX!YP^RO3XMYWOx^Kb  # 
 -9,<+38.3+ !  ! - - !  +M^# 
7+?<3>3?=6373>/. L @KV_OYPZO\[_S]S^O]_XNO\=OM^SYX!3XMYWO^Kb+M^#  ! "   
" - - ! 
M :\Y ^]SXVSO_YP]KVK\c_XNO\=OM^SYX!3XMYWO^Kb+M^#  - - -
 =^YMU9Z^SYX - - -
 0<+85638>/7:6/>98  # ! - -  #  =aOK^/[_S^c - - -
7?>?+60?8.+-  ! ! >\KX]PO\ !   Commission - - -
0<+85638,?36.38.3+
FUND  ! 333 >\KX]PO\   K]YPZ\Y ^ - - -
!!! # >\KX]PO\   -others - - -
"! !# >\KX]PO\ !#   Others - - -
""! !# >\KX]PO\    -YX^\SL_^SYX^Y:\Y`SNOX^0_XN   !"
"! # >\KX]PO\   Total (A) 5,85.89 1,61.64 7,47.53
#!  >\KX]PO\    Ceiling as per the Act ` " !6KUR]LOSXQYP^ROXO^Z\Y ^]YP^RO-YWZKXc
#" " >\KX]PO\ #   MKVM_VK^ONK]ZO\=OM^SYX#"YP^RO-YWZKXSO]+M^
" - - #   >RO-YWZKXcNYO]XY^RK`OKXc=^YMU9Z^SYX:VKXPY\S^]OWZVYcOO]2YaO`O\7KXKQSXQ.S\OM^Y\KXNARYVO^SWO.S\OM^Y\K\OOX^S^VON^Y=^YMU9Z^SYX
YP+LLY^^6KLY\K^Y\SO]?=+_XNO\S^]u3XMOX^S`O=^YMU9Z^SYX:\YQ\KWvKXNS]KV]YOVSQSLVO^YZ_\MRK]O]RK\O]YP+LLY^^6KLY\K^Y\SO]?=+_XNO\S^]
v. SHAREHOLDING OF DIRECTORS AND KEY MANAGERIAL PERSONNEL u+P VSK^O/WZVYcOO=^YMU:_\MRK]O:VKXv^ROZO\[_S]S^O`KV_OYPaRSMRS]SXMV_NONKLY`O

Sr. For each of the Directors and KMP (along with relatives) Shareholding at the beginning Cumulative Shareholding B. Remuneration to Other Directors
No. of the year during the year (` in Lakhs)
Mr R A Shah (along with relatives) No. of % of total shares No. of % of total shares Sr. Particulars of Remuneration Name of Directors
shares of the Company shares of the Company Total
No. Munir R A Shah Ranjan Krishna
 +^^ROLOQSXXSXQYP^ROcOK\ "!  "!  Amount
Shaikh Kapur Mohan Sahni
 .K^OaS]O3XM\OK]O.OM\OK]OSX=RK\ORYVNSXQN_\SXQ^ROcOK\ - - - -
]ZOMSPcSXQ^RO\OK]YX]PY\SXM\OK]ONOM\OK]OOQKVVY^WOX^
 Independent Directors - - - - -
^\KX]PO\LYX_]]aOK^O[_S^cO^M 0OOPY\K^^OXNSXQ,YK\N-YWWS^^OO7OO^SXQ] - !   
 At the end of the year "!  "!  Commission - - - - -
Others - - - - -
8YXOYP^ROY^RO\.S\OM^Y\]ObMOZ^7\<+=RKRKXNXYXOYP^RO5Oc7KXKQO\SKV:O\]YXXOVRYVN]RK\O]SX^RO-YWZKXc
Total (1) - 17.00 10.50 15.00 42.50

68 ANNUAL REPORT 2017-18 69

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(` in Lakhs) ANNEXURE VI
Sr. Particulars of Remuneration Name of Directors Disclosure under Section 197(12) of the Companies Act, 2013 and other disclosures as per Rule 5 of the Companies
No. Total (Appointment and Remuneration of Key Managerial Personnel) Rules, 2014 :
Munir R A Shah Ranjan Krishna Amount
Shaikh Kapur Mohan Sahni S  K >RO ZO\MOX^KQO SXM\OK]O SX \OW_XO\K^SYX YP OKMR .S\OM^Y\ -RSOP 0SXKXMSKV 9P MO\ KXN -YWZKXc =OM\O^K\c YP ^RO
Company and (b) ratio of the remuneration of each director to the median remuneration of the employees of the Company
 9^RO\8YX/bOM_^S`O.S\OM^Y\] - - - - -
PY\^RO XKXMSKVcOK\!"$
0OOPY\K^^OXNSXQ,YK\N-YWWS^^OO7OO^SXQ]  - - - 
Commission - - - - - Name of the Director % Increase in the remuneration (a) Ratio of remuneration of each Director /
Others - - - - - to median remuneration of employees (b)
Total (2) 13.50 - - - 13.50 7\7_XS\=RKSUR - 
Total (B)=(1+2) 13.50 17.00 10.50 15.00 56.00 8YX/bOM_^S`O-RKS\WKX
Ceiling as per the Act ` " !6KUR]LOSXQYP^ROXO^Z\Y ^]YP^RO-YWZKXcMKVM_VK^ONK]ZO\ 7\<+=RKR - 
=OM^SYX#"YP^RO-YWZKXSO]+M^ 3XNOZOXNOX^.S\OM^Y\
7\<KXTKX5KZ_\ - 
C. Remuneration to Key Managerial Personnel Other than Managing Director
3XNOZOXNOX^.S\OM^Y\
(` in Lakhs)
7\5\S]RXK7YRKX=KRXS - 
Sr. Particulars of Remuneration Key Managerial Personnel
3XNOZOXNOX^.S\OM^Y\
No. Rajiv Sonalker Krupa Anandpara Total
7\+WLK^S@OX_  "!
-RSOP0SXKXMSKV9P MO\ Company Secretary
7KXKQSXQ.S\OM^Y\
 1\Y]]]KVK\c
K =KVK\c K] ZO\ Z\Y`S]SYX] MYX^KSXON SX =OM^SYX ! YP ^RO # !"! " 7\<KTS`=YXKVUO\  " 
3XMYWO^Kb+M^#  -RSOP0SXKXMSKV9P MO\KXNARYVO^SWO.S\OM^Y\
L @KV_OYPZO\[_S]S^O]_XNO\=OM^SYX!3XMYWO^Kb+M^#  " ""  Ms Krupa Anandpara " NA
M :\Y ^]SXVSO_YP]KVK\c_XNO\=OM^SYX!3XMYWO^Kb+M^#  - - - -YWZKXc=OM\O^K\c
 =^YMU9Z^SYX - - -  +ZZYSX^ONK]+NNS^SYXKVKXNARYVO^SWO.S\OM^Y\OPPOM^S`O+_Q_]^"!
3 =aOK^/[_S^c - - -  7\+WLK^S@OX_TYSXONOPPOM^S`O=OZ^OWLO\# KXN^RO\OPY\OSXM\OK]OSXRS]\OW_XO\K^SYXMKXXY^LOMKVM_VK^ON
 Commission - - - /X^S^VONPY\=S^^SXQPOO]YP` PY\K^^OXNSXQOKMR,YK\N+_NS^-YWWS^^OOKXN3XNOZOXNOX^.S\OM^Y\]7OO^SXQ]KXN` PY\
K]YPZ\Y ^ - - - attending each of the other Committee Meetings
- others - - - SS >ROZO\MOX^KQOSXM\OK]OSX^ROWONSKX\OW_XO\K^SYXYPOWZVYcOO]SX^RO XKXMSKVcOK\$
 Others - - -
 #
-YX^\SL_^SYX^Y:\Y`SNOX^0_XN " # 
Total 2,50.00# 58.67 3,08.67 iii. Number of permanent employees on the rolls of the Company :
>RO-YWZKXcNYO]XY^RK`OKXc=^YMU9Z^SYX:VKXPY\S^]OWZVYcOO]2YaO`O\KLY`O57:]K\OOX^S^VON^Y=^YMU9Z^SYXYP+LLY^^6KLY\K^Y\SO]?=+  
_XNO\ S^] u3XMOX^S`O =^YMU 9Z^SYX :\YQ\KWv KXN S] KV]Y OVSQSLVO ^Y Z_\MRK]O ]RK\O] YP +LLY^^ 6KLY\K^Y\SO] ?=+ _XNO\ S^] u+P VSK^O /WZVYcOO =^YMU S` +
 `O\KQOZO\MOX^SVOSXM\OK]OWKNOSX^RO]KVK\SO]YPOWZVYcOO]Y^RO\^RKXWKXKQO\SKVZO\]YXXOVSX^ROVK]^ XKXMSKVcOK\KXN
:_\MRK]O:VKXv^ROZO\[_S]S^O`KV_OYPaRSMRS]SXMV_NONKLY`O S^]MYWZK\S]YXaS^R^ROZO\MOX^SVOSXM\OK]OSX^ROWKXKQO\SKV\OW_XO\K^SYXKXNT_]^S MK^SYX^RO\OYP$
+V]YSXMV_NO]]KVK\cK]ARYVO^SWO.S\OM^Y\aS^ROPPOM^P\YW+_Q_]^"!   `O\KQOZO\MOX^KQOSXM\OK]OWKNOSX^RO]KVK\SO]YPOWZVYcOO]Y^RO\^RKX^ROWKXKQO\SKVZO\]YXXOVSX^ROcOK\!"aK]
+
vii. Penalties/Punishment/Compounding of Offences 7KXKQO\SKV\OW_XO\K^SYXS]XY^MYWZK\KLVOaS^RZ\O`SY_]cOK\]SXMO7\+WLK^S@OX_TYSXONOPPOM^S`OP\YW=OZ^OWLO\# KXN
7\<ORKX5RKX\O]SQXONOPPOM^S`O+Z\SV 
Type Section of the Brief Details of Penalty/Punishment/ Authority Appeal made, v. 3 ^ S] KP \WON ^RK^ ^RO \OW_XO\K^SYX ZKSN ^Y .S\OM^Y\] 5Oc 7KXKQO\SKV :O\]YXXOV KXN Y^RO\ /WZVYcOO] S] K] ZO\ ^RO
Companies Act Description Compounding fees imposed [RD/NCLT/ if any Remuneration Policy of the Company.
COURT] (give details)
A. COMPANY
Penalty
Punishment 836
Compounding
B. DIRECTORS
Penalty
Punishment 836
Compounding
C. OTHER OFFICERS IN DEFAULT
Penalty
Punishment 836
Compounding

70 ANNUAL REPORT 2017-18 71

ABBOTT
ABBOTT INDIA
INDIA LIMITED
LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

BUSINESS RESPONSIBILIT Y REPORT

+^+LLY^^3XNSKaO \WVcLOVSO`O^RK^SXXY`K^S`O\O]ZYX]SLVOKXN  ,c L_SVNSXQ K WY\O SXMV_]S`O L_]SXO]] aO KSW ^Y \OKMR WY\O SECTION C : OTHER DETAILS
]_]^KSXKLVOL_]SXO]]ZVKc]KXSWZY\^KX^\YVOSXL_SVNSXQKROKV^Rc ZOYZVO SX WY\O ZVKMO] ^RKX O`O\ LOPY\O 0\YW ]^\OXQ^ROXSXQ >RO-YWZKXcNYO]XY^RK`OKXc]_L]SNSK\SO]2OXMO^ROY^RO\NO^KSV]ZO\^KSXSXQ^Y]_L]SNSK\cMYWZKXSO]K]\O[_S\ON_XNO\^RS]]OM^SYX
^R\S`SXQ ]YMSO^c AO ]^\S`O ^Y PY]^O\ OMYXYWSM OX`S\YXWOX^KV KXN ^RO MKZKMS^c YP ]_ZZVSO\] ^Y M\OK^SXQ Z\YN_M^] ^RK^ OXKLVO
]YMSKV aOVVLOSXQ ^R\Y_QR Y_\ YZO\K^SYX] KXN SX SX^O\KM^SYX aS^R S]XY^KZZVSMKLVO
ZOYZVO ^Y VS`O ROKV^Rc VS`O] aO K\O KVaKc] XNSXQ XOa
Y_\]^KUORYVNO\] YZZY\^_XS^SO] ^Y ObZKXN ^RO ZY]S^S`O SWZKM^ YP Y_\ ZOYZVO SECTION D : BUSINESS RESPONSIBILITY (BR) INFORMATION
AOVO`O\KQOY_\UXYaVONQOYP]MSOXMOL_]SXO]]KM_WOXKXN_XS[_O Z\YN_M^]KXNL_]SXO]]7Y\OY`O\LOSXQK\O]ZYX]SLVOMY\ZY\K^O
\O]Y_\MO] ^Y Z\Y`SNO VK]^SXQ ]YV_^SYX] ^Y QVYLKV ROKV^R MRKVVOXQO] MS^SdOX Ob^OXN] W_MR LOcYXN ZRSVKX^R\YZc AO KZZVc Y_\ 1. Details of Director/Directors responsible for BR
>ROWY]^SWZY\^KX^Z\SY\S^cK\OK]^YY_\]^KUORYVNO\]KXNPY\Y_\ ]MSOXMO ObZO\^S]O KXN ^OMRXYVYQc ^Y KNN\O]] ^RO _\QOX^ KXN
(a) Details of the Director responsible for implementation of the BR policy/policies :
Q\Ya^RK\O$ _XWO^XOON]SXY_\MYWW_XS^SO]YP^OX^R\Y_QRMYVVKLY\K^S`O
ZK\^XO\]RSZ]AO]OOU^YKM^\O]ZYX]SLVcSXKVVYPY_\WK\UO^] 7\+WLK^S@OX_7KXKQSXQ.S\OM^Y\
w  ELIVERING PRODUCT EXCELLENCE - AO K\O
D
YXLORKVPYPY_\ZK^SOX^]OWZVYcOO]MYX]_WO\]MYWW_XS^SO]
MYWWS^^ON ^Y MYX^SX_Y_]Vc SWZ\Y`O KXN SXXY`K^O ^Y KNN\O]] (b) Details of BR Head :
KXNKVVY^RO\]^KUORYVNO\]
VYMKVKXNQVYLKVROKV^RXOON]aRSVOOX]_\SXQRSQR[_KVS^cKXN
WKX_PKM^_\SXQ]^KXNK\N]YPY_\Z\YN_M^]   ^+LLY^^3XNSKaO]^\S`O^YSWZVOWOX^]_]^KSXKLVOZ\KM^SMO]
+ Particulars Company Information
w I MPROVING ACCESS -AO]OOU^YaY\UaS^RKVV]^KUORYVNO\] ^Y \ON_MO ^RO OX`S\YXWOX^KV SWZKM^ YP Y_\ Z\YN_M^] KXN
YZO\K^SYX] /`O\c NKc aO Z_^ Y_\ _XS[_O ^KVOX^ ^Y aY\U .S\OM^Y\3NOX^S MK^SYX8_WLO\ ! "#
^YOXRKXMOKMMO]]^YMK\O^YSWZ\Y`OROKV^RY_^MYWO]
^YaK\N] L_SVNSXQ K ]^\YXQ L_]SXO]] KXN K ROKV^Rc \YL_]^ 8KWO 7\+WLK^S@OX_
w SAFEGUARDING THE ENVIRONMENT -AOaY\U^YaK\N] ]YMSO^c
\ON_MSXQ^ROOX`S\YXWOX^KVSWZKM^]xP\YW^RO]Y_\MSXQYP\Ka .O]SQXK^SYX 7KXKQSXQ.S\OM^Y\
WK^O\SKV]^Y^ROWKX_PKM^_\OKXNNS]^\SL_^SYXYPY_\Z\YN_M^]   RO-YWZKXct],YK\NKZZ\Y`ON:YVSMSO]KXN-YNOYP-YXN_M^
>
^Y^RO_]OKXNNS]ZY]KVYPY_\Z\YN_M^]LcZK^SOX^]MYX]_WO\] K\O K`KSVKLVO YX ^RO -YWZKXct] aOL]S^O x R^^Z$aaaKLLY^^ >OVOZRYXO8_WLO\ #" 
KXNROKV^RMK\OZ\Y`SNO\] MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV /WKSV3. SX`O]^Y\\OVK^SYX]SXNSK*KLLY^^MYW
SECTION A : GENERAL INFORMATION ABOUT THE COMPANY aOLWK]^O\*KLLY^^MYSX
Sr. Particulars Company Information 2. Principle-wise (as per National Voluntary Guidelines (NVGs)) Business Responsibility Policy/Policies
No.
 -Y\ZY\K^O3NOX^S MK^SYX8_WLO\-38 6#72##:6-!   K^SYXKV@YV_X^K\c1_SNOVSXO]YX=YMSKV/X`S\YXWOX^KVKXN/MYXYWSM<O]ZYX]SLSVS^SO]YP,_]SXO]]8@1]\OVOK]ONSX4_Vc
8
 <OQS]^O\ONKNN\O]] -Y\ZY\K^O:K\U=SYX>\YWLKc<YKN7_WLKSx! aRSMRS]O]]OX^SKVVcK]O^YPXSXOZ\SXMSZVO]^RK^YPPO\L_]SXO]]O]KX3XNSKX_XNO\]^KXNSXQKXNKZZ\YKMR^YSXM_VMK^SXQ\O]ZYX]SLVO
 AOL]S^O aaaKLLY^^MYSX L_]SXO]]MYXN_M^>RO]O:\SXMSZVO]K\O$
 /WKSVSN SX`O]^Y\\OVK^SYX]SXNSK*KLLY^^MYW
 0SXKXMSKVCOK\ !" Principle 1 ,_]SXO]]O]]RY_VNQY`O\XaS^R/^RSM]>\KX]ZK\OXMcKXN+MMY_X^KLSVS^c
 =OM^Y\]^RK^^RO-YWZKXcS]OXQKQONSXSXN_]^\SKVKM^S`S^cMYNOaS]O 83--YNO$
+M^S`S^c$:RK\WKMO_^SMKV]
! 6S]^^R\OOUOcZ\YN_M^]]O\`SMO]^RK^^RO-YWZKXcWKX_PKM^_\O] ._ZRK]^YX
Principle 2 ,_]SXO]]O] ]RY_VN Z\Y`SNO QYYN] KXN ]O\`SMO] ^RK^ K\O ]KPO KXN MYX^\SL_^O ^Y ]_]^KSXKLSVS^c ^R\Y_QRY_^
Z\Y`SNO]K]SXLKVKXMO]ROO^ >Rc\YXY\W
?NSVS` ^ROS\VSPOMcMVO
8. Total number of locations where business activity is undertaken
K 8_WLO\YP3X^O\XK^SYXKV6YMK^SYX] 836
Principle 3 ,_]SXO]]O]]RY_VNZ\YWY^O^ROaOVVLOSXQYPKVVOWZVYcOO]
L 8_WLO\YP8K^SYXKV6YMK^SYX] 7KX_PKM^_\SXQZVKX^K^1YK<OQS]^O\ON9P MOKXN-Y\ZY\K^O9P MOK^
7_WLKS=KVO]YP MO]KXNNS]^\SL_^SYXR_L]:KXx3XNSK
# 7K\UO^]]O\`ONLc^RO-YWZKXc6YMKV=^K^O8K^SYXKV3X^O\XK^SYXKV :KX3XNSK=\S6KXUK8OZKV7KVNS`O]KXN,R_^KX
Principle 4 ,_]SXO]]O] ]RY_VN \O]ZOM^ ^RO SX^O\O]^] YP KXN LO \O]ZYX]S`O ^YaK\N] KVV ]^KUORYVNO\] O]ZOMSKVVc ^RO
SECTION B : FINANCIAL DETAILS OF THE COMPANY WK\QSXKVS]ONYXO
Sr. Particulars Company Information
No.
 :KSN?Z-KZS^KV `#
Principle 5 ,_]SXO]]O]]RY_VN\O]ZOM^KXNZ\YWY^OR_WKX\SQR^]
 >Y^KV>_\XY`O\ ` !#6KUR]
 >Y^KV:\Y ^+P^O\>Kb `!"6KUR]
Principle 6 ,_]SXO]]O]]RY_VN\O]ZOM^Z\Y^OM^KXNWKUOOPPY\^]^Y\O]^Y\O^ROOX`S\YXWOX^
4. Total Spending on Corporate Social Responsibility (CSR)
K 38` `#6KUR]
L +]KZO\MOX^KQOYP:\Y ^+P^O\>Kb !YP^RO:\Y ^+P^O\>KbPY\^RO XKXMSKVcOK\!"
 6S]^YPKM^S`S^SO]SXaRSMRObZOXNS^_\OSXKLY`ORK]LOOXSXM_\\ON$  2OKV^R -VSXSM]  :\YQ\KW] ^Y ObZKXN +aK\OXO]] KXN +MMO]] ^Y Principle 7 ,_]SXO]]O] aROX OXQKQON SX SX
_OXMSXQ Z_LVSM KXN \OQ_VK^Y\c ZYVSMc ]RY_VN NY ]Y SX K \O]ZYX]SLVO
2OKV^RMK\O WKXXO\
 8S\WKV.RK\K.KS\c:\YTOM^x,_SVNSXQK=_]^KSXKLVO6YMKV=_ZZVc
-RKSXKXN<_\KV.O`OVYZWOX^^R\Y_QR>\KSXSXQYP.KS\c0K\WO\]
KXNAYWOX/WZYaO\WOX^ Principle 8 ,_]SXO]]O]]RY_VN]_ZZY\^SXMV_]S`OQ\Ya^RKXNO[_S^KLVONO`OVYZWOX^
 =/A+ x -\OK^SXQ K =_]^KSXKLVO 2OKV^RMK\O .OVS`O\c 7YNOV
^R\Y_QR6S`OVSRYYN]
 S-+</<YKN=KPO^c.\S`O:\YWY^SYXYP<YKN=KPO^c+aK\OXO]] Principle 9 ,_]SXO]]O] ]RY_VN OXQKQO aS^R KXN Z\Y`SNO `KV_O ^Y ^ROS\ M_]^YWO\] KXN MYX]_WO\] SX K \O]ZYX]SLVO
^R\Y_QRS-+</=KPO^c.Kc WKXXO\

72 ANNUAL REPORT 2017-18 73

ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

a. Details of Compliance (Y/N) 3. Governance related to Business Responsibility (BR)

Business Product Wellbeing Stakeholder Human Environment Public CSR Customer  3XPY\WK^SYXaS^R\OPO\OXMO^Y,<<P\KWOaY\U
Question Ethics Responsibility of Employees Engagement Rights Policy Relations
Sr. No. Questions Information
P1 P2 P3 P4 P5 P6 P7 P8 P9
.YcY_RK`OZYVSMcZYVSMSO]PY\) C C C C C C 8 C C  3XNSMK^O^ROP\O[_OXMcYP\O`SOaLc^RO,YK\NYP.S\OM^Y\] +XX_KVVcK^^RO^SWOYPKZZ\Y`SXQ^RO,_]SXO]]<O]ZYX]SLSVS^c<OZY\^
-YWWS^^OOYP^RO,YK\NY\-/9^YK]]O]]^RO,<ZO\PY\WKXMOAS^RSX
2K]^ROZYVSMcLOSXQPY\W_VK^ON C C C C C C 8+ C C WYX^R] WYX^R]+XX_KVVcWY\O^RKXcOK\
SXMYX]_V^K^SYXaS^R^RO\OVO`KX^
]^KUORYVNO\])  .YO]^RO-YWZKXcZ_LVS]RK,<Y\K=_]^KSXKLSVS^c<OZY\^)ARK^S] >RO -YWZKXc Z_LVS]RO] ,_]SXO]] <O]ZYX]SLSVS^c <OZY\^ aRSMR PY\W]
.YO]^ROZYVSMcMYXPY\W^YKXc >RO]OZYVSMSO]K\OKVSQXON^YPY\WZK\^YP+LLY^^-YNOYP,_]SXO]]-YXN_M^KNYZ^ONQVYLKVVcK\OSXMYWZVSKXMO ^RORcZO\VSXUPY\`SOaSXQ^RS]\OZY\^)2YaP\O[_OX^VcS^S]Z_LVS]RON) ZK\^YP^RO+XX_KV<OZY\^>RO]KWOS]K`KSVKLVOK^R^^Z$aaaKLLY^^
XK^SYXKVSX^O\XK^SYXKV]^KXNK\N]) aS^R3XNSKXVKa]KXN\OQ_VK^SYX]KXNWOO^SX^O\XK^SYXKV]^KXNK\N] MYSXSX`O]^Y\\OVK^SYX] XKXMSKV]R^WV
3PcO]]ZOMSPc)
2K]^ROZYVSMcLOOXKZZ\Y`ONLc >RO]OZYVSMSO]K\OKNYZ^ONLc^RO,YK\NYP.S\OM^Y\]KXNK\O]SQXONLc^ROKZZ\YZ\SK^OP_XM^SYXROKN]-=<:YVSMc SECTION E : PRINCIPLE-WISE INFORMATION
^RO,YK\N)3PcO]RK]S^LOOX]SQXON S]]SQXONLc^RO-RKS\WKXYP^RO-=<-YWWS^^OO Principle 1 : Businesses should conduct and govern themselves Principle 2 : Businesses should provide goods and services
Lc7.YaXO\-/9KZZ\YZ\SK^O
,YK\N.S\OM^Y\)
with Ethics, Transparency and Accountability that are safe and contribute to sustainability throughout their
.YO]^RO-YWZKXcRK`OK C C C C C C 8+ C C life cycle
TRO-YWZKXcS]MYWWS^^ON^YMYXN_M^SXQL_]SXO]]SXKXO^RSMKV
]ZOMS ONMYWWS^^OOYP^RO,YK\N
.S\OM^Y\9P MSKV^YY`O\]OO^RO KXN VOQKVVc MYWZVSKX^ WKXXO\ >RO -YWZKXc RK] K \YL_]^ KXN >RO -YWZKXc S] MYWWS^^ON ^Y ^RO Z\Y^OM^SYX YP R_WKX ROKV^R
SWZVOWOX^K^SYXYP^ROZYVSMc) MYWZ\OROX]S`O MY\ZY\K^O MYWZVSKXMO Z\YQ\KW NO]SQXON ^Y ]KPO^c KXN ^RO OX`S\YXWOX^ aRO\O aO MYXN_M^ Y_\ L_]SXO]]
3XNSMK^O^ROVSXUPY\^ROZYVSMc^Y
R^^Z$aaaKLLY^^MYSXSX`O]^Y\\OVK^SYX]ZYVSMSO]R^WV ROVZ WKSX^KSX ^RO RSQRO]^ O^RSMKV KXN MYWZVSKXMO ]^KXNK\N] +^^KSXWOX^YPY_\VYXQ\KXQO^K\QO^]^Y\ON_MOOWZVYcOOSXT_\SO]
LO`SOaONYXVSXO) ^YVYaO\OX`S\YXWOX^KVOWS]]SYX]KXN^Y\ON_MOY_\_]OYPXK^_\KV
2K]^ROZYVSMcLOOXPY\WKVVc C C C C C C 8+ C C
>RO-YWZKXct]9P MOYP/^RSM]-YWZVSKXMOZ\Y`SNO]OWZVYcOO]
\O]Y_\MO]SXKVVK]ZOM^]YPY_\Z\YN_M^NO`OVYZWOX^WKX_PKM^_\SXQ
MYWW_XSMK^ON^YKVV\OVO`KX^ aS^R ^RO SXPY\WK^SYX ^YYV] Q_SNKXMO ^\KSXSXQ KXN ]_ZZY\^ ^ROc
SX^O\XKVKXNOb^O\XKV]^KUORYVNO\]) KXNMYWWO\MSKVYZO\K^SYX]\OWKSX]K^YZZ\SY\S^c
XOON aROX WKUSXQ NKc^YNKc L_]SXO]] NOMS]SYX] ^Y OX]_\O ^RK^
.YO]^RO-YWZKXcRK`OSXRY_]O C C C C C C 8+ C C +LLY^^t]O^RSM]KXN`KV_O]K\OSX^OQ\K^ONSX^YS^]L_]SXO]]Z\KM^SMO] 7OO^SXQY_\^K\QO^]KVYXQaS^RKVVYPY_\Y^RO\OX`S\YXWOX^ROKV^R
]^\_M^_\O^YSWZVOWOX^^ROZYVSMc
YX K MYX]S]^OX^ LK]S] K\Y_XN ^RO aY\VN +NRO\SXQ ^Y ^RO]O ]KPO^c KXN OXO\Qc YLTOM^S`O] S] ^RO MYX^SX_K^SYX YP K VYXQ VOQKMc
ZYVSMSO])
=^KXNK\N]S]KXSWZY\^KX^ZK\^YP^ROMYWWS^WOX^^YYZO\K^OaS^R YP \O]ZYX]SLVO L_]SXO]] Z\KM^SMO] ^RK^ \O
OM^ Y_\ MY\O `KV_O] $
.YO]^RO-YWZKXcRK`OK C C C C C C 8+ C C
Q\SO`KXMO\ON\O]]KVWOMRKXS]W :SYXOO\SXQ +MRSO`SXQ -K\SXQ KXN /XN_\SXQ  >YaK\N ^RS] OXN
RYXO]^cPKS\XO]]KXNSX^OQ\S^c
\OVK^ON^Y^ROZYVSMcZYVSMSO]^Y Y_\M_\\OX^UOcYLTOM^S`O]SXMV_NO$
KNN\O]]]^KUORYVNO\]tQ\SO`KXMO]
9_\ -YNO YP ,_]SXO]] -YXN_M^ u^RO -YNOv OWLYNSO] `KV_O] w  Y]^O\SXQ K aY\U OX`S\YXWOX^ ^RK^ Z\YWY^O] OWZVYcOO ROKV^R
0
\OVK^ON^Y^ROZYVSMcZYVSMSO])
2K]^RO-YWZKXcMK\\SONY_^ C C C C C C 8+ C C KXN Z\Y`SNO] K PY_XNK^SYX PY\ OWZVYcOOt] \O]ZYX]SLSVS^SO] KXN KXNZ\YN_M^S`S^cKXNS]_V^SWK^OVcP\OOYPSXT_\SO]%
SXNOZOXNOX^K_NS^O`KV_K^SYXYP LORK`SY\]^RK^ROVZ^ROWWKUO^ROLO]^MRYSMO]PY\^RO-YWZKXc
^ROaY\USXQYP^RS]ZYVSMcLcKX w  YX^SX_Y_]VcSWZ\Y`SXQ^ROOP MSOXMcKXN]_]^KSXKLSVS^cYPY_\
-
PY\ ^ROW]OV`O] KXN PY\ ^RO ZOYZVO ^ROc ]O\`O >RO -YWZKXct]
SX^O\XKVY\Ob^O\XKVKQOXMc) L_]SXO]] KM^S`S^SO] KXN Z\YN_M^] \O]_V^SXQ SX ^RO VYaO\SXQ YP
,YK\N KXN VOKNO\]RSZ ^OKW] P_VVc ]_ZZY\^ ^RO -YNO KXN ^RO Q\OOXRY_]O QK] OWS]]SYX] aK^O\ _]O KXN WSXSWSdSXQ VKXN VV
b. If answer to Sr. No.1 against any principle is ‘No’, please explain why ZYVSMSO]Z\YMON_\O]KXNZ\SXMSZVO]S^OWLYNSO] aK]^O]%
Question P1 P2 P3 P4 P5 P6 P7 P8 P9 1. Does the policy relating to ethics, bribery and corruption w  bZOM^SXQ ^RK^ MYX^\KM^Y\] NYSXQ aY\U YX LORKVP YP +LLY^^
/
>RO-YWZKXcRK]XY^ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ cover only the company? MYXPY\W ^Y \OQ_VK^Y\c \O[_S\OWOX^] KXN WOO^ KZZVSMKLVO
_XNO\]^YYN^ROZ\SXMSZVO] SX^O\XKV/2=/]^KXNK\N]%
>RO-YWZKXcS]XY^K^K]^KQO 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8Y
w :\YWY^SXQ^RO_]OYP]KPOKXNP_OVOP MSOX^L_]SXO]]`ORSMVO]
aRO\OS^ XN]S^]OVPSXKZY]S^SYX
^YPY\W_VK^OKXNSWZVOWOX^^RO 2. Does it extend to the Group/Joint Ventures/Suppliers/ AOOXNOK`Y_\^YWKSX^KSX^RORSQRO]^VO`OVYP[_KVS^c^R\Y_QRY_^Y_\
ZYVSMSO]YX]ZOMS ONZ\SXMSZVO] Contractors/NGOs/Others? L_]SXO]] 9_\ -YWWS^WOX^ ^Y ROKV^R KXN ]KPO^c YP ^RO ZOYZVO aRY
>RO-YWZKXcNYO]XY^ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ CO] _]OY_\Z\YN_M^]S]KVaKc]K^^ROPY\OP\YX^YPO`O\c^RSXQaONY>RO]O
RK`O XKXMSKVY\WKXZYaO\ OPPY\^] ]^K\^ aS^R ]Y_\MSXQ YP WK^O\SKV] PY\ KXN WKX_PKM^_\O YP Y_\
\O]Y_\MO]K`KSVKLVOPY\^RO^K]U 3. How many stakeholder complaints have been received Z\YN_M^]KXNWY`O]^R\Y_QRRYaaOWK\UO^]OVVKXN]_ZZVc^RO]O
3^S]ZVKXXON^YLONYXOaS^RSX 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ SX ^RO ZK]^ XKXMSKV cOK\ KXN aRK^ ZO\MOX^KQO aK] Z\YN_M^]SXMV_NSXQ^R\Y_QRY_\L_]SXO]]ZK\^XO\]NOVS`O\SXQRSQR
XOb^]SbWYX^R] [_KVS^cS]SWZO\K^S`OO`O\c]^OZYP^ROaKc
satisfactorily resolved by the management? If so, provide
3^S]ZVKXXON^YLONYXOaS^RSX 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+ 8+
XOb^YXOcOK\
details thereof. AO K\O MYWWS^^ON ^Y ^SWOVc SNOX^SPcSXQ O`KV_K^SXQ KXN
+XcY^RO\\OK]YX 8+ 8+ 8+ 8+ 8+ 8+ >RO\OS]XY]_MRZYVSMcPY\W_VK^ON 8+ 8+
KNN\O]]SXQ Z\YN_M^ ]KPO^c S]]_O] AO Z\Y`SNO ROKV^RMK\O
  RO-YWZKXcRK]\OMOS`ON]^KUORYVNO\MYWZVKSX^]N_\SXQ
>
ZVOK]O]ZOMSPc >RO -YWZKXc KN`YMK^O] P\YW ^SWO Z\YPO]]SYXKV]KXNSX]^S^_^SYX]aS^R^ROSXPY\WK^SYX^ROcXOONSX
^RO XKXMSKV cOK\ !" 9_^ YP ^RO]O " MYWZVKSX^] aO\O Y\NO\ ^Y _]O -YWZKXc Z\YN_M^] ]KPOVc KXN OPPOM^S`OVc AO ^KUO
^Y^SWOK]KWOWLO\YP`K\SY_]^\KNO
LYNSO] MRKWLO\] KXN K]]YMSK^SYX] SX`O]^SQK^ON SX KMMY\NKXMO aS^R 3X^O\XKV 3X`O]^SQK^SYX] KM^SYX^YZ\O`OX^MY_X^O\POS^SXQSVVOQKVNS`O\]SYXKXN^ROP^YPY_\
^Y KNN\O]] S]]_O] \OVK^ON ^Y ^RO :YVSMcKXN-YWZVSKXMO:\YQ\KWKXNKZZ\YZ\SK^OVc\O]YV`ON Z\YN_M^] AO KNRO\O ^Y KVV KZZVSMKLVO ^\KNO \OQ_VK^SYX] VYMKVVc
ZRK\WKMO_^SMKVSXN_]^\c MYWZVKSX^]K\OZOXNSXQ_XNO\SX`O]^SQK^SYX KXNQVYLKVVc

74 ANNUAL REPORT 2017-18 75

 ABBOTT INDIA LIMITED
AORK`OO]^KLVS]RONa\S^^OXZ\YMON_\O]PY\Z\YN_M^KM^SYX]KXN
\OMKVV]aRSMR\O[_S\OMYWZVO^SYXYPKROKV^RRKdK\NK]]O]]WOX^
WONSMKV K]]O]]WOX^ KXN MY\\OM^S`O KXN Z\O`OX^S`O KM^SYX ZVKX
NO`OVYZWOX^
AO ^KUO Y_\ \O]ZYX]SLSVS^c ^Y OWLON ^RO RSQRO]^ Z\YN_M^ [_KVS^c
KXN ]KPO^c ]^KXNK\N] KM\Y]] Y_\ ]_ZZVc MRKSX `O\c ]O\SY_]Vc
AO WKSX^KSX KX O`KV_K^SYX KXN KZZ\Y`KV ]c]^OW ^RK^ \O[_S\O]
O`SNOXMO ^RK^ K ]_ZZVSO\ MKX MYX]S]^OX^Vc Z\Y`SNO WK^O\SKV Y\
]O\`SMO]WOO^SXQ]ZOMS ON[_KVS^cKXN]KPO^c\O[_S\OWOX^]
1. List up to 3 of your products or services whose design
has incorporated social or environmental concerns,
risks and/or opportunities.
 w ._ZRKVKMKXN-\OWKP X
 w .SQOXO1OVKXN>KLVO^]
 w ,\_POX>KLVO^]
2. For each such product, provide the following details in
_OX^ >\OK^WOX^ :VKX^ ^\OK^ON aK^O\ _]ON PY\ aS^ROXO\Qc\OMY`O\caRO\OK] aK]SXMSXO\K^ON
respect of resource use (energy, water, raw material, etc.)
_]RSXQSXMRKXQO\YYW]   RO -YWZKXct] ZVKX^ K^ 1YK \OMOS`ON u,O]^ /X`S\YXWOX^KV
per unit of product :
(a) Reduction during sourcing/production/distribution
achieved since the previous year throughout the
value chain?
   OSXQ K W_V^SZ\YN_M^ PKMSVS^c Z\YN_M^aS]O \O]Y_\MO
, all employees
MYX]_WZ^SYXS]XY^WOK]_\ONcO^^ROZVKX^MYX^SX_Y_]Vc
^KUO] WOK]_\O] ^Y \ON_MO ^RO MYX]_WZ^SYX >RO ZVKX^
RK] SXM\OK]ON WKX_PKM^_\SXQ cSOVN] ]Y K] ^Y \ON_MO ^RO
aK]^KQO YP Z\OMSY_] \Ka WK^O\SKV] ZKMUKQSXQ WK^O\SKV]
KXN ]YV`OX^] +] K MYWZVSKXMO ^YaK\N] :VK]^SM AK]^O
7KXKQOWOX^ <_VO] aO K\O aY\USXQ YX _]KQO YP WY\O
\OMcMVKLVOWK^O\SKV]SXY_\ZKMUKQSXQYPQYYN]
(b) Reduction during usage by consumers (energy, water)
has been achieved since the previous year?
   ROLYSVO\]RK`OLOOX\_XXSXQYX,SYWK]]^Y\ON_MO^RO
> PY\]KVO]WK\UO^SXQZY]S^SYX]+P^O\^ROS\^\KSXOO]RSZ]_S^KLVO
-9 OWS]]SYX] KXN ^RO OX`S\YXWOX^KV SWZKM^ >RO ]S^O
Z\KM^SMO]^ROZ\SXMSZVOYP<<ON_MO<OMcMVOKXN<O_]O
^Y MYX^SX_Y_]Vc \ON_MO ^RO aK]^O KXN OX`S\YXWOX^KV
SWZKM^] +VV ^RO aK]^O S] NS]ZY]ON ^R\Y_QR 1Y`O\XWOX^
KZZ\Y`ON KQOXMSO] KP^O\ K_NS^ KXN SX^O\XKV KZZ\Y`KV
Z\YMO]]
   OVYa ^KLVO ]RYa] aK^O\ MYX]_WZ^SYX -9 OWS]]SYX]
, ]Y_\MO] PY\ ]_ZZVcSXQ `YV_WSXY_] \Ka WK^O\SKV aRSMR S]
KXN aK]^O QOXO\K^ON N_\SXQ ^RO cOK\ !" K^ ^RO
ZVKX^ >RO KL]YV_^O X_WLO\] K\O RSQRO\ N_O ^Y SXM\OK]O
SX Z\YN_M^SYX KXN ]S^O `KVSNK^SYX KM^S`S^SO] KP^O\ WKTY\
_ZQ\KNK^SYX
76 ANNUAL REPORT 2017-18
Sr. Parameter Unit Quantity
No.
 >Y^KVaK^O\_]ON KL !
 AK]^OQOXO\K^ON 7> !#
 >Y^KV-9O[_S`KVOX^OWS]]SYX] 7> 
P\YWZ_\MRK]ONOVOM^\SMS^c
   YVVYaSXQWOK]_\O]RK`OLOOX^KUOXK^^ROZVKX^N_\SXQ
0 NO`OVYZWOX^ K] aOVV K] R_WKX \O]Y_\MO] XKXMO KXN ]_ZZVc
^ROcOK\!"PY\MYX]O\`K^SYXYP/XO\Qcx
    bS]^SXQ0V_Y\O]MOX^>_LO6SQR^RSQRZYaO\0>6
/ ZRK\WKMO_^SMKV] ^RO Z\YN_M^] K\O XY^ \OMcMVON .S]ZY]KV YP
MYX]_WSXQVSQR^]\OZVKMONaS^ROXO\Qc]K`SXQ6SQR^
/WS^^SXQ .SYNO 6/. VSQR^] SX ;_KVS^c -YX^\YV
K\OK]
   8OaMYXNOX]K^O\OMY`O\cZ_WZSX]^KVVON^YSWZ\Y`O
^ROMYXNOX]K^O\OMY`O\cP\YW^Y"
   YVVYaSXQWOK]_\O]RK`OLOOX^KUOXK^^ROZVKX^N_\SXQ
0 aK]]OX^PY\\OMcMVSXQaK]MYWZY]^ONYX]S^O YP^RO
^ROcOK\!"PY\MYX]O\`K^SYXYPaK^O\x
   /P
^YSVO^
   0V_SNLONN\cO\ V^O\LKQaK]RSXQKXNN\cSXQWKMRSXO
SX]^KVVON^Y]K`OVS^O\]YPaK^O\ZO\aK]RSXQMcMVO
   3X^O\WONSK^O Z\YN_M^ MYX^KSXO\ MVOKXSXQ WKMRSXO
SX]^KVVON^Y]K`OVS^O\]YPaK^O\ZO\MYX^KSXO\
3. Does the Company have procedures in place for
sustainable sourcing (including transportation)?
If yes, what percentage of your inputs was sourced
sustainably? Also, provide details thereof.
  O] ^RO -YWZKXc RK] LOOX aY\USXQ ^Y SXM\OK]O ]Y_\MSXQ YP
C OWZVYcOO] >RO\OPY\O S^ S] SXM_WLOX^ _ZYX ^RO -YWZKXc ^Y
VYMKVZKMUKQSXQWK^O\SKV]^RO\OLc\ON_MSXQ^RO^\KX]ZY\^K^SYX
KXN ^RO \O]_V^KX^ `ORSM_VK\ OWS]]SYX] 0Y\ /bKWZVO aO
OXMY_\KQON ^RO LY^^VO WKX_PKM^_\O\] ^Y ]O^_Z ^ROS\ _XS^ SX
1YK+V]YaS^R^ROXOa1=>\OQSWO^RO]^YMUS]^]K\OLOSXQ
]O\`SMON P\YW ^RO MVY]O]^ -K\\cSXQ KXN 0Y\aK\NSXQ =O\`SMO
:\Y`SNO\]^Y\ON_MO^\KX]ZY\^K^SYXOWS]]SYX]
4. Has the Company taken any steps to procure goods
and services from local & small producers, including
communities surrounding their place of work?
  RO-YWZKXcNYO]Z\YM_\OQYYN]KXN]O\`SMO]P\YWVYMKVKXN
> NS`O\]O ZO\]ZOM^S`O] ObZO\SOXMO] KXN ]USVV] AO K\O MYWWS^^ON
]WKVVZ\YN_MO\]ZK\^SM_VK\VcVYMK^ONXOK\S^]WKX_PKM^_\SXQ
ZVKX^K^1YKSXKMMY\NKXMOaS^R^ROO]^KLVS]RONZ\YMON_\O]
KXN \O[_S\OWOX^] AO RK`O KV]Y SNOX^S ON XOa VYMKV
_]ON SX Z\YN_M^SYX Z\YMO]] + VYXQ^O\W \OVK^SYX]RSZ S]
NO`OVYZONaS^R`OXNY\]KXN^RO>RS\N:K\^c7KX_PKM^_\O\]
^Y OX]_\O L_]SXO]] MYX^SX_S^c KXN MYX^SX_Y_] K`KSVKLSVS^c
YP ^RO Z\YN_M^] ^Y Y_\ UOc ]^KUORYVNO\] SO ^RO ZK^SOX^]
CORPORATE OVERVIEW
+VV^ROUOc`OXNY\]PY\^RO-YWZKXcK\OK]]O]]ONPY\/2=
Z\KM^SMO] KXN MYWZVSKXMO] ^Y OX]_\O ]_]^KSXKLSVS^c KXN K\O
K_NS^ON \OQ_VK\Vc 1YK ]S^O MYX \W] ^RK^ XYXO YP ^RO \Ka
WK^O\SKV] _^SVS]ON K^ ZVKX^ K\O NO\S`ON P\YW ,SYNS`O\]S^c Y\
S^]MYWZYXOX^]
5. Does the Company have a mechanism to recycle products
and waste? If yes, what is the percentage of recycling
of products and waste (separately as <5%, 5-10%, >10%).
Also, provide details thereof.
 O] aRO\O`O\ POK]SLVO ^RO aK]^O] K\O \OMcMVON ,OSXQ
C MYWLSXK^SYX YP ^\KSXSXQ YX^ROTYL ObZO\SOXMO] KXN PY\WKV KXN
RKdK\NY_] aK]^O KXN ]V_NQO ^Y ?V^\K^OMR MOWOX^ PKM^Y\SO]
aRSMR S] _^SVS]ON Lc ^ROW K] K P_OV PY\ WKX_PKM^_\SXQ YP
MOWOX^8YXRKdK\NY_]aK]^OVSUOZKZO\QVK]]O^MK\O]OX^^Y
KZZ\Y`ON`OXNY\]
  RO1YK:VKX^\O^KSX]S^]MO\^S MK^SYXYPDO\YAK]^O^YVKXN VV
> SXMY\ZY\K^O] ]USVV] K]]O]]WOX^] ZO\PY\WKXMO KZZ\KS]KV]
SXZ_\`SOaYPaK]^ONS]ZY]KV3X!" YPY_\^Y^KVaK]^O
aK]^O aRSMR SXMV_NO] RKdK\NY_] aK]^O aK] MY  Z\YMO]]ON
> ]USVV]WKZZSXQKM\Y]]^ROY\QKXS]K^SYX
:\KM^SMO] +aK\Nv P\YW 1YK =^K^O :YVV_^SYX -YX^\YV ,YK\N
\OMYQXSdSXQ ^RO OPPY\^] PY\ \OMcMVSXQ ^RO _]ON aK^O\ P\YW
VS[_SN LY^^VO MVOKXSXQ WKMRSXO] SX MYYVSXQ aK^O\ ^YaO\] SX
_^SVS^c]OM^SYX
Principle 3 : Businesses should promote the well-being of
>RO -YWZKXc MK\O] KLY_^ KXN S] MYXMO\XON PY\ ^RO ROKV^R KXN
aOVVLOSXQ YP S^] OWZVYcOO] >RO -YWZKXct] ]_MMO]] S] NS\OM^Vc
NOZOXNOX^ _ZYX ^RO ]USVV NONSMK^SYX KXN Z\YN_M^S`S^c YP S^]
Z\Y`SNO WOKX] PY\ ^RO OPPOM^S`O M_V^S`K^SYX NO`OVYZWOX^ KXN
_^SVS]K^SYXYPS^]R_WKX\O]Y_\MO]
/`O\cYXO aRY aY\U] K^ +LLY^^ 3XNSK OXMY_X^O\] K Z\YPO]]SYXKV
OX`S\YXWOX^ P\OO P\YW SX^SWSNK^SYX KXN RK\K]]WOX^ /WZVYcOO
ZO\PY\WKXMO KXN KMRSO`OWOX^] K\O OXRKXMON SX KX YZOX KXN
]_ZZY\^S`O aY\U OX`S\YXWOX^ aRSMR S] MRK\KM^O\S]ON Lc W_^_KV
^\_]^KXN\O]ZOM^
A Diverse and Inclusive work place
>Y MYWZO^O OPPOM^S`OVc YX K QVYLKV LK]S] ^RO -YWZKXc XOON]
^Y PY]^O\SXQ KXN ]_ZZY\^SXQ NS`O\]S^c AO LOVSO`O ^RK^ ^RS]
MYWWS^WOX^ROVZ]_]K^^\KM^KXN\O^KSX^KVOX^aRSVOSXXY`K^SXQ
WY\OOPPOM^S`OVcKXNKNKZ^SXQ^Y^ROMRKXQSXQROKV^RMK\OXOON]
9_\ AYWOX 6OKNO\] YP +LLY^^ A6+ OWZVYcOO XO^aY\U S]
NO]SQXON ^Y ROVZ POWKVO OWZVYcOO] P_\^RO\ ^ROS\ MK\OO\] KXN
OWZYaO\^ROS\VOKNO\]RSZK^+LLY^^^R\Y_QR]^\_M^_\ON^\KSXSXQ
NO`OVYZWOX^ KXN XO^aY\USXQ O`OX^] ^KSVY\ON ^Y ^RO ]ZOMS M
XOON]
STATUTORY REPORT FINANCIAL STATEMENTS
Employee Development and Talent Management
,c ^KUSXQ K Z\YKM^S`O KZZ\YKMR ^Y \OM\_S^WOX^ KXN YPPO\SXQ
KN`KXMOWOX^KXNVOKNO\]RSZNO`OVYZWOX^Z\YQ\KW]K^KVVVO`OV]
aOROVZY_\OWZVYcOO]\OKVS]O^ROS\ZY^OX^SKV+VV^ROOWZVYcOO]
RK`O KMMO]] ^Y TYL]ZOMS M ^\KSXSXQ KXN NO`OVYZWOX^ ^Y OX]_\O
]_MMO]]P_V ZO\PY\WKXMO SX ^ROS\ M_\\OX^ \YVO] KM\Y]] ^RO P_VV
\KXQOYPTYL]xP\YWMYWWO\MSKVKXNYZO\K^SYX]^Y\O]OK\MRKXN
MRKSX AO NO`OVYZ M_\\OX^ KXN P_^_\O VOKNO\] ^R\Y_QR K \YL_]^
SXPY\WKV WOX^Y\SXQ >RO\O K\O `K\SY_] MO\^S MK^SYX Z\YQ\KW]
LOSXQMYXN_M^ONLc^RO^\KSXSXQP_XM^SYXPY\P\YX^VSXO OVNPY\MO
aRSMRROVZ^ROWKM[_S\ORSQRO\VO`OVYPMYWZO^OXMSO]
>RO -YWZKXct] \YL_]^ KZZ\YKMR ^Y ^KVOX^ WKXKQOWOX^
]_MMO]]SYX KXN NO`OVYZWOX^ ZVKXXSXQ KXN MK\OO\
Z\YQ\O]]SXQ 9_\ SX^OQ\K^ON ^KVOX^ WKXKQOWOX^ Z\YMO]] QS`O]
SXM\OK]ON `S]SLSVS^c ^Y ^KVOX^ aS^RSX Y_\ Y\QKXS]K^SYX OXRKXMO]
^RO KMM_\KMc YP Y_\ K]]O]]WOX^] KXN N\S`O] MYX]S]^OXMc SX
@K\SY_]^\KSXSXQKXNVOKNO\]RSZNO`OVYZWOX^Z\YQ\KW]MYXN_M^ON
Lc^RO-YWZKXcN_\SXQ^ROcOK\_XNO\\O`SOaK\O$
- IN-STRIDE
 3 X=^\SNO Z\YQ\KW S] KSWON K^ ]^\OXQ^ROXSXQ ^RO VOKNO\]RSZ
ZSZOVSXO ^YaK\N] ]OXSY\ VOKNO\]RSZ ZY]S^SYX] [_KVS^c KXN
[_KX^S^c^YOX]_\OL_]SXO]]MYX^SX_S^cLcM\OK^SXQMYX^SX_Y_]
VOK\XSXQ YZZY\^_XS^SO] PY\ RSQR ZY^OX^SKV ^KVOX^ ^R\Y_QR
=SW_VK^SYX] /6OK\XSXQ 1\Y_Z 7OX^Y\SXQ SXNS`SN_KV
]^\O^MR K]]SQXWOX^]Z\YTOM^] $ WOX^Y\]RSZ KXN PKMO ^SWO
aS^R^KVOX^MY_XMSV
- Management Trainee Program
  KXKQOWOX^>\KSXOO]K\OSXN_M^ONP\YWZ\O]^SQSY_]MYVVOQO]
7
aS^RKXYLTOM^S`O^YL_SVNKNS`O\]OKXN]_ZO\SY\^KVOX^ZYYV
MKXNSNK^O]K\OYPPO\ONTYL]K]ZO\^ROS\ObZO\^S]O
- Global Citizen Development Program
  VYLKV -S^SdOX .O`OVYZWOX^ :\YQ\KW S] SX^OXNON ^Y L_SVN
1
QVYLKV WSXN]O^ MKZKLSVS^SO] L_]SXO]] KXN WK\UO^ KM_WOX
KXNVOKNO\]RSZMKZKLSVS^SO]aRSVOM\OK^SXQKMVY]OXO^aY\UYP
P_^_\O VOKNO\] 3^ KSW] ^Y NO`OVYZ ]USVV] ^Y ROVZ ZK\^SMSZKX^]
WKXKQOSXM\OK]SXQVcMYWZVObKXNMRKVVOXQSXQ\O]ZYX]SLSVS^SO]%
YPPO\]YZZY\^_XS^SO]^YaY\UYXM_\\OX^L_]SXO]]MRKVVOXQO]%
KMMOVO\K^O]NO`OVYZWOX^YPRSQRZY^OX^SKVOK\VcMK\OO\^KVOX^%
Z\Y`SNO] K XO^aY\USXQ ZVK^PY\W KXN ]O\`O] K] K `ORSMVO PY\
K^^\KM^SXQKXN\O^KSXSXQOK\VcMK\OO\^KVOX^
77
 ABBOTT INDIA LIMITED
- Feeder Pool Development Program
  OONO\ :YYV .O`OVYZWOX^ :\YQ\KW S] KSWON K^ KMMOVO\K^SXQ
0  3@/630/A/66KXSX^OQ\K^ONaOVVXO]]Z\YQ\KWS]YPPO\ON
Z\YQ\O]]YPY_\UOc^KVOX^^Y^KUO_ZVOKNO\]RSZ\YVO]K^WSN
WKXKQOWOX^VO`OVSX^ROP_^_\O
- Differential Hiring Strategy
 S^R KX YLTOM^S`O ^Y SXP_]O NSPPO\OX^SKV ^KVOX^ KXN OX]_\O
A >RO -YWZKXct] MYWZOX]K^SYX ZRSVY]YZRc S] ^Y ZKc PY\
NS`O\]S^cKZZ\YbSWK^OVcYPP\YX^VSXO]KVO]ZY]S^SYX]K\O
VVONP\YWP\O]RZRK\WKQ\KN_K^O]ZYYV
- Sales Force Career Development (TRACKS)
  X SX^O\XKV MK\OO\ NO`OVYZWOX^ Z\YQ\KW ^Y ]Y_\MO ^KVOX^
+ aK]+LLY^^3XNSKt]>Y^KV=KXS^K^SYX:\YTOM^SX1_TK\K^aRSMR
SX^O\XKVVc KXN O]^KLVS]R MK\OO\ ZK^R PY\ UOc P_XM^SYX]\YVO]
>ROWKSXPOK^_\O]YP><+-5=Z\YQ\KWK\OMVOK\KXNYLTOM^S`O
Q_SNOVSXO]PY\MK\OO\WY`OWOX^]%M\Y]]P_XM^SYXKVObZY]_\O^Y
L_SVNVOKNO\]RSZ]USVV]%PK]^O\WY`OWOX^PY\RSQRZO\PY\WO\]%
WO\S^YM\K^SMM_V^_\OKXNNO`OVYZWOX^POONLKMU^YL\SNQO^RO
ObS]^SXQ]USVVQKZ]
- Uniform Assessments for First Line and Second Line
Manager roles
  ^\_M^_\ON K]]O]]WOX^ Z\YQ\KW] aO\O MYXN_M^ON PY\ ^RO
= PK\WO\]Lc^\KSXSXQ]O]]SYX]KXNSXP\K]^\_M^_\ONO`OVYZWOX^
0S\]^ 6SXO KXN =OMYXN 6SXO 7KXKQO\] ^Y M\OK^O ]_MMO]]SYX
ZSZOVSXO
- NEXTGEN Leadership Development Program for First
Line Managers
  \YPO]]SYXKV .O`OVYZWOX^ :\YQ\KW S] VK_XMRON PY\ ^RO 0S\]^
: w
6SXO7KXKQO\]3XVSXOaS^RY_\/WZVYcOO@KV_O:\OZY]S^SYXYP
Z\Y`SNSXQLO]^SXMVK]]ObZY]_\OKXNKMMOVO\K^ONNO`OVYZWOX^
PY\RSQRZO\PY\WO\]
- Executive Program in Sales & Marketing
  RO -YWZKXc MYVVKLY\K^ON aS^R ^RO 3XNSKX 3X]^S^_^O
> ^ROOXNYP^RO XKXMSKVcOK\)836
YP 7KXKQOWOX^ 337 3XNSKt] Z\OWSO\ ,_]SXO]] KXN
ObSLVO aY\U ]MRON_VO] KXN YP MO ^SWSXQ] 8. What percentage of your above mentioned employees were
7KXKQOWOX^ 3X]^S^_^O ^Y VK_XMR K MKZKLSVS^cL_SVNSXQ
Z\YQ\KW PY\ ]KVO] WKXKQO\] =Y PK\ # WKXKQO\] RK`O
ZK\^SMSZK^ONSX^RO]OZ\YQ\KW]aS^RWKXc]OM_\SXQ^ROS\ \]^
PY\WKVMO\^S MK^SYX]
SXMRSXQNONSMK^SYX^Y\OKMRSXQY_^^Y^ROWSVVSYX]YP
-YWZOX]K^SYXKXN,OXO ^]
>RO -YWZKXc S] NONSMK^ON ^Y Z\Y`SNSXQ K ]YVSN PY_XNK^SYX YP
OWZVYcOOLOXO ^]^RK^aSVVKVVYaOWZVYcOO]^YWOO^^ROS\ZO\]YXKV
KXNPKWSVcXOON]/WZVYcOOLOXO ^ZRSVY]YZRcS]LK]ONYX^R\OO
Z\SWK\cMY\O`KV_O]$
w  LLY^^ MK\O] KXN S] MYXMO\XON PY\ ^RO ROKV^R aOVPK\O KXN
+ -
XKXMSKVaOVVLOSXQYPS^]OWZVYcOO]%
w  LLY^^ RK] O]^KLVS]RON MYWZO^S^S`O LOXO ^] K] ZK\^ YP ^RO
+ NOZK\^WOX^aS]O Y\ aS^R Y^RO\ MYVVOKQ_O] ^Y ^\KMU ^ROS\
>Y^KV<OaK\N]YPPO\ON^YS^]OWZVYcOO]%
78 ANNUAL REPORT 2017-18
w  LLY^^RK]NO`OVYZON]^KXNK\N]PY\OPPOM^S`OWKXKQOWOX^YP
+ -
OWZVYcOOLOXO ^Z\YQ\KW]
>RO -YWZKXc S] MYWWS^^ON ^Y YPPO\SXQ MYWZ\OROX]S`O KXN
MYWZO^S^S`OLOXO ^ZKMUKQO]NO]SQXON^YWOO^^ROMRKXQSXQXOON]
YPOWZVYcOO]
ZO\PY\WKXMO9_\^Y^KVMYWZOX]K^SYX^K\QO^]\OPO\OXMO^ROWONSKX
YP Y^RO\ VOKNSXQ MYWZKXSO] >RO -YWZKXc RK] ]O^ ^RO PYVVYaSXQ
Q_SNSXQZ\SXMSZVO]PY\/WZVYcOO]>Y^KV-YWZOX]K^SYXZ\YQ\KW]$
w  K]O ]KVK\SO] K\O MYWZO^S^S`O SX ^RO WK\UO^] aRO\O aO
,
MYWZO^O PY\ OWZVYcOO] 3XMOX^S`O ZVKX] K\O NO]SQXON ^Y
LKVKXMO]RY\^KXNVYXQ^O\W XKXMSKVKXN]^\K^OQSMYLTOM^S`O]
^RK^L_SVN]RK\ORYVNO\`KV_OKXN\OaK\NY`O\KVVMYWZKXcKXN
SXNS`SN_KVZO\PY\WKXMO%
w 3 XMOX^S`O MYWZOX]K^SYX LY^R KXX_KV KXN VYXQ^O\W S]
K UOc MYWZYXOX^ YP ^RO -YWZKXc] ZKcPY\ZO\PY\WKXMO
ZRSVY]YZRc%
w  _\ ]^\_M^_\O ^SO] SXNS`SN_KV KaK\N] ^Y LY^R L_]SXO]] KXN
9 4.
Y\ SXNS`SN_KV \O]_V^] ^Y WY^S`K^O Y_\ OWZVYcOO] ^Y KMRSO`O
]_ZO\SY\ZO\PY\WKXMO%
w  YWZOX]K^SYXOVOWOX^]K\ONO]SQXON^YOXMY_\KQOLORK`SY\
- NYO] XY^ WKSX^KSX KXc ]OZK\K^O SXPY\WK^SYX ZO\^KSXSXQ ^Y
^RK^S]MYX]S]^OX^aS^R^ROO^RSMKV`KV_O]O]^KLVS]RONSX+LLY^^
-YNOYP,_]SXO]]-YXN_M^%
 OXO ^] K\O MYWZO^S^S`O SX KXN KZZ\YZ\SK^O PY\ ^RO WK\UO^]
,
aRO\OaOMYWZO^OPY\^KVOX^
Listening to Employees
AO`KV_O^ROYZSXSYX]YPY_\OWZVYcOO]KXN\OQ_VK\Vc]OOU^ROS\
POONLKMU^R\Y_QR`K\SY_]OWZVYcOO]_\`Oc]
Work Life Harmony
>RO -YWZKXc YPPO\]
^Y OXKLVO Y_\ OWZVYcOO] ^Y KMRSO`O LKVKXMO SX ^ROS\ aY\U KXN
ZO\]YXKV\O]ZYX]SLSVS^SO]KXNKM^S`S^SO]AO`SOa^RO]OSXS^SK^S`O]
XY^YXVcK]SWZY\^KX^^YYV]PY\^KVOX^K^^\KM^SYXKXN\O^OX^SYXL_^
KV]YK]UOcMYWZYXOX^]SXY_\KZZ\YKMR^YNS`O\]S^cKXNSXMV_]SYX
Healthy Living Initiatives
AO SX]ZS\O KXN WY^S`K^O Y_\ OWZVYcOO] aS^R ]YMSKV XKXMSKV
WOX^KV KXN ZRc]SMKV Z\YQ\KW] NO]SQXON PY\ ROKV^Rc VS`SXQ SX ^RO
P_VVO]^ZY]]SLVO]OX]O
Exercise across Abbott
  OVVXO]] Z\YQ\KW aRO\OSX OWZVYcOO] PY\W] ^OKW
A 9_\ WKTY\ ]^KUORYVNO\] K\O Y_\ :K^SOX^] -YX]_WO\] KXN
WSX_^O]YPNKSVcObO\MS]OKXN^SWO^ROcZ_^SXObO\MS]SXQ
CORPORATE OVERVIEW
LIVELIFEWELL :
6 KLY_^^ROS\XOON]KXNROVZ]^Y]O\`O^ROWLO^^O\KXNL_SVN]VYXQ
^Y ^RO OWZVYcOO]% XOK\Vc ! ZO\MOX^ YP OWZVYcOO] KXN ^ROS\
]ZY_]O] ZK\^SMSZK^O SX ^RS] Z\YQ\KW 63@/630/A/66
SXMV_NO]$
 w 9XVSXOROKV^RK]]O]]WOX^KXN^YYV]
 w :O\]YXKVROKV^RMYKMRSXQKXNX_^\S^SYXMY_X]OVVSXQ
 w 2OKV^RKaK\OXO]]MKWZKSQX]KXNO`OX^]
 w 9X]S^OSWW_XS]K^SYX]KXNROKV^R]M\OOXSXQ]
 w /WZVYcOO+]]S]^KXMO:\YQ\KW]
1. Please indicate the total number of employees?x X_WLO\YPVYMKVXYXQY`O\XWOX^KVY\QKXSdK^SYX]819]^RO
2. Please indicate the total number of employees hired on
temporary/hired on contractual/casual basis?x ]KXS^K^SYXKXNOXKLVOROKV^RSO\VS`O]+]K\O]_V^YP^RS]Z\YTOM^
3. Please indicate the number of permanent women
employees?x
Please indicate the number of permanent employees with
disabilities?
>YOVSWSXK^OKXcZY]]SLSVS^SO]YPNS]M\SWSXK^SYX^RO-YWZKXc
OWZVYcOONS]KLSVS^SO]
5. Do you have an employee association that is recognized by
management?CO]
6. What percentage of your permanent employees is
members of this recognised employee association?"
7. Please indicate the number of complaints relating to
child labour, forced labour, involuntary labour, sexual
RK\K]]WOX^ SX ^RO VK]^ XKXMSKV cOK\ KXN ZOXNSXQ K] YX
given safety & skill upgradation training in the last year?
  VV XOa TYSXOO] K\O SWZK\^ON ^\KSXSXQ K] K ZK\^ YP ^ROS\
+ >RO]O SXS^SK^S`O] K\O ZK\^ YP ^RO -YWZKXct] MYX^SX_ON PYM_]
SXN_M^SYXZ\YQ\KW
Principle 4 : Businesses should respect the interests of, and be
responsive towards all stakeholders, especially those who are
disadvantaged, vulnerable and marginalized
AO \OMYQXS]O ^RK^ VS]^OXSXQ ^Y Y_\ ]^KUORYVNO\] KXN \O]ZYXNSXQ
^RY_QR^P_VVc ^Y ^ROS\ MYXMO\X] KXN SNOK] K\O `S^KV ^Y Y_\ ]_MMO]]
K] K L_]SXO]] KXN ^Y Y_\ Z\YQ\O]] >RO -YWZKXc RK] LOOX
OXQKQSXQ aS^R L\YKN \KXQO YP ]^KUORYVNO\] YX KX YXQYSXQ LK]S]
-_]^YWO\]% 1Y`O\XWOX^] KXN <OQ_VK^Y\]% 2OKV^RMK\O
:\YPO]]SYXKV]% /WZVYcOO]% 819]% 6YMKV -YWW_XS^SO]% =_ZZVSO\]
STATUTORY REPORT FINANCIAL STATEMENTS
@OXNY\] KXN =RK\ORYVNO\] <OQ_VK\ MYWW_XSMK^SYX KXN
OXQKQOWOX^aS^R^RO]O]^KUORYVNO\]OXRKXMOY_\_XNO\]^KXNSXQ
VK]^SXQ\OVK^SYX]RSZ]
1. Has the Company mapped its internal and external
stakeholders? – CO]
 9
 _^ YP ^RO KLY`O RK] ^RO -YWZKXc SNOX^S ON ^RO
disadvantaged, vulnerable and marginalised stakeholders?
 RO-YWZKXcRK]LOOXQS`SXQK]ZOMSKVPYM_]^YWK\QSXKVS]ON
>
]^KUORYVNO\] ^R\Y_QR `K\SY_] SXS^SK^S`O] 9XO ]_MR SXS^SK^S`O
PYM_]ONYX^RO]KPO^cKXNZ\S`KMcYPaYWOXAY\USXQaS^RK
-YWZKXc VK_XMRON K MYWZ\OROX]S`O KaK\OXO]] ON_MK^SYX
KXN SXP\K]^\_M^_\O Z\YQ\KW ^Y ROVZ ^RO `SVVKQO] SWZ\Y`O
##aYWOXSX^RO`SVVKQO]MS^ONSWZ\Y`ON]KPO^cKXNZ\S`KMc
K]YXOYP^ROWKTY\LOXO ^]YP^ROZ\YTOM^
  R\Y_QR KXY^RO\ SXS^SK^S`O ^RO 8S\WKV .RK\K .KS\c :\YTOM^
>
SX +RWONXKQK\ aO RK`O LOOX OWZYaO\SXQ aYWOX NKS\c
+] K \O]_V^ YP ^RS] Z\YQ\KW NKS\c SXMYWO] RK`O XOK\Vc
NY_LVON KWYXQ ^RO PK\WO\] aRY aO\O ZK\^ YP ^RO Z\YQ\KW
>RS] cOK\ ^RO -YWZKXc RK] ]^K\^ON K XOa SXS^SK^S`O ^RK^
PYM_]O] YX M\OK^SXQ K ]_]^KSXKLVO ROKV^RMK\O NOVS`O\c
WYNOV SX _XNO\]O\`ON K\OK] ^Y QOXO\K^O VS`OVSRYYN] PY\
]OVPOWZVYcON aYWOX SX \_\KV 3XNSK >R\Y_QR KVV Y_\
SXS^SK^S`O]aORK`OLOOX^\cSXQ^YOWZYaO\WK\QSXKVS]ONKXN
`_VXO\KLVO]^KUORYVNO\]^YSWZ\Y`O^ROS\VS`SXQMYXNS^SYX]
  RO -YWZKXc ]^\S`O] ^Y SWZ\Y`O ROKV^RMK\O KXN N\S`O
>
KaK\OXO]] L_SVNSXQ KXN NSKQXY]S] SWZ\Y`OWOX^ ^R\Y_QR
ON_MK^SYX KXN ROKV^R MVSXSM] KNN\O]]SXQ ^RO XOON PY\ LO^^O\
ROKV^RMK\O NSKQXY]^SM KXN ]KXS^K^SYX PKMSVS^SO] K] ZK\^ YP S^]
MYWWS^WOX^^YNYSXQL_]SXO]]\O]ZYX]SLVcKXN]_]^KSXKLVc
  RO-YWZKXcaY\U]MYX^SX_Y_]Vc^YaK\N]ROKV^RON_MK^SYX
>
\OKMRSXQY_^^Y^ROZ_LVSMK^VK\QO^R\Y_QR`K\SY_]MRKXXOV]
KXN_X
_XKaK\OKXN_X]_]ZOM^SXQZK^SOX^]
3. Are there any special initiatives taken by the Company
to engage with the disadvantaged, vulnerable and
marginalized stakeholders? - If so, provide details thereof.
 >RO -YWZKXc] SXS^SK^S`O] ]_MR K] -\OK^SXQ K =_]^KSXKLVO
2OKV^RMK\O .OVS`O\c 7YNOV 8S\WKV .RK\K .KS\c :\YTOM^
KXN>Y^KV=KXS^K^SYX:\YTOM^KSW]^YOWZYaO\WK\QSXKVSdON
aYWOX >RO VK^^O\ ZK\^SM_VK\Vc OK]ON ^RO VS`O] YP ]^_NOX^]
KXN OVNO\Vc aRY NSN XY^ RK`O KMMO]] ^Y ^YSVO^] LOPY\O ^RO
Z\YTOM^
79
 ABBOTT INDIA LIMITED
Principle 5 : Businesses should respect and promote human
rights
>RO -YWZKXc LOVSO`O] SX ^RO NSQXS^c YP O`O\c R_WKX LOSXQ KXN
\O]ZOM^] SXNS`SN_KV \SQR^] >RO]O Z\SXMSZVO] K\O \O
OM^ON SX O`O\cYXOLc\ON_MSXQ^ROOX`S\YXWOX^KVSWZKM^]YPY_\L_]SXO]]
^RO -YWZKXct] WS]]SYX KXN MY\O `KV_O] AO MYX^\SL_^O ^Y ^RO
P_V VWOX^ YP R_WKX \SQR^] ^R\Y_QR MYWZVSKXMO aS^R VKa] KXN
\OQ_VK^SYX]aRO\O`O\aOYZO\K^OK]aOVVK]^R\Y_QRY_\ZYVSMSO]
KXNZ\YQ\KW]9_\QVYLKVQ_SNOVSXO]SXMV_NO$
w :\Y`SNSXQKROKV^RcKXN]KPOaY\USXQOX`S\YXWOX^%
w -YWZVcSXQaS^RMRSVNVKLY_\VKa]%
w  \YWY^SXQ aY\UPY\MO NS`O\]S^c KXN XY^ NS]M\SWSXK^SXQ KQKSX]^
: AO ^KUO ]^OZ] ^Y \ON_MO Y_\ _]O YP OXO\Qc KXN Y^RO\ XK^_\KV
KXc OWZVYcOO PY\ \OK]YX] ]_MR K] \KMO \OVSQSYX MYVY_\ KQO
QOXNO\O^RXSMS^cNS]KLSVS^cWK\S^KV]^K^_]KXN]Ob_KVY\SOX^K^SYX
SXKNNS^SYX^YKXcY^RO\]^K^_]Z\Y^OM^ONLcVYMKVVKa%
w  Y^^YVO\K^SXQRK\K]]WOX^Y\RK\]RY\SXR_WKXO^\OK^WOX^SX
8 Policies, Energy Security, Water, Food Security, Sustainable
^ROaY\UZVKMO%
w :\Y^OM^SXQSXNS`SN_KVZ\S`KMc%
w  \Y`SNSXQMYWZOX]K^SYXKXNLOXO ^]^RK^K\OMYWZO^S^S`OKXN
: Company or extends to the Group/Joint Ventures/
MYWZVc aS^R KZZVSMKLVO VKa] PY\ WSXSW_W aKQO] Y`O\^SWO
RY_\]KXNWKXNK^ONLOXO ^]%
w  XMY_\KQSXQYZOXMYWW_XSMK^SYXLO^aOOXWKXKQOWOX^KXN
/
OWZVYcOO]
3^ S] ^RO -YWZKXct] ZRSVY]YZRc ^Y WKSX^KSX KX YZOX aY\USXQ
OX`S\YXWOX^^RK^KVVYa]P\OOObMRKXQOYPSXPY\WK^SYXLcaKcYP
MYWW_XSMK^SYX MRKXXOV] KM\Y]] ^RO Y\QKXS]K^SYX +VV OWZVYcOO]
K\O KVVYaON ^Y ]RK\O ^ROS\ MYXMO\X] Z\YLVOW] [_O]^SYX] Y\
]_QQO]^SYX]aS^RY_^KXcPOK\YP\O^KVSK^SYXKXNS^S]`S^KV^RK^^RO]O
MYXMO\X]K\ONS]M_]]ONKXN\O]YV`ONSXK^SWOVcWKXXO\
>RO -YWZKXc RK] ZYVSMSO] YX /^RSM] KXN -YWZVSKXMO .S`O\]S^c
KXN 3XMV_]SYX K] aOVV K] YX :\YRSLS^SYX YP 2K\K]]WOX^ K^
AY\UZVKMO
1. Does the policy of the Company on human rights cover
only the Company or extend to the Group/Suppliers/
Contractors/NGOs/Others?
  RO -YWZKXct] -YNO YP ,_]SXO]] -YXN_M^ MY`O\] ^RO
> >RO -YWZKXc S] KV\OKNc aY\USXQ YX SNOX^SPcSXQ UOc /2=
_OXMSXQ Z_LVSM K XK^SYXaSNO \YKN ]KPO^c KaK\OXO]] N\S`O 6O`O\KQSXQ ^RO
Q_SNOVSXO] YX R_WKX \SQR^] KXN S^ S] KZZVSMKLVO ^Y KVV ^RO
]^KUORYVNO\]YP^RO-YWZKXc
2. How many stakeholder complaints have been received in
^ROZK]^ XKXMSKVcOK\KXNaRK^ZO\MOX^aK]]K^S]PKM^Y\SVc
resolved by the Management?
  _\SXQ ^RO cOK\ XY MYWZVKSX^] aO\O \OMOS`ON _XNO\ ^RO
. YX]S^O \O`SOa] KXN ZY^OX^SKV OX`S\YXWOX^KV \S]U] K\O ]RK\ON
=Ob_KV2K\K]]WOX^+M^`SYVK^SYXYP2_WKX<SQR^]
80 ANNUAL REPORT 2017-18
Principle 6 : Businesses should respect, protect, and make
efforts to restore the environment
AO K\O MYWWS^^ON ^Y ]KPOQ_K\NSXQ K ROKV^Rc OX`S\YXWOX^ PY\
>RS] MYWWS^WOX^ ]RKZO] ^RO aKc aO ]Y_\MO WKX_PKM^_\O
NO]SQX KXN NS]^\SL_^O Y_\ Z\YN_M^] + ]_]^KSXKLVO OX`S\YXWOX^
S] O]]OX^SKV PY\ LO^^O\ ROKV^R ]^\YXQO\ MYWW_XS^SO] KXN WY\O
P_V VVSXQ VS`O] 9_\ VYXQ^O\W /X`S\YXWOX^ 2OKV^R KXN =KPO^c
/2= ]^\K^OQc KSW] ^Y Z\Y^OM^ Y_\ ZOYZVO Y_\ ZVKXO^ KXN Y_\
`KV_OAOKMRSO`O^RS]LcNOVS`O\SXQKM\Y]]KX_WLO\YPMY\OK\OK]
^Y\ON_MOKXNWS^SQK^OOX`S\YXWOX^KV\S]U]%NOVS`O\MY]^OP MSOXMc
KXNOX]_\OL_]SXO]]MYX^SX_S^c
\O]Y_\MO] AO ]_ZZY\^ Z\YTOM^] ^RK^ QOXO\K^O OXO\Qc P\YW
\OXOaKLVO ]Y_\MO] K^ aY\U KXN SX Y_\ MYWW_XS^SO] AO ]OOU
aKc]^Y\ON_MO^ROOX`S\YXWOX^KVSWZKM^YPY_\YZO\K^SYX]]_MR
K] ^R\Y_QR aK]^O \ON_M^SYX KXN \OMcMVSXQ KXN Y^RO\ KM^S`S^SO] ^Y
WS^SQK^O OX`S\YXWOX^KV \S]U] AO KNRO\O ^Y ^RO OX`S\YXWOX^KV
VKa]KXN\OQ_VK^SYX]KZZVSMKLVO^YY_\YZO\K^SYX]
1. Does the policy relate to Principle 6 cover only the
Suppliers/Contractors/NGOs/others?
  RO /2= ZYVSMc YP ^RO -YWZKXc MY`O\] KVV OWZVYcOO] KXN
> \OMY`O\cP\YW^Y"0V_SNLONN\cO\ V^O\LKQaK]RSXQ
MYX^\KM^Y\]YP^RO-YWZKXc
2. Does the Company have strategies initiatives to address
global environmental issues such as climate change,
global warming, etc.? Y/N - If yes, please give hyperlink
for webpage etc.
CO] >RO -YWZKXc S] MYWWS^^ON ^Y OX`S\YXWOX^KV Z\Y^OM^SYX
KXNRK]SNOX^S ON^R\OOOX`S\YXWOX^KVZ\SY\S^SO]3XOKMRYXO
aORK`O]O^KWLS^SY_]QYKV]PY\\ON_MSXQOX`S\YXWOX^KVSWZKM^
LcMYWZK\ON^YVO`OV]KXNKNT_]^ONPY\]KVO]
- -VSWK^O MRKXQO $  \ON_M^SYX SX MK\LYX NSYbSNO
O[_S`KVOX^ -9 OWS]]SYX] SO Q\OOXRY_]O QK] E121G
OWS]]SYX] K]]YMSK^ON aS^R Y_\ L_]SXO]] YZO\K^SYX] KXN
^ROOVOM^\SMS^caOZ_\MRK]OSO=MYZOKXNOWS]]SYX]
- AK^O\_]KQO$\ON_M^SYXSX^Y^KVaK^O\SX^KUO
- AK]^OWKXKQOWOX^$\ON_M^SYXSX^Y^KVaK]^O
PYM_]K\OK]KXN^K\QO^]PY\
3. Does the Company identify and assess potential
environmental risks? Y/N
CO] ^RO\O K\O SX^O\XKV ]^KXNK\N] LK]ON YX 3=9 
/X`S\YXWOX^KV \S]U K]]O]]WOX^] K\O _ZNK^ON KXN \O`SOaON
\OQ_VK\Vc >RO -Y\ZY\K^O /2= ^OKW MYXN_M^] SXNOZOXNOX^
aS^R^RO^YZWKXKQOWOX^PY\K^^OX^SYX
CORPORATE OVERVIEW
4. Does the Company have any project related to Clean
Development Mechanism? If so, provide details thereof,
in about 50 words or so. Also, if Yes, whether any
OX`S\YXWOX^KV-YWZVSKXMO\OZY\^S] VON)
association? If Yes, Name only those major ones that your
8Y Z\YTOM^] K\O _XNO\^KUOX ]ZOMS MKVVc _XNO\ -VOKX
.O`OVYZWOX^ 7OMRKXS]W RYaO`O\ ^RO\O S] OWZRK]S]
YX _]KQO YP MVOKX OXO\Qc VSUO ,SYWK]] K^ 1YK ZVKX^
-9OWS]]SYX\ON_M^SYXYZZY\^_XS^SO]K\OPY\WKVVcK]]O]]ON
KXNOWS]]SYX\ON_M^SYXS]KZK\^YPKXX_KV]S^O^K\QO^]KXNUOc
ZO\PY\WKXMOSXNSMK^Y\]
5. Has the Company undertaken any other initiatives on
MVOKX ^OMRXYVYQc OXO\Qc OP MSOXMc \OXOaKLVO OXO\Qc
etc.? If yes, please give hyperlink for web page etc.
CO]>RO-YWZKXcS]MYWWS^^ON^YOX`S\YXWOX^KVZ\Y^OM^SYX
@O\WSMYWZY]^SXQKXN\KSXaK^O\RK\`O]^SXQS]LOSXQZ\KM^SMON
1YK]S^OS]DO\YAK]^O^Y6KXN VVDA6MO\^S ONaS^RWY\O
^RKX#YP^ROaK]^OOS^RO\LOSXQ\OMcMVONY\MYZ\YMO]]ON
YPP]S^O PY\ OXO\Qc \OMY`O\c 8Oa 2@+- ]c]^OW RK] LOOX
SX]^KVVONaS^ROXO\QcOP MSOX^MYWZYXOX^]>ROObS]^SXQ0>6
RSQR ZYaO\ MYX]_WSXQ VSQR^] \OZVKMON aS^R OXO\Qc ]K`SXQ
6/.VSQR^]SX;-K\OK]AK^O\MYX]O\`K^SYXWOK]_\O]SXMV_NO
XOa MYXNOX]K^O \OMY`O\c Z_WZ ^Y SWZ\Y`O ^RO MYXNOX]K^O
KXN N\cSXQ WKMRSXO SX]^KVVON ^Y ]K`O  VS^O\] YP aK^O\ ZO\
aK]RSXQ McMVO KXN SX^O\WONSK^O Z\YN_M^ MYX^KSXO\ MVOKXSXQ
WKMRSXOSX]^KVVON^Y]K`OVS^O\]YPaK^O\ZO\MYX^KSXO\
6. Are the Emissions/Waste generated by the Company
within the permissible limits given by CPCB/SPCB for the
XKXMSKVcOK\LOSXQ\OZY\^ON)
+VV^RO/WS]]SYX]AK]^OQOXO\K^ONLc^RO-YWZKXcS]aS^RSX
^ROZO\WS]]SLVOVSWS^]QS`OXLc-:-,=:-,PY\^RO XKXMSKV
cOK\LOSXQ\OZY\^ON>RO]KWZVO]K\O^O]^ONLcSXNOZOXNOX^
1Y`O\XWOX^KZZ\Y`ONVKLY\K^Y\SO]YXK\OQ_VK\LK]S]
7. Number of show cause/legal notices received from CPCB/
SPCB which are pending (i.e. not resolved to satisfaction)
as on end of Financial Year.
8Y]RYaMK_]OVOQKVXY^SMO]\OMOS`ONP\YW-:-,=:-,K\O
ZOXNSXQ
:\SXMSZVO ! $ ,_]SXO]]O] aROX OXQKQON SX SX
and regulatory policy, should do so in a responsible manner
>RO-YWZKXcLOVSO`O]SXVO`OVZKcSXQ OVNPY\KVVKXNKN`YMK^O]
PY\ PKS\ KXN LKVKXMON ZYVSMc NOMS]SYX] ^RK^ K\O LOXO MSKV PY\ ^RO
ZK^SOX^]KXNZRK\WKMO_^SMKVSXN_]^\cSX3XNSK
>RO-YWZKXcS]KWOWLO\YPSXN_]^\cLYNSO]>RO-YWZKXcaY\U]
aS^R ^RO]O K]]YMSK^SYX] \OQ_VK\Vc KXN KM^S`OVc KXN ]_LWS^] `SOa]
^R\Y_QR^ROWaROXK]UONLc^ROZYVSMcWKUO\]\OQ_VK^Y\]YX^RO
ObS]^SXQY\XOaZYVSMSO]ZO\^KSXSXQ^Y^ROZRK\WKMO_^SMKV]OM^Y\
STATUTORY REPORT FINANCIAL STATEMENTS
>RO -YWZKXc OXNY\]O] SXMV_]S`O ZYVSMSO] KXN ]_]^KSXKLVO
NO`OVYZWOX^^R\Y_QRZK\^SMSZK^SXQSX-=<PY\_W]KXNNS]M_]]SYX]
1. Is your Company a member of any trade and chamber or
business deals with.
CO] ,OVYa K\O ^RO ^\KNO KXN MRKWLO\ Y\ K]]YMSK^SYX aRSMR
^RO-YWZKXcNOKV]aS^R$
  \QKXSdK^SYX YP :RK\WKMO_^SMKV :\YN_MO\] YP 3XNSK
9
9::3
 0ONO\K^SYXYP3XNSKX-RKWLO\]YP-YWWO\MO3XN_]^\SO]
03--3
2. Have you advocated/lobbied through above associations
for the advancement or improvement of public good?
If yes specify the broad areas (drop box : Governance and
Administration, Economic Reforms, Inclusive Development
Business Principles, Others)
CO] ,\YKN K\OK] K\O $ :\SMSXQ SWZVOWOX^K^SYX S]]_O]%
8K^SYXKV:RK\WKMO_^SMKV]:YVSMc%>KbK^SYXZYVSMSO]KXN.\_Q
<OQ_VK^Y\cWK^^O\]
Principle 8 : Businesses should support inclusive growth and
equitable development
AO KSW ^Y OWZYaO\ MYWW_XS^SO] ^Y ^KUO MYX^\YV YP ^ROS\ VS`SXQ
OX`S\YXWOX^] PY\ P_VVO\ ROKV^RSO\ VS`O] >RO -YWZKXct] -=<
ZYVSMcS]PYM_]ONYXPY]^O\SXQOMYXYWSMOX`S\YXWOX^KVKXN]YMSKV
aOVVLOSXQ
  YO] ^RO -YWZKXc RK`O ]ZOMS ON Z\YQ\KW]SXS^SK^S`O]
.
projects in pursuit of the policy related to Principle 8?
If yes, details thereof.
iCARE Road Safety Drive
<YKN=KPO^cRK]LOOXKZK\^YP^RO-YWZKXc]PYM_]^K\QO^ONK^
K`YSNSXQKMMSNOX^]KXNSWZ\Y`SXQVS`O]+LLY^^3XNSKt]S-+</
=KPO^c .\S`O S] QOK\ON ^YaK\N] ]Z\OKNSXQ KaK\OXO]] KLY_^
\YKN]KPO^cWOK]_\O]^YZ\O`OX^\YKNKMMSNOX^]KXN]K`OVS`O]
9\SQSXKVVc ]^K\^ON SX  K] KX SX^O\XKV ^\KSXSXQ Z\YQ\KW
PY\+LLY^^t]OWZVYcOO]S-+</=KPO^c.\S`ORK]O`YV`ONSX^Y
ObZO\SOXMO QKSXON KXN ^RO ^\KSXSXQ _]ON N_\SXQ S^] SX^O\XKV
OWZVYcOO ]KPO^c MKWZKSQX +LLY^^ 3XNSK S] \OKMRSXQ Y_^ ^Y
3XNSKt]Z_LVSM^Y]Z\OKN]KPO^cKaK\OXO]]
9`O\^ROcOK\]aORK`O\OKMRONWY\O^RKX6KUR]ZOYZVO
^R\Y_QR^RS]SXS^SK^S`O3X!"WY\O^RKX7OWLO\]
:KX3XNSK YP Y_\ aY\UPY\MO ON_MK^ON ZOYZVO ^ROc WO^ SX
WONSMKV MVSXSM] RY]ZS^KV] KXN ]MRYYV] KLY_^ ]KPO N\S`SXQ
Z\KM^SMO] >ROc _]ON ^RS] YZZY\^_XS^c ^Y ]RK\O ]SWZVO
81
ABBOTT INDIA LIMITED
KM^SYXKLVO]^OZ]PY\\ON_MSXQ\YKNKMMSNOX^]KXNSXT_\SO]VSUO
aOK\SXQKROVWO^KXNK]OK^LOV^]^KcSXQKVO\^YLOcSXQ]ZOON
VSWS^]KXNK`YSNSXQ^RO_]OYPWYLSVOZRYXOaRSVON\S`SXQ
._\SXQ XKXMSKV cOK\ !" ^RO Z\YQ\KW KV]Y Ob^OXNON
S^] \OKMR Lc MYVVKLY\K^SXQ aS^R ! ]MRYYV] ^Y ON_MK^O ""
]^_NOX^]YXZONO]^\SKX]KPO^cKXN\YKN]KPO^cKaK\OXO]]
Nirmal Dhara Dairy Development Program
3XNSKS]^ROaY\VNt]VK\QO]^Z\YN_MO\YPWSVUKXNXOK\VcRKVP
YP\_\KVRY_]ORYVN]NOZOXNYXNKS\cPK\WSXQPY\K^VOK]^ZK\^
YP^ROS\SXMYWO.O]ZS^O^RS]WKXcNKS\cPK\WO\]MYX^SX_O^Y
LOWK\QSXKVSdONVSWS^ONLcWSNNVOWOXKVKMUYP^OMRXYVYQc
KXN WO^RYN] ^Y Z\YN_MO RSQRO\ [_KVS^c WSVU PY\ K LO^^O\
Z\SMO + P_\^RO\ Z\YLVOW S] ^RK^ aYWOX K\O YP^OX ObMV_NON
P\YW NOMS]SYXWKUSXQ NO]ZS^O ZVKcSXQ K ]SQXS MKX^ \YVO SX
NKS\cSXQaY\U
AY\USXQaS^R:\KLRK^KVYMKVNKS\c]_ZZVSO\KXN>OMRXY=O\`O
K XYXZ\Y ^ Y\QKXS]K^SYX aO NO`OVYZON K NOWYX]^\K^SYX
WYNOV^RK^]^\OXQ^ROX]VYMKVNKS\c]_ZZVcMRKSXKXNOWZYaO\]
]WKVVRYVNO\ PK\WO\] ^Y Z\YN_MO SXM\OK]ON `YV_WO] YP
RSQRO\[_KVS^cWSVU
=SXMO   Y_\ Z\YQ\KW RK] NS\OM^Vc \OKMRON Y`O\ 
]WKVVRYVNO\ NKS\c PK\WO\] RKVP YP aRSMR K\O aYWOX SX
7KRK\K]R^\K KXN 1_TK\K^ AO NO`OVYZON ^RO SXP\K]^\_M^_\O
\O[_S\ON^YObZKXNMKZKMS^cPY\WSVUZ\YN_M^SYXKXNNOVS`O\ON
\YL_]^^\KSXSXQYX^YZSM]\KXQSXQP\YW^ROLK]SM]YPOX]_\SXQ
RSQR[_KVS^c WSVU ^Y ^OMRXSMKV NKS\cSXQ ]USVV] KXSWKV POON
KXN MK\O PK\W WKXKQOWOX^ KXN ^RO L_]SXO]] YP NKS\cSXQ
AO \_X ^\KSXSXQ] ]ZOMS MKVVc PY\ aYWOX PK\WO\] K] aOVV
AO O]^KLVS]RON ^\KX]ZK\OX^ Z\SMSXQ WOMRKXS]W] PY\ ^RO
PK\WO\]t WSVU ^RK^ MVOK\Vc NOWYX]^\K^O ^RO VSXU LO^aOOX
[_KVS^cKXNZ\SMO
._\SXQ VK]^ cOK\ Y_\ Z\YQ\KW RKN \_X XOK\Vc  ^\KSXSXQ
]O]]SYX] PY\ PK\WO\] AO K\O ]OOSXQ K MYX]S]^OX^ SXM\OK]O
SX ^RO `YV_WO YP RSQR[_KVS^c WSVU MYVVOM^ON O`O\c WYX^R
NOWYX]^\K^SXQ ^RO SWZKM^ YP Y_\ Z\YQ\KWt] ^\KSXSXQVON
KZZ\YKMR ,K]ON YX ^RS] ]_MMO]] :\KLRK^ S] MYWWS^^ON ^Y
ObZKXNSXQ^RS]WYNOV^YKNNS^SYXKV`SVVKQO]SX^RO\OQSYX
Y`O\ ^R\OO cOK\] >RS] aSVV QS`O WY\O ]WKVVRYVNO\ PK\WO\]
KMMO]]^YK^\_]^ONKXN^\KX]ZK\OX^WK\UO^KXN^RO]USVV]KXN
SXP\K]^\_M^_\O^RK^^ROcXOON^Y]_ZZVcS^
Health Clinics - Programs to expand Awareness and
Access to Healthcare
+MMO]] ^Y O]]OX^SKV ROKV^RMK\O ]O\`SMO] KXN SXPY\WK^SYX S] K
MYX^SX_SXQMRKVVOXQOPY\WKXcSX3XNSK
+LLY^^ 3XNSK RK] ]O`O\KV Z\YQ\KW] ^Y KNN\O]] ^RS] QKZ
>R\Y_QR YXO ]_MR OPPY\^ +LLY^^ 3XNSK ]_ZZY\^] [_KVS ON
NYM^Y\] KXN ROKV^RMK\O Z\YPO]]SYXKV] ^Y ObZKXN NS]OK]e
82 ANNUAL REPORT 2017-18
CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS
dSKQXY]S] KXN KMMO]] ^Y MK\O >RS] SXMV_NO] Z\YQ\KW] 4. What is your Company’s direct contribution to Z\Y`SNO SXPY\WK^SYX ^RK^ S] MYX]S]^OX^ aS^R ]MSOX^S M O`SNOXMO
^Y \KS]O KaK\OXO]] KXN SWZ\Y`O MK\O PY\ OZSVOZ]c KXN community development projects and the details of the VOKNSXQ WONSMKV Z\KM^SMO KXN ^RO KZZ\Y`ON Z\YN_M^ VKLOVVSXQ
VS`O\ NS]OK]O] 3X ^RO cOK\ !" ^RO]O Z\YQ\KW] \OKMRON projects undertaken)? \O[_S\OWOX^
KZZ\YbSWK^OVc   NS]^\SM^] SX WY\O ^RKX  ]^K^O] \OKMRSXQ
Particulars ` in Lakhs 1. What percentage of customer complaints/consumer cases
Y_^ ^Y  6KUR] ZOYZVO ^R\Y_QR Y`O\ " KaK\OXO]]
K\OZOXNSXQK]YX^ROOXNYP XKXMSKVcOK\)
MKWZKSQX] 2OKV^R-VSXSM]:\YQ\KW]^YObZKXN 
+aK\OXO]]KXN+MMO]]^Y2OKV^RMK\O
Creating a Sustainable Healthcare Delivery Model -YWZVKSX^]WONSMKVKXNXYXWONSMKVaO\O\OMOS`ONLc
through Livelihoods 8S\WKV.RK\K.KS\c:\YTOM^ #" ^RO-YWZKXcKXN\O]ZYXNONK]ZO\^RO-YWZKXcZYVSMSO]KXN
Z\YMON_\O]Lc7K\MR"
=/A+-\OK^SXQK=_]^KSXKLVO2OKV^RMK\O  
>RO -YWZKXc RK] SXS^SK^ON K XOa Z\YTOM^ SX ZK\^XO\]RSZ
.OVS`O\c7YNOV^R\Y_QR6S`OVSRYYN] 2. Does the Company display product information on the
aS^R =/A+ =OVP/WZVYcON AYWOXt] +]]YMSK^SYX ^Y
SWZ\Y`OKMMO]]^Y[_KVS^cROKV^RMK\OSX3XNSKAY\USXQaS^R i-+</<YKN=KPO^c.\S`O "" product label, over and above what is mandated as per
=/A+ aRSMR \OZ\O]OX^] _XNO\Z\S`SVOQON ]OVPOWZVYcON local laws?
5. Have you taken steps to ensure that this community
aYWOX aY\UO\] aRY OK\X K VS`SXQ ^R\Y_QR ^ROS\ YaX
development initiative is successfully adopted by the CO]>RO-YWZKXcNS]ZVKc]\OVO`KX^SXPY\WK^SYXYXZ\YN_M^
VKLY_\Y\]WKVVL_]SXO]]O]+LLY^^3XNSKS]]OOUSXQ^YM\OK^O
community? Please explain in 50 words, or so. VKLOV]SXKMMY\NKXMOaS^RKZZVSMKLVO]^K^_^Y\c\O[_S\OWOX^]
K ]_]^KSXKLVO ROKV^RMK\O NOVS`O\c WYNOV aS^RSX =/A+
MYWW_XS^SO] 0Y\ -YWW_XS^c6ON >Y^KV =KXS^K^SYX :\YTOM^ 8S\WKV .RK\K  3 ] ^RO\O KXc MK]O VON Lc KXc ]^KUORYVNO\ KQKSX]^ ^RO
.KS\c :\YTOM^ KXN ^RO Z\YQ\KW ^Y -\OK^O K =_]^KSXKLVO Company regarding unfair trade practices, irresponsible
>RS] Z\YQ\KW KSW] ^Y SWZ\Y`O ROKV^R Y_^MYWO] QOXO\K^O
2OKV^RMK\O 7YNOV aO KSWON K^ OWLONNSXQ ]_]^KSXKLSVS^c advertising and/or anti-competitive behaviour during
VS`OVSRYYN] KXN M\OK^O KX OMY]c]^OW aS^R KVV ]^KUORYVNO\]
SX^Y ^RO MY\O YP Y_\ OXQKQOWOX^ aS^R ^RO LOXO MSK\SO] ^ROVK]^ `OcOK\]KXNZOXNSXQK]YXOXNYP XKXMSKVcOK\)
KXNUOcZK\^XO\].YM^Y\]:RK\WKMSO]6KL]aRSVOOX]_\SXQ
>R\Y_QR MYX^SX_Y_] ^\KSXSXQ KXN WYXS^Y\SXQ YP ^RO `K\SY_] If so, provide details thereof.
LY^R KPPY\NKLSVS^c YP ]O\`SMO] PY\ =/A+ WOWLO\] K] aOVV
SX^O\`OX^SYX]aOOX]_\ON^RK^MYWW_XS^SO]XY^YXVcKNYZ^ON
K]K XKXMSKVVc]_]^KSXKLVOROKV^RMK\OOMY]c]^OW  MK]O VON KQKSX]^ ^RO -YWZKXc KVVOQSXQ
Y_\ SXS^SK^S`O] L_^ KV]Y OWL\KMON ^RO LOXO ^] ^RK^ ^ROc
>RS]Z\YQ\KWaSVVON_MK^O=/A+WOWLO\]YX`K\SY_]ROKV^R ObZO\SOXMONK]K\O]_V^ KX^SMYWZO^S^S`O Z\KM^SMO] S] ZOXNSXQ SX `K\SY_] ]^KQO]
MYXNS^SYX]aRSVO^\KSXSXQMYWW_XS^cROKV^RMK\OaY\UO\]YX LOPY\O^RO-YWZO^S^SYX-YWWS]]SYXYP3XNSK
Principle 9 : Business should engage with and provide value to
Z\Y`SNSXQ MYX]S]^OX^ MYWW_XS^cLK]ON MK\O >RO Z\YQ\KW 4. Did your Company carry out any consumer survey/
their customers and consumers in a responsible manner
aSVVKV]YSWZ\Y`OKMMO]]^Y[_KVS ONNYM^Y\]KXNZRK\WKMSO] consumer satisfaction trends?
AO Z\SY\S^SdO ^RO ROKV^R KXN aOVVLOSXQ YP Y_\ ZK^SOX^] KXN
SXY\NO\^YNO`OVYZKROKV^RMK\OOMY]c]^OW^YZ\Y`SNO[_KVS^c
MYX]_WO\] AO K\O MYWWS^^ON ^Y aY\USXQ aS^R ROKV^R MK\O
KXN KPPY\NKLVO ROKV^RMK\O PKMSVS^SO] KXN O`OX^_KVVc SWZ\Y`O CO]
Z\YPO]]SYXKV]^YZ\Y`SNO^ROWaS^R^SWOVcKXNKMM_\K^OSXPY\WK^SYX
ROKV^R]OOUSXQLORK`SY_\SXMYWW_XS^SO]
^Y K]]S]^ ^ROW SX WKUSXQ NOMS]SYX] KXN Z\Y`SNSXQ KN`SMO ^Y ^ROS\ For and on behalf of the Board
2. Are the programs/projects undertaken through in- ZK^SOX^]
house team/own foundation/external NGO/government
structures/any other organisation? 9_\ ]^K^OWOX^] KLY_^ Y_\ Z\YN_M^] SX KVV WK^O\SKV] KXN Munir Shaikh R A Shah
MYWW_XSMK^SYX] K\O LKVKXMON KXN ^\_^RP_V KXN MYX]S]^OX^ -RKS\WKX   .S\OM^Y\
2OKV^R-VSXSM]:\YQ\KW]^Y .S\OM^3WZVOWOX^K^SYX aS^R ^RO KZZ\Y`ON VKLOV 3X Z\YWY^SXQ Y_\ Z\YN_M^] aO .38$# !  .38$#"1
ObZKXN+aK\OXO]]KXN+MMO]]^Y
2OKV^RMK\O
8S\WKV.RK\K.KS\c:\YTOM^x .S\OM^3WZVOWOX^K^SYX
,_SVNSXQK=_]^KSXKLVO6YMKV
=_ZZVc-RKSX
=/A+-\OK^SXQK=_]^KSXKLVO .S\OM^3WZVOWOX^K^SYX
2OKV^RMK\O.OVS`O\c7YNOV
i-+</<YKN=KPO^c.\S`O .S\OM^3WZVOWOX^K^SYX
3. Have you done any impact assessment of your initiative?
-KZ^_\SXQKXN[_KX^SPcSXQSWZKM^S]YP_^WY]^SWZY\^KXMO^Y
KVV YP +LLY^^t] MS^SdOX]RSZ Z\YTOM^] +VV Y_\ SXS^SK^S`O] RK`O K
XOON]K]]O]]WOX^WSNVSXOKXNOXNVSXOO`KV_K^SYX-_\\OX^Vc
aOK\OMYWZVO^SXQ^ROOXNVSXOO`KV_K^SYXPY\^RO-YWW_XS^c
6ON>Y^KV=KXS^K^SYX:\YTOM^KXNSXS^SK^SXQWSNVSXOO`KV_K^SYX
PY\8S\WKV.RK\K.KS\c:\YTOM^
83
 ABBOTT
ABBOTT INDIA
INDIA LIMITED
LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

R E P O R T O N C O R P O R AT E
GOVERNANCE c) During the year under review, 7 Board Meetings were held on MEETING OF INDEPENDENT DIRECTORS
COMPANY’S PHILOSOPHY ON CORPORATE BOARD OF DIRECTORS the following dates : In terms of requirements of the Companies Act, 2013, Rules framed
GOVERNANCE thereunder and Regulation 25(3) of the Securities and Exchange
a) As on the date of this Report i.e. May 14, 2018, the Board May 19, 2017; July 18, 2017; August 8, 2017; November 13, 2017;
The Company’s philosophy on Corporate Governance is to conduct December 19, 2017; February 14, 2018 and March 27, 2018. Board of India (Listing Obligations and Disclosure Requirements)
its business in a manner, which is ethical and transparent with all comprises 7 Directors including 2 Executive and 5 Non-
Executive Directors, of which 3 are Independent Directors. Regulations, 2015, a meeting of Independent Directors was
the stakeholders of the Company, including members, creditors The option for attending Board/Committee Meetings via
and employees. The Company operates in compliance with all The Directors are professionals, having expertise in their held on May 19, 2017. The said Meeting was attended by all the
audio-visual means is provided to the Directors.
regulatory and policy requirements as well as industry ethical respective functional areas and bring a wide range of skills Independent Directors.
guidelines. The Company also has strict guiding principles laid out and experience to the Board. d) Details of the Directors seeking appointment/re-appointment
and communicated through its Code of Business Conduct, which at the forthcoming Annual General Meeting as required AUDIT COMMITTEE
is subject to regular audits to ensure that controls and compliances b) The composition of the Board of Directors, their attendance under Regulation 36(3) of the Securities and Exchange Board
at the Board Meetings held during the year under review The composition, role, terms of reference as well as powers
are maintained at a high standard. The Company’s philosophy on of India (Listing Obligations and Disclosure Requirements)
and at the last Annual General Meeting along with the of the Audit Committee of the Company are in compliance
Corporate Governance is, thus, concerned with the ethics, values Regulations, 2015 and Secretarial Standards issued by the
and morals of the Company and its directors, who are expected to number of directorships and memberships held in various with the provisions of Section 177 of the Companies Act,
committees in other companies, as on March 31, 2018, are Institute of Company Secretaries of India are annexed to the 2013 and Regulation 18 of the Securities and Exchange Board
act in the best interests of the Company and remain accountable to
WOWLO\]KXNY^RO\LOXO MSK\SO]PY\^ROS\KM^SYX] given in the table below : Notice convening the Annual General Meeting, which forms of India (Listing Obligations and Disclosure Requirements)
part of the Annual Report. Regulations, 2015.
Name of the Director Category of Total Attendance at Number of Number of e) There is no inter-se relationship between any of the Directors.
Composition :
Directorship Board Directorships Committee
Meetings Board Annual in other positions f) None of the Directors holds any shares of the Company except
held in Meetings General companies1 in other for Mr R A Shah, who, along with his relatives, holds 6,874 The Committee comprises 3 Independent Directors and
2017-18 held in Meeting companies2 shares as on March 31, 2018. 1 Non-Executive Director as on the date of this Report.
2017-18 (July 18, 2017)
g) As required under the Regulation 30 of the Securities The composition of the Audit Committee, category of its
Mr Munir Shaikh Non-Executive Director 7 6 Yes 2 NIL and Exchange Board of India (Listing Obligations and Members, their attendance at the Committee Meetings held
Chairman of the Board
Disclosure Requirements) Regulations, 2015, the Company during the year under review is given in the table below :
Mr Ambati Venu Executive Director 7 7 Yes NIL NIL RK]P\YW^SWO^Y^SWOXY^S ON^RO,=/6SWS^ON\OQK\NSXQKVV Sr. Name of the Member Category Number of
Managing Director appointments/re-appointments/resignations of Directors No. Meetings
Mr R A Shah Non-Executive, 7 7 Yes 113 73 during the year under review. 2017-18
Independent Director Held Attended
FAMILIARISATION PROGRAMS FOR INDEPENDENT
Mr Kaiyomarz Marfatia Non-Executive Director 7 7 Yes NIL NIL Mr R A Shah Independent
DIRECTORS 1.
Chairman Director
5 5

Mr Krishna Mohan Sahni Non-Executive, 7 7 Yes NIL NIL As a part of Induction and Continuing Education Program for Non-Executive
Independent Director 2. Mr Munir Shaikh 5 4
Independent Directors, periodic presentations are made by the Director
Mr Rajiv Sonalker Executive Director 7 4 NA NIL NIL Managing Director/Commercial Directors/Function Heads at Independent
3. Mr Krishna Mohan Sahni 5 5
Whole-time Director the Board Meetings to apprise the Directors with the Company’s Director
(appointed effective August 8, 2017) business strategies, long term plans, budgets, operations and Independent
4. Ms Anisha Motwani1 NA NA
performance. In addition, these presentations also provide insight Director
Ms Anisha Motwani Non-Executive, 7 NA NA 54 2
(appointed effective April 25, 2018) Independent Director into various growth opportunities for the Company, operational Mr Ranjan Kapur
Independent
and environmental challenges associated with the Company’s 5. (ceased to be a Member 5 3
Director
Mr Sachin Dharap Non-Executive Director 7 2 Yes NIL NIL effective January 27, 2018)
business operations, products, Management’s risk mitigation
(resigned effective August 8, 2017)
plans, human resources updates, etc. 1. appointed as a Member effective May 14, 2018.
Mr Ranjan Kapur Non-Executive, 7 4 Yes 6 5
1 The Directors are regularly briefed on the Company’s policies
(demised on January 27, 2018) Independent Director Ms Krupa Anandpara, Company Secretary is the Secretary of the
and procedures, with regards to distribution channels, business Committee.
Mr Bhasker Iyer Non-Executive Director 7 7 Yes NIL NIL model, cash and treasury management, accounting systems and
(resigned effective March 31, 2018) SX^O\XKV XKXMSKV MYX^\YV] O^M :VKX^ `S]S^ S] K\\KXQON PY\ ^RO Role :
Directors to acquaint them with the manufacturing process and
Ms Nancy Berce Non-Executive Director 7 2 Yes NIL NIL The role of the Committee includes :
(resigned effective March 31, 2018) the products manufactured in-house.
The Company also arranges various knowledge dissemination w  `O\]SQR^ YP ^RO -YWZKXct] XKXMSKV \OZY\^SXQ Z\YMO]] KXN
Y
1. Includes directorship in private companies, alternate directorship and directorship in foreign companies. However, it does not include the directorships in ^RONS]MVY]_\OYPS^] XKXMSKVSXPY\WK^SYX^YOX]_\O^RK^^RO
companies registered under Section 8 of the Companies Act, 2013. sessions by external faculty to keep the Independent Directors
updated with the current happenings, relevant news and legal/ XKXMSKV]^K^OWOX^]K\OMY\\OM^]_P MSOX^KXNM\ONSLVO%
2. Includes Membership/Chairmanship of Audit Committee and Stakeholders Relationship Committee.
regulatory changes. w \ OMYWWOXNK^SYXPY\KZZYSX^WOX^\OW_XO\K^SYXKXN^O\W]YP
3. Mr R A Shah holds directorship in 9 other public companies, 1 private company and 1 foreign company. His directorships include Chairmanship of 3 companies
and Vice-Chairmanship of 1 company and 1 alternate directorship. His Committee positions include Chairmanship of 4 committees.
Details of such programs conducted by the Company for the appointment of auditors of the Company;
4. Ms Anisha Motwani holds directorship in 4 other public companies and 1 private company. XKXMSKVcOK\!"K\OK`KSVKLVOYX^ROaOL]S^OYP^RO-YWZKXc w K ZZ\Y`KV YP ZKcWOX^ ^Y ]^K^_^Y\c K_NS^Y\] PY\ KXc Y^RO\
5. Mr Ranjan Kapur ceased to be Director due to his sad demise on January 27, 2018. He held directorships in 1 other public company and 5 private companies. at http://www.abbott.co.in/investor-relations/policies.html services rendered by them;

84 ANNUAL REPORT 2017-18 85

 ABBOTT INDIA LIMITED
w \ O`SOaSXQ aS^R ^RO WKXKQOWOX^ ^RO KXX_KV XKXMSKV
statements and auditor’s report thereon before submission to
the Board for approval, with particular reference to :
a) matters required to be included in the Directors’
Responsibility Statement to be included in the Board’s
Report in terms of clause (c) of sub-section 3 of
Section 134 of the Companies Act, 2013;
b) changes, if any, in accounting policies and practices and
reasons for the same;
c) major accounting entries involving estimates based on
the exercise of judgment by management;
 N ] SQXS MKX^KNT_]^WOX^]WKNOSX^RO XKXMSKV]^K^OWOX^]
OM^SXQ ]RY\^ KXN VYXQ^O\W
K\S]SXQY_^YPK_NS^ XNSXQ]%
e) compliance with listing and other legal requirements
\OVK^SXQ^Y^RO XKXMSKV]^K^OWOX^]%
f) disclosure of any related party transactions;
 Q WYNS ONYZSXSYX]SX^RON\KP^K_NS^\OZY\^%
w \ O`SOaSXQ aS^R ^RO WKXKQOWOX^ ^RO [_K\^O\Vc XKXMSKV
statements before submission to the Board for approval;
w \ O`SOaSXQ KXN WYXS^Y\SXQ ^RO K_NS^Y\t] SXNOZOXNOXMO KXN
performance and effectiveness of audit process;
w K ZZ\Y`KV Y\ KXc ]_L]O[_OX^ WYNS MK^SYX YP ^\KX]KM^SYX] YP
the Company with related parties;
w ]M\_^SXcYPSX^O\MY\ZY\K^OVYKX]KXNSX`O]^WOX^]%
w ` KV_K^SYXYP_XNO\^KUSXQ]Y\K]]O^]YP^RO-YWZKXcaRO\O`O\
it is necessary;
w O `KV_K^SYXYPSX^O\XKV XKXMSKVMYX^\YV]KXN\S]UWKXKQOWOX^
systems;
w  YXS^Y\SXQ^ROOXN_]OYPP_XN]\KS]ON^R\Y_QRZ_LVSMYPPO\]
W Mr R A Shah, Chairman of the Audit Committee attended the
and related matters;
w \ O`SOaSXQ aS^R ^RO WKXKQOWOX^ ZO\PY\WKXMO YP ]^K^_^Y\c
and internal auditors, adequacy of the internal control
systems;
w \ O`SOaSXQ ^RO KNO[_KMc YP SX^O\XKV K_NS^ P_XM^SYX SP KXc
including the structure of the internal audit department,
]^KP XQKXN]OXSY\S^cYP^ROYP MSKVROKNSXQ^RONOZK\^WOX^
reporting structure, coverage and frequency of internal audit;
w  S]M_]]SYX aS^R SX^O\XKV K_NS^Y\] YP KXc ]SQXS MKX^ XNSXQ]
N on the basis of such assessment;
and follow up thereon;
w \ O`SOaSXQ ^RO XNSXQ] YP KXc SX^O\XKV SX`O]^SQK^SYX] Lc ^RO
internal auditors into matters where there is suspected fraud
or irregularity or a failure of internal control systems of a
material nature and reporting the matter to the Board;
86 ANNUAL REPORT 2017-18
CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS
w discussion with statutory auditors before the audit The composition of the Nomination and Remuneration The Role of the Committee in relation to Remuneration matters
commences, about the nature and scope of audit as well as Committee, category of its Members and their attendance at the include :
post-audit discussion to ascertain any areas of concern; Committee Meetings held during the year under review is given w \ OMYWWOXN^Y^RO,YK\NKZYVSMc\OVK^SXQ^Y^RO\OW_XO\K^SYX
w ^YVYYUSX^Y^RO\OK]YX]PY\]_L]^KX^SKVNOPK_V^]SX^ROZKcWOX^ in the table below : for the Directors, Key Managerial Personnel and other
to the depositors, debenture holders, members (in case of employees. The Committee shall, while formulating the
Sr. Name of the Member Category Number of
non-payment of declared dividends) and creditors; policy ensure that :
No. Meetings
2017-18 - the level and composition of remuneration is reasonable
w KZZ\Y`KV YP KZZYSX^WOX^ YP -RSOP 0SXKXMSKV 9P MO\ SO ^RO
Held Attended KXN]_P MSOX^^YK^^\KM^\O^KSXKXNWY^S`K^ONS\OM^Y\]YP
Whole-time Finance Director or any other person heading the
the quality, required to run the company successfully;
XKXMOP_XM^SYXY\NS]MRK\QSXQ^RK^P_XM^SYXKP^O\K]]O]]SXQ^RO 1. Mr R A Shah1 Independent
4 4
Chairman Director - relationship of remuneration to performance is clear and
[_KVS MK^SYX]ObZO\SOXMOKXNLKMUQ\Y_XNO^MYP^ROMKXNSNK^O%
Non-Executive meets appropriate performance benchmarks; and
w \ O`SOaSXQ ^RO P_XM^SYXSXQ YP ^RO @SQSV 7OMRKXS]WARS]^VO 2. Mr Munir Shaikh 4 4
Director - remuneration to Directors, Key Managerial Personnel
Blower Mechanism;
3. 2 Independent
NA NA
and the Senior Management involves a balance between
Ms Anisha Motwani Director
w M K\\cSXQY_^KXcY^RO\P_XM^SYX]K]WKcLOZ\O]M\SLON_XNO\ bON KXN SXMOX^S`O ZKc \O
the Companies Act, 2013, Rules framed thereunder and Mr Ranjan Kapur performance objectives appropriate to the working of the
Independent
Regulation 18 of the Securities and Exchange Board of 4. (ceased to be a Member
Director
4 3 company and its goals.
effective January 27, 2018)
India (Listing Obligations and Disclosure Requirements) w \ OMYWWOXN^Y^RO,YK\NKVV\OW_XO\K^SYXSXaRK^O`O\PY\W
Regulations, 2015 or as may be delegated by the Board, from Mr Bhasker Iyer payable to the Senior Management;
Non-Executive
time to time. 5. (ceased to be a Member 4 4
Director
effective March 31, 2018) w ^YMYX]SNO\KXcY^RO\WK^^O\]K]WKcLONOVOQK^ONLc^RO,YK\N
The Committee also reviews various information prescribed
1. appointed as a Chairman effective April 25, 2018. Meetings :
under Part C of Schedule II as referred in Regulation 18(3) of the
2. appointed as a Member effective April 25, 2018.
Securities and Exchange Board of India (Listing Obligations and During the year under review, the Committee met 4 times on the
Disclosure Requirements) Regulations, 2015. Ms Krupa Anandpara, Company Secretary, is the Secretary of the following dates :
Committee.
Meetings : May 19, 2017; July 18, 2017; August 8, 2017 and March 27, 2018.
During the year under review, the Committee met 5 times on the Role :
Mr Ranjan Kapur, then Chairman of the Committee attended the
following dates : The Role of the Committee in relation to Nomination matters Annual General Meeting of the Company to answer the Shareholders’
May 19, 2017; August 8, 2017; November 13, 2017; December 19, include : queries in compliance with the requirements of Regulation 19(3) of
the Securities and Exchange Board of India (Listing Obligations and
2017 and February 14, 2018.
w P Y\W_VK^SXQ M\S^O\SK PY\ SNOX^SPcSXQ ]_S^KLVO MKXNSNK^O] PY\ Disclosure Requirements) Regulations, 2015.
>RO -RSOP 0SXKXMSKV 9P MO\ \OWKSX] Z\O]OX^ K^ KVV ^RO +_NS^ directors and senior management;
Performance Evaluation Criteria for Independent Directors :
Committee Meetings. All the meetings are attended by the
Statutory Auditors. Internal and Cost Auditors are invited to the w S NOX^SPc ZO\]YX] aRY K\O [_KVS ON ^Y LOMYWO NS\OM^Y\] The Company has devised Board Evaluation Framework and
Meetings, as and when required. and appointed as the senior management in accordance Policy, which sets a mechanism and criteria for the evaluation
with criteria laid down and recommend to the Board their of the Board, Board Committees and Directors, including
Independent Directors.
appointment and removal;
Annual General Meeting held on July 18, 2017 in compliance
with the requirements of Regulation 18(1)(d) of the Securities w P Y\W_VK^SXQ ^RO M\S^O\SK PY\ NO^O\WSXSXQ ^RO [_KVS MK^SYX] Performance Evaluation of the Directors is done through
self-assessment and group discussions, based on suggested
and Exchange Board of India (Listing Obligations and Disclosure positive attributes and independence of a director;
set of parameters such as Directors’ attendance and effective
Requirements) Regulations, 2015.
w NO`S]SXQZYVSMcYX^RONS`O\]S^cYP^RO,YK\N% participation at Board/Committee Meetings, their contribution
NOMINATION AND REMUNERATION COMMITTEE at the meetings, leveraging on his/her experience to provide the
w P Y\W_VK^SXQ ^RO M\S^O\SK PY\ O`KV_K^SYX YP ZO\PY\WKXMO YP necessary insights/guidance on Board discussions and display of
The composition, role, terms of reference as well as powers of the Board, its Committees and individual Directors and review candour in expressing views even when they are in divergence
Nomination and Remuneration Committee of the Company are in its implementation and compliance and whether to extend or with the rest of the Board, etc.
compliance with the provisions of Section 178 of the Companies continue the term of appointment of the independent director
Act, 2013 and Regulation 19 of the Securities and Exchange Board STAKEHOLDERS RELATIONSHIP COMMITTEE
of India (Listing Obligations and Disclosure Requirements) The composition, role, terms of reference as well as powers of
Regulations, 2015. w O X]_\SXQ^RK^^RO\OS]KXKZZ\YZ\SK^OSXN_M^SYXZ\YQ\KWWOSX the Stakeholders Relationship Committee of the Company are in
place for new directors and reviewing its effectiveness; compliance with the provisions of Section 178 of the Companies
Composition : Act, 2013 and Regulation 20 of the Securities and Exchange
w ^ Y MYX]SNO\ KXc Y^RO\ WK^^O\] K] WKc LO NOVOQK^ON Lc ^RO Board of India (Listing Obligations and Disclosure Requirements)
The Committee comprises 2 Independent Directors and
1 Non-Executive Director as on the date of this Report. Board. Regulations, 2015.
87
 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

Composition : Summary of Shareholders’ Grievances : Role : Sr. Name of the Member Category Number of
No. Meetings
The Committee comprises 1 Independent Director, A summary of complaints received and resolved by the Company The role of the Committee includes : 2017-18
1 Non-Executive Director and 1 Executive Director, as on the to the satisfaction of the shareholders/investors during the
w P Y\W_VK^O KXN \OMYWWOXN PY\ ^RO KMMOZ^KXMO YP ^RO ,YK\N Held Attended
date of this Report. year under review, is given below :
the Corporate Social Responsibility Policy (“CSR Policy”) Mr Ambati Venu Managing
1. 1 1
The composition of the Stakeholders Relationship Committee, Particulars Number interalia, to include the CSR activities, specify the modalities Chairman Director
category of its Members and their attendance at the Committee of execution, implementation schedules and recommend the Non-Executive
Pending at the beginning of the year - 2. Mr Kaiyomarz Marfatia 1 1
Meetings held during the year under review is given in the same to the Board of Directors; Director
table below : Received during the year 6* Independent
w S NOX^SPc ^RO -=< Z\YTOM^]KM^S`S^SO]Z\YQ\KW] ^Y LO 3. Mr Krishna Mohan Sahni 1 1
Resolved during the year 4 undertaken by the Company (“CSR activities”), in alignment Director
Sr. Name of the Member Category Number of
No. Meetings with Company’s CSR Policy and Schedule VII of the 4. Mr Rajiv Sonalker
Whole-time
1 1
Pending at the end of the year 2
2017-18 Companies Act, 2013; Director
Held Attended * includes 1 letter received from the Ministry of Corporate Affairs and Mr Sachin Dharap
w \ O`SOa LO]^ Z\KM^SMO] SX ^RO UOc -=< K\OK] Lc KZZ\YZ\SK^O Non-Executive
1. Mr Kaiyomarz Marfatia1 Non-Executive 4 4 4 letters from the Securities and Exchange Board of India (SCORES). 5. (ceased to be a Member 1 NA
Director internal/external analysis; Director
Chairman effective August 8, 2017)
Independent As on March 31, 2018, there were no pending share transfers. w \ OMYWWOXN^ROKWY_X^YPObZOXNS^_\O^YLOSXM_\\ONYX^RO
2. Mr R A Shah 4 4 Ms Krupa Anandpara, Company Secretary, is the Secretary
Director
-=<KM^S`S^SO]PY\OKMR XKXMSKVcOK\YP^RO-YWZKXc% of the Committee.
Managing CORPORATE SOCIAL RESPONSIBILITY COMMITTEE
3. Mr Ambati Venu 4 4 w  O`S]O ]_S^KLVO ^\KX]ZK\OX^ 7YXS^Y\SXQ 7OMRKXS]W PY\
N
Director The composition, role, terms of reference as well as powers of Role :
Mr Bhasker Iyer the Corporate Social Responsibility (“CSR”) Committee of the monitoring progress/status of implementation of the CSR
(ceased to be a Chairman/ Non-Executive Company are in compliance with the provisions of Section 135 activities; The role of the Committee includes :
4. 4 4
Member effective Director of the Companies Act, 2013 and Companies (Corporate Social w \ OMOS`O \OZY\^] KXN \O`SOa KM^S`S^SO] P\YW ObOM_^S`O KXN w WYXS^Y\SXQKXNSWZVOWOX^SXQ<S]U7KXKQOWOX^:VKX]%
March 31, 2018) Responsibility Policy) Rules, 2014. specialist groups managing CSR activities;
1. appointed as a Chairman effective May 14, 2018. w O X]_\O^RK^^ROKNO[_KMcYP^RO-YWZKXct]<S]U7KXKQOWOX^
Composition : w  YXS^Y\-=<:YVSMcP\YW^SWO^Y^SWOKXN\O`S]O^RO]KWOK]
W
Ms Krupa Anandpara, Company Secretary, is the Secretary of Framework is being assessed and that action is taken if it is
The Committee comprises 1 Independent Director, and when needed;
^RO -YWWS^^OO =RO KV]Y KM^] K] ^RO -YWZVSKXMO 9P MO\ YP ^RO inadequate;
Company. 1 Non-Executive Director and 1 Executive Director, as on the w M K\\c Y_^ ]_MR Y^RO\ P_XM^SYX] K] WKc LO Z\O]M\SLON Lc ^RO
date of this Report. Companies Act, 2013 or CSR Rules or as may be delegated by w \ OZY\^SXQ <S]U 7KXKQOWOX^ KM^S`S^SO] KXN SXPY\WK^SYX
Role : the Board, from time to time. including top risks and mitigation, to the Audit Committee
The composition of the Corporate Social Responsibility
The role of the Committee includes : and Board;
Committee, category of its Members and their attendance at the Meetings :
w \ O]ZYXN^Y^ROQ\SO`KXMO]SXQOXO\KVKXN\OVK^SXQ^Y^\KX]PO\ Committee Meetings held during the year under review is given w  XNO\]^KXN ^RO ]SQXS MKX^ Y\ RSQR \S]U] KPPOM^SXQ -YWZKXc
_
in the table below : During the year under review, the Committee met 3 times on the and ensuring that processes to mitigate them are effective;
transmission and transposition of shares, non-receipt of
declared dividends, interest, non-receipt of Annual Report, following dates :
Sr. Name of the Member Category Number of w \ O`SOaSXQKXNKWOXNSXQ<S]U7KXKQOWOX^0\KWOaY\UP\YW
duplicate, split, consolidation and re-materialisation of share May 19, 2017; August 8, 2017 and November 13, 2017.
No. Meetings time to time;
MO\^S MK^O]O^MYPKVVWOWLO\]SXK^SWOLY_XNWKXXO\%
2017-18
w  YXS^Y\KXN\O`SOa^ROZO\PY\WKXMOKXN]O\`SMO]^KXNK\N]YP
W RISK MANAGEMENT COMMITTEE w  ^RO\P_XM^SYX]K]WKcLONOVOQK^ONLc^RO,YK\NP\YW^SWO^Y
Y
Held Attended
the Registrar and Share Transfer Agent of the Company and The composition, role, terms of reference as well as powers of time.
1. Mr Munir Shaikh Non-Executive 3 3
provide continuous guidance to improve the service levels for Risk Management Committee of the Company are in compliance Meetings :
Chairman Director
members and other security holders; with the provisions of Regulation 21 of the Securities and
2. Mr Krishna Mohan Sahni Independent 3 3 During the year under review, the Committee met once on
w O X]_\O [_SMU \ON\O]]KV YP ^RO MYWZVKSX^] \OMOS`ON P\YW Exchange Board of India (Listing Obligations and Disclosure
Director
Requirements) Regulations, 2015. February 14, 2018.
Members and other security holders and maintain cordial 3. Mr Ambati Venu Managing 3 3
relations with them; Director REMUNERATION OF DIRECTORS
Composition :
w  YXS^Y\^ROX_WLO\YPQ\SO`KXMO]\OMOS`ON\O]YV`ONY\ZOXNSXQ
W 4. Mr Ranjan Kapur Independent 3 2
at the beginning and end of the quarter and from time to time. (ceased to be a Member Director The Committee comprises 1 Independent Director, Executive Directors
effective January 27, 2018) 1 Non-Executive Director and 2 Executive Directors as on the
Meetings : The Executive Directors are paid remuneration in accordance
5. Mr Sachin Dharap Non-Executive 3 1 date of this Report.
with the limits prescribed under the Companies Act, 2013 and
During the year under review, the Committee met 4 times on the (ceased to be a Member Director
The composition of the Risk Management Committee, the Remuneration Policy of the Company. Such remuneration is
following dates : effective August 8, 2017)
category of its Members, their attendance at the Committee considered and approved by the Nomination and Remuneration
May 19, 2017; August 8, 2017; November 13, 2017 and Ms Krupa Anandpara, Company Secretary, is the Secretary Meetings held during the year under review is given in the Committee, the Board of Directors and the Shareholders of the
February 14, 2018. of the Committee. table below : Company.

88 ANNUAL REPORT 2017-18 89

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

Details of remuneration paid to the Executive Directors are as follows : The said Policy is available on the website of the Company at `SS-Y\ZY\K^O3NOX^S MK^SYX8_WLO\-38
(` in Lakhs) http://www.abbott.co.in/investor-relations/policies.html Adequate L24239MH1944PLC007330
safeguards are provided against victimization of director(s) or
Terms of Agreement Mr Ambati Venu Mr Rajiv Sonalker viii) 3X^O\XK^SYXKV=OM_\S^SO]3NOX^S MK^SYX8_WLO\3=38
employee(s) or any other person who raises concerns using such
Managing Director Whole-time Director
mechanism. INE358A01014
(w.e.f. August 8, 2017)
Period of appointment 5 years 2 years No employee has been denied access to the Audit Committee. ix) Stock Code (BSE)
500488
Date of appointment September 29, 2016 August 8, 2017 MEANS OF COMMUNICATION
Salary & Other Allowances 2,94.88 95.29 a) The quarterly, half-yearly and annual results are published x) Market Price Data (High/Low) on BSE
in one English daily newspaper (Business Standard - pan (`)
Perquisites 1,73.33 33.28
India) and one Marathi newspaper (Loksatta) published from Month High Low
Contribution to Provident Fund 12.40 5.41 Mumbai. The quarterly results/shareholding patterns/notice April, 2017 4,863.60 4,356.00
Performance Linked Incentive 1,05.28 27.66 YP,YK\N7OO^SXQ]YP MSKVXOa]\OVOK]OK\OWKNOK`KSVKLVOYX May, 2017 4,441.05 3,996.00
the website of the Company at www.abbott.co.in June, 2017 4,426.95 4,120.00
Notice Period Three Months Three Months
b) During the year under review, the Company has, upon July, 2017 4,615.00 4,170.00
Severance Fees There is no separate provision for payment of severance fees.
request, met a few institutional investors in one-on-one August, 2017 4,478.15 4,151.00
Stock Option The Company does not have any Stock Option Plan for its employees. However, Managing Director and meetings and group meetings. No presentations were made to September, 2017 4,280.00 4,035.00
Whole-time Director are entitled to Restricted Stock Units of Abbott Laboratories, USA under its “Long Term the institutional investors/analysts. October, 2017 4,420.00 4,100.00
3XMOX^S`O:\YQ\KWv^ROZO\[_S]S^O`KV_OYPaRSMRS]SXMV_NONKLY`O+V]Y\OPO\XY^O#MYP XKXMSKV]^K^OWOX^]
November, 2017 5,401.30 4,210.15
GENERAL SHAREHOLDER INFORMATION
December, 2017 5,707.20 5,167.05
Non-Executive Directors i) Annual General Meeting January, 2018 5,666.00 5,210.00
During the year under review, Mr Munir Shaikh, Mr R A Shah, Mr Ranjan Kapur and Mr Krishna Mohan Sahni were paid sitting Wednesday, July 18, 2018 at 3.30 p.m. February, 2018 6,109.95 5,243.90
fees amounting to ` 13.50 Lakhs, ` 17.00 Lakhs, ` 10.50 Lakhs and ` 15.00 Lakhs respectively, for attending Board Meetings and RAMA WATUMULL AUDITORIUM, K C College, March, 2018 5,895.00 5,300.00
various Committee Meetings. 124, Dinshaw Wachha Road, Vidyasagar Prin. K. M. Kundnani
Chowk, Churchgate, Mumbai - 400 020 xi) Performance in comparison to broad based indices
None of the Non-Executive Directors had any pecuniary relationship or transactions with the Company. Mr R A Shah is a Partner of April 1, 2017 to March 31, 2018
M/s Crawford Bayley & Co. During the year, the Company availed various professional services from M/s Crawford Bayley & Co. ii) Financial year
Normalised (100)
and remitted ` 4.93 Lakhs towards the same. The quantum of professional fees received by M/s Crawford Bayley & Co., from the April 1, 2017 to March 31, 2018
Company forms a very small portion of the total revenues of M/s Crawford Bayley & Co and also a marginal portion of total revenue
of the Company. iii) Book Closure Abbo� Stock Price Sensex Healthcare Index
Thursday, July 12, 2018 to Wednesday, July 18, 2018
140
GENERAL BODY MEETINGS (both days inclusive)
130
Financial Date Time Location No. of Special Resolutions iv) E-Voting Period 120
Year 110
From 9.00 a.m. (IST) on Sunday, July 15, 2018
100
2016-17 July 18, 2017 3.30 p.m. RAMA AND SUNDRI WATUMULL AUDITORIUM, K C College, - Upto 5.00 p.m. (IST) on Tuesday, July 17, 2018
90
124, Dinshaw Wachha Road, Vidyasagar Prin. K. M. Kundnani Chowk,
v) Dividend Payment Date 80
Churchgate, Mumbai – 400 020

8
On and from July 24, 2018

/1

/1

/1

/1

/1

/1

/1

/1

/1

/1

/1

/1
2015-16 July 18, 2016 3.30 p.m. RAMA AND SUNDRI WATUMULL AUDITORIUM, K C College, 1

04

05

06

07

08

09

10

11

12

01

02

03
124, Dinshaw Wachha Road, Vidyasagar Prin. K. M. Kundnani Chowk, (Re-appointment of Mr R A Shah as vi) Listing on Stock Exchange
Churchgate, Mumbai – 400 020 Independent Director) xii) Registrar and Share Transfer Agent
BSE Limited
2014-15 July 29, 2015 3.30 p.m. RAMA AND SUNDRI WATUMULL AUDITORIUM, K C College, 1 Phiroze Jeejeebhoy Towers Karvy Computershare Private Limited
124, Dinshaw Wachha Road, Vidyasagar Prin. K. M. Kundnani Chowk, (Approval of Related Party Dalal Street Unit : Abbott India Limited
Churchgate, Mumbai – 400 020 Transactions with Abbott Products Mumbai – 400 001
Operations AG., Switzerland) Karvy Selenium Tower B, B-24, Rajabhadur Mansion,
Telephone No.: +91-22-2272 1233/4, +91-22-6654 5695 Plot 31-32, Gachibowli, 6, Ambalal Doshi Marg,
During the year, no special resolutions were passed through postal ballot. Fax : +91-22-2272 1919 Financial District, Nanakramguda, Behind BSE Limited,
Website : www.bseindia.com Hyderabad – 500 032 Fort, Mumbai - 400 001
As on date, there is no special resolution proposed to be conducted through postal ballot. Tel No: +91-40-6716 2222; Tel No: +91-22-6623 5412
Email : corp.relations@bseindia.com
Fax No: +91-40-2344 0674
VIGIL MECHANISM/WHISTLE BLOWER POLICY   RO KXX_KV VS]^SXQ POO] PY\ ^RO XKXMSKV cOK\ !" aK]
> Email : einward.ris@karvy.com
The Company has the Vigil Mechanism/Whistle Blower Policy called “Abbott India Limited – Procedure for Internal Investigations” paid to the BSE Limited as per Regulation 14 of the of the Website : www.karvycomputershare.com
in place, in terms of the requirements of the Companies Act, 2013 and Regulation 22 of the Securities and Exchange Board of India Securities and Exchange Board of India (Listing Obligations Details of various centres of Karvy are available on
(Listing Obligations and Disclosure Requirements) Regulations, 2015. and Disclosure Requirements) Regulations, 2015. www.karvycomputershare.com

90 ANNUAL REPORT 2017-18 91

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

xiii) Share Transfer System xvi) Disclosure in respect of equity shares transferred in xviii) Dematerialisation of Shares as on March 31, 2018 and OTHER DISCLOSURES
“Abbott India Limited - Unclaimed Suspense Account” liquidity a) There were no Related Party Transactions entered into by the
Share Transfer Committee comprising the Directors
in terms of Regulation 39(4) and Schedule VI of the
KXN YP MSKV] YP ^RO -YWZKXc K^^OXN ^Y ^RO ]RK\O ^\KX]PO\ The shares of the Company are compulsorily traded in -YWZKXcN_\SXQ^ROcOK\^RK^RKNZY^OX^SKVMYX
SM^aS^R^RO
Securities and Exchange Board of India (Listing
formalities at least once in a fortnight. The said Committee electronic mode and are available for trading with both the interests of the Company at large.
Obligations and Disclosure Requirements) Regulations,
KV]Y MYX]SNO\] \O[_O]^] \OMOS`ON PY\ N_ZVSMK^O MO\^S MK^O] depositories in India namely, National Securities Depository
2015 is as under : b) Policies on dealing with Related Party Transactions and
split / consolidation, dematerialisation, rematerialisation, Limited (NSDL) and Central Depository Services (India)
transfer and transmission of shares. Materiality and on Determination of Materiality of Event or
No. of No. of Limited (CDSL).
Information for Disclosure are disclosed on the website of
Share transfer requests received at the Registrar & Share Particulars Shareholders Equity
2,07,20,738 Equity Shares representing 97.51% of the the Company at http://www.abbott.co.in/investor-relations/
Transfer Agent are normally processed and delivered within Shares
Company’s total paid-up share capital were held in policies.html
15 days from the date of lodgement in cases where documents Aggregate number of shareholders 191 24,671 dematerialised mode, as on March 31, 2018.
are complete and in order. Requests for dematerialisation and the outstanding shares in the c) In the preparation of Financial Statements, no differential
YP ]RK\O] K\O Z\YMO]]ON KXN ^RO MYX \WK^SYX S] QS`OX ^Y Unclaimed Suspense Account lying as xix) The Company has not issued any GDR/ADR or Warrants treatment from that prescribed in the Accounting Standards
the depositories within 15 days from the date of receipt of on April 1, 2017 or any other convertible instruments. has been followed.
complete set of documents. Number of shareholders who NIL NIL
xx) Foreign Exchange risk and hedging activities d) Pursuant to the disclosures made by the Senior Management
approached the Company for transfer
xiv) Distribution of Shareholding as on March 31, 2018 of shares and shares transferred from ^Y^RO,YK\N^RO\OaO\OXYWK^O\SKV XKXMSKVKXNMYWWO\MSKV
The Company has foreign exchange exposure and hedging is
Distribution No. of % to Total No. of % to suspense account during the year NYXOPY\K]SQXS MKX^ZY\^SYXYP^RO]KWO transactions entered into by them where they have personal
Shareholders Shares held Total Number of shareholders and aggregate NIL NIL SX^O\O]^ KXN aRSMR MY_VN RK`O ZY^OX^SKV MYX
SM^ aS^R ^RO
xxi) Plant Location
(1) (2) (3) (4) (5) number of shares transferred to the interest of the Company at large.
Upto 500 21,277 94.22 13,81,978 6.50 Unclaimed Suspense Account during L-18/19, Verna Industrial Estate, Goa
the year e) There were no instances of non-compliance by the Company,
501 to 1000 690 3.05 4,94,422 2.33 xxii) Address for correspondence no penalties/strictures imposed on the Company by the Stock
Aggregate number of shareholders 191 24,671
1001 to 2000 351 1.55 5,04,558 2.37 Abbott India Limited Exchange or the Securities and Exchange Board of India or
and outstanding shares in the
2001 to 3000 111 0.49 2,72,548 1.30 Unclaimed Suspense Account lying as CIN : L24239MH1944PLC007330 any statutory authority on any matters related to the capital
3001 to 4000 50 0.22 1,75,228 0.82 on March 31, 2018 markets during the last three years.
4001 to 5000 33 0.15 1,49,769 0.70 <OQS]^O\ONYP MO$ -Y\ZY\K^O9P MO$
+VV LOXO ^] KMM\_SXQ YX ]_MR ]RK\O] ]RKVV LO M\ONS^ON ^Y f) In terms of requirement of Regulation 17(8) of the Securities
5001 to 10000 31 0.14 2,21,167 1.04
Shares Department Shares Department
Unclaimed Suspense Account for a period of seven years. and Exchange Board of India (Listing Obligations and
3, Corporate Park, 16th Floor, Godrej BKC,
ABOVE 10000 40 0.18 1,80,49,632 84.94 >RO\OKP^O\ ^RO ]KSN ]RK\O] SXMV_NSXQ KVV LOXO ^] KMM\_ON Disclosure Requirements) Regulations, 2015, Chief Executive
Sion-Trombay Road, Plot C – 68, ‘’G’’ Block,
TOTAL 22,583 100.00 2,12,49,302 100.00 thereon shall be transferred by the Company to IEPF 9P MO\ -/9 KXN -RSOP 0SXKXMSKV 9P MO\ -09 RK`O WKNO
Mumbai – 400 071 Bandra-Kurla Complex,
Authority in accordance with provisions of Section 124(5) K MO\^S MK^SYX ^Y ^RO ,YK\N YP .S\OM^Y\] SX ^RO Z\O]M\SLON
Tel No: +91-22-6797 8888 Near MCA Club, Bandra (East),
xv) Shareholding Pattern as on March 31, 2018 and (6) of the Companies Act, 2013 and Rules framed format, which has been reviewed by the Audit Committee and
Fax: +91-22-6797 8727 Mumbai – 400 051
thereunder. The voting rights in respect of such shares taken on record by the Board.
Category of Shareholders No. of Shares % to Total Tel No: +91-22-3816 2000
shall remain frozen till the rightful owner claims such
Promoters 1,59,34,048 74.99 Fax: +91-22-3816 2400 g) Code of Business Conduct for Board of Directors and Senior
Equity Shares.
Banks 5,637 0.03 Management lays down various principles of ethics and
Email : investorrelations.india@abbott.com
Financial Institutions 1,00,881 0.47 xvii) In terms of requirements of Section 124(6) of the Companies compliance. The Code has been posted on the Company’s website
Website : www.abbott.co.in
Foreign Institutional Investors 26,442 0.12 Act, 2013 read with the Investor Education and Protection at http://www.abbott.co.in/investor-relations/policies.html
Foreign Portfolio Corporation 5,98,494 2.82 Fund Authority (Accounting, Audit, Transfer and Refund) Karvy Computershare Private Limited
Insurance Companies 39,631 0.19 Rules, 2016, all shares in respect of which dividend has not Unit : Abbott India Limited h) The Company has complied with all the mandatory
Mutual Funds 11,30,435 5.32 been paid or claimed for 7 (seven) consecutive years or more requirements of the Securities and Exchange Board of
are required to be transferred to Investor Education and Karvy Selenium Tower B, B-24, Rajabhadur Mansion, India (Listing Obligations and Disclosure Requirements)
Domestic Companies 1,36,691 0.64
Protection Fund Authority (“IEPF Authority”). Plot 31-32, Gachibowli, 6, Ambalal Doshi Marg, Regulations, 2015.
Non-Domestic Companies 471 00.0
Financial District, Behind BSE Limited,
Non-Resident Indians 82,350 0.39 Accordingly, 51,809 Equity Shares held by 317 Shareholders Nanakramguda, Fort, Mumbai - 400 001 i) The Company has complied with all the Corporate Governance
Directors & Relatives 6,874 0.03 were transferred to the IEPF Authority in November, 2017. Hyderabad – 500 032 Tel No: +91-22-6623 5412 \O[_S\OWOX^]]ZOMS ONSX<OQ_VK^SYX]!^YKXN^Y!KXN
Unclaimed Suspense Account 24,671 0.12 No claims have been received till date. clauses (b) to (i) of sub-regulation (2) of Regulation 46 of the
Tel No: +91-40-6716 2222
Investor Education and Protection 51,809 0.24 Fax No: +91-40-2344 0674 Securities and Exchange Board of India (Listing Obligations
The details of shares so transferred is available on the
Fund (IEPF) Authority and Disclosure Requirements) Regulations, 2015. As the
Company’s website under the Investor Section at http://
Others 31, 10,868 14.64 Email : einward.ris@karvy.com Company does not have any subsidiary, Regulation 24 is not
www.abbott.co.in/investor-relations/other-information/
TOTAL 2,12,49,302 100.00 unclaimed-dividend.html Website : www.karvycomputershare.com
applicable to the Company.

92 ANNUAL REPORT 2017-18 93

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

Compliance with Discretionary requirements : >RO 1_SNKXMO 8Y^O YX <OZY\^] Y\ -O\^S MK^O] PY\ =ZOMSKV vi. Performed necessary inquiries with the management and
Purposes requires that we comply with the ethical KV]Y YL^KSXON XOMO]]K\c ]ZOMS M \OZ\O]OX^K^SYX] P\YW
i)  RO[_K\^O\VcKXNRKVPcOK\Vc XKXMSKV\O]_V^]K\OZ_LVS]RON
> ii) Reporting of Internal Auditors is directly to the management.
requirements of the Code of Ethics issued by the Institute of
in two newspapers as prescribed by the Securities Audit Committee. Chartered Accountants of India.
and Exchange Board of India (Listing Obligations SSS >
 RO -YWZKXc RK] S^] XKXMSKV ]^K^OWOX^] aS^R _XWYNS ON The above-mentioned procedures include examining
and Disclosure Requirements) Regulations, 2015, and 6. We have complied with the relevant applicable requirements evidence supporting the particulars in the Corporate
audit opinion.
are also available on the website of the Company at of the Standard on Quality Control (SQC) 1, Quality Control Governance Report on a test basis. Further, our scope of
For and on behalf of the Board
for Firms that Perform Audits and Reviews of Historical work under this report did not involve us performing audit
www.abbott.co.in In view of the above, the results were not
Financial Information, and Other Assurance and Related tests for the purposes of expressing an opinion on the
separately circulated to all the Members. Munir Shaikh R A Shah
Mumbai Chairman Director Services Engagements. PKS\XO]]Y\KMM_\KMcYPKXcYP^RO XKXMSKVSXPY\WK^SYXY\
May 14, 2018 DIN : 00096273 DIN : 00009851 ^RO XKXMSKV]^K^OWOX^]YP^RO-YWZKXc^KUOXK]KaRYVO
7. The procedures selected depend on the auditor’s judgement,
including the assessment of the risks associated in compliance Opinion
of the Corporate Governance Report with the applicable 8. Based on the procedures performed by us as referred in
DECLARATION UNDER SCHEDULE V(D) OF THE SECURITIES AND EXCHANGE BOARD OF INDIA criteria. Summary of key procedures performed include : paragraph 7 above, and according to the information and
(LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 explanations given to us, we are of the opinion that the Company
i. Reading and understanding of the information prepared
As required under Schedule V(D) of the Securities and Exchange Board of India (Listing Obligations and Disclosure has complied with the conditions of Corporate Governance
by the Company and included in its Corporate Governance
<O[_S\OWOX^] <OQ_VK^SYX]  3 RO\OLc MYX \W ^RK^ KVV ^RO ,YK\N 7OWLO\] KXN =OXSY\ 7KXKQOWOX^ :O\]YXXOV YP ^RO as stipulated in the Listing Regulations, as applicable as at
Report;
-YWZKXcRK`OKP \WONMYWZVSKXMOaS^R^RO+LLY^^3XNSK-YNOYP,_]SXO]]-YXN_M^K]KZZVSMKLVO^Y^ROWPY\^ROcOK\OXNON March 31, 2018, referred to in paragraph 1 above.
March 31, 2018.  SS 9
 L^KSXONKXN`O\S ON^RK^^ROMYWZY]S^SYXYP^RO,YK\N
Other matters and Restriction on Use
of Directors w.r.t. Executive and Non-Executive Directors
has been met throughout the reporting period; 9. This report is neither an assurance as to the future viability of
Ambati Venu
March 31, 2018 Managing Director ^RO-YWZKXcXY\^ROOP MSOXMcY\OPPOM^S`OXO]]aS^RaRSMR
iii. Obtained and read the Directors Register as on March 31,
Mumbai DIN : 07614849 the Management has conducted the affairs of the Company.
"KXN`O\S ON^RK^K^VOK]^YXOAYWOX.S\OM^Y\aK]YX
the Board during the year; 10. This report is addressed to and provided to the Members of the
Company solely for the purpose of enabling it to comply with
INDEPENDENT AUDITOR’S REPORT ON COMPLIANCE WITH THE CONDITIONS OF CORPORATE GOVERNANCE iv. Obtained and read the Minutes of the following its obligations under the Listing Regulations with reference to
AS PER PROVISIONS OF CHAPTER IV OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING Committee Meetings held from April 1, 2017 to March 31, Corporate Governance Report accompanied with by a report
OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 2018 : thereon from the Statutory Auditors and should not be used
The Members of (a) Board of Directors Meeting; by any other person or for any other purpose. Accordingly,
Abbott India Limited we do not accept or assume any liability or any duty of care
3, Corporate Park, (b) Audit Committee; or for any other purpose or to any other party to whom it is
Sion-Trombay Road, shown or into whose hands it may come without our prior
(c) Annual General Meeting; consent in writing. We have no responsibility to update this
Mumbai – 400 071.
report for events and circumstances occurring after the date
(d) Nomination and Remuneration Committee;
1. The accompanying Corporate Governance Report prepared by 3. The Management along with the Board of Directors are also of this report.
Abbott India Limited (hereinafter the “Company”), contains responsible for ensuring that the Company complies with (e) Stakeholders Relationship Committee;
details as required by the provisions of Chapter IV of the For S R B C & CO LLP
the conditions of Corporate Governance as stipulated in the
Securities and Exchange Board of India (Listing Obligations (f ) Risk Management Committee; Chartered Accountants
Listing Regulations, issued by the Securities and Exchange
and Disclosure Requirements) Regulations, 2015, as amended ICAI Firm Registration Number: 324982E/E300003
Board of India. (g) Corporate Social Responsibility Committee;
(“the Listing Regulations”) (‘Applicable criteria’) with respect
to Corporate Governance for the year ended March 31, 2018. Auditor’s Responsibility (h) Independent Directors Meeting. per Ravi Bansal
This report is required by the Company for annual submission Partner
to the Stock Exchange and to be sent to the Shareholders of 4. Pursuant to the requirements of the Listing Regulations, our v. Obtained necessary representations and declarations Membership Number: 49365
the Company. responsibility is to express a reasonable assurance in the form from directors of the Company including the independent Place: Mumbai
of an opinion whether the Company has complied with the directors ; Date: May 14, 2018
Management’s Responsibility ]ZOMS M\O[_S\OWOX^]YP^RO6S]^SXQ<OQ_VK^SYX]\OPO\\ON^YSX
2. The preparation of the Corporate Governance Report is the paragraph 1 above.
responsibility of the Management of the Company including
5. We conducted our examination of the Corporate Governance
the preparation and maintenance of all relevant supporting
Report in accordance with the Guidance Note on Reports
records and documents. This responsibility also includes the
Y\ -O\^S MK^O] PY\ =ZOMSKV :_\ZY]O] KXN ^RO 1_SNKXMO 8Y^O
design, implementation and maintenance of internal control
relevant to the preparation and presentation of the Corporate YX -O\^S MK^SYX YP -Y\ZY\K^O 1Y`O\XKXMO Loth issued by
Governance Report. the Institute of Chartered Accountants of India (“ICAI”).

94 ANNUAL REPORT 2017-18 95

ABBOTT
ABBOTT INDIA
INDIA LIMITED
LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

INDEPENDENT AUDITOR’S REPORT

To the Members of Abbott India Limited
REPORT ON THE IND AS FINANCIAL STATEMENTS
AORK`OK_NS^ON^ROKMMYWZKXcSXQ3XN+= XKXMSKV]^K^OWOX^]
of Abbott India Limited (“the Company”), which comprise the
,KVKXMO=ROO^K]K^7K\MR"^RO=^K^OWOX^YP:\Y ^KXN
6Y]]SXMV_NSXQ^RO]^K^OWOX^YP9^RO\-YWZ\OROX]S`O3XMYWO
^RO -K]R 0VYa =^K^OWOX^ KXN ^RO =^K^OWOX^ YP -RKXQO] SX
/[_S^cPY\^ROcOK\^ROXOXNONKXNK]_WWK\cYP]SQXS MKX^
KMMY_X^SXQZYVSMSO]KXNY^RO\ObZVKXK^Y\cSXPY\WK^SYX
MANAGEMENT’S RESPONSIBILITY FOR THE IND AS
FINANCIAL STATEMENTS
>RO -YWZKXct] ,YK\N YP .S\OM^Y\] S] \O]ZYX]SLVO PY\ ^RO
WK^^O\] ]^K^ON SX =OM^SYX  YP ^RO -YWZKXSO] +M^ 
(“the Act”) with respect to the preparation of these Ind AS
XKXMSKV ]^K^OWOX^] ^RK^ QS`O K ^\_O KXN PKS\ `SOa YP ^RO
XKXMSKV ZY]S^SYX XKXMSKV ZO\PY\WKXMO SXMV_NSXQ Y^RO\
MYWZ\OROX]S`OSXMYWOMK]R
Ya]KXNMRKXQO]SXO[_S^cYP^RO OPINION
-YWZKXcSXKMMY\NKXMOaS^RKMMY_X^SXQZ\SXMSZVO]QOXO\KVVc
KMMOZ^ONSX3XNSKSXMV_NSXQ^RO3XNSKX+MMY_X^SXQ=^KXNK\N]
3XN+=]ZOMS ON_XNO\=OM^SYXYP^RO+M^\OKNaS^R^RO
-YWZKXSO] 3XNSKX +MMY_X^SXQ =^KXNK\N] <_VO]  K]
KWOXNON >RS] \O]ZYX]SLSVS^c KV]Y SXMV_NO] WKSX^OXKXMO YP
adequate accounting records in accordance with the provisions
of the Act for safeguarding of the assets of the Company and
PY\ Z\O`OX^SXQ KXN NO^OM^SXQ P\K_N] KXN Y^RO\ S\\OQ_VK\S^SO]%
Ya]KXN^ROMRKXQO]SXO[_S^cPY\^ROcOK\
]OVOM^SYX KXN KZZVSMK^SYX YP KZZ\YZ\SK^O KMMY_X^SXQ ZYVSMSO]%
WKUSXQ T_NQWOX^] KXN O]^SWK^O] ^RK^ K\O \OK]YXKLVO KXN
Z\_NOX^% KXN ^RO NO]SQX SWZVOWOX^K^SYX KXN WKSX^OXKXMO
YP KNO[_K^O SX^O\XKV XKXMSKV MYX^\YV ^RK^ aO\O YZO\K^SXQ
OPPOM^S`OVc PY\ OX]_\SXQ ^RO KMM_\KMc KXN MYWZVO^OXO]] YP
^RO KMMY_X^SXQ \OMY\N] \OVO`KX^ ^Y ^RO Z\OZK\K^SYX KXN
Z\O]OX^K^SYXYP^RO3XN+= XKXMSKV]^K^OWOX^]^RK^QS`OK^\_O
KXNPKS\`SOaKXNK\OP\OOP\YWWK^O\SKVWS]]^K^OWOX^aRO^RO\
N_O^YP\K_NY\O\\Y\
+X K_NS^ SX`YV`O] ZO\PY\WSXQ Z\YMON_\O] ^Y YL^KSX K_NS^
O`SNOXMO KLY_^ ^RO KWY_X^] KXN NS]MVY]_\O] SX ^RO XKXMSKV
]^K^OWOX^] >RO Z\YMON_\O] ]OVOM^ON NOZOXN YX ^RO K_NS^Y\t]
T_NQWOX^ SXMV_NSXQ ^RO K]]O]]WOX^ YP ^RO \S]U] YP WK^O\SKV
WS]]^K^OWOX^YP^RO3XN+= XKXMSKV]^K^OWOX^]aRO^RO\N_O
^YP\K_NY\O\\Y\3XWKUSXQ^RY]O\S]UK]]O]]WOX^]^ROK_NS^Y\
MYX]SNO\]SX^O\XKV XKXMSKVMYX^\YV\OVO`KX^^Y^RO-YWZKXct]
Z\OZK\K^SYX YP ^RO 3XN += XKXMSKV ]^K^OWOX^] ^RK^ QS`O K
true and fair view in order to design audit procedures that
K\O KZZ\YZ\SK^O SX ^RO MS\M_W]^KXMO] +X K_NS^ KV]Y SXMV_NO]
O`KV_K^SXQ ^RO KZZ\YZ\SK^OXO]] YP KMMY_X^SXQ ZYVSMSO] _]ON
KXN ^RO \OK]YXKLVOXO]] YP ^RO KMMY_X^SXQ O]^SWK^O] WKNO Lc
^RO -YWZKXct] .S\OM^Y\] K] aOVV K] O`KV_K^SXQ ^RO Y`O\KVV
Z\O]OX^K^SYX YP ^RO 3XN += XKXMSKV ]^K^OWOX^] AO LOVSO`O
^RK^ ^RO K_NS^ O`SNOXMO aO RK`O YL^KSXON S] ]_P MSOX^ KXN
appropriate to provide a basis for our audit opinion on the Ind
+= XKXMSKV]^K^OWOX^]
In our opinion and to the best of our information and
KMMY\NSXQ ^Y ^RO ObZVKXK^SYX] QS`OX ^Y _] ^RO 3XN +=
XKXMSKV ]^K^OWOX^] QS`O ^RO SXPY\WK^SYX \O[_S\ON Lc ^RO
Act in the manner so required and give a true and fair view
SX MYXPY\WS^c aS^R ^RO KMMY_X^SXQ Z\SXMSZVO] QOXO\KVVc
accepted in India, of the state of affairs of the Company as
K^7K\MR"S^]Z\Y ^SXMV_NSXQY^RO\MYWZ\OROX]S`O
SXMYWOS^]MK]R
OXNONYX^RK^NK^O
REPORT ON OTHER LEGAL AND REGULATORY
REQUIREMENTS
  ] \O[_S\ON Lc ^RO -YWZKXSO] +_NS^Y\t] \OZY\^ 9\NO\
+
 u^RO9\NO\vS]]_ONLc^RO-OX^\KV1Y`O\XWOX^YP
3XNSKSX^O\W]YP=_L]OM^SYXYP=OM^SYXYP^RO+M^
aOQS`OSX^ROu+XXOb_\OvK]^K^OWOX^YX^ROWK^^O\]
]ZOMS ONSXZK\KQ\KZR]KXNYP^RO9\NO\
 N 3 X Y_\ YZSXSYX ^RO KPY\O]KSN 3XN += XKXMSKV S  RO -YWZKXc RK] NS]MVY]ON ^RO SWZKM^ YP
>
]^K^OWOX^] MYWZVc aS^R ^RO +MMY_X^SXQ =^KXNK\N] ZOXNSXQVS^SQK^SYX]YXS^] XKXMSKVZY]S^SYXSXS^]
]ZOMS ON _XNO\ =OM^SYX  YP ^RO +M^ \OKN 3XN+= XKXMSKV]^K^OWOX^]x<OPO\8Y^O^Y
with Companies (Indian Accounting Standards) ^RO3XN+= XKXMSKV]^K^OWOX^]
+WOXNWOX^<_VO] K]KWOXNON%
  SS  RO -YWZKXc NSN XY^ RK`O KXc VYXQ^O\W
>
 O 9
 X ^RO LK]S] YP a\S^^OX \OZ\O]OX^K^SYX] \OMOS`ON MYX^\KM^] SXMV_NSXQ NO\S`K^S`O MYX^\KM^] PY\
P\YW ^RO NS\OM^Y\] K] YX 7K\MR  " KXN ^KUOX aRSMR ^RO\O aO\O KXc WK^O\SKV PY\O]OOKLVO
on record by the Board of Directors, none of the VY]]O]
NS\OM^Y\] S] NS][_KVS ON K] YX 7K\MR  " P\YW
  SSS >
 RO\O RK] LOOX XY NOVKc SX ^\KX]PO\\SXQ
LOSXQKZZYSX^ONK]KNS\OM^Y\SX^O\W]YP=OM^SYX 
amounts, required to be transferred, to the
YP^RO+M^%
3X`O]^Y\/N_MK^SYXKXN:\Y^OM^SYX0_XNLc^RO
 P  A
 S^R\O]ZOM^^Y^ROKNO[_KMcYP^ROSX^O\XKV XKXMSKV -YWZKXc
MYX^\YV] Y`O\ XKXMSKV \OZY\^SXQ YP ^RO -YWZKXc
aS^R\OPO\OXMO^Y^RO]O3XN+= XKXMSKV]^K^OWOX^] For S R B C & CO LLP
KXN ^RO YZO\K^SXQ OPPOM^S`OXO]] YP ]_MR MYX^\YV] Chartered Accountants
\OPO\^YY_\]OZK\K^O<OZY\^SXu+XXOb_\Ov^Y^RS] 3-+30S\W<OQS]^\K^SYX8_WLO\$#"//
\OZY\^%
Q A
 S^R\O]ZOM^^Y^ROY^RO\WK^^O\]^YLOSXMV_NONSX per Ravi Bansal
^RO +_NS^Y\t] <OZY\^ SX KMMY\NKXMO aS^R <_VO  YP :K\^XO\
^RO-YWZKXSO]+_NS^KXN+_NS^Y\]<_VO]SX 7OWLO\]RSZ8_WLO\$# 
our opinion and to the best of our information and :VKMO$7_WLKS
KMMY\NSXQ^Y^ROObZVKXK^SYX]QS`OX^Y_]$ .K^O$7Kc"

AUDITOR’S RESPONSIBILITY  +]\O[_S\ONLc=OM^SYXYP^RO+M^aO\OZY\^^RK^$

9_\ \O]ZYX]SLSVS^c S] ^Y ObZ\O]] KX YZSXSYX YX ^RO]O 3XN +=
XKXMSKV ]^K^OWOX^] LK]ON YX Y_\ K_NS^ AO RK`O ^KUOX SX^Y
account the provisions of the Act, the accounting and auditing
]^KXNK\N] KXN WK^^O\] aRSMR K\O \O[_S\ON ^Y LO SXMV_NON
in the audit report under the provisions of the Act and the
<_VO] WKNO ^RO\O_XNO\ AO MYXN_M^ON Y_\ K_NS^ YP ^RO 3XN
+= XKXMSKV ]^K^OWOX^] SX KMMY\NKXMO aS^R ^RO =^KXNK\N] YX
Auditing, issued by the Institute of Chartered Accountants
YP3XNSKK]]ZOMS ON_XNO\=OM^SYXYP^RO+M^>RY]O
=^KXNK\N] \O[_S\O ^RK^ aO MYWZVc aS^R O^RSMKV \O[_S\OWOX^]
KXNZVKXKXNZO\PY\W^ROK_NS^^YYL^KSX\OK]YXKLVOK]]_\KXMO
KLY_^aRO^RO\^RO XKXMSKV]^K^OWOX^]K\OP\OOP\YWWK^O\SKV
WS]]^K^OWOX^
 K A
 ORK`O]Y_QR^KXNYL^KSXONKVV^ROSXPY\WK^SYXKXN
ObZVKXK^SYX]aRSMR^Y^ROLO]^YPY_\UXYaVONQOKXN
LOVSOPaO\OXOMO]]K\cPY\^ROZ_\ZY]OYPY_\K_NS^%
(b) In our opinion, proper books of account as required
Lc VKa RK`O LOOX UOZ^ Lc ^RO -YWZKXc ]Y PK\ K] S^
KZZOK\]P\YWY_\ObKWSXK^SYXYP^RY]OLYYU]%
 M >
 RO ,KVKXMO =ROO^ =^K^OWOX^ YP :\Y ^ KXN 6Y]]
SXMV_NSXQ ^RO =^K^OWOX^ YP 9^RO\ -YWZ\OROX]S`O
3XMYWO^RO-K]R0VYa=^K^OWOX^KXN=^K^OWOX^YP
-RKXQO] SX /[_S^c NOKV^ aS^R Lc ^RS] <OZY\^ K\O SX
KQ\OOWOX^aS^R^ROLYYU]YPKMMY_X^%

96 ANNUAL REPORT 2017-18 97

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

ANNEXURE 1 TO THE INDEPENDENT AUDITOR’S REPORT OF EVEN DATE ON THE STANDALONE FINANCIAL  L +MMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OX^Y_]XY_XNS]Z_^ONKWY_X^]ZKcKLVOSX\O]ZOM^YPZ\Y`SNOX^P_XN
STATEMENTS OF ABBOTT INDIA LIMITED OWZVYcOO]t]^K^OSX]_\KXMOSXMYWO^Kb]O\`SMO^Kb]KVO]^KbN_^cYPM_]^YWN_^cYPObMS]O`KV_OKNNON^Kb1YYN]KXN
S K >RO-YWZKXcRK]WKSX^KSXONZ\YZO\\OMY\N]]RYaSXQP_VVZK\^SM_VK\]SXMV_NSXQ[_KX^S^K^S`ONO^KSV]KXN]S^_K^SYXYP bON =O\`SMO]>Kb1=>MO]]KXNY^RO\]^K^_^Y\cN_O]aO\OY_^]^KXNSXQK^^ROcOK\OXNPY\KZO\SYNYPWY\O^RKX]SbWYX^R]
K]]O^] P\YW^RONK^O^ROcLOMKWOZKcKLVOObMOZ^K]LOVYa$

 L  YWO bONK]]O^]aO\OZRc]SMKVVc`O\S ONLc^ROWKXKQOWOX^N_\SXQ^ROcOK\SXKMMY\NKXMOaS^RKZVKXXONZ\YQ\KWWO

= Name of the Statute Nature of Dues Amount Period to which the Due Date Date of
YP`O\SPcSXQ^ROWYXMOSX^R\OOcOK\]aRSMRSXY_\YZSXSYXS]\OK]YXKLVORK`SXQ\OQK\N^Y^RO]SdOYP^RO-YWZKXcKXN^RO (` in Lakhs) amount relates Payment
XK^_\OYPS^]K]]O^]8YWK^O\SKVNS]M\OZKXMSO]aO\OXY^SMONYX]_MR`O\S MK^SYX >RO4RK\URKXN>KbYX :\YPO]]SYX^Kb  8Y`t =OZt! Various dates ""
:\YPO]]SYX]>\KNO]-KVVSXQ]
 M +MMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OXLc^ROWKXKQOWOX^^RO^S^VONOON]YPSWWY`KLVOZ\YZO\^SO]SXMV_NON KXN/WZVYcWOX^]+M^
SXZ\YZO\^cZVKX^KXNO[_SZWOX^K\OROVNSX^ROXKWOYP^RO-YWZKXcObMOZ^PY\^ROPYVVYaSXQ$ 7KNRcK:\KNO]R:\YPO]]SYX- :\YPO]]SYX^Kb  +Z\t!=OZt! Various dates Yet to be paid
KV>Kb+M^##
Sr. Asset Gross Block at Net Block at Remarks
No. Category March 31, 2018 March 31, 2018
(` in Lakhs) (` in Lakhs)  M +MMY\NSXQ^Y^RO\OMY\N]YP^RO-YWZKXc^RON_O]YPSXMYWO^Kb]KVO]^Kb]O\`SMO^KbN_^cYPM_]^YWN_^cYPObMS]O`KV_O
KNNON^KbKXNMO]]YXKMMY_X^YPKXcNS]Z_^OK\OK]PYVVYa]$
 ,_SVNSXQ] !#!   >RO^S^VONOON]K\OSX^ROO\]^aRSVOXKWOYP^RO-YWZKXc
Name of the Statute Nature of Dues Amount disputed Forum where dispute is Period to which the
 ,_SVNSXQ]   " !! >RO^S^VONOON]K\OSX^ROXKWOYP^ROOX^S^c^RK^aK]WO\QON in ` Lakhs (net of pending amount relates
aS^R^RO-YWZKXc payments)
3XMYWO>Kb+M^#  3XMYWO>Kb "  ITAT +C !
  >ROKLY`OKWY_X^]SXMV_NOs+]]O^]ROVNPY\]KVOt +C#
+C
SS >
 RO WKXKQOWOX^ RK] MYXN_M^ON ZRc]SMKV `O\S MK^SYX YP SX`OX^Y\c K^ \OK]YXKLVO SX^O\`KV] N_\SXQ ^RO cOK\ KXN XY WK^O\SKV
+C
NS]M\OZKXMSO]aO\OXY^SMONYX]_MRZRc]SMKV`O\S MK^SYX +C
SSS +
 MMY\NSXQ ^Y ^RO SXPY\WK^SYX KXN ObZVKXK^SYX] QS`OX ^Y _] ^RO -YWZKXc RK] XY^ Q\KX^ON KXc VYKX] ]OM_\ON Y\ _X]OM_\ON -OX^\KV/bMS]O+M^# /bMS]O._^c  -YWWS]]SYXO\+ZZOKV] ####
^Y MYWZKXSO] \W] VSWS^ON VSKLSVS^c ZK\^XO\]RSZ] Y\ Y^RO\ ZK\^SO] MY`O\ON SX ^RO \OQS]^O\ WKSX^KSXON _XNO\ =OM^SYX "# YP ^RO  Commissioner ####
-YWZKXSO]+M^+MMY\NSXQVc^ROZ\Y`S]SYX]YPMVK_]OSSSKLKXNMYP^RO9\NO\K\OXY^KZZVSMKLVO^Y^RO-YWZKXcKXN  Assistant Commissioner ##KXN##!^Y
ROXMOXY^MYWWOX^ON_ZYX
 ! CESTAT 
S` 3 XY_\YZSXSYXKXNKMMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OX^Y_]Z\Y`S]SYX]YP=OM^SYX"KXN" YP^RO-YWZKXSO] >RO,YWLKc=KVO]>Kb =KVO]>Kb #"! .OZ_^c-YWWS]]SYXO\YP=KVO] ###
+M^SX\O]ZOM^YPVYKX]^YNS\OM^Y\]SXMV_NSXQOX^S^SO]SXaRSMR^ROcK\OSX^O\O]^ONKXNSX\O]ZOM^YPVYKX]KXNKN`KXMO]QS`OX +M^## >Kb
SX`O]^WOX^]WKNOKXNQ_K\KX^OO]KXN]OM_\S^SO]QS`OXRK`OLOOXMYWZVSONaS^RLc^RO-YWZKXc ?^^K\:\KNO]R@KV_O @KV_O+NNON>Kb  +NNS^SYXKV-YWWS]]SYXO\YP "^Y
+NNON>Kb+M^" -YWWO\MSKV>Kb+ZZOKV]
`  RO-YWZKXcRK]XY^KMMOZ^ONKXcNOZY]S^]aS^RSX^ROWOKXSXQYP=OM^SYX]!^Y! YP^RO+M^KXN^RO-YWZKXSO]+MMOZ^KXMOYP
>
-OX^\KV=KVO]>Kb+M^ =KVO]>Kb " +NNS^SYXKV-YWWS]]SYXO\YP 
.OZY]S^]<_VO]K]KWOXNON+MMY\NSXQVc^ROZ\Y`S]SYX]YPMVK_]O`YP^RO9\NO\K\OXY^KZZVSMKLVO # ?^^K\:\KNO]R -YWWO\MSKV>Kb+ZZOKV]
`S A
 ORK`OL\YKNVc\O`SOaON^ROLYYU]YPKMMY_X^WKSX^KSXONLc^RO-YWZKXcZ_\]_KX^^Y^RO\_VO]WKNOLc^RO-OX^\KV1Y`O\XWOX^ 5O\KVK1OXO\KV=KVO] =KVO]>Kb  =KVO]>Kb+ZZOVVK^O>\SL_XKV 
PY\^ROWKSX^OXKXMOYPMY]^\OMY\N]_XNO\=OM^SYX"YP^RO-YWZKXSO]+M^\OVK^ON^Y^ROWKX_PKM^_\OYPPY\W_VK^SYX] >Kb+M^#  +NNS^SYXKV,OXMR
KXNK\OYP^ROYZSXSYX^RK^Z\SWKPKMSO^RO]ZOMS ONKMMY_X^]KXN\OMY\N]RK`OLOOXWKNOKXNWKSX^KSXONAORK`OXY^RYaO`O\ 1YK@KV_O+NNON>Kb @KV_O+NNON>Kb ! +NNS^SYXKV-YWWS]]SYXO\YP  !
WKNOKNO^KSVONObKWSXK^SYXYP^RO]KWO +M^ -YWWO\MSKV>KbO]
-OX^\KV=KVO]>Kb#  =KVO]>Kb #" +NNS^SYXKV-YWWS]]SYXO\YP  ^Y#
`SS K  XNS]Z_^ON ]^K^_^Y\c N_O] SXMV_NSXQ Z\Y`SNOX^ P_XN OWZVYcOO]t ]^K^O SX]_\KXMO SXMYWO ^Kb ]KVO] ^Kb ]O\`SMO ^Kb N_^c
? 1YK -YWWO\MSKV>KbO]
YP M_]^YW N_^c YP ObMS]O `KV_O KNNON ^Kb 1YYN] KXN =O\`SMO] >Kb 1=> MO]] KXN Y^RO\ WK^O\SKV ]^K^_^Y\c N_O] RK`O   ! Assistant Commissioner of #
QOXO\KVVcLOOX\OQ_VK\VcNOZY]S^ONaS^R^ROKZZ\YZ\SK^OK_^RY\S^SO]^RY_QR^RO\ORK`OLOOXNOVKc]SXPOaMK]O]YPZKcWOX^ -YWWO\MSKV>KbO]:KXKTS1YK
YPZ\YPO]]SYXKV^Kb
-OX^\KV=KVO]>Kb+M^ =KVO]>Kb # Deputy Commissioner of  !
# 1_TK\K^ -YWWO\MSKV>KbO]+ZZOKV]
7KRK\K]R^\K@KV_O @KV_O+NNON>Kb ! !" .OZ_^c-YWWS]]SYXO\YP=KVO] 
+NNON>Kb+M^ >Kb+ZZOKV]
-_]^YW]+M^#  Custom Duty  -YWWS]]SYXO\+ZZOKV] ##
! CESTAT ^Y

98 ANNUAL REPORT 2017-18 99

 ABBOTT INDIA LIMITED
`SSS >RO -YWZKXc NSN XY^ RK`O KXc Y_^]^KXNSXQ VYKX] Y\
LY\\YaSXQN_O]SX\O]ZOM^YPK XKXMSKVSX]^S^_^SYXY\LKXU
Y\ ^Y QY`O\XWOX^ Y\ N_O] ^Y NOLOX^_\O RYVNO\] N_\SXQ ^RO
cOK\
Sb +
 MMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OXLc^RO
management, the Company has not raised any money by way
YPSXS^SKVZ_LVSMYPPO\P_\^RO\Z_LVSMYPPO\NOL^SX]^\_WOX^]
KXN ^O\W VYKX] ROXMO \OZY\^SXQ _XNO\ MVK_]O Sb S] XY^
KZZVSMKLVO^Y^RO-YWZKXcKXNROXMOXY^MYWWOX^ON_ZYX
b  K]ON_ZYX^ROK_NS^Z\YMON_\O]ZO\PY\WONPY\^ROZ_\ZY]O
, Management’s Responsibility for Internal Financial Controls
YP\OZY\^SXQ^RO^\_OKXNPKS\`SOaYP^RO XKXMSKV]^K^OWOX^]
KXNKMMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OXLc
OM^^RO^\KX]KM^SYX]KXNNS]ZY]S^SYX]YP^ROK]]O^]YP^RO
the management, we report that no fraud by the Company
Y\XYP\K_NWK^O\SKVP\K_NYX^RO-YWZKXcLc^ROYP MO\]
KXNOWZVYcOO]YP^RO-YWZKXcRK]LOOXXY^SMONY\\OZY\^ON
N_\SXQ^ROcOK\
bS +
 MMY\NSXQ ^Y ^RO SXPY\WK^SYX KXN ObZVKXK^SYX] QS`OX Lc
^RO WKXKQOWOX^ ^RO WKXKQO\SKV \OW_XO\K^SYX RK] LOOX
ZKSNZ\Y`SNON SX KMMY\NKXMO aS^R ^RO \O[_S]S^O KZZ\Y`KV]
WKXNK^ON Lc ^RO Z\Y`S]SYX] YP =OM^SYX #! \OKN aS^R
=MRON_VO@^Y^RO-YWZKXSO]+M^
bSS 3 X Y_\ YZSXSYX ^RO -YWZKXc S] XY^ K XSNRS MYWZKXc
>RO\OPY\O^ROZ\Y`S]SYX]YPMVK_]ObSSYP^ROY\NO\K\OXY^
KZZVSMKLVO^Y^RO-YWZKXcKXNROXMOXY^MYWWOX^ON_ZYX
bSSS +MMY\NSXQ ^Y ^RO SXPY\WK^SYX KXN ObZVKXK^SYX] QS`OX Lc
^RO WKXKQOWOX^ ^\KX]KM^SYX] aS^R ^RO \OVK^ON ZK\^SO] K\O
100 ANNUAL REPORT 2017-18
SX MYWZVSKXMO aS^R =OM^SYX !! KXN "" YP -YWZKXSO] +M^
 aRO\O KZZVSMKLVO KXN ^RO NO^KSV] RK`O LOOX NS]MVY]ON
SX ^RO XY^O] ^Y ^RO XKXMSKV ]^K^OWOX^] K] \O[_S\ON Lc ^RO
KZZVSMKLVOKMMY_X^SXQ]^KXNK\N]
bS` +MMY\NSXQ ^Y ^RO SXPY\WK^SYX KXN ObZVKXK^SYX] QS`OX ^Y _]
KXN YX KX Y`O\KVV ObKWSXK^SYX YP ^RO ,KVKXMO =ROO^ ^RO
-YWZKXcRK]XY^WKNOKXcZ\OPO\OX^SKVKVVY^WOX^Y\Z\S`K^O
ZVKMOWOX^YP]RK\O]Y\P_VVcY\ZK\^VcMYX`O\^SLVONOLOX^_\O]
during the year under review and hence, reporting
\O[_S\OWOX^] _XNO\ MVK_]O bS` K\O XY^ KZZVSMKLVO ^Y ^RO
-YWZKXcKXNXY^MYWWOX^ON_ZYX
b` +
 MMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OXLc^RO
management, the Company has not entered into any non-
cash transactions with directors or persons connected with
RSWK]\OPO\\ON^YSX=OM^SYX#YP-YWZKXSO]+M^
b`S +MMY\NSXQ^Y^ROSXPY\WK^SYXKXNObZVKXK^SYX]QS`OX^Y_]
^ROZ\Y`S]SYX]YP=OM^SYX3+YP^RO<O]O\`O,KXUYP3XNSK
+M^#K\OXY^KZZVSMKLVO^Y^RO-YWZKXc
For S R B C & CO LLP
Chartered Accountants
3-+30S\W<OQS]^\K^SYX8_WLO\$#"// KXNNO^OM^SYXYPP\K_N]KXNO\\Y\]^ROKMM_\KMcKXNMYWZVO^OXO]]
per Ravi Bansal
:K\^XO\
7OWLO\]RSZ8_WLO\$# 
:VKMO$7_WLKS
.K^O$7Kc"
CORPORATE OVERVIEW
ANNEXURE 2 TO THE INDEPENDENT AUDITOR’S REPORT OF EVEN DATE ON THE STANDALONE FINANCIAL
STATEMENTS OF ABBOTT INDIA LIMITED
Report on the Internal Financial Controls under Clause (i)
of Sub-section 3 of Section 143 of the Companies Act, 2013
(“the Act”)
AO RK`O K_NS^ON ^RO SX^O\XKV XKXMSKV MYX^\YV] Y`O\ XKXMSKV
reporting of Abbott India Limited (“the Company”) as of
7K\MR  " SX MYXT_XM^SYX aS^R Y_\ K_NS^ YP ^RO XKXMSKV
]^K^OWOX^]YP^RO-YWZKXcPY\^ROcOK\OXNONYX^RK^NK^O
>RO -YWZKXct] 7KXKQOWOX^ S] \O]ZYX]SLVO PY\ O]^KLVS]RSXQ KXN
WKSX^KSXSXQ SX^O\XKV XKXMSKV MYX^\YV] LK]ON YX ^RO SX^O\XKV
MYX^\YV Y`O\ XKXMSKV \OZY\^SXQ M\S^O\SK O]^KLVS]RON Lc ^RO
-YWZKXcMYX]SNO\SXQ^ROO]]OX^SKVMYWZYXOX^]YPSX^O\XKVMYX^\YV
]^K^ONSX^RO1_SNKXMO8Y^OYX+_NS^YP3X^O\XKV0SXKXMSKV-YX^\YV]
9`O\ 0SXKXMSKV <OZY\^SXQ S]]_ON Lc ^RO 3X]^S^_^O YP -RK\^O\ON
+MMY_X^KX^] YP 3XNSK >RO]O \O]ZYX]SLSVS^SO] SXMV_NO ^RO NO]SQX
SWZVOWOX^K^SYX KXN WKSX^OXKXMO YP KNO[_K^O SX^O\XKV XKXMSKV
MYX^\YV] ^RK^ aO\O YZO\K^SXQ OPPOM^S`OVc PY\ OX]_\SXQ ^RO Y\NO\Vc
KXN OP MSOX^ MYXN_M^ YP S^] L_]SXO]] SXMV_NSXQ KNRO\OXMO ^Y ^RO
-YWZKXct]ZYVSMSO]^RO]KPOQ_K\NSXQYPS^]K]]O^]^ROZ\O`OX^SYX
YP ^RO KMMY_X^SXQ \OMY\N] KXN ^RO ^SWOVc Z\OZK\K^SYX YP \OVSKLVO
XKXMSKVSXPY\WK^SYXK]\O[_S\ON_XNO\^RO-YWZKXSO]+M^
Auditor’s Responsibility
9_\ \O]ZYX]SLSVS^c S] ^Y ObZ\O]] KX YZSXSYX YX ^RO -YWZKXct]
SX^O\XKV XKXMSKV MYX^\YV] Y`O\ XKXMSKV \OZY\^SXQ LK]ON YX Y_\
K_NS^AOMYXN_M^ONY_\K_NS^SXKMMY\NKXMOaS^R^RO1_SNKXMO
8Y^O YX +_NS^ YP 3X^O\XKV 0SXKXMSKV -YX^\YV] 9`O\ 0SXKXMSKV
<OZY\^SXQ ^RO u1_SNKXMO 8Y^Ov KXN ^RO =^KXNK\N] YX +_NS^SXQ
K]]ZOMS ON_XNO\=OM^SYXYP^RO-YWZKXSO]+M^^Y
^ROOb^OX^KZZVSMKLVO^YKXK_NS^YPSX^O\XKV XKXMSKVMYX^\YV]KXN
LY^R S]]_ON Lc ^RO 3X]^S^_^O YP -RK\^O\ON +MMY_X^KX^] YP 3XNSK
>RY]O=^KXNK\N]KXN^RO1_SNKXMO8Y^O\O[_S\O^RK^aOMYWZVc
aS^RO^RSMKV\O[_S\OWOX^]KXNZVKXKXNZO\PY\W^ROK_NS^^YYL^KSX
\OK]YXKLVO K]]_\KXMO KLY_^ aRO^RO\ KNO[_K^O SX^O\XKV XKXMSKV
MYX^\YV]Y`O\ XKXMSKV\OZY\^SXQaK]O]^KLVS]RONKXNWKSX^KSXON
KXNSP]_MRMYX^\YV]YZO\K^ONOPPOM^S`OVcSXKVVWK^O\SKV\O]ZOM^]
9_\K_NS^SX`YV`O]ZO\PY\WSXQZ\YMON_\O]^YYL^KSXK_NS^O`SNOXMO
KLY_^^ROKNO[_KMcYP^ROSX^O\XKV XKXMSKVMYX^\YV]]c]^OWY`O\
XKXMSKV \OZY\^SXQ KXN ^ROS\ YZO\K^SXQ OPPOM^S`OXO]] 9_\ K_NS^
YP SX^O\XKV XKXMSKV MYX^\YV] Y`O\ XKXMSKV \OZY\^SXQ SXMV_NON
YL^KSXSXQ KX _XNO\]^KXNSXQ YP SX^O\XKV XKXMSKV MYX^\YV] Y`O\
XKXMSKV \OZY\^SXQ K]]O]]SXQ ^RO \S]U ^RK^ K WK^O\SKV aOKUXO]]
ObS]^] KXN ^O]^SXQ KXN O`KV_K^SXQ ^RO NO]SQX KXN YZO\K^SXQ
OPPOM^S`OXO]] YP SX^O\XKV MYX^\YV LK]ON YX ^RO K]]O]]ON \S]U >RO
Z\YMON_\O]]OVOM^ONNOZOXNYX^ROK_NS^Y\t]T_NQOWOX^SXMV_NSXQ
^RO K]]O]]WOX^ YP ^RO \S]U] YP WK^O\SKV WS]]^K^OWOX^ YP ^RO
XKXMSKV]^K^OWOX^]aRO^RO\N_O^YP\K_NY\O\\Y\
AOLOVSO`O^RK^^ROK_NS^O`SNOXMOaORK`OYL^KSXONS]]_P MSOX^
and appropriate to provide a basis for our audit opinion on the
SX^O\XKV XKXMSKVMYX^\YV]]c]^OWY`O\ XKXMSKV\OZY\^SXQ
STATUTORY REPORT FINANCIAL STATEMENTS
Meaning of Internal Financial Controls Over Financial
Reporting
+MYWZKXct]SX^O\XKV XKXMSKVMYX^\YVY`O\ XKXMSKV\OZY\^SXQS]
KZ\YMO]]NO]SQXON^YZ\Y`SNO\OK]YXKLVOK]]_\KXMO\OQK\NSXQ^RO
\OVSKLSVS^c YP XKXMSKV \OZY\^SXQ KXN ^RO Z\OZK\K^SYX YP XKXMSKV
]^K^OWOX^] PY\ Ob^O\XKV Z_\ZY]O] SX KMMY\NKXMO aS^R QOXO\KVVc
KMMOZ^ONKMMY_X^SXQZ\SXMSZVO]
+ MYWZKXct] SX^O\XKV XKXMSKV MYX^\YV Y`O\ XKXMSKV \OZY\^SXQ
SXMV_NO] ^RY]O ZYVSMSO] KXN Z\YMON_\O] ^RK^  ZO\^KSX ^Y ^RO
WKSX^OXKXMOYP\OMY\N]^RK^SX\OK]YXKLVONO^KSVKMM_\K^OVcKXN
PKS\Vc\O
MYWZKXc%  Z\Y`SNO \OK]YXKLVO K]]_\KXMO ^RK^ ^\KX]KM^SYX] K\O
\OMY\NONK]XOMO]]K\c^YZO\WS^Z\OZK\K^SYXYP XKXMSKV]^K^OWOX^]
SXKMMY\NKXMOaS^RQOXO\KVVcKMMOZ^ONKMMY_X^SXQZ\SXMSZVO]KXN
^RK^\OMOSZ^]KXNObZOXNS^_\O]YP^ROMYWZKXcK\OLOSXQWKNOYXVc
in accordance with authorisations of management and directors
YP ^RO MYWZKXc% KXN  Z\Y`SNO \OK]YXKLVO K]]_\KXMO \OQK\NSXQ
Z\O`OX^SYX Y\ ^SWOVc NO^OM^SYX YP _XK_^RY\S]ON KM[_S]S^SYX _]O
Y\NS]ZY]S^SYXYP^ROMYWZKXct]K]]O^]^RK^MY_VNRK`OKWK^O\SKV
OPPOM^YX^RO XKXMSKV]^K^OWOX^]
Inherent Limitations of Internal Financial Controls Over
Financial Reporting
,OMK_]O YP ^RO SXRO\OX^ VSWS^K^SYX] YP SX^O\XKV XKXMSKV MYX^\YV]
Y`O\ XKXMSKV \OZY\^SXQ SXMV_NSXQ ^RO ZY]]SLSVS^c YP MYVV_]SYX
Y\ SWZ\YZO\ WKXKQOWOX^ Y`O\\SNO YP MYX^\YV] WK^O\SKV
WS]]^K^OWOX^]N_O^YO\\Y\Y\P\K_NWKcYMM_\KXNXY^LONO^OM^ON
+V]YZ\YTOM^SYX]YPKXcO`KV_K^SYXYP^ROSX^O\XKV XKXMSKVMYX^\YV]
Y`O\ XKXMSKV\OZY\^SXQ^YP_^_\OZO\SYN]K\O]_LTOM^^Y^RO\S]U^RK^
^ROSX^O\XKV XKXMSKVMYX^\YVY`O\ XKXMSKV\OZY\^SXQWKcLOMYWO
inadequate because of changes in conditions, or that the degree of
MYWZVSKXMOaS^R^ROZYVSMSO]Y\Z\YMON_\O]WKcNO^O\SY\K^O
Opinion
3X Y_\ YZSXSYX ^RO -YWZKXc RK] SX KVV WK^O\SKV \O]ZOM^]
KX KNO[_K^O SX^O\XKV XKXMSKV MYX^\YV] ]c]^OW Y`O\ XKXMSKV
\OZY\^SXQ KXN ]_MR SX^O\XKV XKXMSKV MYX^\YV] Y`O\ XKXMSKV
\OZY\^SXQ aO\O YZO\K^SXQ OPPOM^S`OVc K] K^ 7K\MR  " LK]ON
YX^ROSX^O\XKVMYX^\YVY`O\ XKXMSKV\OZY\^SXQM\S^O\SKO]^KLVS]RON
Lc^RO-YWZKXcMYX]SNO\SXQ^ROO]]OX^SKVMYWZYXOX^]YPSX^O\XKV
MYX^\YV]^K^ONSX^RO1_SNKXMO8Y^OYX+_NS^YP3X^O\XKV0SXKXMSKV
-YX^\YV] 9`O\ 0SXKXMSKV <OZY\^SXQ S]]_ON Lc ^RO 3X]^S^_^O YP
-RK\^O\ON+MMY_X^KX^]YP3XNSK
For S R B C & CO LLP
Chartered Accountants
3-+30S\W<OQS]^\K^SYX8_WLO\$#"//
per Ravi Bansal
:K\^XO\
7OWLO\]RSZ8_WLO\$# 
:VKMO$7_WLKS
.K^O$7Kc"
101
ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

BALANCE SHEET STATEMENT OF PROFIT AND LOSS

AS A T M A RC H 31, 2018 F O R T H E YEA R EN DED M A R CH 3 1 , 2 0 18
+VVKWY_X^]SX`6KUR]_XVO]]Y^RO\aS]O]^K^ON +VVKWY_X^]SX`6KUR]_XVO]]Y^RO\aS]O]^K^ON
8Y^O] As at March 31, 2018 +]K^7K\MR!
ASSETS For the Year ended For the Year ended
8Y^O] March 31, 2018 March 31, 2017
Non-current Assets
:\YZO\^cZVKX^KXNO[_SZWOX^  78,58.56 !  INCOME
-KZS^KVaY\USXZ\YQ\O]]  2,16.69  Revenue from operations  3307,12.17 #" #
9^RO\SX^KXQSLVOK]]O^]  2,79.60 # 9^RO\SXMYWO ! 116,98.72 ! "
3X^KXQSLVOK]]O^]_XNO\NO`OVYZWOX^  - "
TOTAL INCOME 3424,10.89 ## 
0SXKXMSKVK]]O^]
Loans 15,02.58   EXPENSES
9^RO\ XKXMSKVK]]O^] ! 22,70.67 " # -Y]^YPWK^O\SKV]MYX]_WON " 295,72.38 #!
.OPO\\ON^KbK]]O^]XO^  14,59.96 " :_\MRK]O]YP]^YMUSX^\KNO # 1711,22.00 #! !
9^RO\XYXM_\\OX^K]]O^] " 14,83.65 !!"
-RKXQO]SXSX`OX^Y\SO]YP XS]RONQYYN]]^YMUSX^\KNOKXNaY\USXZ\YQ\O]]  (102,19.94) 
Total Non-current Assets 150,71.71 !!"!
Current Assets /bMS]ON_^cYX]KVO] 8,61.82  
Inventories # 585,32.72   /WZVYcOOLOXO ^]ObZOX]O  393,69.27 !
0SXKXMSKVK]]O^] Finance costs  3,82.21  
>\KNO\OMOS`KLVO]  263,44.30 ! ## .OZ\OMSK^SYXKXNKWY\^S]K^SYXObZOX]O  16,18.54  "
-K]RKXNMK]RO[_S`KVOX^]  37,67.71 "
9^RO\ObZOX]O]  475,56.35 !# 
,KXULKVKXMO]Y^RO\^RKXMK]RKXNMK]RO[_S`KVOX^]  993,67.32 """ "
Loans  205,47.81 # TOTAL EXPENSES 2802,62.63 #"
9^RO\ XKXMSKVK]]O^]  40,21.24 "!! PROFIT BEFORE TAX 621,48.26  #!
-_\\OX^^KbK]]O^]XO^ 15,73.39 " TAX EXPENSES
9^RO\M_\\OX^K]]O^]  89,58.95 !"
"# " -_\\OX^^KbObZOX]O  223,51.00  ""
2231,13.44
+]]O^]ROVNPY\]KVO  34,33.76 - >KbKNT_]^WOX^PY\OK\VSO\cOK\]  (1,62.69) # 
Total Current Assets 2265,47.20 "# " .OPO\\ON^KbM\ONS^  (1,61.83)  
TOTAL ASSETS 2416,18.91  " TOTAL TAX EXPENSES 220,26.48 #"#
EQUITY AND LIABILITIES PROFIT FOR THE YEAR 401,21.78 !  ""
Equity Other Comprehensive Income
/[_S^c]RK\OMKZS^KV ! 21,24.93 # 3^OW]^RK^aSVVXY^LO\OMVK]]S ON]_L]O[_OX^Vc^YZ\Y ^Y\VY]]
9^RO\O[_S^c " 1671,51.12   #!
<OWOK]_\OWOX^YPNO XONLOXO ^ZVKX  (1,67.72) " #
Total Equity 1692,76.05 " #
3XMYWO^KbYXKLY`O  60.08 ##
Non-current Liabilities
:\Y`S]SYX] # 55,34.51 !# Total Other Comprehensive Income, net of tax (1,07.64) "! 
Total Non-current Liabilities 55,34.51 !# Total Comprehensive Income for the year, net of tax 400,14.14 !!!!
Current Liabilities EARNINGS PER EQUITY SHARE
0SXKXMSKVVSKLSVS^SO] ,K]SMKXN.SV_^ON`0KMO`KV_OYP`OKMR  188.81 #
>\KNOZKcKLVO] 
=SQXS MKX^KMMY_X^SXQZYVSMSO] 
._O^YWSM\YKXN]WKVVOX^O\Z\S]O] 5,83.88 !#
Due to others 474,78.60 !"
>ROKMMYWZKXcSXQXY^O]K\OKXSX^OQ\KVZK\^YP^RO XKXMSKV]^K^OWOX^]
9^RO\ XKXMSKVVSKLSVS^SO]  48,98.43  #
0Y\KXNYXLORKVPYP^RO,YK\NYP.S\OM^Y\]
9^RO\M_\\OX^VSKLSVS^SO]  32,81.56  "
As per our report of even date
:\Y`S]SYX]  77,46.92 !#"
-_\\OX^^KbVSKLSVS^SO]XO^ " # For S R B C & CO LLP AMBATI VENU R A SHAH
28,18.96
Total Current Liabilities 668,08.35  " Chartered Accountants Managing Director Director
3-+30S\W<OQS]^\K^SYX8Y#"// .38$! "# .38$#"
TOTAL EQUITY AND LIABILITIES 2416,18.91  "
=SQXS MKX^KMMY_X^SXQZYVSMSO]  per RAVI BANSAL RAJIV SONALKER KRUPA ANANDPARA
>ROKMMYWZKXcSXQXY^O]K\OKXSX^OQ\KVZK\^YP^RO XKXMSKV]^K^OWOX^] :K\^XO\ -09KXNARYVO^SWO.S\OM^Y\ Company Secretary
0Y\KXNYXLORKVPYP^RO,YK\NYP.S\OM^Y\] 7OWLO\]RSZ8Y#  .38$!#!" 7OWLO\]RSZ8Y+-= 
As per our report of even date
For S R B C & CO LLP AMBATI VENU R A SHAH
Chartered Accountants Managing Director Director :VKMO$7_WLKS :VKMO$7_WLKS
3-+30S\W<OQS]^\K^SYX8Y#"// .38$! "# .38$#" .K^O$7Kc" .K^O$7Kc"

per RAVI BANSAL RAJIV SONALKER KRUPA ANANDPARA

:K\^XO\ -09KXNARYVO^SWO.S\OM^Y\ Company Secretary
7OWLO\]RSZ8Y#  .38$!#!" 7OWLO\]RSZ8Y+-= 
:VKMO$7_WLKS :VKMO$7_WLKS
.K^O$7Kc" .K^O$7Kc"

102 ANNUAL REPORT 2017-18 103

ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

STATEMENT OF CHANGES IN EQUITY STATEMENT OF CASH FLOWS

F O R T H E Y E A R END ED MA R C H 31, 2018 F O R T H E YEA R EN DED M A R CH 3 1 , 2 0 18
+VVKWY_X^]SX`6KUR]_XVO]]Y^RO\aS]O]^K^ON +VVKWY_X^]SX`6KUR]_XVO]]Y^RO\aS]O]^K^ON
A. EQUITY SHARE CAPITAL :
For the Year ended For the Year ended
Equity shares of ` 10 each issued, subscribed and fully paid Number of Amount March 31, 2018 7K\MR!
shares
As at April 1, 2016 # # OPERATING ACTIVITIES
3XM\OK]ONOM\OK]ON_\SXQ^ROcOK\ - - :\Y ^LOPY\O^Kb 621,48.26  #!
As at March 31, 2017 # # +NT_]^WOX^]^Y\OMYXMSVOZ\Y ^LOPY\O^Kb^YXO^MK]R
Ya]$
3XM\OK]ONOM\OK]ON_\SXQ^ROcOK\ - -
.OZ\OMSK^SYXYPZ\YZO\^cZVKX^KXNO[_SZWOX^ 14,50.20 !"!
As at March 31, 2018 2,12,49,302 21,24.93
+WY\^S]K^SYXYPSX^KXQSLVOK]]O^] 1,68.34 
B. OTHER EQUITY : ?X\OKVS]ONObMRKXQOQKSXVY]]XO^ 1,06.63 !
Items of Other 6Y]]YX]KVOa\S^OYPPYPZ\YZO\^cZVKX^KXNO[_SZWOX^XO^ 28.00 ""
Comprehensive
Reserves and Surplus (Refer Note 18) 1KSXYXK]]SQXWOX^YP^\KNOWK\U] (45,30.26) -
Income Total
(Refer Note 18) Other Finance income (71,39.83) ! "
Amalgamation Capital Capital Share Based General Retained Remeasurement Equity
Reserve Reserve Redemption Compensation Reserve Earnings YPNO XON Finance costs 3,82.21  
Reserve Reserve LOXO ^ZVKX
Balances as at April 1, 2016 !"   " ""  !#"# "#"!!  !#! +WY\^S]K^SYXYPNOPO\\ONVOK]O\OX^KV] 1,39.02 ! 
:\Y ^PY\^ROcOK\OXNON7K\MR! - - - - - !  "" - !  "" +VVYaKXMOPY\NY_L^P_VNOL^] 71.44 "
<OWOK]_\OWOX^YPNO XONLOXO ^ZVKX +VVYaKXMOPY\NY_L^P_VKN`KXMO]KXNNOZY]S^] 81.09 !
XO^YP^Kb - - - - - - "!  "! 
Total Comprehensive Income for the year - - - - - !  "" "!  !!!! :\Y`S]SYXPY\VSUOVc]KVO]\O^_\X]NK^OObZS\cKXNNKWKQONZ\YN_M^]XO^ 7,53.69 # 
>\KX]PO\P\YW:\Y ^KXN6Y]]^Y1OXO\KV =RK\OLK]ONMYWZOX]K^SYXObZOX]O 7,97.57 "
Reserve - - - - ! # ! # - -
.S`SNOXNPY\^ROcOK\OXNON7K\MR  6SKLSVS^SO]Z\Y`S]SYX]XYVYXQO\\O[_S\ONa\S^^OXLKMU - "!
<OPO\8Y^O! - - - - - !!  - !!  9ZO\K^SXQ:\Y ^LOPY\OaY\USXQMKZS^KVMRKXQO] 544,56.36 ##!!
.S`SNOXNNS]^\SL_^SYX^Kb<OPO\8Y^O! - - - - -  - 
=RK\OLK]ONMYWZOX]K^SYX^YOWZVYcOO]
<OPO\8Y^O - - - " - - - " Adjustments for (increase)/decrease in :
Transfer from Share Based Compensation
<O]O\`O^Y1OXO\KV<O]O\`O - - -   - - -
(i) >\KNO\OMOS`KLVO] (87,85.30) # 
Balances as at March 31, 2017 !"   "  # !"#" " "!!   #! (ii) Inventories (84,69.60) "
:\Y ^PY\^ROcOK\OXNON7K\MR" - - - - - !" - !" (iii) 6YKX]Y^RO\ XKXMSKVK]]O^]KXNY^RO\K]]O^] (23,29.64) " 
<OWOK]_\OWOX^YPNO XONLOXO ^ZVKX
XO^YP^Kb - - - - - - !  !  Adjustments for increase/(decrease) in :
Total Comprehensive Income for the year - - - - - !" !   (i) >\KNOZKcKLVO] 4,77.76 !#
>\KX]PO\P\YW:\Y ^KXN6Y]]^Y1OXO\KV
(ii) :\Y`S]SYX]Y^RO\ XKXMSKVVSKLSVS^SO]KXNY^RO\VSKLSVS^SO] 4,10.92 
Reserve - - - - " " - -
.S`SNOXNPY\^ROcOK\OXNON7K\MR! 357,60.50  ###
<OPO\8Y^O! - - - - - "##! - "##!
3XMYWO^KbZKSNSXMV_NSXQ>.=XO^ (204,90.13) "!"
.S`SNOXNNS]^\SL_^SYX^Kb<OPO\8Y^O! - - - - - ! - !
=RK\OLK]ONMYWZOX]K^SYX^YOWZVYcOO] 8O^MK]R
Ya]P\YWYZO\K^SXQKM^S`S^SO]+ 152,70.37 !#
<OPO\8Y^O - - - !#!! - - - !#!!
Transfer from Share Based Compensation
<O]O\`O^Y1OXO\KV<O]O\`O - - - !# !# - - - INVESTING ACTIVITIES
Balances as at March 31, 2018 37.82 5,22.62 2,52.48 20,95.22 337,25.95 1309,12.39 (3,95.36) 1671,51.12 :\YMOON]P\YW]KVOYPZ\YZO\^cZVKX^KXNO[_SZWOX^ 16.90 "#
>ROKMMYWZKXcSXQXY^O]K\OKXSX^OQ\KVZK\^YP^RO XKXMSKV]^K^OWOX^] :_\MRK]OYPZ\YZO\^cZVKX^KXNO[_SZWOX^SXMV_NSXQMKZS^KVaY\USXZ\YQ\O]]KXN
0Y\KXNYXLORKVPYP^RO,YK\NYP.S\OM^Y\] MKZS^KVKN`KXMO] (16,74.42)  
As per our report of even date
:_\MRK]OYPY^RO\SX^KXQSLVOK]]O^] (1.32) "
For S R B C & CO LLP AMBATI VENU R A SHAH
Chartered Accountants Managing Director Director :\YMOON]P\YWK]]SQXWOX^YP^\KNOWK\U] 51,42.28 -
3-+30S\W<OQS]^\K^SYX8Y#"// .38$! "# .38$#" :_\MRK]OYP^\KNOWK\U] (7,50.50) -
per RAVI BANSAL RAJIV SONALKER KRUPA ANANDPARA 3X`O]^WOX^SX bONNOZY]S^]WK^_\SXQLOcYXNWYX^R]XO^ (105,12.79) "# # 
:K\^XO\ -09KXNARYVO^SWO.S\OM^Y\ Company Secretary 6YKXQS`OX^YK\OVK^ONZK\^c (200,00.00) -
7OWLO\]RSZ8Y#  .38$!#!" 7OWLO\]RSZ8Y+-= 
3X^O\O]^\OMOS`ONYXNOZY]S^] XKXMOSXMYWO 62,96.33 
:VKMO$7_WLKS :VKMO$7_WLKS 8O^MK]R
Ya]P\YWSX`O]^SXQKM^S`S^SO], (214,83.52) 
.K^O$7Kc" .K^O$7Kc"

104 ANNUAL REPORT 2017-18 105

ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

NOTES TO THE FINANCIAL STATEMENTS

F O R T H E YEA R EN DED M A R CH 3 1 , 2 0 18
+VVKWY_X^]SX`6KUR]_XVO]]Y^RO\aS]O]^K^ON 1. COMPANY INFORMATION    w -K]R Y\ MK]R O[_S`KVOX^ _XVO]] \O]^\SM^ON
  LLY^^ 3XNSK 6SWS^ON s>RO -YWZKXct S] K Z_LVSM VSWS^ON
+ P\YW LOSXQ ObMRKXQON Y\ _]ON ^Y ]O^^VO K
For the Year ended For the Year ended VSKLSVS^c PY\ K^ VOK]^ ^aOV`O WYX^R] KP^O\ ^RO
MYWZKXc NYWSMSVON KXN SXMY\ZY\K^ON SX 3XNSK _XNO\ ^RO
March 31, 2018 7K\MR! Z\Y`S]SYX] YP -YWZKXSO] +M^ # >RO -YWZKXc S] VS]^ON reporting period
FINANCING ACTIVITIES KXN^\KNONYX^RO,YWLKc=^YMU/bMRKXQOKXNKV]Y^\KNON    +VVY^RO\K]]O^]K\OMVK]]S ONK]XYXM_\\OX^
YX^RO8K^SYXKV=^YMU/bMRKXQO>RO\OQS]^O\ONYP MOYP^RO
Interest paid (12.66) !#    +VSKLSVS^cS]M_\\OX^aROX$
-YWZKXcS]-Y\ZY\K^OZK\U=SYX>\YWLKc\YKN7_WLKS
:KcWOX^YPNS`SNOXN (84,99.72) !!  !3XNSK    w 3^S]ObZOM^ON^YLO]O^^VONSXXY\WKVYZO\K^SXQ
.S`SNOXNNS]^\SL_^SYX^Kb (17,30.34)    RO -YWZKXc S] YXO YP ^RO VOKNSXQ W_V^SXK^SYXKV
> McMVO
8O^MK]R
Ya]_]ONSX XKXMSXQKM^S`S^SO]- (102,42.72) "#!  ZRK\WKMO_^SMKV MYWZKXSO] SX 3XNSK KXN YZO\K^O] aS^R KX    w 3^S]ROVNZ\SWK\SVcPY\^ROZ_\ZY]OYP^\KNSXQ
YaXONWKX_PKM^_\SXQPKMSVS^cSX1YKKXN`K\SY_]SXNOZOXNOX^
MYX^\KM^^RS\NZK\^cWKX_PKM^_\O\]LK]ONKM\Y]]^ROMY_X^\c    w 3^ S] N_O ^Y LO ]O^^VON aS^RSX ^aOV`O WYX^R]
Net increase/(decrease) in cash and cash equivalents (A+B+C) (164,55.87)  >RO -YWZKXc ]OVV] S^] Z\YN_M^] ^R\Y_QR SXNOZOXNOX^ after the reporting period
-K]RKXNMK]RO[_S`KVOX^]K^^ROLOQSXXSXQYP^ROcOK\ 202,23.58 #" NS]^\SL_^Y\]Z\SWK\SVcaS^RSX3XNSK    w >RO\O S] XY _XMYXNS^SYXKV \SQR^ ^Y NOPO\ ^RO
Cash and cash equivalents at the end of the year (Refer Note 11) 37,67.71 " 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ]O^^VOWOX^ YP ^RO VSKLSVS^c PY\ K^ VOK]^ ^aOV`O
months after the reporting period
2.1 Basis of preparation
   +VVY^RO\VSKLSVS^SO]K\OMVK]]S ONK]XYXM_\\OX^
=SQXS MKX^KMMY_X^SXQZYVSMSO]<OPO\8Y^O   >
 RO XKXMSKV ]^K^OWOX^] K\O Z\OZK\ON YX ^RO KMM\_KV
basis of accounting and in accordance with the Indian    .
 OPO\\ON^KbK]]O^]KXNVSKLSVS^SO]K\OMVK]]S ONK]
>ROKMMYWZKXcSXQXY^O]K\OKXSX^OQ\KVZK\^YP^RO XKXMSKV]^K^OWOX^]
Accounting Standards (hereinafter referred to as the Ind XYXM_\\OX^K]]O^]KXNVSKLSVS^SO]
Note : +=XY^S ON_XNO\^RO-YWZKXSO]3XNSKX+MMY_X^SXQ b) Foreign currency translation
-K]R0VYa=^K^OWOX^RK]LOOXZ\OZK\ON_XNO\^RO3XNS\OM^7O^RYNK]]O^Y_^SX3XN+=!s=^K^OWOX^YP-K]R0VYa]taRO\OLcZ\Y ^PY\^ROcOK\ =^KXNK\N] <_VO]  KXN \OVO`KX^ KWOXNWOX^]
^RO\OKP^O\ Functional and presentation currency
S]KNT_]^ONPY\^ROOPPOM^]YP^\KX]KM^SYX]YPKXYXMK]RXK^_\OKXcNOPO\\KV]Y\KMM\_KV]YPZK]^Y\P_^_\OYZO\K^SXQMK]R\OMOSZ^]Y\ZKcWOX^]KXN
S^OWYPSXMYWOY\ObZOX]O]K]]YMSK^ONaS^RSX`O]^SXQY\ XKXMSXQMK]R
Ya]>ROMK]R
Ya]P\YWYZO\K^SXQSX`O]^SXQKXN XKXMSXQKM^S`S^SO]   /
 PPOM^S`O +Z\SV    ^RO -YWZKXc RK] KNYZ^ON KVV    3 ^OW] SXMV_NON SX ^RO XKXMSKV ]^K^OWOX^] YP ^RO
YP^RO-YWZKXcK\O]OQ\OQK^ON the Ind AS standards and the adoption was carried out Company are measured using the currency of
SX KMMY\NKXMO aS^R 3XN +=  s0S\]^^SWO KNYZ^SYX YP the primary economic environment in which the
3XNSKX+MMY_X^SXQ=^KXNK\N]taS^R+Z\SVK]^RO -YWZKXc YZO\K^O] ^RO P_XM^SYXKV M_\\OXMc
0Y\KXNYXLORKVPYP^RO,YK\NYP.S\OM^Y\] >RO XKXMSKV ]^K^OWOX^] K\O Z\O]OX^ON SX 3XNSKX
As per our report of even date
^\KX]S^SYX NK^O >RO ^\KX]S^SYX aK] MK\\SON Y_^ P\YW
3XNSKX +MMY_X^SXQ :\SXMSZVO] QOXO\KVVc KMMOZ^ON SX Rupee (`aRSMRS]^RO-YWZKXc]P_XM^SYXKVKXN
For S R B C & CO LLP AMBATI VENU R A SHAH Z\O]OX^K^SYXM_\\OXMc
3XNSK K] Z\O]M\SLON _XNO\ =OM^SYX  YP ^RO +M^ \OKN
Chartered Accountants Managing Director Director
aS^R <_VO ! YP ^RO -YWZKXSO] +MMY_X^] <_VO]  Transactions and balances
3-+30S\W<OQS]^\K^SYX8Y#"// .38$! "# .38$#"
aRSMRaK]^ROZ\O`SY_]1++:
   0
 Y\OSQX M_\\OXMc ^\KX]KM^SYX] K\O ^\KX]VK^ON SX^Y
per RAVI BANSAL RAJIV SONALKER KRUPA ANANDPARA   >
 RO XKXMSKV ]^K^OWOX^] RK`O LOOX Z\OZK\ON YX K ^RO P_XM^SYXKV M_\\OXMc _]SXQ ^RO ObMRKXQO \K^O]
:K\^XO\ -09KXNARYVO^SWO.S\OM^Y\ Company Secretary RS]^Y\SMKVMY]^LK]S]ObMOZ^PY\MO\^KSX XKXMSKVK]]O^] K^^RONK^O]YP^RO^\KX]KM^SYX]0Y\OSQXObMRKXQO
7OWLO\]RSZ8Y#  .38$!#!" 7OWLO\]RSZ8Y+-=  KXNVSKLSVS^SO]WOK]_\ONK^PKS\`KV_OY\KWY\^S]ONMY]^ QKSX] KXN VY]]O] \O]_V^SXQ P\YW ^RO ]O^^VOWOX^
  >
 RO XKXMSKV]^K^OWOX^]K\OKZZ\Y`ONPY\S]]_OLc^RO YP ]_MR ^\KX]KM^SYX] KXN P\YW ^RO ^\KX]VK^SYX YP
:VKMO$7_WLKS :VKMO$7_WLKS -YWZKXct],YK\NYP.S\OM^Y\]YX7Kc" WYXO^K\c K]]O^] KXN VSKLSVS^SO] NOXYWSXK^ON SX
.K^O$7Kc" .K^O$7Kc" PY\OSQXM_\\OXMSO]K^cOK\OXNObMRKXQO\K^O]K\O
  =_WWK\cYP]SQXS MKX^KMMY_X^SXQZYVSMSO] QOXO\KVVc\OMYQXS]ONSX^RO=^K^OWOX^YP:\Y ^KXN
  K -_\\OX^KXNXYXM_\\OX^MVK]]S MK^SYX 6Y]]
  VV K]]O^] KXN VSKLSVS^SO] K\O Z\O]OX^ON SX ^RO
+    8
 YXWYXO^K\c K]]O^] KXN VSKLSVS^SO] NOXYWSXK^ON
,KVKXMO =ROO^ LK]ON YX M_\\OX^ Y\ XYXM_\\OX^ SX K PY\OSQX M_\\OXMc KXN WOK]_\ON K^ RS]^Y\SMKV
MVK]]S MK^SYXK]ZO\^RO-YWZKXct]XY\WKVYZO\K^SXQ MY]^K\O^\KX]VK^ONK^^ROObMRKXQO\K^OZ\O`KVOX^
McMVO KXN Y^RO\ M\S^O\SK ]O^ Y_^ SX =MRON_VO 333 YP K^^RONK^OYP^RO^\KX]KM^SYX
^RO -YWZKXSO] +M^  ,K]ON YX ^RO XK^_\O YP c) Fair value measurement
products and the time between the acquisition of
K]]O^]PY\Z\YMO]]SXQKXN^ROS\\OKVS]K^SYXSX^YMK]R    >
 RO -YWZKXc WOK]_\O] XKXMSKV SX]^\_WOX^] K^
KXNMK]RO[_S`KVOX^]^RO-YWZKXcRK]K]MO\^KSXON PKS\ `KV_O K^ OKMR ,KVKXMO =ROO^ NK^O 0KS\ `KV_O
S^]YZO\K^SXQMcMVOK]^aOV`OWYX^R]PY\^ROZ_\ZY]O S] ^RO Z\SMO ^RK^ aY_VN LO \OMOS`ON YX ]KVO YP KX
YP M_\\OX^XYXM_\\OX^ MVK]]S MK^SYX YP K]]O^] KXN K]]O^ Y\ ZKSN ^Y ^\KX]PO\ K VSKLSVS^c SX KX Y\NO\Vc
VSKLSVS^SO]+XK]]O^S]^\OK^ONK]M_\\OX^aROXS^S]$ transaction between market participants at the
WOK]_\OWOX^ NK^O >RO PKS\ `KV_O WOK]_\OWOX^
   w /bZOM^ON^YLO\OKVS]ONY\SX^OXNON^YLO]YVN is based on the presumption that the transaction
Y\MYX]_WONSXXY\WKVYZO\K^SXQMcMVO ^Y]OVV^ROK]]O^Y\^\KX]PO\^ROVSKLSVS^c^KUO]ZVKMO
   w 2OVNZ\SWK\SVcPY\^ROZ_\ZY]OYP^\KNSXQ OS^RO\$
   w /bZOM^ON^YLO\OKVS]ONaS^RSX^aOV`OWYX^R]    w 3X ^RO Z\SXMSZKV WK\UO^ PY\ ^RO K]]O^ Y\
after the reporting period VSKLSVS^cY\

106 ANNUAL REPORT 2017-18 107

 ABBOTT INDIA LIMITED
   w 3 X ^RO KL]OXMO YP K Z\SXMSZKV WK\UO^ SX ^RO
most advantageous market for the asset or
VSKLSVS^c
   >
 RO Z\SXMSZKV Y\ ^RO WY]^ KN`KX^KQOY_] WK\UO^
W_]^LOKMMO]]SLVOLc^RO-YWZKXc>ROPKS\`KV_O
YP KX K]]O^ Y\ K VSKLSVS^c S] WOK]_\ON _]SXQ ^RO
K]]_WZ^SYX] ^RK^ WK\UO^ ZK\^SMSZKX^] aY_VN _]O
aROX Z\SMSXQ ^RO K]]O^ Y\ VSKLSVS^c K]]_WSXQ ^RK^
Ya] ^Y ^RO -YWZKXc YX S^] YaX KMMY_X^ ^Kb \OQ_VK^SYX] K\O ]_LTOM^ ^Y SX^O\Z\O^K^SYX KXN
market participants act in their economic best
SX^O\O]^
   +
 PKS\`KV_OWOK]_\OWOX^YPKXYX XKXMSKVK]]O^
^KUO]SX^YKMMY_X^KWK\UO^ZK\^SMSZKX^t]KLSVS^c^Y
QOXO\K^O OMYXYWSM LOXO ^] Lc _]SXQ ^RO K]]O^ SX
S^]RSQRO]^KXNLO]^_]OY\Lc]OVVSXQS^^YKXY^RO\
WK\UO^ZK\^SMSZKX^^RK^aY_VN_]O^ROK]]O^SXS^]
RSQRO]^KXNLO]^_]O
   >
 RO -YWZKXc _]O] `KV_K^SYX ^OMRXS[_O] ^RK^ K\O
appropriate in the circumstances and for which
]_P MSOX^NK^KK\OK`KSVKLVO^YWOK]_\OPKS\`KV_O
WKbSWS]SXQ ^RO _]O YP \OVO`KX^ YL]O\`KLVO SXZ_^]
KXN WSXSWS]SXQ ^RO _]O YP _XYL]O\`KLVO SXZ_^]
OM^S^]O]^SWK^OYP^RO_]OP_VVS`O]KXN\O]SN_KV
ARO\O\O[_S\ONKZZ\YZ\SK^OOb^O\XKV`KV_O\]K\O
SX`YV`ON
   +
 VV K]]O^] KXN VSKLSVS^SO] PY\ aRSMR PKS\ `KV_O S]
WOK]_\ONY\NS]MVY]ONSX^RO XKXMSKV]^K^OWOX^]
K\O MK^OQY\S]ON aS^RSX ^RO PKS\ `KV_O RSO\K\MRc
NO]M\SLONK]PYVVYa]LK]ONYX^ROVYaO]^VO`OVSXZ_^
^RK^S]]SQXS MKX^^Y^ROPKS\`KV_OWOK]_\OWOX^K]
KaRYVO$
   w  O`OVy;_Y^ON_XKNT_]^ONZ\SMO]SXKM^S`O
6 K\OZO\PY\WONKXNS]]^K^ONXO^YP]O\`SMO^Kb
WK\UO^]PY\SNOX^SMKVK]]O^]Y\VSKLSVS^SO]
   w  O`OV  SP VO`OV  POON S] XY^ K`KSVKLVO
6 
KZZ\YZ\SK^O y @KV_K^SYX ^OMRXS[_O] PY\
aRSMR^ROVYaO]^VO`OVSXZ_^^RK^S]]SQXS MKX^
^Y ^RO PKS\ `KV_O WOK]_\OWOX^ S] NS\OM^Vc Y\
SXNS\OM^VcYL]O\`KLVO
   w  O`OVSPVO`OVKXNPOONS]XY^K`KSVKLVO
6 instrument or a shorter period, where appropriate,
KZZ\YZ\SK^O y @KV_K^SYX ^OMRXS[_O] PY\
aRSMR^ROVYaO]^VO`OVSXZ_^^RK^S]]SQXS MKX^
^Y^ROPKS\`KV_OWOK]_\OWOX^S]_XYL]O\`KLVO
   0
 Y\ XKXMSKVK]]O^]KXNVSKLSVS^SO]WK^_\SXQaS^RSX
YXO cOK\ P\YW ^RO ,KVKXMO =ROO^ NK^O KXN aRSMR
K\O XY^ MK\\SON K^ PKS\ `KV_O ^RO MK\\cSXQ KWY_X^
KZZ\YbSWK^O]PKS\`KV_ON_O^Y^RO]RY\^WK^_\S^c
YP^RO]OSX]^\_WOX^]
   >
 RO-YWZKXc\OMYQXS]O]^\KX]PO\]LO^aOOXVO`OV]
YP PKS\ `KV_O RSO\K\MRc K^ ^RO OXN YP \OZY\^SXQ
ZO\SYNN_\SXQaRSMRMRKXQORK]YMM_\\ON
d) Revenue recognition
   <
 O`OX_O S] \OMYQXS]ON ^Y ^RO Ob^OX^ S^ S]
Z\YLKLVO ^RK^ ^RO OMYXYWSM LOXO ^] aSVV
Ya that may become necessary due to certain
^Y ^RO -YWZKXc KXN ^RO \O`OX_O MKX LO \OVSKLVc
WOK]_\ON\OQK\NVO]]YPaROX^ROZKcWOX^S]LOSXQ
WKNO<O`OX_OS]WOK]_\ONK^^ROPKS\`KV_OYP^RO
MYX]SNO\K^SYX \OMOS`ON Y\ \OMOS`KLVO ^KUSXQ SX^Y
KMMY_X^ MYX^\KM^_KVVc NO XON ^O\W] YP ZKcWOX^
108 ANNUAL REPORT 2017-18
KXNObMV_NSXQ^KbO]Y\N_^SO]MYVVOM^ONYXLORKVPYP
^ROQY`O\XWOX^>RO-YWZKXcRK]MYXMV_NON^RK^
S^S]^ROZ\SXMSZKVSXKVVYPS^]\O`OX_OK\\KXQOWOX^]
]SXMO S^ S] ^RO Z\SWK\c YLVSQY\ SX KVV ^RO \O`OX_O
K\\KXQOWOX^]K]S^RK]Z\SMSXQVK^S^_NOKXNS]KV]Y
ObZY]ON^YSX`OX^Y\cKXNM\ONS^\S]U]
   >
 RO-YWZKXcRK]K]]_WON^RK^\OMY`O\cYPObMS]O
N_^c
   1
KXN^R_]\O`OX_OSXMV_NO]ObMS]ON_^c_Z^Y4_XO
 ! K] ^RO ]KWO QY^ ]_L]_WON SX 1YYN] KXN  
=O\`SMO]>Kb1=>aS^ROPPOM^P\YW4_Vc!
   2
 YaO`O\ ]KVO] ^Kb@KV_O +NNON >Kb @+>
1YYN] KXN =O\`SMO] >Kb 1=> S] XY^ \OMOS`ON Lc
^RO-YWZKXcYXS^]YaXKMMY_X^<K^RO\S^S]^Kb
MYVVOM^ONYX`KV_OKNNON^Y^ROMYWWYNS^cLc^RO
]OVVO\YXLORKVPYP^ROQY`O\XWOX^+MMY\NSXQVcS^
S]ObMV_NONP\YW\O`OX_O  
Sale of products
   <
 O`OX_OP\YW]KVOYPZ\YN_M^]S]\OMYQXS]ONaROX
the risks and rewards of ownership is passed on
^Y ^RO M_]^YWO\] <O`OX_O P\YW ]KVO YP Z\YN_M^]
 
S] ]^K^ON ObMV_]S`O YP ]KVO] ^Kb @KV_O +NNON >Kb
@+> 1YYN] KXN =O\`SMO] >Kb 1=> KXN K\O XO^
YP]KVO]\O^_\X]NS]MY_X^]Z\Y`S]SYXPY\KX^SMSZK^ON
\O^_\X]YXObZS\cWKNOYX^ROLK]S]YPWKXKQOWOX^
ObZOM^K^SYX^KUSXQSX^YKMMY_X^ZK]^ObZO\SOXMO
Rendering of Services
Service income is recognised as per the terms of
^ROMYX^\KM^]K\\KXQOWOX^]aROX\OVK^ON]O\`SMO]
Interest income  
  0
 Y\ KVV XKXMSKV SX]^\_WOX^] WOK]_\ON K^
amortised cost, interest income is recorded
using the effective interest rate, which is the rate
^RK^ ObKM^Vc NS]MY_X^] ^RO O]^SWK^ON P_^_\O MK]R
\OMOSZ^]^R\Y_QR^ROObZOM^ONVSPOYP^RO XKXMSKV
 
^Y ^RO XO^ MK\\cSXQ KWY_X^ YP ^RO XKXMSKV K]]O^
3X^O\O]^ SXMYWO S] SXMV_NON SX s9^RO\ 3XMYWOt SX
^RO=^K^OWOX^YP:\Y ^KXN6Y]]
Income from assignment of trademarks
Income from assignment of trademarks is  
\OMYQXS]ON SX ^RO =^K^OWOX^ YP :\Y ^ KXN 6Y]]
YXP_V VWOX^YPYLVSQK^SYX]K]ZO\^RO_XNO\VcSXQ
KQ\OOWOX^aS^R^ROL_cO\
e) Taxes
 
Current income tax
   >
 Kb ObZOX]O MYWZ\S]O] YP M_\\OX^ KXN NOPO\\ON
^Kb KXN SXMV_NO] KXc KNT_]^WOX^] \OVK^ON ^Y ZK]^
ZO\SYN]SXM_\\OX^KXNY\NOPO\\ON^KbKNT_]^WOX^]
^Y S^] aY\USXQ MYXNS^SYX PY\ S^] SX^OXNON _]O
NO`OVYZWOX^] Y\ \O`SOa] N_\SXQ ^RO \OVO`KX^
ZO\SYN >RO Z\Y`S]SYX PY\ M_\\OX^ ^Kb S] WKNO K^
^RO\K^OYP^KbK]KZZVSMKLVOPY\^ROSXMYWOYP^RO
Z\O`SY_] cOK\ K] NO XON _XNO\ ^RO 3XMYWO ^Kb
+M^# 
CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS
 _\\OX^ SXMYWO ^Kb \OVK^SXQ ^Y S^OW] \OMYQXS]ON
-    >
 RO -YWZKXc SNOX^S O] KXN NO^O\WSXO] MY]^ YP
OS^RO\ SX Y^RO\ MYWZ\OROX]S`O SXMYWO Y\ NS\OM^Vc OKMRMYWZYXOX^ZK\^YP^ROZVKX^KXNO[_SZWOX^
SXO[_S^cS]KV]Y\OMYQXS]ONSXY^RO\MYWZ\OROX]S`O ]OZK\K^OVcSP^ROMYWZYXOX^ZK\^RK]KMY]^aRSMR
income or in equity, as appropriate and not in S] ]SQXS MKX^ ^Y ^RO ^Y^KV MY]^ YP ^RO ZVKX^ KXN
^RO =^K^OWOX^ YP :\Y ^ KXN 6Y]] 7KXKQOWOX^ O[_SZWOX^ KXN RK] _]OP_V VSPO ^RK^ S] WK^O\SKVVc
NSPPO\OX^ P\YW ^RK^ YP ^RO \OWKSXSXQ ZVKX^ KXN
ZO\SYNSMKVVc O`KV_K^O] ZY]S^SYX] ^KUOX SX ^RO ^Kb
O[_SZWOX^
\O^_\X]aS^R\O]ZOM^^Y]S^_K^SYX]SXaRSMRKZZVSMKLVO
 KSX] Y\ VY]]O] K\S]SXQ P\YW NO\OMYQXS^SYX YP
O]^KLVS]RO]Z\Y`S]SYX]aRO\OKZZ\YZ\SK^O ^KXQSLVO Z\YZO\^c ZVKX^ KXN O[_SZWOX^ K\O
 -
 _\\OX^ ^Kb K]]O^] KXN M_\\OX^ ^Kb VSKLSVS^SO] K\O measured as the difference between the net
YPP]O^ aROX ^RO\O S] K VOQKVVc OXPY\MOKLVO \SQR^ NS]ZY]KVZ\YMOON]KXN^ROMK\\cSXQKWY_X^YP^RO
K]]O^KXNK\O\OMYQXS]ONSX^RO=^K^OWOX^YP:\Y ^
to set off the recognised amounts and there is an
SX^OX^SYX ^Y ]O^^VO ^RO K]]O^ KXN ^RO VSKLSVS^c YX K KXN6Y]]aROX^ROK]]O^S]NO\OMYQXS]ON
XO^LK]S] Depreciation is provided, pro-rata for the period
YP _]O YX ^RO ]^\KSQR^ VSXO WO^RYN LK]ON YX ^RO
Deferred tax \O]ZOM^S`OO]^SWK^OYP_]OP_VVS`O]K]QS`OXLOVYa
 .
 OPO\\ON ^Kb S] \OMYQXS]ON _]SXQ ^RO ,KVKXMO /]^SWK^ON _]OP_V VS`O] YP K]]O^] K\O NO^O\WSXON
Sheet approach on temporary differences at the LK]ONYX^OMRXSMKVZK\KWO^O\]K]]O]]WOX^]
\OZY\^SXQNK^OLO^aOOX^RO^KbLK]O]YPK]]O^]KXN    >
 RO WKXKQOWOX^ LOVSO`O] ^RK^ _]OP_V VS`O]
VSKLSVS^SO]KXN^ROS\MK\\cSXQKWY_X^]PY\ XKXMSKV M_\\OX^Vc_]ONaRSMRS]K]Z\O]M\SLON_XNO\:K\^
\OZY\^SXQZ_\ZY]O]K^^RO\OZY\^SXQNK^O -YP=MRON_VO33^Y^RO-YWZKXSO]+M^PKS\Vc
 >
 RO MK\\cSXQ KWY_X^ YP NOPO\\ON ^Kb K]]O^] S] \O
`KV_O] YP Z\YZO\^c ZVKX^ KXN O[_SZWOX^ ^RY_QR
reviewed at each reporting date and reduced
^Y ^RO Ob^OX^ ^RK^ S^ S] XY VYXQO\ Z\YLKLVO ^RK^ ^RO]OVS`O]SXMO\^KSXMK]O]K\ONSPPO\OX^P\YWVS`O]
Z\O]M\SLON_XNO\=MRON_VO33
]_P MSOX^ ^KbKLVO Z\Y ^ aSVV LO K`KSVKLVO ^Y KVVYa
KVVY\ZK\^YP^RONOPO\\ON^KbK]]O^^YLO_^SVS]ON
Method of depreciation Straight line
?X\OMYQXS]ON NOPO\\ON ^Kb K]]O^] K\O \OK]]O]]ON
Type of assets Useful life in years
at each reporting date and are recognised to the
Ob^OX^ ^RK^ S^ RK] LOMYWO Z\YLKLVO ^RK^ P_^_\O 6OK]ORYVN6KXN 9`O\VOK]OZO\SYNSO
^KbKLVOZ\Y ^]aSVVKVVYa^RONOPO\\ON^KbK]]O^^Y #cOK\]
LO\OMY`O\ON 6OK]ORYVN3WZ\Y`OWOX^] 9`O\Z\SWK\cVOK]O
ZO\SYNSO^YcOK\]
 .
 OPO\\ON ^Kb K]]O^] KXN VSKLSVS^SO] K\O WOK]_\ON
,_SVNSXQ]
K^ ^RO ^Kb \K^O] ^RK^ K\O ObZOM^ON ^Y KZZVc SX ^RO
cOK\ aROX ^RO K]]O^ S] \OKVS]ON Y\ ^RO VSKLSVS^c 0KM^Y\c,_SVNSXQ #cOK\]WYX^R]
S] ObZOM^ON ^Y LO \OMY`O\ON Y\ ]O^^VON LK]ON YX <O]SNOX^SKV,_SVNSXQ] cOK\]
^Kb \K^O] KXN ^Kb VKa] ^RK^ RK`O LOOX OXKM^ON Y\ :VKX^KXN/[_SZWOX^
]_L]^KX^S`OVcOXKM^ONK^^RO\OZY\^SXQNK^O Anaesthetic Equipment cOK\]
 .
 OPO\\ON^Kb\OVK^SXQ^YS^OW]\OMYQXS]ONOS^RO\SX 9^RO\] #^YcOK\]
Y^RO\ MYWZ\OROX]S`O SXMYWO Y\ SX O[_S^c S] KV]Y 0_\XS^_\OKXN0Sb^_\O] cOK\]
recognised in other comprehensive income or in 9P MO/[_SZWOX^
equity, as appropriate and not in the Statement of Computers cOK\]
:\Y ^KXN6Y]] 9^RO\] cOK\]
 .
 OPO\\ON^KbK]]O^]KXNNOPO\\ON^KbVSKLSVS^SO]K\O @ORSMVO] cOK\]
YPP]O^SPKVOQKVVcOXPY\MOKLVO\SQR^ObS]^]^Y]O^YPP
 3X\O]ZOM^YP^RO]OK]]O^]^ROWKXKQOWOX^O]^SWK^O
M_\\OX^^KbK]]O^]KQKSX]^M_\\OX^^KbVSKLSVS^SO]
YP _]OP_V VS`O] LK]ON YX ^OMRXSMKV K]]O]]WOX^ S]
f) Property, plant and equipment VYaO\^RKX^RO_]OP_VVSPOZ\O]M\SLON_XNO\ZK\^-YP
=MRON_VO33^Y^RO-YWZKXSO]+M^
 :\YZO\^cZVKX^KXNO[_SZWOX^K\O]^K^ONK^MY]^
YPKM[_S]S^SYXVO]]KMM_W_VK^ONNOZ\OMSK^SYXKXN    >
 RO \O]SN_KV `KV_O] _]OP_V VS`O] KXN WO^RYN] YP
SWZKS\WOX^ SX `KV_O SP KXc -Y]^ PY\ ]_L]O[_OX^ NOZ\OMSK^SYXYPZ\YZO\^cZVKX^KXNO[_SZWOX^K\O
additions comprises the purchase price and \O`SOaON K^ OKMR XKXMSKV cOK\ OXN KXN KNT_]^ON
KXc Y^RO\ K^^\SL_^KLVO MY]^ YP L\SXQSXQ ^RO K]]O^ Z\Y]ZOM^S`OVcSPKZZ\YZ\SK^O
Advances paid towards the acquisition of property,
=_L]O[_OX^ ObZOXNS^_\O] K\O KNNON ^Y S^] Q\Y]] ZVKX^KXNO[_SZWOX^Y_^]^KXNSXQK^OKMR,KVKXMO
LYYU`KV_OYXVcSPS^SXM\OK]O]^ROP_^_\OLOXO ^] =ROO^ NK^O S] MVK]]S ON K] MKZS^KV KN`KXMO] _XNO\
P\YW ^RO ObS]^SXQ K]]O^ LOcYXN S^] Z\O`SY_]Vc s9^RO\ XYXM_\\OX^ K]]O^]t KXN ^RO MY]^ YP K]]O^]
assessed standard of performance and cost of the XY^Z_^^Y_]OLOPY\O]_MRNK^OK\ONS]MVY]ON_XNO\
S^OWMKXLOWOK]_\ON\OVSKLVc s-KZS^KVaY\USXZ\YQ\O]]t
109
 ABBOTT INDIA LIMITED
g) Intangible assets
   3 X^KXQSLVO K]]O^] K\O MK\\SON K^ MY]^ XO^ YP
KMM_W_VK^ONKWY\^S]K^SYXKXNSWZKS\WOX^VY]]O]
SP KXc -Y]^ YP KX SX^KXQSLVO K]]O^ MYWZ\S]O] YP
Z_\MRK]O Z\SMO KXN K^^\SL_^KLVO ObZOXNS^_\O YX
WKUSXQ^ROK]]O^\OKNcPY\S^]SX^OXNON_]O
 3 X^KXQSLVOK]]O^]KM[_S\ON]OZK\K^OVcK\OWOK]_\ON
YXSXS^SKV\OMYQXS^SYXK^MY]^3X^KXQSLVOK]]O^]K\O
KWY\^S]ONY`O\^RO_]OP_VOMYXYWSMVSPOKXNK]]O]]ON
for impairment whenever there is an indication
^RK^ ^RO SX^KXQSLVO K]]O^ WKc LO SWZKS\ON >RO
amortisation period and the amortisation method
PY\KXSX^KXQSLVOK]]O^K\O\O`SOaONK^VOK]^K^^RO
OXN YP OKMR \OZY\^SXQ ZO\SYN >RO KWY\^S]K^SYX
ObZOX]O YX SX^KXQSLVO K]]O^] S] \OMYQXS]ON SX ^RO
=^K^OWOX^YP:\Y ^KXN6Y]]
Method of amortisation Straight Line
Type of assets Useful life in years
Ya]_]SXQKNS]MY_X^\K^O^RK^\O
OM^]^ROM_\\OX^
Software ^YcOK\]
Trademarks cOK\]
   1
 KSX] Y\ VY]]O] K\S]SXQ P\YW NO\OMYQXS^SYX YP KX
SX^KXQSLVO K]]O^ K\O WOK]_\ON K] ^RO NSPPO\OXMO
Ya]
LO^aOOX ^RO XO^ NS]ZY]KV Z\YMOON] KXN ^RO
carrying amount of the asset and are recognised in
Ya]YP^RK^K]]O^ a change in the estimates used to determine the
^RO=^K^OWOX^YP:\Y ^KXN6Y]]aROX^ROK]]O^S]
NO\OMYQXS]ON
h) Assets held for sale
  \YZO\^c ZVKX^ KXN O[_SZWOX^ K\O MVK]]S ON K]
: 
K]]O^] ROVN PY\ ]KVO SP ^ROS\ MK\\cSXQ KWY_X^] K\O
^Y LO \OMY`O\ON Z\SXMSZKVVc ^R\Y_QR K ]KVO \K^RO\
^RKX ^R\Y_QR MYX^SX_SXQ _]O >RO MYXNS^SYX PY\
MVK]]S MK^SYX YP ROVN PY\ ]KVO S] WO^ aROX ^RO XYX
M_\\OX^K]]O^S]K`KSVKLVOPY\SWWONSK^O]KVOKXN^RO
]KWO S] RSQRVc Z\YLKLVO YP LOSXQ MYWZVO^ON aS^RSX
YXOcOK\P\YW^RONK^OYPMVK]S MK^SYXK]ROVNPY\]KVO
Ya YP
K^SYX amortised cost
   :
 \YZO\^cZVKX^KXNO[_SZWOX^\O^S\ONP\YWKM^_KV
_]OKXNROVNPY\NS]ZY]KVK\O]^K^ONK^^ROVYaO\YP
^ROS\ XO^ LYYU `KV_O KXN XO^ \OKVS]KLVO `KV_O KXN
Ya] K^ K Z\O^Kb \K^O ^RK^ \O
OM^] M_\\OX^
K\O NS]MVY]ON ]OZK\K^OVc _XNO\ s-_\\OX^ K]]O^]t
9XMOMVK]]S ONK]ROVNPY\]KVO^RO]OK]]O^]K\OXY^
NOZ\OMSK^ON
i) Research and development
   <
 O`OX_O ObZOXNS^_\O ZO\^KSXSXQ ^Y \O]OK\MR
S] MRK\QON ^Y ^RO =^K^OWOX^ YP :\Y ^ KXN 6Y]]
.O`OVYZWOX^MY]^]YPZ\YN_M^]K\OKV]YMRK\QON^Y
^RO=^K^OWOX^YP:\Y ^KXN6Y]]_XVO]]KZ\YN_M^t]
^OMRXSMKVPOK]SLSVS^cRK]LOOXO]^KLVS]RONSXaRSMR
MK]O]_MRObZOXNS^_\OS]MKZS^KVS]ON
   .
 O`OVYZWOX^ ObZOXNS^_\O] YX KX SXNS`SN_KV
Z\YTOM^K\O\OMYQXS]ONK]KXSX^KXQSLVOK]]O^aROX
^RO-YWZKXcMKXNOWYX]^\K^O$
   w  RO ^OMRXSMKV POK]SLSVS^c YP MYWZVO^SXQ ^RO
> SXMV_NO]MY]^YPZ_\MRK]OKXNY^RO\MY]^]SXM_\\ON
SX^KXQSLVO K]]O^ ]Y ^RK^ ^RO K]]O^ aSVV LO
OM^
K`KSVKLVOPY\_]OY\]KVO
110 ANNUAL REPORT 2017-18
   w 3^] SX^OX^SYX ^Y MYWZVO^O KXN S^] KLSVS^c KXN
SX^OX^SYX^Y_]OY\]OVV^ROK]]O^
   w 2Ya^ROK]]O^aSVVQOXO\K^OP_^_\OOMYXYWSM
LOXO ^]
   w >ROK`KSVKLSVS^cYP\O]Y_\MO]^YMYWZVO^O^RO
asset
   w >RO KLSVS^c ^Y WOK]_\O \OVSKLVc ^RO
ObZOXNS^_\ON_\SXQNO`OVYZWOX^
TROKWY_X^MKZS^KVS]ONMYWZ\S]O]YPObZOXNS^_\O
^RK^ MKX LO NS\OM^Vc K^^\SL_^ON Y\ KVVYMK^ON YX
K \OK]YXKLVO KXN MYX]S]^OX^ LK]S] ^Y M\OK^SXQ
producing and making the asset ready for its
SX^OXNON _]O :\YZO\^c ZVKX^ KXN O[_SZWOX^
_^SVS]ON PY\ \O]OK\MR KXN NO`OVYZWOX^ K\O
MKZS^KVS]ONKXNNOZ\OMSK^ONSXKMMY\NKXMOaS^R^RO
ZYVSMSO] ]^K^ON PY\ Z\YZO\^c ZVKX^ KXN O[_SZWOX^
KXNNOZ\OMSK^SYX
j) Leases
The determination of whether an arrangement is a
VOK]OS]LK]ONYX^RO]_L]^KXMOYP^ROK\\KXQOWOX^
K^^ROSXMOZ^SYXYP^ROVOK]O>ROK\\KXQOWOX^S]Y\
MYX^KSX]KVOK]OSPP_V VVWOX^YP^ROK\\KXQOWOX^S]
NOZOXNOX^YX^RO_]OYPK]ZOMS MK]]O^Y\K]]O^]
and the arrangement conveys a right to use the
K]]O^ Y\ K]]O^] O`OX SP ^RK^ \SQR^ S] XY^ ObZVSMS^Vc
]ZOMS ONSXKXK\\KXQOWOX^
Company as a lessee
  6
 OK]O]aRO\OVO]]Y\OPPOM^S`OVc\O^KSX]]_L]^KX^SKVVc
KVV ^RO \S]U] KXN LOXO ^] YP YaXO\]RSZ YP ^RO
VOK]ONS^OW]K\OMVK]]S ONK]YZO\K^SXQVOK]O>RO
-YWZKXc S] K VO]]OO _XNO\ ]_MR K\\KXQOWOX^]
9ZO\K^SXQ VOK]O ZKcWOX^] K\O \OMYQXS]ON K] KX
ObZOX]O SX ^RO =^K^OWOX^ YP :\Y ^ KXN 6Y]] YX
]^\KSQR^ VSXO LK]S] Y`O\ VOK]O ^O\W _XVO]] ^RO
ZKcWOX^] ^Y ^RO VO]]Y\ K\O ]^\_M^_\ON ^Y SXM\OK]O
SXVSXOaS^RObZOM^ONQOXO\KVSX
Company as a lessor
Leases in which the Company does not transfer
]_L]^KX^SKVVcKVV^RO\S]U]KXN\OaK\N]YPKXK]]O^
K\O MVK]]S ON K] YZO\K^SXQ VOK]O <OX^KV SXMYWO
P\YW YZO\K^SXQ VOK]O S] \OMYQXS]ON YX K ]^\KSQR^
VSXO LK]S] Y`O\ ^RO ^O\W YP ^RO \OVO`KX^ VOK]O
Contingent rents are recognised as revenue in the
cOK\SXaRSMR^ROcK\OOK\XON
k) Inventories
   3 X`OX^Y\SO] MYX]S]^] YP \Ka WK^O\SKV] ZKMUSXQ
WK^O\SKV] aY\USXZ\YQ\O]] ]^YMUSX^\KNO KXN
XS]RONQYYN]3X`OX^Y\SO]K\O`KV_ONK^VYaO\YP
MY]^KXNXO^\OKVS]KLVO`KV_O-Y]^S]NO^O\WSXONYX
0S\]^3X0S\]^9_^LK]S]
 Y]^ YP \Ka WK^O\SKV] KXN ZKMUSXQ WK^O\SKV]
- then the entity reverts to recognising impairment
SXL\SXQSXQ^ROSX`OX^Y\SO]^Y^ROS\Z\O]OX^VYMK^SYX
KXNMYXNS^SYX
CORPORATE OVERVIEW
   -
 Y]^ YP aY\USXZ\YQ\O]] KXN XS]RON QYYN]
SXMV_NO] NS\OM^ WK^O\SKV] VKLY_\ KXN Z\YZY\^SYX
YPWKX_PKM^_\SXQY`O\ROKN]LK]ONYX^ROXY\WKV
YZO\K^SXQ MKZKMS^c aRO\O`O\ KZZVSMKLVO -Y]^ YP
XS]RON QYYN] SXMV_NO] ObMS]O N_^c KXN Y^RO\
costs incurred in bringing the inventories to their
Z\O]OX^VYMK^SYXKXNMYXNS^SYX
   -
 Y]^YP]^YMUSX^\KNOSXMV_NO]MY]^YPZ_\MRK]OKXN
other costs incurred in bringing the inventories to
^ROS\Z\O]OX^VYMK^SYXKXNMYXNS^SYX
   8
 O^ \OKVS]KLVO `KV_O S] ^RO O]^SWK^ON ]OVVSXQ Z\SMO
SX^ROY\NSXK\cMY_\]OYPL_]SXO]]VO]]O]^SWK^ON
MY]^]YPMYWZVO^SYXKXNO]^SWK^ONMY]^]XOMO]]K\c
^Y WKUO ^RO ]KVO 2YaO`O\ WK^O\SKV] KXN Y^RO\
S^OW]ROVNPY\_]OSX^ROZ\YN_M^SYXYPSX`OX^Y\SO]
K\O XY^ a\S^^OX NYaX LOVYa MY]^ SP ^RO XS]RON
Z\YN_M^]SXaRSMR^ROcaSVVLO_]ONK\OObZOM^ON
^YLO]YVNK^Y\KLY`OMY]^
l) Impairment
Financial assets
   XKXMSKVK]]O^S]K]]O]]ONK^OKMR\OZY\^SXQNK^O^Y
+ assessing impairment, assets are grouped at the
determine whether there is any objective evidence
^RK^ S^ S] SWZKS\ON + XKXMSKV K]]O^ S] MYX]SNO\ON
to be impaired, if objective evidence indicates that
one or more events have had a negative effect on
^ROO]^SWK^ONP_^_\OMK]R
   3 X KMMY\NKXMO aS^R 3XN += # ^RO -YWZKXc
KZZVSO] /bZOM^ON -\ONS^ 6Y]] /-6 WYNOV PY\
WOK]_\OWOX^KXN\OMYQXS^SYXYPSWZKS\WOX^VY]]
YX ^RO PYVVYaSXQ XKXMSKV K]]O^] KXN M\ONS^ \S]U
ObZY]_\O$
   K  \KNO\OMOS`KLVO]Y\KXcMYX^\KM^_KV\SQR^^Y
>
\OMOS`O MK]R Y\ KXY^RO\ XKXMSKV K]]O^ ^RK^
\O]_V^ P\YW ^\KX]KM^SYX] ^RK^ K\O aS^RSX ^RO
]MYZOYP3XN+="
   L 9^RO\ XKXMSKVK]]O^]aRSMRK\OWOK]_\ONK^
   >
 RO -YWZKXc PYVVYa] ]SWZVS ON KZZ\YKMR PY\
\OMYQXS^SYXYPSWZKS\WOX^VY]]KVVYaKXMOYX>\KNO
\OMOS`KLVO]>RO-YWZKXc\OMYQXS]O]SWZKS\WOX^
VY]] KVVYaKXMO LK]ON YX VSPO^SWO /-6] K^ OKMR
\OZY\^SXQNK^O\SQR^P\YWS^]SXS^SKV\OMYQXS^SYX
   0
 Y\ \OMYQXS^SYX YP SWZKS\WOX^ VY]] YX Y^RO\
XKXMSKV K]]O^] KXN \S]U ObZY]_\O ^RO -YWZKXc
determines that whether there has been a
]SQXS MKX^ SXM\OK]O SX ^RO M\ONS^ \S]U ]SXMO SXS^SKV
\OMYQXS^SYX 3P M\ONS^ \S]U RK] XY^ SXM\OK]ON
]SQXS MKX^Vc WYX^R /-6 S] _]ON ^Y Z\Y`SNO
PY\ SWZKS\WOX^ VY]] 2YaO`O\ SP M\ONS^ \S]U RK]
SXM\OK]ON]SQXS MKX^VcVSPO^SWO/-6S]_]ON3PSXK
]_L]O[_OX^ZO\SYNM\ONS^[_KVS^cYP^ROSX]^\_WOX^
SWZ\Y`O]]_MR^RK^^RO\OS]XYVYXQO\K]SQXS MKX^
SXM\OK]O SX M\ONS^ \S]U ]SXMO SXS^SKV \OMYQXS^SYX
VY]]KVVYaKXMOLK]ONYXWYX^R/-6
  -6 K\O WOK]_\ON SX K WKXXO\ ^RK^ ^ROc \O
/ of one or more uncertain future events not
_XLSK]ON KXN Z\YLKLSVS^c aOSQR^ON KWY_X^]
STATUTORY REPORT FINANCIAL STATEMENTS
determined by a range of outcomes, taking into
KMMY_X^ ^RO ^SWO `KV_O YP WYXOc KXN Y^RO\
\OK]YXKLVOSXPY\WK^SYXK`KSVKLVOK]K\O]_V^YPZK]^
events, current conditions and forecasts of future
OMYXYWSMMYXNS^SYX]
8YX XKXMSKVK]]O^]
>ROMK\\cSXQKWY_X^YPXYX XKXMSKVK]]O^]Y^RO\
than inventories are assessed at each reporting
date to ascertain whether there is any indication of
SWZKS\WOX^3PKXc]_MRSXNSMK^SYXObS]^]Y\aROX
KXX_KVSWZKS\WOX^^O]^SXQPY\KXK]]O^S]\O[_S\ON
^ROX ^RO K]]O^t] \OMY`O\KLVO KWY_X^ S] O]^SWK^ON
+XSWZKS\WOX^VY]]S]\OMYQXS]ONK]KXObZOX]OSX
^RO =^K^OWOX^ YP :\Y ^ KXN 6Y]] PY\ ^RO KWY_X^
Lc aRSMR ^RO K]]O^t] MK\\cSXQ KWY_X^ ObMOON] S^]
\OMY`O\KLVO KWY_X^ >RO \OMY`O\KLVO KWY_X^
S] ^RO RSQRO\ YP KX K]]O^t] PKS\ `KV_O VO]] MY]^ ^Y
]OVV KXN `KV_O SX _]O @KV_O SX _]O S] K]MO\^KSXON
through discounting of the estimated future cash
WK\UO^K]]O]]WOX^]YP^RO^SWO`KV_OYPWYXOcKXN
^RO \S]U ]ZOMS M ^Y ^RO K]]O^] 0Y\ ^RO Z_\ZY]O YP
VYaO]^VO`OV]SX^YMK]RQOXO\K^SXQ_XS^]PY\aRSMR
^RO\OK\O]OZK\K^OVcSNOX^S KLVOMK]R
 X SWZKS\WOX^ VY]] S] \O`O\]ON SP ^RO\O RK] LOOX
+
\OMY`O\KLVOKWY_X^+XSWZKS\WOX^VY]]S]\O`O\]ON
YXVc ^Y ^RO Ob^OX^ ^RK^ ^RO K]]O^t] MK\\cSXQ KWY_X^
NYO] XY^ ObMOON ^RO MK\\cSXQ KWY_X^ ^RK^ aY_VN
have been determined, net of depreciation or
KWY\^S]K^SYXSPXYSWZKS\WOX^RKNLOOX\OMYQXS]ON
m) Provisions and contingencies
Provisions
+ Z\Y`S]SYX S] \OMYQXS]ON SP K] K \O]_V^ YP K
ZK]^ O`OX^ ^RO -YWZKXc RK] K Z\O]OX^ VOQKV
Y\ MYX]^\_M^S`O YLVSQK^SYX ^RK^ S] \OK]YXKLVc
O]^SWKLVO KXN S^ S] Z\YLKLVO ^RK^ KX Y_^
\O]Y_\MO] OWLYNcSXQ OMYXYWSM LOXO ^] aSVV LO
\O[_S\ON ^Y ]O^^VO ^RO YLVSQK^SYX :\Y`S]SYX] K\O
NO^O\WSXON Lc NS]MY_X^SXQ ^RO ObZOM^ON P_^_\O
MK]R
WK\UO^K]]O]]WOX^]YP^RO^SWO`KV_OYPWYXOcKXN
^RO\S]U]]ZOMS M^Y^ROVSKLSVS^c
Provision for sales return and date expiry :
The Company as per trade practice accepts returns
P\YW WK\UO^ aRSMR K\O Z\SWK\SVc SX ^RO XK^_\O
YP ObZS\ON Y\ XOK\ ObZS\c Z\YN_M^] :\Y`S]SYX]
for such returns are estimated on the basis of
RS]^Y\SMKV ObZO\SOXMO WK\UO^ MYXNS^SYX] KXN
]ZOMS MMYX^\KM^_KV^O\W]KXNK\OZ\Y`SNONPY\
Contingencies
   +MYX^SXQOX^VSKLSVS^cS]$
   w K ZY]]SLVO YLVSQK^SYX ^RK^ K\S]O] P\YW ZK]^
O`OX^]KXNaRY]OObS]^OXMOaSVVLOMYX \WON
YXVc Lc ^RO YMM_\\OXMO Y\ XYXYMM_\\OXMO
aRYVVcaS^RSX^ROMYX^\YVYP^RO-YWZKXc%Y\
111
 ABBOTT INDIA LIMITED
   w K  Z\O]OX^ YLVSQK^SYX ^RK^ K\S]O] P\YW ZK]^
O`OX^]L_^S]XY^\OMYQXS]ONLOMK_]O$
    S^ S] XY^ Z\YLKLVO ^RK^ KX Y_^
Ya YP YP ^RO NO XON LOXO ^ YLVSQK^SYX] S] LK]ON YX ^RO
\O]Y_\MO] OWLYNcSXQ OMYXYWSM LOXO ^]
aSVVLO\O[_S\ON^Y]O^^VO^ROYLVSQK^SYX%Y\
    ^RO KWY_X^ YP ^RO YLVSQK^SYX MKXXY^ LO
WOK]_\ONaS^R]_P MSOX^\OVSKLSVS^c
  X /WZVYcOOLOXO ^]
=RY\^^O\WOWZVYcWOX^LOXO ^]$
 VV OWZVYcOO LOXO ^] ZKcKLVO aS^RSX  months
+ Lc ^RO :K\OX^ -YWZKXc >RO M_W_VK^S`O ObZOX]O
YP ]O\`SMO ]_MR K] ]KVK\SO] aKQO] LYX_] ObQ\K^SK
WONSMKV LOXO ^] O^M K\O \OMYQXS]ON SX ^RO cOK\ SX
OM^]^ROOb^OX^^YaRSMR ^Y SXS^SKV \OMYQXS^SYX ^RO]O K\O WOK]_\ON K^
aRSMR^ROOWZVYcOO]\OXNO\^RO\OVK^ON]O\`SMOKXN
K\OZ\O]OX^ONK]M_\\OX^OWZVYcOOLOXO ^YLVSQK^SYX
aS^RSX^RO,KVKXMO=ROO^>O\WSXK^SYXLOXO ^]K\O
\OMYQXS]ONK]KXObZOX]OK]KXNaROXSXM_\\ON
   =
 RY\^^O\W VOK`O LOXO ^ S] Z\Y`SNON K^
undiscounted amount during the accounting
ZO\SYNLK]ONYX^RO]O\`SMO\OXNO\ONLcOWZVYcOO]
.O XONMYX^\SL_^SYXZVKX$
   -
 YX^\SL_^SYX] ^Y NO XON MYX^\SL_^SYX ]MROWO]
]_MR K] =^K^O QY`O\XON :\Y`SNOX^ 0_XN KXN
/WZVYcOO :OX]SYX =MROWO /WZVYcOO]t =^K^O
3X]_\KXMO =MROWO =_ZO\KXX_K^SYX /WZVYcOO]t
.OZY]S^ 6SXUON 3X]_\KXMO KXN 1\Y_Z 6SPO
3X]_\KXMOK\OMRK\QONK]KXObZOX]OLK]ONYX^RO
amount of contribution required to be made as and
aROX]O\`SMO]K\O\OXNO\ONLc^ROOWZVYcOO]>RO
KLY`OLOXO ^]K\OMVK]]S ONK]NO XONMYX^\SL_^SYX
]MROWO]KXN^RO-YWZKXcRK]XYP_\^RO\NO XON
YLVSQK^SYX]LOcYXN^ROMYX^\SL_^SYX]
   3 P ^RO MYX^\SL_^SYX ZKcKLVO ^Y ^RO ]MROWO PY\
]O\`SMO \OMOS`ON LOPY\O ^RO ,KVKXMO =ROO^ NK^O
ObMOON] ^RO MYX^\SL_^SYX KV\OKNc ZKSN ^RO NO MS^
Ya] ObZOM^ON    w 0SXKXMSKVK]]O^]K^PKS\`KV_O
ZKcKLVO ^Y ^RO ]MROWO S] \OMYQXS]ON K] K VSKLSVS^c
KP^O\ NON_M^SXQ ^RO MYX^\SL_^SYX KV\OKNc ZKSN
3P ^RO MYX^\SL_^SYX KV\OKNc ZKSN ObMOON] ^RO
contribution due for services received before the
Ya] KXN ^RO comprise cash at banks and on hand and short-
,KVKXMO=ROO^NK^O^ROXObMO]]S]\OMYQXS]ONK]KX
K]]O^^Y^ROOb^OX^^RK^^ROZ\OZKcWOX^aSVVVOKN
Ya] ^RK^ K\O ]YVOVc VO]] aRSMR K\O ]_LTOM^ ^Y KX SX]SQXS MKX^ \S]U YP
^YK\ON_M^SYXSXP_^_\OZKcWOX^Y\KMK]R\OP_XN
   .O XONLOXO ^ZVKX$
   >
 RO -YWZKXc RK] NO XON LOXO ^ ZVKX SX ^RO
PY\W YP 1\K^_S^c 6YXQ =O\`SMO ,OXO ^] KXN :Y]^
<O^S\OWOX^ 7ONSMKV ,OXO ^] K] ZO\ ZYVSMSO] YP
^RO -YWZKXc >RO -YWZKXct] XO^ YLVSQK^SYX SX
\O]ZOM^ YP ^RO NO XON LOXO ^ ZVKX S] MKVM_VK^ON
Ya] s) Dividend distribution to equity shareholders
Lc O]^SWK^SXQ ^RO KWY_X^ YP P_^_\O LOXO ^ ^RK^
OWZVYcOORK]OK\XONSXObMRKXQOYP^ROS\]O\`SMO
in the current and prior periods and discounted
LKMU^Y^ROM_\\OX^`KV_K^SYXNK^O^YK\\S`OK^^RO
Z\O]OX^`KV_OYP^RONO XONLOXO ^YLVSQK^SYX>RO
NO XON LOXO ^ YLVSQK^SYX S] NON_M^ON P\YW ^RO
PKS\`KV_OYPZVKXK]]O^]^YK\\S`OK^^ROXO^K]]O^
VSKLSVS^c aRSMR XOON ^Y LO KMMY_X^ON PY\ SX ^RO
LYYU]YPKMMY_X^]YP^RO-YWZKXc
112 ANNUAL REPORT 2017-18
 +]\O[_S\ONLc3XN+=#s/WZVYcOO,OXO ^]t^RO
NS]MY_X^ \K^O _]ON ^Y K\\S`O K^ ^RO Z\O]OX^ `KV_O
3XNSKX QY`O\XWOX^ ]OM_\S^c cSOVN] Z\O`KSVSXQ K]
K^^RO,KVKXMO=ROO^NK^O^RK^RK`OWK^_\S^cNK^O
O[_S`KVOX^^Y^RO^OX_\OYP^ROYLVSQK^SYX
   >
 ROMKVM_VK^SYXS]ZO\PY\WONLcK[_KVS ONKM^_K\c
_]SXQ ^RO Z\YTOM^ON _XS^ M\ONS^ WO^RYN AROX
^RO MKVM_VK^SYX \O]_V^] SX K XO^ K]]O^ ZY]S^SYX ^RO
\OMYQXS]ONK]]O^S]VSWS^ON^Y^ROZ\O]OX^`KV_OYP
OMYXYWSMLOXO ^]K`KSVKLVOSXPY\WYP\ON_M^SYX]
SXP_^_\OMYX^\SL_^SYX]
The Company recognises remeasurements of
KM^_K\SKV QKSX] KXN VY]]O] SX ZY]^ \O^S\OWOX^
WONSMKV LOXO ^ ZVKX] SWWONSK^OVc SX Y^RO\
MYWZ\OROX]S`OSXMYWOKXNKVV^ROY^RO\ObZOX]O]
\OVK^ON ^Y ZY]^ \O^S\OWOX^ WONSMKV LOXO ^ ZVKX]
K] OWZVYcOO LOXO ^ ObZOX]O] SX ^ROS\ =^K^OWOX^
YP :\Y ^ KXN 6Y]] <OWOK]_\OWOX^] K\O XY^
\OMVK]]S ON ^Y =^K^OWOX^ YP :\Y ^ KXN 6Y]] SX
]_L]O[_OX^ZO\SYN
   A
 ROX^ROLOXO ^]YP^ROZVKXK\OMRKXQONY\aROX
KZVKXS]M_\^KSVONY\]O^^VOWOX^YMM_\]^ROZY\^SYX
YP ^RO MRKXQON LOXO ^ \OVK^ON ^Y ZK]^ ]O\`SMO Lc
OWZVYcOO] Y\ ^RO QKSX Y\ VY]] YX M_\^KSVWOX^
Y\ ]O^^VOWOX^ S] \OMYQXS]ON SWWONSK^OVc SX ^RO
=^K^OWOX^YP:\Y ^KXN6Y]]
   9^RO\OWZVYcOOLOXO ^]$
   9
 ^RO\ OWZVYcOO LOXO ^] MYWZ\S]O YP VOK`O
encashment which is provided for, based on the
KM^_K\SKV`KV_K^SYXMK\\SONY_^K]K^^ROOXNYP^RO
cOK\
   6
 SKLSVS^SO]\OMYQXS]ONSX\O]ZOM^YPY^RO\VYXQ^O\W
OWZVYcOOLOXO ^]K\OWOK]_\ONK^^ROZ\O]OX^`KV_O
YP ^RO O]^SWK^ON P_^_\O MK]R Y_^
K]]O^]KXN]O^^VO^ROVSKLSVS^SO]]SW_V^KXOY_]Vc
to be made by the Company in respect of services
Z\Y`SNONLcOWZVYcOO]_Z^Y^RO\OZY\^SXQNK^O
o) Earnings per equity share
 >RO ,K]SM /K\XSXQ] :O\ O[_S^c =RK\O /:= S]
MYWZ_^ONLcNS`SNSXQ^ROXO^Z\Y ^KP^O\^KbPY\^RO
cOK\ K^^\SL_^KLVO ^Y ^RO O[_S^c ]RK\ORYVNO\] YP ^RO
Company by weighted average number of equity
]RK\O]Y_^]^KXNSXQN_\SXQ^ROcOK\
   .
 SV_^ONOK\XSXQ]ZO\O[_S^c]RK\OK\OMYWZ_^ONLc
NS`SNSXQ^ROXO^Z\Y ^K^^SL_^KLVO^YO[_S^cRYVNO\]
of the Company by the weighted average number
of equity shares considered for deriving basic
OK\XSXQ] ZO\ O[_S^c ]RK\O KXN KV]Y ^RO aOSQR^ON
K`O\KQO X_WLO\ YP O[_S^c ]RK\O] ^RK^ MY_VN
RK`O LOOX S]]_ON _ZYX MYX`O\]SYX YP KVV NSV_^S`O
ZY^OX^SKV O[_S^c ]RK\O] >RO NSV_^S`O ZY^OX^SKV
equity shares are adjusted for the proceeds
\OMOS`KLVO RKN ^RO O[_S^c ]RK\O] LOOX KM^_KVVc
S]]_ONK^PKS\`KV_OSO^ROK`O\KQOWK\UO^`KV_OYP
^ROO[_S^c]RK\O].SV_^S`OZY^OX^SKVO[_S^c]RK\O]
are deemed converted as of the beginning of the
ZO\SYN_XVO]]S]]_ONK^KVK^O\NK^O
CORPORATE OVERVIEW
p) Share based compensation
 LLY^^ 6KLY\K^Y\SO] ?=+ LOSXQ ^RO ?V^SWK^O
+
2YVNSXQ -YWZKXc RK] QS`OX \O]^\SM^ON ]^YMU
YZ^SYXZVKX^Y^ROOWZVYcOO]YP^RO-YWZKXc
   :
 _\]_KX^ ^Y 3XN +=  s=RK\OLK]ON :KcWOX^t
^RO-YWZKXc\OMYQXS]O]KXObZOX]OLK]ONYX^RO
PKS\`KV_OYP^RO]^YMUYZ^SYX]K]K^Q\KX^NK^O>RO
ObZOX]O]K\OKWY\^S]ONY`O\^RO`O]^SXQZO\SYN>RO
corresponding credit is given to equity because the
award represents in substance equity contribution
recognised for stock options at each reporting date
_X^SV^RO`O]^SXQNK^O\O
^RO`O]^SXQZO\SYNRK]ObZS\ONKXN^RO-YWZKXct]
best estimate of the number of equity instruments
^RK^aSVV_V^SWK^OVc`O]^
q) Financial instruments
   +
  XKXMSKV SX]^\_WOX^ S] KXc MYX^\KM^ ^RK^ QS`O]
\S]O^YK XKXMSKVK]]O^YPYXOOX^S^cKXNK XKXMSKV
VSKLSVS^cYPO[_S^cSX]^\_WOX^YPKXY^RO\OX^S^c
Financial assets
Recognition and measurement
   +
 VV XKXMSKV K]]O^] K\O \OMYQXS]ON SXS^SKVVc K^
PKS\ `KV_O ZV_] SX ^RO MK]O YP XKXMSKV K]]O^] XY^
\OMY\NON K^ s0KS\ `KV_O ^R\Y_QR Z\Y ^ Y\ VY]]t
^\KX]KM^SYX MY]^] ^RK^ K\O K^^\SL_^KLVO ^Y ^RO
KM[_S]S^SYX YP ^RO XKXMSKV K]]O^ 0SXKXMSKV K]]O^]
K\O MVK]]S ON K^ SXS^SKV \OMYQXS^SYX K] XKXMSKV
K]]O^]WOK]_\ONK^PKS\`KV_OY\K]s0SXKXMSKVK]]O^]
WOK]_\ONK^KWY\^S]ONMY]^t
   0
 Y\Z_\ZY]O]YP]_L]O[_OX^WOK]_\OWOX^ XKXMSKV
K]]O^]K\OMVK]]S ONSXPYVVYaSXQMK^OQY\SO]$
   w 0SXKXMSKVK]]O^]K^KWY\^S]ONMY]^
   +
  XKXMSKVK]]O^S]WOK]_\ONK^KWY\^S]ONMY]^XO^
of impairment, if the objective of the Company’s
L_]SXO]] WYNOV S] ^Y RYVN ^RO XKXMSKV K]]O^
^Y MYVVOM^ ^RO MYX^\KM^_KV MK]R
MYX^\KM^_KV ^O\W] YP ^RO XKXMSKV K]]O^ QS`O \S]O
YX ]ZOMS ON NK^O] ^Y MK]R
ZKcWOX^]YPZ\SXMSZKVKXNSX^O\O]^YX^ROZ\SXMSZKV
KWY_X^Y_^]^KXNSXQ
   +
 VVY^RO\ XKXMSKVK]]O^]K\OWOK]_\ONK^PKS\`KV_O
^R\Y_QR=^K^OWOX^YP:\Y ^KXN6Y]]
Derecognition
   >
 RO -YWZKXc NO\OMYQXS]O] K XKXMSKV K]]O^ YXVc
aROX ^RO MYX^\KM^_KV \SQR^] ^Y ^RO MK]R
P\YW^ROK]]O^ObZS\O]Y\S^^\KX]PO\]^RO XKXMSKV
K]]O^KXN]_L]^KX^SKVVcKVV^RO\S]U]KXN\OaK\N]YP
YaXO\]RSZYP^ROK]]O^
Financial liabilities
Recognition and measurement
 0SXKXMSKV VSKLSVS^SO] K\O MVK]]S ON K^ SXS^SKV
\OMYQXS^SYX K] OS^RO\ s0SXKXMSKV VSKLSVS^SO] K^ PKS\
STATUTORY REPORT FINANCIAL STATEMENTS
`KV_O ^R\Y_QR Z\Y ^ Y\ VY]]t Y\ s9^RO\ XKXMSKV
VSKLSVS^SO]t
   K 0
 SXKXMSKVVSKLSVS^SO]K\OMVK]]S ONK]s0SXKXMSKV
VSKLSVS^SO]K^PKS\`KV_O^R\Y_QRZ\Y ^Y\VY]]t
SP ^ROc K\O ROVN PY\ ^\KNSXQ Y\ SP ^ROc K\O
NO]SQXK^ONK] XKXMSKVVSKLSVS^SO]K^PKS\`KV_O
^R\Y_QR Z\Y ^ Y\ VY]] >RO]O K\O WOK]_\ON
SXS^SKVVcK^PKS\`KV_OaS^R]_L]O[_OX^MRKXQO]
\OMYQXS]ONSXZ\Y ^Y\VY]]
   L 9
 ^RO\ XKXMSKV VSKLSVS^SO] K\O SXS^SKVVc
WOK]_\ON K^ PKS\ `KV_O XO^ YP NS\OM^Vc
K^^\SL_^KLVO ^\KX]KM^SYX MY]^] =_L]O[_OX^
amortised cost using the effective interest
\K^OWO^RYN
Derecognition
   +
  XKXMSKV VSKLSVS^c S] NO\OMYQXS]ON aROX ^RO
YLVSQK^SYX _XNO\ ^RO VSKLSVS^c S] NS]MRK\QON Y\
MKXMOVVON Y\ ObZS\O] AROX KX ObS]^SXQ XKXMSKV
VSKLSVS^c S] \OZVKMON Lc KXY^RO\ P\YW ^RO ]KWO
VOXNO\YX]_L]^KX^SKVVcNSPPO\OX^^O\W]Y\^RO^O\W]
YP KX ObS]^SXQ VSKLSVS^c K\O ]_L]^KX^SKVVc WYNS ON
]_MR KX ObMRKXQO Y\ WYNS MK^SYX S] ^\OK^ON K]
^RO NO\OMYQXS^SYX YP ^RO Y\SQSXKV VSKLSVS^c KXN ^RO
\OMYQXS^SYXYPKXOaVSKLSVS^c>RONSPPO\OXMOSX^RO
respective carrying amounts is recognised in the
=^K^OWOX^YP:\Y ^KXN6Y]]
   9PP]O^^SXQYP XKXMSKVSX]^\_WOX^]
   0
 SXKXMSKV K]]O^] KXN XKXMSKV VSKLSVS^SO] K\O YPP]O^
KXN ^RO XO^ KWY_X^ S] \OZY\^ON SX ^RO ,KVKXMO
=ROO^SP^RO\OS]KM_\\OX^VcOXPY\MOKLVOVOQKV\SQR^
to offset the recognised amounts and there is an
SX^OX^SYX ^Y ]O^^VO YX K XO^ LK]S] ^Y \OKVS]O ^RO
r) Cash and cash equivalents
   -
 K]R KXN MK]R O[_S`KVOX^] SX ^RO ,KVKXMO =ROO^
term deposits with a maturity of three months or
MRKXQO]SX`KV_O
   0
 Y\ ^RO Z_\ZY]O YP ^RO =^K^OWOX^ YP -K]R 0VYa]
MK]RKXNMK]RO[_S`KVOX^]MYX]S]^YPMK]RKXN]RY\^
^O\WNOZY]S^]K]NO XONKLY`OXO^YPY_^]^KXNSXQ
bank overdrafts, if any, as they are considered as an
SX^OQ\KVZK\^YP^RO-YWZKXct]MK]RWKXKQOWOX^
   >
 RO -YWZKXc \OMYQXS]O] K VSKLSVS^c ^Y WKUO
MK]R NS]^\SL_^SYX] ^Y O[_S^c RYVNO\] aROX ^RO
distribution is authorised and the distribution is no
VYXQO\K^^RONS]M\O^SYXYP^RO-YWZKXc+]ZO\^RO
MY\ZY\K^OVKa]SX3XNSKKNS]^\SL_^SYXS]K_^RY\S]ON
aROX S^ S] KZZ\Y`ON Lc ^RO ]RK\ORYVNO\] +
MY\\O]ZYXNSXQ KWY_X^ S] \OMYQXS]ON NS\OM^Vc SX
O[_S^cSX^ROcOK\YPKZZ\Y`KV
113
 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

3 PROPERTY, PLANT AND EQUIPMENT 4 OTHER INTANGIBLE ASSETS

Leasehold Leasehold Buildings Plant and Furniture 9P MO Vehicles Total Software Trademarks Total
Land Improve- (Refer Equipment and Equipment
Gross carrying value
ments Note (b) (Refer Fixtures
and (e)) Note (a)) As at April 1, 2016  " -  "
Gross carrying value Additions  " -   "
As at April 1, 2016 ! ! #  #"#    # #" .S]ZY]KV] " - "
Additions -    !" #  - !  As at March 31, 2017 ! - !
.S]ZY]KV] - - ! #     ## Additions " ! " 
As at March 31, 2017 ! ! "  #" "  ! !  .S]ZY]KV] -        
Additions - #  !#    # -  As at March 31, 2018 5,46.53 86.84 6,33.37
9^RO\KNT_]^WOX^]<OPO\8Y^ONLOVYa - -   " - - - -   "
.S]ZY]KV] - -  "     - 
Amortisation
As at March 31, 2018 37.55 84.38 19,99.34 75,90.42 4,51.84 15,73.67 54.67 117,91.87
As at April 1, 2016 # - #
Accumulated depreciation Amortisation for the year  - 
As at April 1, 2016    # !! ! !#   .S]ZY]KV] " - "
Depreciation charge for the year  # ! "!! ## !  !"! As at March 31, 2017 !! - !!
.S]ZY]KV] - -  ##     !# Amortisation for the year "  #  "
As at March 31, 2017  !!  #  "# " !!# .S]ZY]KV] -    
Depreciation charge for the year   "" ##     # 
As at March 31, 2018 3,41.92 11.85 3,53.77
9^RO\KNT_]^WOX^]<OPO\8Y^ONLOVYa - -  - - - - 
.S]ZY]KV] - -    "# "# - 
As at March 31, 2018 1.50 19.82 2,44.41 23,76.51 2,37.66 10,00.06 53.35 39,33.31
Net carrying value
As at March 31, 2018 2,04.61 74.99 2,79.60
Net carrying value As at March 31, 2017 # - #
As at March 31, 2018 36.05 64.56 17,54.93 52,13.91 2,14.18 5,73.61 1.32 78,58.56
As at March 31, 2017   !  ! !#! #" #"   !  5 INTANGIBLE ASSETS UNDER DEVELOPMENT
As at March 31, 2018 +]K^7K\MR!
Details of Capital work-in-progress
3X^KXQSLVOK]]O^]_XNO\NO`OVYZWOX^ - "
As at March 31, 2018 +]K^7K\MR!
-KZS^KVaY\USXZ\YQ\O]] 2,16.69  - "
2,16.69 
6 NON-CURRENT FINANCIAL ASSETS - LOANS
Notes :
As at March 31, 2018 +]K^7K\MR!
 K 3 XMV_NONSX:VKX^KXN/[_SZWOX^K\OKXKO]^RO^SMO[_SZWOX^SX]^KVVONK^`K\SY_]RY]ZS^KV]P\OOYPMY]^aS^R^ROSX^OX^SYXYPZ\YM_\SXQL_]SXO]]
.OZY]S^]aS^RLYNcMY\ZY\K^O]KXNY^RO\]$
PY\^RO-YWZKXct]Z\YN_M^]$
0Y\Z\OWS]O]aS^RK\OVK^ONZK\^c<OPO\8Y^O. 12,12.28 -
Net Block For premises with others ""
1,58.94
Class of Asset As at March 31, 2018 As at March 31, 2017
+QKSX]^^OXNO\]<OPO\KLOVYa 1,31.36 !#
:VKX^KXN/[_SZWOX^ 4,20.92 
15,02.58  
 L 3 XMV_NONSXL_SVNSXQ]S]KXKWY_X^YP` 0.00* Lakhs 7K\MR!$`6KUR]\OZ\O]OX^SXQ`KV_OYP]RK\O]SXMYYZO\K^S`ORY_]SXQ
]YMSO^c
(a) Break-up for security details :
 M +NNS^SYX]SXMV_NOMKZS^KVObZOXNS^_\OYP` 1.71 Lakhs 7K\MR!$` 6KUR]SXM_\\ONK^-YWZKXct]SXRY_]O<.PKMSVS^cK^1YK As at March 31, 2018 +]K^7K\MR!
 N 9^RO\KNT_]^WOX^]N_\SXQ^ROcOK\\OZ\O]OX^]K]]O^]\OMVK]]S ONK]s+]]O^]ROVNPY\]KVOt_XNO\s-_\\OX^K]]O^]t<OPO\8Y^O  Deposits against tenders :
 O  RO ^S^VO NOON] YP L_SVNSXQ] RK`SXQ XO^ LYYU `KV_O YP ` 40,29.19 Lakhs 7K\MR  ! $ `   6KUR] K\O SX O\]^aRSVO XKWO YP ^RO
> Secured, considered good - -
-YWZKXcY\SX^ROXKWOYP^ROOX^S^c^RK^QY^WO\QONaS^R^RO-YWZKXc>RS]SXMV_NO]YP MOZ\OWS]O]RK`SXQXO^LYYU`KV_OYP` 34,33.76 Unsecured, considered good 1,31.36 !#
Lakhs 7K\MR!$`836]RYaXK]s+]]O^]ROVNPY\]KVOt .Y_L^P_V 3,96.12 
 P  >ROKWY_X^YPMYX^\KM^_KVMYWWS^WOX^]PY\^ROKM[_S]S^SYXYPZ\YZO\^cZVKX^KXNO[_SZWOX^S]NS]MVY]ONSX8Y^OL 5,27.48 
6O]]$+VVYaKXMOPY\NY_L^P_VKN`KXMO]KXNNOZY]S^] (3,96.12) 
 LOVYa` 
1,31.36 !#

114 ANNUAL REPORT 2017-18 115

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

7 NON-CURRENT FINANCIAL ASSETS - OTHERS (UNSECURED, CONSIDERED GOOD) 11 CASH AND CASH EQUIVALENTS
As at March 31, 2018 +]K^7K\MR! As at March 31, 2018 +]K^7K\MR!
.OZY]S^]aS^RLKXU]aS^RWK^_\S^cYPWY\O^RKXWYX^R] 3,66.07 #### ,KVKXMO]aS^RLKXU]
/bZOM^ON\OSWL_\]OWOX^^YaK\N]VSUOVc]KVO]\O^_\X\OSWL_\]KLVO In current accounts 37,67.25 !"
<OPO\8Y^O# 19,04.60 ""! .OZY]S^]aS^RY\SQSXKVWK^_\S^cYPVO]]^RKX^R\OOWYX^R]* -  
22,70.67 " # Cash on hand 0.46 
37,67.71 "
8 OTHER NON-CURRENT ASSETS (UNSECURED, CONSIDERED GOOD) *<OZ\O]OX^]^SWONOZY]S^]K^ bON\K^O]WKSX^KSX^ONaS^R`K\SY_]LKXU]Lc^RO-YWZKXc
As at March 31, 2018 +]K^7K\MR!
-KZS^KVKN`KXMO] 4.21 ! 12 BANK BALANCES OTHER THAN CASH AND CASH EQUIVALENTS
VAT Deposits 2,14.25   As at March 31, 2018 +]K^7K\MR!
Deposits against co-marketing agreement 11,00.00   Margin deposit and deposit against guarantees and tenders 3,14.09 "
.OPO\\ONVOK]OK]]O^] 1,65.19 " /K\WK\UONLKXULKVKXMO^YaK\N]NS`SNOXN 3,18.23  "
14,83.65 !!"
>O\WNOZY]S^]aS^RY\SQSXKVWK^_\S^cYPWY\O^RKX^R\OOWYX^R]L_^VO]]^RKX
3XMV_NO]` 1,38.87 Lakhs 7K\MR!$836^YaK\N]NOZY]S^QS`OX^YK\OVK^ONZK\^c<OPO\8Y^O. ^aOV`OWYX^R]* 987,35.00 "" 
993,67.32 """ "
9 INVENTORIES (AT LOWER OF COST OR NET REALISABLE VALUE)
  >RO]OLKVKXMO]K\OK`KSVKLVOPY\_]OYXVc^YaK\N]]O^^VOWOX^YPMY\\O]ZYXNSXQ_XZKSNNS`SNOXNVSKLSVS^SO]
As at March 31, 2018 +]K^7K\MR!  *<OZ\O]OX^]^SWONOZY]S^]K^ bON\K^O]WKSX^KSX^ONaS^R`K\SY_]LKXU]Lc^RO-YWZKXc
<KaWK^O\SKV]KXNZKMUSXQWK^O\SKV] 76,81.75 ##
Work-in-progress 3,67.31 ### 13 CURRENT FINANCIAL ASSETS - LOANS (UNSECURED, CONSIDERED GOOD)
Finished goods 62,37.72  !" As at March 31, 2018 +]K^7K\MR!
Stock-in-trade @ 442,45.94 #! Loans
585,32.72   6YKX^YK\OVK^ONZK\^c<OPO\8Y^O.KXN8Y^O 200,00.00 -
3XMV_NO]QYYN]SX^\KX]S^` 40,88.53 Lakhs7K\MR!$` ! 6KUR] Deposits with body corporates and others
 *3XMV_NO]QYYN]SX^\KX]S^` 3,20.40 Lakhs7K\MR!$`  #6KUR] For premises 5,47.81 #
 ._\SXQ^ROcOK\OXNON7K\MR"` 11,51.89 Lakhs 7K\MR!$` !# 6KUR]aK]\OMYQXS]ONK]KXObZOX]O^YaK\N] 205,47.81 #
Z\Y`S]SYXPY\]VYaWY`SXQObZS\ONKXNXOK\ObZS\cSX`OX^Y\SO]

10 TRADE RECEIVABLES 14 CURRENT FINANCIAL ASSETS - OTHERS (UNSECURED, CONSIDERED GOOD)

As at March 31, 2018 +]K^7K\MR!
As at March 31, 2018 +]K^7K\MR!
>\KNO\OMOS`KLVO] 240,71.64  ! Interest accrued but not due on bank deposits 15,05.12 "
<OMOS`KLVO]P\YW\OVK^ONZK\^SO]<OPO\8Y^O. 22,72.66  !  <OMOS`KLVO]P\YW\OVK^ONZK\^SO]<OPO\8Y^O. 5,94.80 !#
263,44.30 ! ## /bZOM^ON\OSWL_\]OWOX^^YaK\N]VSUOVc]KVO]\O^_\X\OSWL_\]KLVO
<OPO\8Y^O 16,48.41 !!
Break-up for security details : 9^RO\\OMOS`KLVO] 2,72.91  !
As at March 31, 2018 +]K^7K\MR! 40,21.24 "!!
Trade receivables :
Secured, considered good - - 15 OTHER CURRENT ASSETS
Unsecured, considered good 263,44.30 ! ##
As at March 31, 2018 +]K^7K\MR!
?X]OM_\ONMYX]SNO\ONNY_L^P_V 11,38.53 !!
:\OZKSNObZOX]O] 5,44.13 
274,82.83 "!###
+N`KXMO]^YOWZVYcOO]KXN]_ZZVSO\] 29,46.29  !
6O]]$+VVYaKXMOPY\NY_L^P_VNOL^] (11,38.53) !! ,KVKXMOaS^RM_]^YW]KXNObMS]OYXM_\\OX^KMMY_X^ 12,53.12 # #
263,44.30 ! ## 1=>\OMOS`KLVO] 39,11.80 -
>RO\OK\OXY^\KNOY\Y^RO\\OMOS`KLVO]aRSMRK\ON_OP\YWNS\OM^Y\]Y\Y^RO\YP MO\]YP^RO-YWZKXcOS^RO\]O`O\KVVcY\TYSX^Vc .OPO\\ONVOK]OK]]O^] 1,42.03  "
aS^RKXcY^RO\ZO\]YX+V]Y^RO\OK\OXY^\KNOY\Y^RO\\OMOS`KLVO]aRSMRK\ON_OP\YW \W]Y\Z\S`K^OMYWZKXSO]SXaRSMRKXc 9^RO\] 1,61.58 # !
NS\OM^Y\S]KZK\^XO\KNS\OM^Y\Y\KWOWLO\
89,58.95 !"
 0Y\^O\W]KXNMYXNS^SYX]\OVK^SXQ^Y\OVK^ONZK\^c\OMOS`KLVO]\OPO\8Y^O
 0Y\SXPY\WK^SYXYX XKXMSKV\S]UWKXKQOWOX^YLTOM^S`O]KXNZYVSMSO]\OPO\8Y^O 3XMV_NO]` 1,18.71 Lakhs 7K\MR!$836^YaK\N]NOZY]S^QS`OX^YK\OVK^ONZK\^c<OPO\8Y^O.

116 ANNUAL REPORT 2017-18 117

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

16 ASSETS HELD FOR SALE Details of shareholders holding more than 5% shares in the As at March 31, 2018 +]K^7K\MR!
As at March 31, 2018 +]K^7K\MR! Company : Number of % Holding 8_WLO\YP 2YVNSXQ
shares shares
+]]O^]ROVNPY\]KVO+^VYaO\YPMK\\cSXQKWY_X^KXNPKS\`KV_O 34,33.76 -
S +LLY^^-KZS^KV3XNSK6^N?5 1,07,19,097 50.45% !##! 
34,33.76 - SS +LLY^^2OKV^RMK\O:\YN_M^]6^N?5 !# ! 
37,44,951 17.62%
:Y]^MYX]YVSNK^SYX_XNO\9XO+LLY^^YP MO^RO-YWZKXcaSVVXYVYXQO\\O[_S\O^aYYP MOZ\OWS]O]K^7_WLKS>RO-YWZKXc SSS ,\S^S]R-YVVYSN]6^N?5 14,70,000 6.92% ! #
ObZOM^]^YNS]ZY]OYPP^RO]KWO^R\Y_QRKLSNNSXQZ\YMO]]LOPY\OOXNYP7K\MR#+MMY\NSXQVc^ROXO^LYYU`KV_OYP^RO]KSN 1,59,34,048 74.99% #" !##
K]]O^]S]\OMVK]]S ONK]s+]]O^]ROVNPY\=KVOt_XNO\s-_\\OX^+]]O^]t>RO-YWZKXcRK]XY^MRK\QONNOZ\OMSK^SYXYX^RO]OK]]O^]ZY]^
^RS]\OMVK]]S MK^SYXK]ZO\^RO\O[_S\OWOX^]YP3XN+= Dividend paid and proposed : For the year ended For the year ended
March 31, 2018 7K\MR!
>RO^S^VONOON]YP^RO]OK]]O^]K\OSXO\]^aRSVOXKWOYP^RO-YWZKXcY\SX^ROXKWOYP^ROOX^S^c^RK^QY^WO\QONaS^R^RO-YWZKXc Dividend on equity shares declared and paid :
0SXKV.S`SNOXNPY\^ROcOK\OXNON7K\MR!$` 40 per share 84,99.72 !!
17 EQUITY SHARE CAPITAL 7K\MR $`ZO\]RK\O
Authorised share capital : .S`SNOXNNS]^\SL_^SYX^KbYX XKVNS`SNOXN 17,30.34 
Equity shares of ` OKMR .K^OYPKZZ\Y`KVNK^OYP+XX_KV1OXO\KV7OO^SXQ July 18, 2017 4_Vc"
Proposed dividend on equity shares :
Number of shares Amount 0SXKVNS`SNOXNPY\^ROcOK\OXNON7K\MR"$` 50 per share 106,24.65 "##!
As at April 1, 2016 ! ! 7K\MR!$`ZO\]RK\O
Changes during the year - - =ZOMSKVNS`SNOXNPY\^ROcOK\OXNON7K\MR"$` 5 per share 10,62.47 -
7K\MR!$836
As at March 31, 2017 ! !
.S`SNOXNNS]^\SL_^SYX^KbYXZ\YZY]ONNS`SNOXN 24,02.32 !
Changes during the year - -  :\YZY]ONNS`SNOXN]YXO[_S^c]RK\O]K\O]_LTOM^^YKZZ\Y`KVK^^RO+XX_KV1OXO\KV7OO^SXQKXNK\OXY^\OMYQXS]ONK]KVSKLSVS^c
As at March 31, 2018 2,75,00,000 27,50.00 SXMV_NSXQNS`SNOXNNS]^\SL_^SYX^Kb^RO\OYXK]K^7K\MR"KXN7K\MR!
Terms/rights attached to equity shares
18 OTHER EQUITY
>RO-YWZKXcRK]YXVcYXOMVK]]YPO[_S^c]RK\O]aS^R`Y^SXQ\SQR^]RK`SXQKZK\`KV_OYP` ZO\]RK\O>RO-YWZKXcNOMVK\O]KXN Items of Other
ZKc]NS`SNOXN]SX3XNSKX<_ZOO]>RONS`SNOXNZ\YZY]ONLc^RO,YK\NYP.S\OM^Y\]S]]_LTOM^^Y^ROKZZ\Y`KVYP^RO]RK\ORYVNO\]SX Reserves and Surplus Comprehensive
Income Total
^ROOX]_SXQ+XX_KV1OXO\KV7OO^SXQ>RO\OWS^^KXMOYPNS`SNOXNY_^]SNO3XNSKS]QY`O\XONLc3XNSKXVKaYXPY\OSQXObMRKXQOKXN Other
S]]_LTOM^^YKZZVSMKLVONS]^\SL_^SYX^KbO] Amalgamation Capital Capital Share Based General Retained Remeasurement Equity
Reserve Reserve Redemption Compensation Reserve Earnings YPNO XON
 3X^ROO`OX^YPVS[_SNK^SYXYP^RO-YWZKXc^RO]RK\ORYVNO\]YPO[_S^c]RK\O]aSVVLOOX^S^VON^Y\OMOS`O\OWKSXSXQK]]O^]YP^RO Reserve Reserve LOXO ^ZVKX
-YWZKXcKP^O\NS]^\SL_^SYXYPKVVZ\OPO\OX^SKVKWY_X^]>RONS]^\SL_^SYXaSVVLOSXZ\YZY\^SYX^Y^ROX_WLO\YPO[_S^c]RK\O]ROVN As at April 1, 2016 !"   " ""  !#"# "#"!!  !#!
:\Y ^PY\^ROcOK\OXNON7K\MR! - - - - - !  "" - !  ""
Lc^RO]RK\ORYVNO\]
<OWOK]_\OWOX^YPNO XONLOXO ^ZVKX
XO^YP^Kb - - - - - - "!  "! 
Issued, Subscribed and Paid up capital : Number of shares Amount
>\KX]PO\P\YW:\Y ^KXN6Y]]^Y1OXO\KV
Equity shares of ` 10 each fully paid Reserve - - - - ! # ! # - -
.S`SNOXNPY\^ROcOK\OXNON7K\MR
As at April 1, 2016 # #  <OPO\8Y^O! - - - - - !!  - !! 
Changes during the year - - .S`SNOXNNS]^\SL_^SYX^Kb<OPO\8Y^O! - - - - -  - 
=RK\OLK]ONMYWZOX]K^SYX^YOWZVYcOO]
As at March 31, 2017 # # <OPO\8Y^O - - -  " - - -  "
Changes during the year - - Transfer from Share Based Compensation
<O]O\`O^Y1OXO\KV<O]O\`O - - -   - - -
As at March 31, 2018 2,12,49,302 21,24.93 As at March 31, 2017 !"   "  # !"#" " "!!   #!
:\Y ^PY\^ROcOK\OXNON7K\MR" - - - - - !" - !"
<OWOK]_\OWOX^YPNO XONLOXO ^ZVKX
Details of Equity shares of ` 10 each fully paid held by the Holding As at As at XO^YP^Kb - - - - - - !  ! 
Company and subsidiaries of the Ultimate Holding Company : March 31, 2018 7K\MR! >\KX]PO\P\YW:\Y ^KXN6Y]]^Y1OXO\KV
Reserve - - - - " " - -
i) 1,07,19,0977K\MR!$!##!+LLY^^-KZS^KV3XNSK6^N?5 .S`SNOXNPY\^ROcOK\OXNON7K\MR
2YVNSXQ-YWZKXc 10,71.91 !# !<OPO\8Y^O! - - - - - "##! - "##!
ii) 37,44,9517K\MR!$!#+LLY^^2OKV^RMK\O:\YN_M^]6^N .S`SNOXNNS]^\SL_^SYX^Kb<OPO\8Y^O! - - - - - ! - !
! =RK\OLK]ONMYWZOX]K^SYX^YOWZVYcOO]
?5=_L]SNSK\cYP^RO?V^SWK^O2YVNSXQ-YWZKXc 3,74.50
<OPO\8Y^O - - - !#!! - - - !#!!
iii) 14,70,0007K\MR!$!,\S^S]R-YVVYSN]6^N?5 Transfer from Share Based Compensation
=_L]SNSK\cYP^RO?V^SWK^O2YVNSXQ-YWZKXc 1,47.00 ! <O]O\`O^Y1OXO\KV<O]O\`O - - - !# !# - - -
As at March 31, 2018 37.82 5,22.62 2,52.48 20,95.22 337,25.95 1309,12.39 (3,95.36) 1671,51.12
 >RO?V^SWK^O2YVNSXQ-YWZKXcS]+LLY^^6KLY\K^Y\SO]?=+
 9XKMMY_X^YPMKXMOVVK^SYXYP]RK\OYZ^SYX]KaK\NON^YOWZVYcOO]

118 ANNUAL REPORT 2017-18 119

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

Nature and purpose of reserves : Other Comprehensive Income (OCI) section - Deferred tax related to items recognised in OCI during the year :
1. Amalgamation Reserve For the year ended For the year ended
>RS]aK]M\OK^ONYXKWKVQKWK^SYXYP,OOW2OKV^RMK\O6SWS^ONKXN@KVOXMSK:RK\WKMO_^SMKV]6SWS^ONaRYVVcYaXON]_L]SNSK\c March 31, 2018 7K\MR!
YP^RO-YWZKXcaS^RKZZYSX^ONNK^OK]4_Vc##"+VVK]]O^]KXNVSKLSVS^SO]YPO\]^aRSVO,OOW2OKV^RMK\O6SWS^ONKXN@KVOXMSK 8O^VY]]QKSXYX\OWOK]_\OWOX^YPNO XONLOXO ^ZVKX 60.08 ##
:RK\WKMO_^SMKV] 6SWS^ON aO\O ^\KX]PO\\ON ^Y ^RO -YWZKXc KXN KVV ]RK\O] ROVN Lc ^RO -YWZKXc SX O\]^aRSVO ,OOW 2OKV^RMK\O
6SWS^ON KXN @KVOXMSK :RK\WKMO_^SMKV] 6SWS^ON aO\O MKXMOVVON >RO KWKVQKWK^SYX aK] KMMY_X^ON _XNO\ s:YYVSXQ YP 3X^O\O]^] Income tax expense charged to OCI 60.08 ##
WO^RYNtK]Z\O]M\SLONSX^ROX+MMY_X^SXQ=^KXNK\NS]]_ONLc^RO3X]^S^_^OYP-RK\^O\ON+MMY_X^KX^]YP3XNSK <OMYXMSVSK^SYXYP^KbObZOX]OKXN^ROKMMY_X^SXQZ\Y ^W_V^SZVSONLc3XNSKt]NYWO]^SM^Kb\K^OPY\7K\MR"KXN7K\MR!$
2. Capital Reserve For the year ended For the year ended
  RS] aK] M\OK^ON YX KWKVQKWK^SYX YP 6OXL\YYU :RK\WKMO_^SMKV] 6SWS^ON K aRYVVc YaXON ]_L]SNK\c YP ^RO -YWZKXc aS^R ^RO
> March 31, 2018 7K\MR!
KZZYSX^ONNK^OK]9M^YLO\+VV^ROK]]O^]KXNVSKLSVS^SO]YPO\]^aRSVO6OXL\YYU:RK\WKMO_^SMKV]6SWS^ONaO\O^\KX]PO\\ON
+MMY_X^SXQZ\Y ^LOPY\OSXMYWO^Kb 621,48.26  #!
^Y ^RO -YWZKXc KXN KVV ]RK\O] ROVN Lc ^RO -YWZKXc SX ^RO O\]^aRSVO 6OXL\YYU :RK\WKMO_^SMKV] 6SWS^ON aO\O MKXMOVVON >RO
KWKVQKWK^SYXaK]KMMY_X^ON_XNO\^ROs:_\MRK]O7O^RYNtK]Z\O]M\SLONSX^ROXKZZVSMKLVO+MMY_X^SXQ=^KXNK\NS]]_ONLc^RO 6O]]$6YXQ^O\WMKZS^KVQKSX]^KbON]OZOK\K^OVc (8,38.43) -
3X]^S^_^OYP-RK\^O\ON+MMY_X^KX^]YP3XNSK 613,09.83  #!
3. Capital Redemption Reserve +^3XNSKt]]^K^_^Y\cSXMYWO^Kb\K^OYP34.61%7K\MR!$  212,18.11  
 >RS]aK]M\OK^ONKMMY\NSXQ^Y=OM^SYX!!+YP^RO-YWZKXSO]+M^# Lc^\KX]PO\\SXQ^ROPKMO`KV_OYP]RK\O]LY_QR^LKMUN_\SXQ +NT_]^WOX^]SX\O]ZOM^YPM_\\OX^SXMYWO^KbYPZ\O`SY_]cOK\] (1,62.69) # 
^ROZO\SYN^Y"P\YWP\OO\O]O\`O]
3WZKM^YPMRKXQOSXSXMYWO^Kb\K^OYXNOPO\\ON^Kb (34.40) -
4. Share Based Compensation Reserve
8YXNON_M^SLVOObZOX]O]PY\^KbZ_\ZY]O] 8,81.67 "
 >RO -YWZKXct] OWZVYcOO] K\O KaK\NON <O]^\SM^ON =^YMU ?XS^] <=?] YP ^RO ?V^SWK^O 2YVNSXQ -YWZKXc +LLY^^ 6KLY\K^Y\SO]
?=+>RO=RK\O,K]ON-YWZOX]K^SYX<O]O\`OS]_]ON^Y\OMYQXS]O^ROPKS\`KV_OYP^RO<=?]KaK\NON^Y^ROOWZVYcOO]>ROKaK\N 219,02.69 #"#
\OZ\O]OX^]SX]_L]^KXMOO[_S^cMYX^\SL_^SYX]Lc^RO?V^SWK^O2YVNSXQ-YWZKXc 3XMYWO^KbYXVYXQ^O\WMKZS^KVQKSX]YXK]]SQXWOX^YP^\KNOWK\U] 1,23.79 -
5. General Reserve At the effective income tax rate of 35.44% 7K\MR!$  
 1OXO\KV<O]O\`OS]_]ONP\YW^SWO^Y^SWO^Y^\KX]PO\Z\Y ^]P\YW\O^KSXONOK\XSXQ]PY\KZZ\YZ\SK^SYXZ_\ZY]O]1OXO\KV<O]O\`OS] 3XMYWO^KbObZOX]O\OZY\^ONSX^RO=^K^OWOX^YP:\Y ^KXN6Y]] 220,26.48 #"#
M\OK^ONLcK^\KX]PO\P\YWYXOMYWZYXOX^YPO[_S^c^YKXY^RO\KXNS]XY^KXS^OWYPs9^RO\MYWZ\OROX]S`OSXMYWOt
6. Retained Earnings Deferred tax :
 <O^KSXON /K\XSXQ] K\O ^RO Z\Y ^] ^RO -YWZKXc RK] OK\XON ^SVV NK^O VO]] KXc ^\KX]PO\ ^Y 1OXO\KV <O]O\`O NS`SNOXN] Y\ Y^RO\  >RO^KbOPPOM^YP]SQXS MKX^^OWZY\K\cNSPPO\OXMO]^RK^\O]_V^ONSXNOPO\\ONSXMYWO^KbK]]O^]KXNVSKLSVS^SO]K\OK]PYVVYa]$
NS]^\SL_^SYX]ZKSN^Y^RO]RK\ORYVNO\] Balance Sheet =^K^OWOX^YP:\Y ^KXN6Y]]
! <OWOK]_\OWOX^YPNO XONLOXO ^ZVKX For the For the
 .SPPO\OXMO]LO^aOOX^ROSX^O\O]^SXMYWOYXZVKXK]]O^]KXN^RO\O^_\XKM^_KVVcKMRSO`ONKXNKXcMRKXQO]SX^ROVSKLSVS^SO]Y`O\^RO As at As at year ended year ended
cOK\N_O^YMRKXQO]SXKM^_K\SKVK]]_WZ^SYX]Y\ObZO\SOXMOKNT_]^WOX^]aS^RSX^ROZVKX]K\O\OMYQXS]ONSXs9^RO\MYWZ\OROX]S`O March 31, 2018 7K\MR! March 31, 2018 7K\MR!
SXMYWOtKXN]_L]O[_OX^VcXY^\OMVK]]S ON^Y^RO=^K^OWOX^YP:\Y ^KXN6Y]] Deferred tax assets
19 NON-CURRENT PROVISIONS :\Y`S]SYXPY\MYWZOX]K^ONKL]OXMO] 8,87.14 ### 26.85 ""
As at March 31, 2018 +]K^7K\MR! 1\K^_S^cKXNY^RO\OWZVYcOOLOXO ^] 3,99.09 ! (1,81.64)  " 
:\Y`S]SYXPY\OWZVYcOOLOXO ^]$ :\Y`S]SYXPY\NY_L^P_VNOL^] 3,97.85 ! 9.59  "
:Y]^<O^S\OWOX^7ONSMKV,OXO ^] 1,19.21 " 9^RO\S^OW]YPNS]KVVYaKXMO_XNO\=OM^SYX,KXNK
6YXQ=O\`SMO,OXO ^] 1,30.10 # SKYP^RO3XMYWO>Kb+M^#  8,31.03 ! (4,03.52) !
9^RO\]$ 9^RO\S^OW]QS`SXQ\S]O^Y^OWZY\K\cNSPPO\OXMO] 1,11.74 "" 93.14 #
0Y\VSUOVc]KVO]\O^_\X]KXNNK^OObZS\c<OPO\8Y^O 33,80.60 ! Deferred tax liabilities
0Y\VSUOVc]KVO]\O^_\X]\OSWL_\]KLVO<OPO\8Y^O 19,04.60 ""! Depreciation (9,25.24) " 1,23.10  #
55,34.51 !# 9^RO\S^OW]QS`SXQ\S]O^Y^OWZY\K\cNSPPO\OXMO] (2,41.65) " 1,10.57  !
Net deferred tax assets 14,59.96 "
20 INCOME TAXES
Deferred tax income (2,21.91) ## 
The major components of income tax expense for the years ended March 31, 2018 and March 31, 2017 are :
 /b^\KM^YP=^K^OWOX^YP:\Y ^KXN6Y]]$ .OPO\\ON^KbSXMYWOM\ONS^ON^Y:\Y ^KXN6Y]] (1,61.83)  
 :\Y ^KXN6Y]]]OM^SYX$ .OPO\\ON^KbSXMYWOM\ONS^ON^Y9-3 (60.08) ##
For the year ended For the year ended (2,21.91) ## 
March 31, 2018 7K\MR!
Current income tax : <O
OM^ONSX^RO,KVKXMO=ROO^K]PYVVYa]$
-_\\OX^^KbObZOX]O 223,51.00  ""
As at March 31, 2018 +]K^7K\MR!
>KbKNT_]^WOX^PY\OK\VSO\cOK\] (1,62.69) # 
Deferred tax : .OPO\\ON^KbK]]O^] 26,26.85 !!
<OVK^SXQ^YY\SQSXK^SYXKXN\O`O\]KVYP^OWZY\K\cNSPPO\OXMO] (1,61.83)   .OPO\\ON^KbVSKLSVS^SO] (11,66.89) #
3XMYWO^KbObZOX]O\OZY\^ONSX^RO=^K^OWOX^YP:\Y ^KXN6Y]] 220,26.48 #"# Deferred tax assets (net) 14,59.96 "

120 ANNUAL REPORT 2017-18 121

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

Reconciliation of deferred tax assets (net) : 23 OTHER CURRENT LIABILITIES

For the year ended For the year ended As at March 31, 2018 +]K^7K\MR!
March 31, 2018 7K\MR! =^K^_^Y\cN_O]SXMV_NSXQZ\Y`SNOX^P_XNKXN^KbNON_M^ONK^]Y_\MO 6,31.44 "!
Opening balance as at April 1 12,38.05 #" # @+>ZKcKLVO - ##
>KbSXMYWON_\SXQ^ROZO\SYN\OMYQXS]ONSX:\Y ^Y\6Y]] 1,61.83  1=>ZKcKLVO 10,67.27 -
>KbSXMYWON_\SXQ^ROZO\SYN\OMYQXS]ONSX9-3 60.08 ## Advances from customers 2,37.21 "
Closing balance as at March 31 14,59.96 " 9^RO\] 13,45.64 !"#
32,81.56  "
21 TRADE PAYABLES
As at March 31, 2018 +]K^7K\MR! 24 CURRENT PROVISIONS
._O^YWSM\YKXN]WKVVOX^O\Z\S]O]<OPO\KLOVYa 5,83.88 !# As at March 31, 2018 +]K^7K\MR!
._O^Y\OVK^ONZK\^SO]<OPO\8Y^O. 73,07.83 !"" :\Y`S]SYXPY\OWZVYcOOLOXO ^]$
Due to others 401,70.77 #! Compensated absences 25,38.74  #
480,62.48 ! # :Y]^\O^S\OWOX^WONSMKVLOXO ^] 10.60 ""
6YXQ]O\`SMOLOXO ^] 34.40  !
 0Y\^O\W]KXNMYXNS^SYX]\OVK^SXQ^Y\OVK^ONZK\^cZKcKLVO]\OPO\8Y^O
1\K^_S^c 8,47.78 "!
 0Y\SXPY\WK^SYXYX XKXMSKV\S]UWKXKQOWOX^YLTOM^S`O]KXNZYVSMSO]\OPO\8Y^O
Superannuation 1,06.30 #
(a) Details of dues to Micro and Small Enterprises under the Micro, Small and Medium Enterprises Development Act,
:\Y`S]SYXPY\VSUOVc]KVO]\O^_\X]KXNNK^OObZS\c<OPO\8Y^O 25,60.69 "#!
2006 (MSMED Act, 2006) *
:\Y`S]SYXPY\VSUOVc]KVO]\O^_\X]\OSWL_\]KLVO<OPO\8Y^O 16,48.41 !!
As at March 31, 2018 +]K^7K\MR!
77,46.92 !#"
S >
 ROZ\SXMSZKVKWY_X^\OWKSXSXQ_XZKSN^YKXc]_ZZVSO\L_^aS^RSXN_O
NK^OK]ZO\^RO7=7/.+M^  5,83.88 !#
25 DISCLOSURE PURSUANT TO IND AS 37 ‘PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSET’
(ii) Interest due on above remaining unpaid - -
TOWARDS PROVISIONS FOR SALES RETURN, DATE EXPIRY AND DAMAGED PRODUCTS
SSS 3 X^O\O]^ZKSNLc^RO-YWZKXcSX^O\W]YP=OM^SYX YP^RO7SM\Y=WKVVKXN
7ONS_W/X^O\Z\S]O].O`OVYZWOX^+M^ KVYXQaS^R^ROKWY_X^YP^RO Likely Sales Likely Sales Total
ZKcWOX^WKNO^Y^RO]_ZZVSO\LOcYXN^ROKZZYSX^ONNKcN_\SXQ^ROcOK\ - - returns and returns -
date expiry reimbursable
S` 3 X^O\O]^ N_O KXN ZKcKLVO PY\ ^RO ZO\SYN YP NOVKc SX WKUSXQ ZKcWOX^
(which have been paid but beyond the appointed day during the year) but Carrying Amount as at April 1, 2016 "#!! # #!!  " 
aS^RY_^ KNNSXQ SX^O\O]^ ]ZOMS ON _XNO\ ^RO 7SM\Y =WKVV KXN 7ONS_W +NN$8O^KWY_X^Z\Y`SNONa\S^^OXLKMUN_\SXQ^ROcOK\*   #  #
/X^O\Z\S]O].O`OVYZWOX^+M^ - -
Carrying Amount as at March 31, 2017 * ### #  """
(v) Interest accrued and remaining unpaid - -
+NN$8O^KWY_X^Z\Y`SNONa\S^^OXLKMUN_\SXQ^ROcOK\* ##    "
`S 3 X^O\O]^\OWKSXSXQN_OKXNZKcKLVOO`OXSX^RO]_MMOONSXQcOK\]_X^SV
]_MRNK^OaROX^ROSX^O\O]^N_O]K]KLY`OK\OKM^_KVVcZKSN^Y^RO]WKVV Carrying Amount as at March 31, 2018 * 59,41.29 35,53.01 94,94.30
enterprises - - *3XMV_NO]_XaSXNSXQYPNS]MY_X^KXNOPPOM^YPMRKXQO]SXNS]MY_X^\K^OYXZ\Y`S]SYXYP` 1,95.51 Lakhs 7K\MR!$` # 
  >ROKLY`OSXPY\WK^SYXRK]LOOXNO^O\WSXON^Y^ROOb^OX^]_MRZK\^SO]RK`OLOOXSNOX^S ONYX^ROLK]S]YPSXPY\WK^SYXK`KSVKLVO 6KUR]<OPO\8Y^O
aS^R^RO-YWZKXc  -K\\cSXQKWY_X^MYWZ\S]O]YP$
As at March 31, 2018 +]K^7K\MR!
22 CURRENT FINANCIAL LIABILITIES - OTHERS
Non-current provision :
As at March 31, 2018 +]K^7K\MR! 0Y\VSUOVc]KVO]\O^_\X]KXNNK^OObZS\c<OPO\8Y^O# 33,80.60 !
Deposits from a customer 60.35   0Y\VSUOVc]KVO]\O^_\X]\OSWL_\]KLVO<OPO\8Y^O# 19,04.60 ""!
:KcKLVO]PY\MKZS^KVObZOXNS^_\O 3.97 #! Current provision :
?XZKSNNS`SNOXN 3,18.23  " 0Y\VSUOVc]KVO]\O^_\X]KXNNK^OObZS\c<OPO\8Y^O 25,60.69 "#!
=KVK\SO]aKQO]SXMOX^S`O]KXNLYX_]ZKcKLVO^YOWZVYcOO] 41,20.89  ! 0Y\VSUOVc]KVO]\O^_\X]\OSWL_\]KLVO<OPO\8Y^O 16,48.41 !!
.OZY]S^P\YWK\OVK^ONZK\^c<OPO\8Y^O. 44.66 - 94,94.30 """
9^RO\]Z\SWK\SVc\YcKV^SO]ZKcKLVO 3,50.33   Nature of Provision :
48,98.43  #  >RO Z\Y`S]SYX S] PY\ KX^SMSZK^ON \O^_\X] YX ObZS\c aRSMR S] WKNO YX ^RO LK]S] YP WKXKQOWOX^ ObZOM^K^SYX ^KUSXQ SX^Y KMMY_X^
  3X\O]ZOM^YP^ROKWY_X^]K]WOX^SYXON_XNO\=OM^SYXYP^RO-YWZKXSO]+M^XYN_O]K\O\O[_S\ON^YLOM\ONS^ON^Y^RO
RS]^Y\SMKVObZO\SOXMOKXNWK\UO^MYXNS^SYX]
3X`O]^Y\/N_MK^SYXKXN:\Y^OM^SYX0_XNK]YX7K\MR"KXN7K\MR!  >ROObZOM^ON^SWSXQYPKXc\O]_V^SXQY_^
Ya]YPOMYXYWSMLOXO ^]\KXQO]P\YWWYX^R^YWYX^R]

122 ANNUAL REPORT 2017-18 123

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

26 REVENUE FROM OPERATIONS 28 COST OF MATERIALS CONSUMED

For the year ended For the year ended For the year ended For the year ended
March 31, 2018 7K\MR! March 31, 2018 7K\MR!
=KVOYPZ\YN_M^]SXMV_NSXQObMS]ON_^c<OPO\KKXNMLOVYa 3273,90.01 #! ! Inventory at the beginning of the year 94,32.09  !
<OXNO\SXQYP]O\`SMO]<OPO\LLOVYa 21,54.06  +NN$:_\MRK]O]N_\SXQ^ROcOK\ 278,22.04 !#
3295,44.07 #!! 6O]]$3X`OX^Y\cK^^ROOXNYP^ROcOK\ (76,81.75) ##
9^RO\YZO\K^SXQ\O`OX_O 295,72.38 #!
=KVOYP]M\KZ 86.97 !
3X]_\KXMOM_]^YW]KXNMK\\SO\]MVKSW] 1,20.65 " 29 PURCHASES OF STOCK-IN-TRADE
7S]MOVVKXOY_]SXMYWO
For the year ended For the year ended
A\S^OLKMUYPZ\Y`S]SYX]XYVYXQO\\O[_S\ON - "! March 31, 2018 7K\MR!
Duty drawback 26.35 "! >KLVO^] 203,85.21 "!
9^RO\] 9,34.13 "#" 3XTOM^KLVO] 1301,17.89 #!
>Y^KVY^RO\YZO\K^SXQ\O`OX_O 11,68.10   Liquids !!
147,83.31
3307,12.17 #" #
-KZ]_VO] 7,11.31 #
(a) Sale of products : 9SX^WOX^] 4,29.91 !"#
For the year ended For the year ended 1\KX_VO] 3,87.76 !#
March 31, 2018 7K\MR!
:YaNO\ 7,62.88 !
>KLVO^] 1271,21.34 # "
9^RO\] 35,43.73 "
3XTOM^KLVO] 1336,25.89  ##
Liquids 483,97.32 " 1711,22.00 #! !
-KZ]_VO] 115,61.44 #
9SX^WOX^] 14,21.44 # " 30 CHANGES IN INVENTORIES OF FINISHED GOODS, STOCK-IN-TRADE AND WORK-IN-PROGRESS
1\KX_VO] 8,09.78   For the year ended For the year ended
:YaNO\ 13,70.85  " March 31, 2018 7K\MR!
9^RO\] 30,81.95 ## 9ZOXSXQ=^YMU
3273,90.01 #! ! Finished goods 66,78.06  !
(b) Service income includes : <OPO\8Y^O- Stock-in-trade 329,57.03 " ""
For the year ended Work-in-progress 9,95.94 !"
For the year ended
March 31, 2018 7K\MR! 6O]]$-VY]SXQ=^YMU
=RK\ONKXN]_ZZY\^]O\`SMO]\OXNO\ON^Y+LLY^^2OKV^RMK\O:\S`K^O6^N3XNSK 16,27.73  "" Finished goods (62,37.72)  !" 
=RK\ONKXN]_ZZY\^]O\`SMO]^Y+LLY^^:\YN_M^]9ZO\K^SYX]+1=aS^dO\VKXN 5,26.33  " Stock-in-trade (442,45.94) #!
21,54.06  Work-in-progress (3,67.31) ###
(c) =
 KVOYPZ\YN_M^]SXMV_NO]ObMS]ON_^cMYVVOM^ONP\YWM_]^YWO\]YP` 8,61.82 Lakhs 7K\MR!$`  6KUR]=KVO (102,19.94) 
YP Z\YN_M^] XO^ YP ObMS]O N_^c S] ` 3265,28.19 Lakhs 7K\MR  ! $ ` "   6KUR] <O`OX_O P\YW YZO\K^SYX] PY\
ZO\SYN]_Z^Y4_XO!SXMV_NO]ObMS]ON_^c0\YW4_Vc!YXaK\N]ObMS]ON_^cKXNWY]^SXNS\OM^^KbO]SX3XNSKRK`O 31 EMPLOYEE BENEFITS EXPENSE
LOOX\OZVKMONLc1YYN]KXN=O\`SMO]>Kb1=>>RO-YWZKXcMYVVOM^]1=>YXLORKVPYP^RO1Y`O\XWOX^2OXMO1=>S]XY^
For the year ended For the year ended
SXMV_NONSX\O`OX_OP\YWYZO\K^SYX]3X`SOaYP^ROKPY\O]KSNMRKXQOSXSXNS\OM^^KbO]\O`OX_OP\YWYZO\K^SYX]PY\^ROcOK\
March 31, 2018 7K\MR!
OXNON7K\MR"S]XY^MYWZK\KLVOaS^R^RK^YP^ROZ\O`SY_]cOK\
=KVK\SO]aKQO]KXNLYX_] 349,65.69 
27 OTHER INCOME Contribution to provident and other funds 29,10.99 
For the year ended For the year ended =RK\OLK]ONMYWZOX]K^SYX^YOWZVYcOO]<OPO\8Y^O#M 7,97.57  "
March 31, 2018 7K\MR! =^KPPaOVPK\OObZOX]O 6,95.02  
3X^O\O]^SXMYWOYX XKXMSKVK]]O^]MK\\SONK^KWY\^S]ONMY]^$ 393,69.27 !
3X^O\O]^SXMYWOYXVYKX^YK\OVK^ONZK\^c<OPO\8Y^O- 5,20.55 -
3X^O\O]^SXMYWOYX bONNOZY]S^] 64,56.85 !! 32 FINANCE COSTS
3X^O\O]^SXMYWOYXY^RO\]P\YWOWZVYcOO]KXNY^RO\\OMOS`KLVO] 33.99 " For the year ended For the year ended
Other non-operating income : March 31, 2018 7K\MR!
Income from assignment of trademarks 45,30.26 - 3X^O\O]^ObZOX]OYX`K\SY_]]^K^_^Y\cZKcWOX^] 1,86.70 !
<OX^KVSXMYWOP\YWK\OVK^ONZK\^c<OPO\8Y^O- 28.63 - Unwinding of discount and effect of changes in discount rate on provisions
Interest income on security deposits 1,28.44 !! <OPO\8Y^O 1,95.51 # 
116,98.72 ! " 3,82.21  

124 ANNUAL REPORT 2017-18 125

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

33 DEPRECIATION AND AMORTISATION EXPENSE (b) Details of Corporate Social Responsibility (CSR) expenditure :
For the year ended For the year ended
  RO-YWZKXcLOVSO`O]^RK^\O]ZYX]SLVOKXN]_]^KSXKLVOL_]SXO]]ZVKc]KXSWZY\^KX^\YVOSXL_SVNSXQKROKV^RcKXN^R\S`SXQ
>
March 31, 2018 7K\MR!
]YMSO^c +] ZK\^ YP S^] MYWWS^WOX^ ^Y NY L_]SXO]] \O]ZYX]SLVc KXN ]_]^KSXKLVc ^RO -YWZKXc ]^\S`O] ^Y OXRKXMO KMMO]] ^Y
.OZ\OMSK^SYXYPZ\YZO\^cZVKX^KXNO[_SZWOX^<OPO\8Y^O 14,50.20 !"! ROKV^RMK\OKXNPY]^O\OMYXYWSMOX`S\YXWOX^KVKXN]YMSKVaOVVLOSXQLcNOVS`O\SXQVK]^SXQ]YV_^SYX]^Y]YMSKVMRKVVOXQO]
+WY\^S]K^SYXYPSX^KXQSLVOK]]O^]<OPO\8Y^O 1,68.34 
  +
 ] K ZK\^ YP S^] -=< YLVSQK^SYX] ^RO -YWZKXc _XNO\^YYU ]O`O\KV SXS^SK^S`O] N_\SXQ ^RO cOK\ >RO]O SXMV_NON <YKN =KPO^c
16,18.54  "
+aK\OXO]]N\S`O^R\Y_QRS-K\O=KPO^c.KcKXN8S\WKV.RK\K.KS\c:\YTOM^aRSMRPYM_]O]YXSWZ\Y`SXQVS`OVSRYYN]^R\Y_QR
ON_MK^SYX]USVVNO`OVYZWOX^KXNaYWOXOWZYaO\WOX^3XKNNS^SYX^Y^RO]OY_\ZK\^XO\]RSZaS^R=/A+=OVP/WZVYcON
34 OTHER EXPENSES AYWOXt]+]]YMSK^SYXKVYXQaS^R`K\SY_]programmesPYM_]ONYXOXRKXMSXQKMMO]]^YROKV^RMK\OKXNSWZ\Y`SXQKaK\OXO]]YP
For the year ended For the year ended ROKV^RS]]_O]aO\OMYXN_M^ONKM\Y]]3XNSK
March 31, 2018 7K\MR!
For the For the
Consumption of stores 4,06.43    year ended year ended
:YaO\KXNP_OV 10,26.24 !!#! March 31, 2018 7K\MR!
<OX^<OPO\8Y^OK 46,12.37  #"! 1\Y]]KWY_X^\O[_S\ON^YLO]ZOX^Lc^RO-YWZKXcN_\SXQ^ROcOK\K]ZO\=OM^SYX 7,87.21  "#
<OZKS\]^YL_SVNSXQ] 45.48  " YP^RO-YWZKXSO]+M^
<OZKS\]^YZVKX^KXNWKMRSXO\c 2,24.79 
Amount spent during the year ending on March 31, 2018 : In cash Yet to be paid Total
Repairs (others) 4,75.23 #!" in cash
Insurance 3,14.77 "
S -YX]^\_M^SYXKM[_S]S^SYXYPKXcK]]O^ - - -
<K^O]KXN^KbO] 17,16.22 !#
SS 9^RO\]
+N`O\^S]SXQZ_LVSMS^cKXN]KVO]Z\YWY^SYX 91,57.20 " # #
9X `K\SY_] Z\YQ\KWWO] ^Y ObZKXN KaK\OXO]] KXN
Freight and forwarding charges 30,59.15 !  KMMO]]^YROKV^RMK\O 4,54.87 88.23 5,43.10
>\K`OVVSXQKXNL_]SXO]]WOO^SXQ] 99,98.93 #!#
9XS-K\O<YKN=KPO^c+aK\OXO]]N\S`O 62.18 6.63 68.81
Commission to carrying and forwarding agents 34,77.85 !
9X8S\WKV.RK\K.KS\c:\YTOM^ 1,19.82 - 1,19.82
/bMRKXQOVY]]XO^ 5,02.35 " 
9X=/A+=OVP/WZVYcONAYWOX]+]]YMSK^SYX 1,46.35 - 1,46.35
Bad debts written off 1,10.21 #
+NWSXS]^\K^S`OObZOX]O]\OVK^ON^Y-=<KM^S`S^SO] 34.14 - 34.14
6O]]$+NT_]^ONKQKSX]^OK\VSO\cOK\t]Z\Y`S]SYX (1,10.21) #
- - 8,17.36 94.86 9,12.22
+VVYaKXMOPY\NY_L^P_VNOL^] 71.44 "
:\YPO]]SYXKVPOO]KXNY^RO\]O\`SMO] 71,32.64 !!# Amount spent during the year ending on March 31, 2017 : In cash Yet to be paid Total
6Y]]YX]KVOa\S^OYPPYPZ\YZO\^cZVKX^KXNO[_SZWOX^XO^ "" in cash
28.00
/bMS]ON_^c<OPO\8Y^OMLOVYa (4,31.10) "#  S -YX]^\_M^SYXKM[_S]S^SYXYPKXcK]]O^ - - -
:KcWOX^^YK_NS^Y\]<OPO\8Y^OKLOVYa 1,31.32 " SS 9^RO\]
-=<ObZOXNS^_\O<OPO\8Y^OLLOVYa 9,12.22 !# 9X `K\SY_] Z\YQ\KWWO] ^Y ObZKXN KaK\OXO]] KXN
KMMO]]^YROKV^RMK\O  #  #
7S]MOVVKXOY_]ObZOX]O] 46,94.82  
475,56.35 !#  9XS-K\O<YKN=KPO^c+aK\OXO]]N\S`O "#  
9X8S\WKV.RK\K.KS\c:\YTOM^  " -  "
(a) Payment to auditors +NWSXS]^\K^S`OObZOX]O]\OVK^ON^Y-=<KM^S`S^SO]  - 
For the year ended For the year ended   #  !#
March 31, 2018 7K\MR!
(c) /
 bMS]ON_^cSXMV_NON_XNO\s9^RO\ObZOX]O]t\OZ\O]OX^]^RONSPPO\OXMOSXKWY_X^YPObMS]ON_^cYXMVY]SXQ]^YMUKXNYZOXSXQ
As auditor ]^YMUYP XS]RONQYYN]KXNObMS]ON_^cZKSNYX^ROQYYN]NS]^\SL_^ONK]P\OOQYYN]WONSMKV]KWZVO]
Audit fees 63.80  
>KbK_NS^POO] 13.75  35 COMPONENTS OF OTHER COMPREHENSIVE INCOME (OCI)
Limited review 25.50 "" For the year ended For the year ended
March 31, 2018 7K\MR!
In other capacity <OWOK]_\OWOX^]YPZY]^OWZVYcWOX^LOXO ^]$<OPO\8Y^O"
9^RO\]O\`SMO]SXMV_NSXQMO\^S MK^SYXPOO] 21.13  1\K^_S^c (1,53.93) ! 
<OSWL_\]OWOX^YPObZOX]O] 7.14 !"! :Y]^\O^S\OWOX^WONSMKVLOXO ^]MROWO (13.79) #
1,31.32 " (1,67.72) " #

126 ANNUAL REPORT 2017-18 127

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

36 EARNINGS PER EQUITY SHARE (EPS) Intangible assets under development

 >ROPYVVYaSXQ\O
OM^]^ROSXMYWOKXN]RK\ONK^K_]ONSX^RO,K]SMKXN.SV_^ON/:=MYWZ_^K^SYX]$  >RO-YWZKXcMKZS^KVS]O]SX^KXQSLVOK]]O^]_XNO\NO`OVYZWOX^PY\KZ\YTOM^SXKMMY\NKXMOaS^R^ROKMMY_X^SXQZYVSMc3XS^SKVMKZS^KVS]K^SYX
YP MY]^] S] LK]ON YX WKXKQOWOX^t] T_NQOWOX^ ^RK^ ^OMRXYVYQSMKV KXN OMYXYWSM POK]SLSVS^c S] MYX \WON P_^_\O OMYXYWSM LOXO ^] K\O
For the year ended For the year ended Z\YLKLVO^RO-YWZKXcRK]^ROSX^OX^SYXKXNKLSVS^c^YMYWZVO^OKXN_]O^ROK]]O^KXN^ROMY]^MKXLOWOK]_\ON\OVSKLVc+V]Y\OPO\8Y^O
March 31, 2018 7K\MR!
Fair value measurement of financial instruments
:\Y ^K^^\SL_^KLVO^YO[_S^cRYVNO\]PY\,K]SM.SV_^ONOK\XSXQ] 401,21.78 !  ""
AOSQR^ONK`O\KQOX_WLO\YPO[_S^c]RK\O]PY\,K]SM.SV_^ON/:= 2,12,49,302 #   ROX^ROPKS\`KV_O]YP XKXMSKVK]]O^]KXN XKXMSKVVSKLSVS^SO]\OMY\NONSX^RO,KVKXMO=ROO^MKXXY^LOWOK]_\ONLK]ONYX[_Y^ON
A
Z\SMO]SXKM^S`OWK\UO^]^ROS\PKS\`KV_OS]WOK]_\ON_]SXQKZZ\YZ\SK^O`KV_K^SYX^OMRXS[_O]>ROSXZ_^]PY\^RO]O`KV_K^SYX]K\O
Basic/Diluted EPS ` (Face value of ` 10 per share) 188.81 # ^KUOX P\YW YL]O\`KLVO ]Y_\MO] aRO\O ZY]]SLVO L_^ aRO\O ^RS] S] XY^ POK]SLVO K NOQ\OO YP T_NQOWOX^ S] \O[_S\ON SX O]^KLVS]RSXQ
>RO\ORK`OLOOXXY^\KX]KM^SYX]SX`YV`SXQO[_S^c]RK\O]Y\ZY^OX^SKVO[_S^c]RK\O]LO^aOOX^RO\OZY\^SXQNK^OKXN^RONK^OYP PKS\ `KV_O] 4_NQOWOX^] SXMV_NO MYX]SNO\K^SYX] YP `K\SY_] SXZ_^] SXMV_NSXQ VS[_SNS^c \S]U M\ONS^ \S]U `YVK^SVS^c O^M -RKXQO] SX
K_^RY\S]K^SYXYP^RO]O XKXMSKV]^K^OWOX^] K]]_WZ^SYX]T_NQOWOX^]KLY_^^RO]OPKM^Y\]MY_VNKPPOM^^RO\OZY\^ONPKS\`KV_OYP XKXMSKVSX]^\_WOX^]+V]Y\OPO\8Y^O
Provision for inventories
37 SIGNIFICANT ACCOUNTING JUDGEMENTS, ESTIMATES AND ASSUMPTIONS   \Y`S]SYXS]WKNOSX^RO XKXMSKV]^K^OWOX^]PY\]VYaKXNXYXWY`SXQS^OW]LK]ONYXO]^SWK^O]\OQK\NSXQ^ROS\_]KLSVS^c0_\^RO\PY\
:
XS]RONQYYN]KXN]^YMUSX^\KNOKVVSX`OX^Y\SO]ObZS\SXQaS^RSX]SbWYX^R]KXNXY^ObZOM^ON^YLO]YVNRK`OLOOXP_VVcZ\Y`SNON
 ROZ\OZK\K^SYXYP^RO-YWZKXct] XKXMSKV]^K^OWOX^]SXMYXPY\WS^caS^R3XN+=\O[_S\O]WKXKQOWOX^^YWKUOT_NQOWOX^]O]^SWK^O]
>
PY\+V]Y\OPO\8Y^O#
KXNK]]_WZ^SYX]^RK^KPPOM^^RO\OZY\^ONKWY_X^]YP\O`OX_O]ObZOX]O]K]]O^]KXNVSKLSVS^SO]KXN^ROKMMYWZKXcSXQNS]MVY]_\O]KXN
^RONS]MVY]_\OYPMYX^SXQOX^VSKLSVS^SO]?XMO\^KSX^cKLY_^^RO]OK]]_WZ^SYX]KXNO]^SWK^O]MY_VN\O]_V^SXY_^MYWO]^RK^\O[_S\OK Impairment of trade receivables
WK^O\SKVKNT_]^WOX^^Y^ROMK\\cSXQKWY_X^YPK]]O^]Y\VSKLSVS^SO]KPPOM^ONSXP_^_\OZO\SYN]>ROO]^SWK^O]KXNK]]YMSK^ONK]]_WZ^SYX]   Y\ ^RO Z_\ZY]O YP WOK]_\SXQ VSPO^SWO ObZOM^ON M\ONS^ VY]] KVVYaKXMO YP ^\KNO \OMOS`KLVO] ^RO -YWZKXc RK] _]ON K Z\KM^SMKV
0
K\OLK]ONYXRS]^Y\SMKVObZO\SOXMOKXN`K\SY_]Y^RO\PKM^Y\]^RK^K\OLOVSO`ON^YLO\OK]YXKLVO_XNO\^ROMS\M_W]^KXMO]ObS]^SXQaROX ObZONSOX^K]ZO\WS^^ON_XNO\3XN+=#>RS]ObZOM^ONM\ONS^VY]]KVVYaKXMOS]MYWZ_^ONLK]ONYXKZ\Y`S]SYXWK^\SbaRSMR^KUO]
^RO XKXMSKV ]^K^OWOX^] aO\O Z\OZK\ON >RO O]^SWK^O] KXN _XNO\VcSXQ K]]_WZ^SYX] K\O \O`SOaON YX KX YXQYSXQ LK]S] <O`S]SYX ^Y SX^YKMMY_X^RS]^Y\SMKVM\ONS^VY]]ObZO\SOXMOKXNKNT_]^ONPY\PY\aK\NVYYUSXQSXPY\WK^SYX>ROVY]]KVVYaKXMOPY\Y^RO\ XKXMSKV
KMMY_X^SXQO]^SWK^O]S]\OMYQXS]ONSX^ROcOK\SXaRSMR^ROO]^SWK^O]K\O\O`S]ONKXNSXKXcP_^_\OcOK\KPPOM^ON K]]O^]K\OLK]ONYXK]]_WZ^SYX]KLY_^\S]UYPNOPK_V^>RO-YWZKXc_]O]T_NQWOX^]SXWKUSXQ^RO]OK]]_WZ^SYX]LK]ONYXS^]ZK]^
RS]^Y\cObS]^SXQWK\UO^MYXNS^SYX]KXNMO\^KSX^cYP\OKVS]K^SYX+V]Y\OPO\8Y^O
ESTIMATES AND ASSUMPTIONS
Impairment of other financial assets
  ROUOcK]]_WZ^SYX]MYXMO\XSXQ^ROP_^_\OKXNY^RO\UOc]Y_\MO]YPO]^SWK^SYXK^^RO\OZY\^SXQNK^OaRSMRWKcMK_]OKWK^O\SKV
>
  RO VY]] KVVYaKXMO PY\ Y^RO\ XKXMSKV K]]O^] K\O LK]ON YX K]]_WZ^SYX] KLY_^ \S]U YP NOPK_V^ >RO -YWZKXc _]O] T_NQWOX^] SX
>
KNT_]^WOX^^Y^ROMK\\cSXQKWY_X^]YPK]]O^]KXNVSKLSVS^SO]aS^RSX^ROXOb^ XKXMSKVcOK\K\ONO]M\SLONLOVYa>RO-YWZKXcLK]ON
WKUSXQ^RO]OK]]_WZ^SYX]LK]ONYXS^]ZK]^RS]^Y\cObS]^SXQWK\UO^MYXNS^SYX]KXNMO\^KSX^cYP\OKVS]K^SYX+VY]\OPO\8Y^O 
S^]K]]_WZ^SYX]KXNO]^SWK^O]YXZK\KWO^O\]K`KSVKLVOaROX^RO XKXMSKV]^K^OWOX^]aO\OZ\OZK\ON/bS]^SXQMS\M_W]^KXMO]KXN
K]]_WZ^SYX]KLY_^P_^_\ONO`OVYZWOX^]RYaO`O\WKcMRKXQON_O^YWK\UO^MRKXQO]Y\MS\M_W]^KXMO]K\S]SXQ^RK^K\OLOcYXN^RO Provision for sales return and date expiry
MYX^\YVYP^RO-YWZKXc=_MRMRKXQO]K\O\O
OM^ONSX^ROK]]_WZ^SYX]aROX^ROcYMM_\   RO -YWZKXc K] ZO\ ^\KNO Z\KM^SMO KMMOZ^] \O^_\X] P\YW WK\UO^ aRSMR K\O Z\SWK\SVc SX ^RO XK^_\O YP ObZS\ON Y\ XOK\ ObZS\c
>
Z\YN_M^]:\Y`S]SYX]PY\]_MR\O^_\X]K\OO]^SWK^ONYX^ROLK]S]YPRS]^Y\SMKVObZO\SOXMOKXNWK\UO^MYXNS^SYX]KXNK\OZ\Y`SNONPY\
Discounting of security deposits
KMMY\NSXQVc+V]Y\OPO\8Y^O
The Company has considered State Bank of India (SBI) base rate of respective periods in which transaction had occurred for
Non-current assets held for sale
WOK]_\SXQNOZY]S^LOSXQ XKXMSKVK]]O^]K^KWY\^S]ONMY]^<OPO\8Y^O!3X^O\O]^SXMYWOYX]OM_\S^cNOZY]S^]
  ]]O^]ROVNPY\]KVOK\OWOK]_\ONK^^ROVYaO\YPMK\\cSXQKWY_X^Y\PKS\`KV_OVO]]MY]^]^Y]OVV>RONO^O\WSXK^SYXYPPKS\`KV_OVO]]
+
Useful lives of Property, plant and equipment MY]^]^Y]OVVSXMV_NO]_]OYPWKXKQOWOX^O]^SWK^O]KXNK]]_WZ^SYX>ROPKS\`KV_OYP^ROK]]O^]ROVNPY\]KVORK]LOOXO]^SWK^ON
_]SXQ`KV_K^SYX^OMRXS[_OSOWK\UO^KZZ\YKMR+V]Y\OPO\8Y^O 
 >RO-YWZKXc\O`SOa]^RO_]OP_VVSPOYPZ\YZO\^cZVKX^KXNO[_SZWOX^K^^ROOXNYPOKMR\OZY\^SXQZO\SYN>RS]\OK]]O]]WOX^WKc
\O]_V^SXMRKXQOSXNOZ\OMSK^SYXObZOX]OSXP_^_\OZO\SYN]<OPO\8Y^OP PY\WKXKQOWOX^O]^SWK^OYP_]OP_VVS`O] 38 EMPLOYEE BENEFITS
Defined benefit plans (Gratuity benefits) K .O XONMYX^\SL_^SYXZVKX]
 >RO MY]^ YP ^RO NO XON LOXO ^ Q\K^_S^c ZVKX KXN Y^RO\ ZY]^ OWZVYcWOX^ WONSMKV LOXO ^] KXN ^RO Z\O]OX^ `KV_O YP ^RO Q\K^_S^c   S :\Y`SNOX^0_XN/WZVYcOO]t:OX]SYX0_XN
YLVSQK^SYXK\ONO^O\WSXON_]SXQKM^_K\SKV`KV_K^SYX]+XKM^_K\SKV`KV_K^SYXSX`YV`O]WKUSXQ`K\SY_]K]]_WZ^SYX]^RK^WKcNSPPO\   SS /WZVYcOO]t=^K^O3X]_\KXMO
P\YWKM^_KVNO`OVYZWOX^]SX^ROP_^_\O>RO]OSXMV_NO^RONO^O\WSXK^SYXYP^RONS]MY_X^\K^OP_^_\O]KVK\cSXM\OK]O]KXNWY\^KVS^c iii) Superannuation Fund
\K^O]._O^Y^ROMYWZVObS^SO]SX`YV`ONSX^RO`KV_K^SYXKXNS^]VYXQ^O\WXK^_\OKNO XONLOXO ^YLVSQK^SYXS]RSQRVc]OX]S^S`O^Y
  S` /WZVYcOO]t.OZY]S^6SXUON3X]_\KXMO=MROWO
MRKXQO]SX^RO]OK]]_WZ^SYX]+VVK]]_WZ^SYX]K\O\O`SOaONK^OKMR\OZY\^SXQNK^O
  ` 1\Y_Z6SPO3X]_\KXMO-Y`O\
  ROZK\KWO^O\WY]^]_LTOM^^YMRKXQOS]^RONS]MY_X^\K^O3XNO^O\WSXSXQ^ROKZZ\YZ\SK^ONS]MY_X^\K^O^ROWKXKQOWOX^MYX]SNO\]
>
^ROSX^O\O]^\K^O]YPQY`O\XWOX^LYXN]SXM_\\OXMSO]MYX]S]^OX^aS^R^ROM_\\OXMSO]YP^ROZY]^OWZVYcWOX^LOXO ^YLVSQK^SYX >RO-YWZKXcRK]\OMYQXS]ONPYVVYaSXQKWY_X^]K]ObZOX]OSX^RO=^K^OWOX^YP:\Y ^KXN6Y]]$
For the year ended For the year ended
  ROWY\^KVS^c\K^OS]LK]ONYXZ_LVSMVcK`KSVKLVOWY\^KVS^c^KLVO]PY\^RO]ZOMS MMY_X^\SO]>RY]OWY\^KVS^c^KLVO]^OXN^YMRKXQO
>
March 31, 2018 7K\MR!
YXVc K^ SX^O\`KV SX \O]ZYX]O ^Y NOWYQ\KZRSM MRKXQO] 0_^_\O ]KVK\c SXM\OK]O KXN Q\K^_S^c SXM\OK]O K\O LK]ON YX ObZOM^ON P_^_\O
SX
K^SYX\K^O]SX^ROMY_X^\c Included in contribution to Provident and Other Funds <OPO\8Y^O
/WZVYcO\t]MYX^\SL_^SYX^Y:\Y`SNOX^0_XN/WZVYcOO]t:OX]SYX0_XN 14,84.71 !
 0_\^RO\NO^KSV]KLY_^Q\K^_S^cYLVSQK^SYX]K\OQS`OXSX8Y^O"
/WZVYcO\t]MYX^\SL_^SYX^Y=_ZO\KXX_K^SYX0_XN 3,08.97 "
Share based compensation to employees Included in staff welfare expenses<OPO\8Y^O
  ROPKS\`KV_OYP\O]^\SM^ON]^YMU_XS^]ZVKXS]WOK]_\ONK^^RONK^OYPQ\KX^_]SXQ^RO,VKMU=MRYVO]YZ^SYXZ\SMSXQWYNOV>RO
> /WZVYcO\t]MYX^\SL_^SYX^Y/WZVYcOO]t.OZY]S^6SXUON3X]_\KXMO=MROWO 44.37 
O]^SWK^OKV]Y\O[_S\O]NO^O\WSXK^SYXYP^ROWY]^KZZ\YZ\SK^OSXZ_^]^Y^RO`KV_K^SYXWYNOVSXMV_NSXQ^RO`YVK^SVS^cNS`SNOXNcSOVN :\OWS_WZKSNSX\O]ZOM^YP1\Y_Z6SPO3X]_\KXMO-Y`O\ 41.08 #!
\S]UP\OOSX^O\O]^\K^O]ObZOM^ONVSPOYP]RK\OYZ^SYXO^MaRSMRK\ONS]MVY]ONSX^RO8Y^O# :\OWS_WZKSNSX\O]ZOM^YP/WZVYcOO]t=^K^O3X]_\KXMO=MROWO 27.13 !!!

128 ANNUAL REPORT 2017-18 129

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

L .O XONLOXO ^ZVKX] Gratuity (Funded) :Y]^<O^S\OWOX^7ONSMKV,OXO ^]

(Non-funded)
S Gratuity :3XMV_NONK]ZK\^YPMYX^\SL_^SYX^YZ\Y`SNOX^KXNY^RO\P_XN]SX8Y^O/WZVYcOOLOXO ^]ObZOX]O
As at As at As at As at
   1
 \K^_S^cS]ZKcKLVO^YKVVOVSQSLVOOWZVYcOO]YP^RO-YWZKXcYX\O^S\OWOX^NOK^RZO\WKXOX^NS]KLVOWOX^KXN\O]SQXK^SYX March 31, 2018 7K\MR! March 31, 2018 7K\MR!
SX^O\W]YP^ROZ\Y`S]SYXYP^RO:KcWOX^YP1\K^_S^c+M^#!Y\-YWZKXct]=MROWOaRSMRO`O\S]WY\OLOXO MSKV,OXO ^] III) Net (asset)/liability recognised in the
aY_VNLOZKSNK^^RO^SWOYP^RO]OZK\K^SYXLK]ONYXOWZVYcOO]t]KVK\cKXN^OX_\OYPOWZVYcWOX^aS^R^RO-YWZKXc Balance Sheet
  SS :
 Y]^<O^S\OWOX^7ONSMKV,OXO ^]:<7,$3XMV_NONK]ZK\^YP]^KPPaOVPK\OObZOX]O]SX8Y^O/WZVYcOOLOXO ^] :\O]OX^`KV_OYPNO XONLOXO ^YLVSQK^SYX
ObZOX]O at the end of the year 58,47.13   1,29.81 !
0KS\`KV_OYPZVKXK]]O^]K^^ROOXNYP^RO
   ?
 XNO\^RS]]MROWO]OVOM^Q\Y_ZYP]OXSY\OWZVYcOO]KXN^ROS\]ZY_]OK\OMY`O\ONPY\RY]ZS^KVS]K^SYXLOXO ^]KP^O\^RO
year (unquoted insurer managed funds) (49,99.35)  - -
OWZVYcOORK]\O^S\ONP\YW^RO-YWZKXc>ROMY`O\S]K`KSVKLVO^Y^RO]OLOXO MSK\SO]_X^SV^ROcK\OKVS`O>RO-YWZKXc
RK]Z\YM_\ONKQ\Y_ZRY]ZS^KVS]K^SYXMY`O\P\YWKXSX]_\KXMOMYWZKXcPY\Z\Y`SNSXQ^RO]OLOXO ^]^Y^RO]OLOXO MSK\SO] +WY_X^\OMYQXS]ONSX^RO,KVKXMO=ROO^
8O^P_XNONYLVSQK^SYX 8,47.78 "! 1,29.81 !
  SSS 6YXQ=O\`SMO,OXO ^]6=,$3XMV_NONK]ZK\^YP]KVK\SO]KXNaKQO]SX8Y^O/WZVYcOOLOXO ^]ObZOX]O Net liability-current (Refer Note 24) 8,47.78 "! 10.60 ""
   ?
 XNO\^RS]]MROWOVYXQ]O\`SMOLOXO ^]KMM\_O]^Y^ROOWZVYcOOaRSVOSX]O\`SMOKXNS]ZKcKLVO_ZYXMYWZVO^SYXYP Net liability-non-current (Refer Note 19) - - 1,19.21 "
]^SZ_VK^ON]O\`SMOaS^R^RO-YWZKXc
Gratuity (Funded) :Y]^<O^S\OWOX^7ONSMKV,OXO ^] For the For the For the For the
(Non-funded) year ended year ended year ended year ended
March 31, 2018 7K\MR! March 31, 2018 7K\MR!
For the For the For the For the
year ended year ended year ended year ended IV) Expenses recognised in the Statement of
March 31, 2018 7K\MR! March 31, 2018 7K\MR! :\Y ^KXN6Y]]PY\^ROcOK\
I) -RKXQOSXZ\O]OX^`KV_OYPNO XON Current service cost 4,17.80   1.22 "#
LOXO ^YLVSQK^SYXN_\SXQ^ROcOK\
:K]^]O\`SMOMY]^ 6,64.26 - - -
:\O]OX^`KV_OYPNO XONLOXO ^YLVSQK^SYX
at the beginning of the year 45,65.20 #!! 1,17.23  3X^O\O]^MY]^YXLOXO ^YLVSQK^SYXXO^ 18.99  8.18 !#"
Interest cost 3,16.27 # " 8.18 !#" 9XOCOK\<OXOaKLVO>O\W+]]_\KXMO
9C<>+:\OWS_W 29.71   - -
Current service cost 4,17.80   1.22 "#
Total expenses included in Employee
:K]^]O\`SMOMY]^ 6,64.26 - - - LOXO ^]ObZOX]O 11,30.76 # 9.40 ""!
,OXO ^]ZKSN (2,97.23) #!# (10.61) !!!
V) Recognised in other comprehensive
+M^_K\SKVMRKXQO]K\S]SXQP\YWMRKXQO]SX income for the year
demographic assumptions 57.39 - - -
+M^_K\SKVMRKXQO]K\S]SXQP\YWMRKXQO]SX
+M^_K\SKVMRKXQO]K\S]SXQP\YWMRKXQO]SX demographic assumptions 57.39 - - -
XKXMSKVK]]_WZ^SYX] (42.16)   (5.48)  
+M^_K\SKVMRKXQO]K\S]SXQP\YWMRKXQO]SX
+M^_K\SKVMRKXQO]K\S]SXQP\YWMRKXQO]SX XKXMSKVK]]_WZ^SYX] (42.16)   (5.48)  
ObZO\SOXMOKNT_]^WOX^] 1,65.60 #! 19.27 
+M^_K\SKVMRKXQO]K\S]SXQP\YWMRKXQO]SX
:\O]OX^`KV_OYPNO XONLOXO ^ ObZO\SOXMOKNT_]^WOX^] 1,65.60 #! 19.27 
obligation at the end of the year 58,47.13   1,29.81 !
<O^_\XYXZVKXK]]O^]ObMV_NSXQSX^O\O]^
income (26.90) !"  - -
II) Change in fair value of plan assets during Recognised in other comprehensive
the year income for the year (Refer Note 35) 1,53.93 !  13.79 #
0KS\`KV_OYPZVKXK]]O^]K^^ROLOQSXXSXQYP
VI) 7K^_\S^cZ\Y VOYPNO XONLOXO ^
the year 41,53.33 !!  - -
obligation
Interest income 2,97.28 ! - -
AS^RSX^ROXOb^WYX^R]XOb^KXX_KV
-YX^\SL_^SYX]ZKSNLc^ROOWZVYcO\ 8,19.07  " 10.61 !!! reporting period) 12,13.21 " 10.61 ""
,OXO ^]ZKSNP\YW^ROP_XN (2,97.23) #!# (10.61) !!! ,O^aOOXKXNcOK\] 29,14.54  43.87  !
<O^_\XYXZVKXK]]O^]ObMV_NSXQSX^O\O]^ ,O^aOOX KXN#cOK\] 19,16.95 " 44.89 !#
income 26.90 !" - -
0Y\cOK\]KXNKLY`O 40,97.12 "! " 2,00.26 #
Fair value of plan assets at the end of the
year 49,99.35  - -

130 ANNUAL REPORT 2017-18 131

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

Gratuity (Funded) :Y]^<O^S\OWOX^7ONSMKV,OXO ^]   RO K`O\KQO N_\K^SYX YP ^RO NO XON LOXO ^ ZVKX YLVSQK^SYX K^ ^RO OXN YP ^RO \OZY\^SXQ ZO\SYN PY\ 1\K^_S^c S] 5.65 years
>
(Non-funded) 7K\MR!$cOK\]KXNPY\:<7,S]8.12 years 7K\MR!$""cOK\]
As at As at As at As at Notes :
March 31, 2018 7K\MR! March 31, 2018 7K\MR!
 S >ROKM^_K\SKV`KV_K^SYXYPZVKXK]]O^]KXN^ROZ\O]OX^`KV_OYP^RONO XONLOXO ^YLVSQK^SYXaO\OMK\\SONY_^K]K^7K\MR
VII) =OX]S^S`S^cKXKVc]S]PY\]SQXS MKX^ ">ROZ\O]OX^`KV_OYP^RONO XONLOXO ^YLVSQK^SYXKXN^RO\OVK^ONM_\\OX^]O\`SMOMY]^KXNZK]^]O\`SMOMY]^aO\O
assumption is as below : WOK]_\ON_]SXQ^RO:\YTOM^ON?XS^-\ONS^7O^RYN
1. Increase/(decrease) on present value of
 SS .S]MY_X^\K^OS]LK]ONYX^ROZ\O`KSVSXQWK\UO^cSOVN]YP3XNSKX1Y`O\XWOX^]OM_\S^SO]K]K^^RO,KVKXMO=ROO^NK^OPY\^RO
NO XONLOXO ^]YLVSQK^SYXK^^ROOXNYP
O]^SWK^ON^O\WYP^ROYLVSQK^SYX]
the year
3WZKM^YPLZ]SXM\OK]OSXNS]MY_X^\K^O (2.75%) "  (3.91%)   SSS >RO]KVK\cO]MKVK^SYX\K^OS]K\\S`ONKP^O\^KUSXQSX^YMYX]SNO\K^SYX^RO]OXSY\S^c^ROZ\YWY^SYXKXNY^RO\\OVO`KX^PKM^Y\]]_MR
K]NOWKXNKXN]_ZZVcSXOWZVYcWOX^WK\UO^
3WZKM^YPLZ]NOM\OK]OSXNS]MY_X^\K^O 2.90% ! 4.22%  
3WZKM^YPLZ]SXM\OK]OSXROKV^RMK\OMY]^ - - 8.84% # 
39 SHARE BASED COMPENSATION TO EMPLOYEES
3WZKM^YPLZ]NOM\OK]OSXROKV^RMK\OMY]^ - - (7.74%) "
3WZKM^YPSXM\OK]OLccOK\SXVSPOObZOM^KXMc - - 3.64%   a) International Stock Ownership Plan (Stocks of Abbott Laboratories, USA, being Ultimate Holding Company)
3WZKM^YPNOM\OK]OLccOK\SXVSPO   +
 LLY^^6KLY\K^Y\SO]?=+RK]KXs+P VSK^O/WZVYcOO=^YMU:_\MRK]O:VKXtOWZVYcOO]RK\OZ_\MRK]OZVKXaRO\OLc]ZOMS ON
ObZOM^KXMc - - (3.64%)   OWZVYcOO]YPS^]]_L]SNSK\SO]RK`OLOOXQS`OXK\SQR^^YZ_\MRK]O]RK\O]YP+LLY^^6KLY\K^Y\SO]?=+/`O\cOWZVYcOOaRYYZ^]
3WZKM^YPLZ]SXM\OK]OSX\K^OYP]KVK\c PY\^RO]MROWOMYX^\SL_^O]LcaKcYPZKc\YVVNON_M^SYX]_Z^YYPRS]MK]R\OW_XO\K^SYXSOLK]SM]KVK\cPY\YP MO\]KXN
increase 2.73%  # - - LK]SM]KVK\cKXNNOK\XO]]KVVYaKXMOPY\]^KPPMK^OQY\c^YaK\N]Z_\MRK]OYP]RK\O]YXKWYX^RVcLK]S]Y`O\^ROZ_\MRK]OMcMVO
3WZKM^YPLZ]NOM\OK]OSX\K^OYP]KVK\c YP]SbWYX^R]
increase (2.65%)   - -   >
 ROWKbSW_W^RK^KXOWZVYcOOMKXMYX^\SL_^O^Y^ROZVKXS]?=ZO\Z_\MRK]OMcMVOY\?=ZO\MKVOXNK\cOK\
2. Sensitivity analysis method +^^ROOXNYP^ROMcMVOKMM_W_VK^ONZKc\YVVNON_M^SYX]K\O_]ON^YZ_\MRK]O]RK\O]K^KNS]MY_X^ONZ\SMO>ROZ_\MRK]OZ\SMO
YP^RO]RK\OS]"YP^ROVO]]O\YPPKS\WK\UO^`KV_OOS^RO\YX^RO \]^Y\VK]^NKcYP^ROZ_\MRK]OMcMVO>RO]RK\O]YP+LLY^^
  >
 RO =OX]S^S`S^c KXKVc]S] KLY`O RK`O LOOX NO^O\WSXON LK]ON YX K WO^RYN ^RK^ Ob^\KZYVK^O] ^RO SWZKM^ YX NO XON LOXO ^ 6KLY\K^Y\SO]?=+K\OVS]^ONaS^R^RO8OaCY\U=^YMU/bMRKXQO?=+KXNK\OZ_\MRK]ONYXLORKVPYP^ROOWZVYcOO]K^WK\UO^
YLVSQK^SYXK]K\O]_V^YP\OK]YXKLVOMRKXQO]SXUOcK]]_WZ^SYX]YMM_\SXQK^^ROOXNYP^RO\OZY\^SXQZO\SYN Z\SMOVO]]NS]MY_X^KVVYMK^ON^YZK\^SMSZKX^]K]YPVK]^NKcYP^ROZ_\MRK]OMcMVO>ROMYXMO]]SYXSX^ROZ\SMOYP^RO]RK\O]S]
Gratuity (Funded) :Y]^<O^S\OWOX^7ONSMKV,OXO ^] OX^S\OVcLY\XOLc+LLY^^6KLY\K^Y\SO]?=+
(Non-funded)    _\SXQ^ROcOK\OXNON7K\MR"17,811 shares 7K\MR!$# !]RK\O]aO\OZ_\MRK]ONLcOWZVYcOO]K^aOSQR^ON
.
As at As at As at As at K`O\KQOPKS\`KV_OYPUS$ 38.71 7K\MR!$?=##ZO\]RK\O
March 31, 2018 7K\MR! March 31, 2018 7K\MR!
VIII) The major categories of plan assets as a b) Employees Stock Options Plan (Stocks of Abbott Laboratories, USA, being Ultimate Holding Company)
percentage of total   +
 LLY^^6KLY\K^Y\SO]?=+RK]KXs3XMOX^S`O=^YMU9Z^SYX:\YQ\KWtaRO\OLc]ZOMS ONOWZVYcOO]YPS^]]_L]SNSK\SO]MY`O\ON
Insurer managed funds 100%  - - Lc^ROZVKXK\OQ\KX^ONKXYZ^SYX^YZ_\MRK]O]RK\O]YP+LLY^^6KLY\K^Y\SO]?=+K^K bONZ\SMOQ\KX^Z\SMOaRSMR]RKVVLO
>RO>\_]^OO]RK`O^KUOX:YVSMcP\YW6SPO3X]_\KXMO-Y\ZY\K^SYXYP3XNSK63-KXNZKc]Z\OWS_W63-SX^_\XWKXKQO] K^VOK]^YP^ROPKS\WK\UO^`KV_OYP^ROMYWWYX]RK\OPY\K bONZO\SYNYP^SWO+VV^ROYZ^SYX]_XNO\^RS]]MROWORK`O
^ROK]]O^]aRSMRS]aS^RSX^ROZO\WS]]SLVOVSWS^]Z\O]M\SLONSX^ROSX]_\KXMO\OQ_VK^SYX]>RO-YWZKXcNYO]XY^PY\]OOKXc `O]^ONLOPY\O+Z\SVKXNROXMOK]ZO\^ROObOWZ^SYXK`KSVONSX3XN+=s0S\]^^SWOKNYZ^SYXYP3XNSKX+MMY_X^SXQ
WK^O\SKV\S]UP\YW^RO]OSX`O]^WOX^] =^KXNK\N]tXYYZ^SYX]MYWZOX]K^SYXObZOX]O]K\OSXM_\\ONLc^RO-YWZKXcN_\SXQ^ROcOK\>RO]RK\O]YP+LLY^^6KLY\K^Y\SO]
?=+K\OVS]^ONaS^R^RO8OaCY\U=^YMU/bMRKXQO?=+>ROQ\KX^]S]]_ONK\O`O]^ONSXYXO^RS\NSX]^KVVWOX^]Y`O\K^R\OOcOK\
IX) Actuarial assumptions ZO\SYNKXNRK`OKcOK\]MYX^\KM^_KVVSPO
Gratuity (Funded) :Y]^<O^S\OWOX^7ONSMKV,OXO ^]
(Non-funded) For the year ended For the year ended
As at As at As at As at March 31, 2018 7K\MR!
March 31, 2018 7K\MR! March 31, 2018 7K\MR! Number of Weighted 8_WLO\YP Weighted
Discount rate 7.75% ! 7.75% ! options average options average
=KVK\cO]MKVK^SYX 10% until year _X^SVcOK\ - - exercise price ObO\MS]OZ\SMO
2 inclusive, and SXMV_]S`OKXN US $ ?=
7% thereafter !^RO\OKP^O\ 9_^]^KXNSXQK^^ROLOQSXXSXQYP^ROcOK\ 7,700 27.80   !"
7Y\^KVS^c\K^ON_\SXQOWZVYcWOX^ Indian Assured Indian Assured - - 6O]]$/bO\MS]ONN_\SXQ^ROcOK\ (7,700) (27.80)  #  !
Lives Mortality 6S`O]7Y\^KVS^c
6O]]$/bZS\ONN_\SXQ^ROcOK\ - - - -
(2006-08) Ult  "?V^
table ^KLVO 6O]]$>\KX]PO\Y_^N_\SXQ^ROcOK\ - - - -
<K^OYPVOK`SXQ]O\`SMO Age related +QO\OVK^ON - - Outstanding at the end of the year - - !! !"
7Y\^KVS^cZY]^\O^S\OWOX^\K^O - - PA (90) :+# /bO\MS]KLVOK^^ROOXNYP^ROcOK\ - - !! !"
Mortality table 7Y\^KVS^c^KLVO
+XX_KVSXM\OK]OSXROKV^RMK\OMY]^] - - 6%     RO aOSQR^ON K`O\KQO ]RK\O Z\SMO K^ ^RO NK^O YP ObO\MS]O PY\ ]^YMU YZ^SYX] ObO\MS]ON N_\SXQ ^RO cOK\ aK] US$ 76.57
>
7K\MR!$?= KXNaOSQR^ONK`O\KQO\OWKSXSXQMYX^\KM^_KVVSPOS]NIL year7K\MR!$""cOK\]
/bZOM^ON\O^S\OWOX^KQOYPOWZVYcOO] 58/60 years, as " cOK\]K] 60 years cOK\]
applicable KZZVSMKLVO >ROK`O\KQOObO\MS]OZ\SMOPY\YZ^SYX]Y_^]^KXNSXQK^^ROOXNYP^ROcOK\aK]US$ NIL 7K\MR!$?= !^Y?=!"
  bZOM^ON MYX^\SL_^SYX ^Y ^RO NO XON LOXO ^ ZVKX 1\K^_S^c PY\ ^RO XOb^ KXX_KV \OZY\^SXQ ZO\SYN S] ` 8,48.00 Lakhs
/ During the year, ` 83.03 Lakhs 7K\MR!$`!6KUR]aS^RRYVNSXQ^KbO]RK]LOOXNOZY]S^ONaS^R^KbK_^RY\S^SO]
7K\MR!$` 6KUR] KQKSX]^ObMO\MS]ONYZ^SYX]

132 ANNUAL REPORT 2017-18 133

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

c) Employees Restricted Stock Options Plan (Stocks of Abbott Laboratories, USA, being Ultimate Holding Company) Disclosures with respect to operating leases :
 LLY^^6KLY\K^Y\SO]?=+K]ZK\^YP^ROs6YXQ>O\W3XMOX^S`O:\YQ\KWtRK]YPPO\ON<O]^\SM^ON=^YMU?XS^]<=?]^Y]ZOMS ON
+ For the year ended For the year ended
OWZVYcOO]YPS^]]_L]SNSK\SO]aRO\OLc^ROOWZVYcOO]MY`O\ONLc^ROZVKXK\OQ\KX^ON_XS^]>RO_XS^]aROX`O]^ONLOMYWO March 31, 2018 7K\MR!
]RK\O] YP +LLY^^ 6KLY\K^Y\SO] ?=+ K^ K 836 -Y]^ >RO ]RK\O] YP +LLY^^ 6KLY\K^Y\SO] ?=+ K\O VS]^ON aS^R ^RO 8Oa CY\U S  ZO\K^SXQVOK]OZKcWOX^]\OMYQXS]ONSX^RO=^K^OWOX^YP:\Y ^
9
=^YMU/bMRKXQO?=+>ROQ\KX^]S]]_ONK\O`O]^ONSXYXO^RS\NSX]^KVWOX^]Y`O\K^R\OOcOK\ZO\SYN:_\]_KX^^Y3XN+= KXN6Y]]_XNO\s<OX^t<OPO\8Y^O 46,12.37  #"!
s=RK\OLK]ON:KcWOX^t^ROPKS\`KV_OYP^RO<=?]RK`OLOOX\OMY\NONLc^RO-YWZKXc>ROPKS\`KV_OYP^RO<=?]S]O]^SWK^ON
K^^ROQ\KX^NK^O_]SXQ,VKMU=MRYVO]YZ^SYXZ\SMSXQWYNOV^KUSXQSX^YKMMY_X^^RO^O\W]KXNMYXNS^SYX]_ZYXaRSMR]_MR SS 0_^_\O WSXSW_W VOK]O \OX^KV ZKcKLVO] _XNO\ XYXMKXMOVVKLVO
YZO\K^SXQVOK]O]$
<=?]aO\OQ\KX^ON
Within one year 45,85.38  
For the year ended For the year ended
March 31, 2018 7K\MR! +P^O\YXOcOK\L_^XY^WY\O^RKX `OcOK\] 54,83.04 "#
Number of Weighted 8_WLO\YP Weighted 7Y\O^RKX `OcOK\] - -
options average options average    >RO\OK\OXY]_LVOK]O]
exercise price ObO\MS]OZ\SMO
US $ ?= (ii) Operating lease commitments - Company as lessor
9_^]^KXNSXQK^^ROLOQSXXSXQYP^ROcOK\ 55,667 NA " 8+
    RO-YWZKXcRK]\OMYQXS]ON\OX^SXMYWOP\YWVOK]SXQYPKZ\YZO\^cKWY_X^SXQ^Y` 28.63 Lakhs7K\MR!$836
>
+NN$1\KX^ONN_\SXQ^ROcOK\ 28,749 NA   8+ SX^RO=^K^OWOX^YP:\Y ^KXN6Y]]_XNO\s9^RO\3XMYWOt<OPO\8Y^O!>ROVOK]OKQ\OOWOX^S]YPMKXMOVVKLVOXK^_\O
+NN$>\KX]PO\SXN_\SXQ^ROcOK\ - NA " 8+
b. Commitments
6O]]$/bO\MS]ONN_\SXQ^ROcOK\ (22,176) NA  ! 8+
As at March 31, 2018 +]K^7K\MR!
6O]]$-KXMOVVON/bZS\ONN_\SXQ^ROcOK\ (2,863) NA ! 8+
/]^SWK^ONKWY_X^YPMYX^\KM^]\OWKSXSXQ^YLOObOM_^ONYXMKZS^KV
6O]]$>\KX]PO\Y_^N_\SXQ^ROcOK\ (2,250) NA   8+
account and not provided for (net of advances) 5,69.73  
Outstanding at the end of the year 57,127 NA  ! 8+
c. Contingent liabilities
   RO aOSQR^ON K`O\KQO ]RK\O Z\SMO K^ ^RO NK^O YP ObO\MS]O PY\ ]^YMU YZ^SYX] ObO\MS]ON N_\SXQ ^RO cOK\ aK] US$ 59.77
>
7K\MR!$?= # Claims against company not acknowledged as debts
  >
 ROPYVVYaSXQ^KLVO]VS]^^ROSXZ_^]^Y^ROWYNOV]_]ONPY\^RO<O]^\SM^ON=^YMU9Z^SYXZVKXPY\^ROcOK\]OXNON7K\MR"   S 3 X0OL\_K\c## ^RO1Y`O\XWOX^RKNWKNOK^OX^K^S`OMVKSWPY\K]_WYP`  6KUR]^YLOZKSNSX^Y^RO.\_Q]:\SMO]
KXN7K\MR!\O]ZOM^S`OVc$ /[_KVS]K^SYX +MMY_X^ .:/+ YX KMMY_X^ YP _XSX^OXNON LOXO ^ KVVOQONVc OXTYcON Lc ^RO -YWZKXc N_\SXQ ^RO ZO\SYN
As at March 31, 2018 +]K^7K\MR! 7Kc#"^Y+_Q_]^#"!>RS]aK]MYX^O]^ONLc^RO-YWZKXcKXN]_L]O[_OX^VcN_\SXQ^ROcOK\OXNON8Y`OWLO\
K XKVNOWKXNaK]\OMOS`ONPY\`   6KUR]SXMV_NSXQSX^O\O]^YP` ##6KUR]_Z^Y7K\MR
.S`SNOXNcSOVN 0% 
>RO-YWZKXcLOSXQKQQ\SO`ONYP^RO]KSNNOWKXNKXNLK]ONYXVOQKVKN`SMOYL^KSXONSX^RS]\OQK\NMYX^O]^ON^ROKLY`O
/bZOM^ON`YVK^SVS^c 18.76% " XKVNOWKXNYP`   6KUR]KXN VONKa\S^ZO^S^SYXLOPY\O^RO,YWLKc2SQR-Y_\^^Y\O]^\KSX^ROQY`O\XWOX^P\YW
<S]UxP\OOSX^O\O]^\K^O 2.10%  \OMY`O\SXQ^RO]KSNKWY_X^>RO,YWLKc2SQR-Y_\^RK]KNWS^^ON^ROa\S^ZO^S^SYXKXNQ\KX^ON]^KcYP^RO\OMY`O\cYP
/bZOM^ONVSPOYP<O]^\SM^ON=^YMU?XS^]cOK\] 2 years cOK\] ^ROKWY_X^]_LTOM^^Y^RO-YWZKXcP_\XS]RSXQKLKXUQ_K\KX^OOSX\O]ZOM^YP^ROZ\SXMSZKVKWY_X^YP`  6KUR]>RO
]KSNLKXUQ_K\KX^OORK]LOOXP_\XS]RON>RO-YWZKXcRYaO`O\Y_^YPKL_XNKX^MK_^SYXKXNLK]ONYXS^]_XNO\]^KXNSXQ
Weighted average share price (`) ` 3,787.18 ` #
of the facts and circumstances of the case provided for a sum of ` 1,11.78 Lakhs7K\MR!$` !"#6KUR]SXMV_NSXQ
7YNOV_]ON Black Scholes ,VKMU=MRYVO] SX^O\O]^VSKLSVS^c^SVVNK^O
  >
 ROObZOM^ONVSPOYP^RO<=?]S]LK]ONYXRS]^Y\SMKVNK^KKXNM_\\OX^ObZOM^K^SYX]KXNS]XY^XOMO]]K\SVcSXNSMK^S`OYPObO\MS]O As at March 31, 2018 +]K^7K\MR!
ZK^^O\X]^RK^WKcYMM_\>ROObZOM^ON`YVK^SVS^c\O
OM^]^ROK]]_WZ^SYX^RK^^RORS]^Y\SMKV`YVK^SVS^cY`O\KZO\SYN]SWSVK\^Y^RO
VSPOYP^ROYZ^SYX]S]SXNSMK^S`OYPP_^_\O^\OXN]aRSMRWKcXY^XOMO]]K\SVcLO^ROKM^_KVY_^MYWO SS=KVO]>Kb 35,00.22 !!! !

During the year, ` 2,91.71 Lakhs7K\MR!$` #"!6KUR]aS^RRYVNSXQ^KbO]RK]LOOXNOZY]S^ONaS^R^KbK_^RY\S^SO] 3^S]XY^Z\KM^SMKLVOPY\^RO-YWZKXc^YO]^SWK^O^RO^SWSXQ]YPMK]RY_^

Ya]SPKXcSX\O]ZOM^YP^ROKLY`OZOXNSXQ
KQKSX]^ObMO\MS]ONYZ^SYX] \O]YV_^SYX YP ^RO \O]ZOM^S`O Z\YMOONSXQ] K] S^ S] NO^O\WSXKLVO YXVc YX \OMOSZ^ YP T_NQOWOX^]NOMS]SYX] ZOXNSXQ aS^R
`K\SY_]PY\_W]K_^RY\S^SO]
40 COMMITMENTS AND CONTINGENCIES
a. Leases
41 SEGMENT REPORTING
(i) Operating lease commitments - Company as lessee
 ZO\K^SXQ ]OQWOX^] K\O NO XON K] MYWZYXOX^] YP KX OX^O\Z\S]O PY\ aRSMR NS]M\O^O XKXMSKV SXPY\WK^SYX S] K`KSVKLVO ^RK^ S]
9
 RO-YWZKXcRK]YL^KSXON`K\SY_]\O]SNOX^SKVYP MOZ\OWS]O]SXMV_NSXQP_\XS^_\OKXN ^^SXQ]^RO\OSXK]KZZVSMKLVO
> O`KV_K^ON\OQ_VK\VcLc^ROMRSOPYZO\K^SXQNOMS]SYXWKUO\SXNOMSNSXQRYa^YKVVYMK^O\O]Y_\MO]KXNK]]O]]SXQZO\PY\WKXMO>RO
_XNO\YZO\K^SXQVOK]OY\VOK`OKXNVSMOXMOKQ\OOWOX^]>RO]OQOXO\KVVc\KXQOLO^aOOXWYX^R]^YcOK\]_XNO\VOK`O -YWZKXct]MRSOPYZO\K^SXQNOMS]SYXWKUO\S]^RO7KXKQSXQ.S\OM^Y\KXN^RO-YWZKXcRK]YXVcYXO\OZY\^KLVOL_]SXO]]]OQWOX^SO
KXNVSMOXMOY\VYXQO\PY\Y^RO\VOK]O]KXNK\O\OXOaKLVOLcW_^_KVMYX]OX^YXW_^_KVVcKQ\OOKLVO^O\W]=YWOYP^RO s:RK\WKMO_^SMKV]t
VOK]O KQ\OOWOX^] RK`O Z\SMO O]MKVK^SYX MVK_]O >RO -YWZKXc RK] QS`OX \OP_XNKLVO SX^O\O]^ P\OO ]OM_\S^c NOZY]S^] SX
KMMY\NKXMOaS^R^ROKQ\OON^O\W]>RO\OK\OXY\O]^\SM^SYX]SWZY]ONLc^RO]OK\\KXQOWOX^]
   6OK]OZKcWOX^]K\O\OMYQXS]ONSX^RO=^K^OWOX^YP:\Y ^KXN6Y]]_XNO\s<OX^t

134 ANNUAL REPORT 2017-18 135

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

42 RELATED PARTY DISCLOSURE ii) Sales to fellow subsidiaries :

A) Parties where control exists :
For the year ended For the year ended
  ?V^SWK^O2YVNSXQ-YWZKXc$+LLY^^6KLY\K^Y\SO]?=+ March 31, 2018 7K\MR!
  2YVNSXQ-YWZKXc$+LLY^^-KZS^KV3XNSK6^N?5 Abbott Healthcare Private Ltd., India
B) Other related parties with whom transactions have taken place during the year : =KVO]YP]^YMUSX^\KNO 53,65.79 !#
I) Fellow subsidiaries : =KVO]YP\KaWK^O\SKV] 54,94.81 #"#

   ,\S^S]R-YVVYSN]6^N?5
   +LLY^^2OKV^RMK\O:\YN_M^]6^N?5 iii) Purchases from fellow subsidiaries :
   +LLY^^2OKV^RMK\O:\S`K^O6^N3XNSK For the year ended For the year ended
March 31, 2018 7K\MR!
   +LLY^^3X^O\XK^SYXKV66-?=+
Abbott Healthcare Private Ltd., India
   +LLY^^:\YN_M^]9ZO\K^SYX]+1=aS^dO\VKXN
   +LLY^^6KLY\K^Y\SO]=SXQKZY\O:^O6^N=SXQKZY\O :_\MRK]OYP\KaWK^O\SKV] 4,57.99 -

   +LLY^^7KX_PKM^_\SXQ:^O6^N=SXQKZY\O :_\MRK]OYP]^YMUSX^\KNO 138,76.53 #"!

   +LLY^^1WL2-Y511O\WKXc :_\MRK]OYPZ\YWY^SYXKVQYYN] 1,84.84 !"
   +VO\O7ONSMKV:\S`K^O6SWS^ON3XNSK Conversion charges 2,39.65  

II) Key Management personnel : Abbott Products Operations AG., Switzerland

:_\MRK]OYP\KaWK^O\SKV] 185,78.10 #"
   7\+WLK^S@OX_7KXKQSXQ.S\OM^Y\aOP=OZ^OWLO\# 
:_\MRK]OYP]^YMUSX^\KNO 39,34.76 #!
   7\<KTS`=YXKVUO\ARYVO^SWO.S\OM^Y\aOP+_Q_]^"!
   7\<ORKX+5RKX7KXKQSXQ.S\OM^Y\^SVV+Z\SV 
   7\7_XS\=RKSUR-RKS\WKX iv) Purchase of trademarks from Ultimate Holding Company and fellow subsidiary :
   7\<KTOXN\K=RKR3XNOZOXNOX^.S\OM^Y\ For the year ended For the year ended
March 31, 2018 7K\MR!
   7\<KXTKX5KZ_\3XNOZOXNOX^.S\OM^Y\MOK]ON^YLO^RO.S\OM^Y\OPPOM^S`O4KX_K\c!"N_O^YNOWS]O
Abbott Laboratories, USA
   7\5\S]RXK7YRKX=KRXS3XNOZOXNOX^.S\OM^Y\
:_\MRK]OYP^\KNOWK\U] 2,83.14 -
C) Transactions during the year :
Abbott GmbH & Co. K.G., Germany
I) Transactions with the Holding Company during the year
:_\MRK]OYP^\KNOWK\U] 4,27.65 -
For the year ended For the year ended
March 31, 2018 7K\MR!
v) Loan/deposit and interest to/from fellow subsidiaries :
Abbott Capital India Ltd., U.K.
For the year ended For the year ended
Remittance of dividend 42,87.64 ! " March 31, 2018 7K\MR!
Abbott Healthcare Private Ltd., India
II) Transactions with Fellow Subsidiaries during the year Interest free security deposit paid 14,79.87 -
i) Remittance of dividend : Interest free security deposit received 44.66 -
For the year ended For the year ended Alere Medical Private Limited, India
March 31, 2018 7K\MR!
6YKXQS`OX<OPO\8Y^O 200,00.00 -
British Colloids Ltd., U.K.
3X^O\O]^SXMYWOYXKLY`OVYKX<OPO\8Y^O! 5,20.55 -
Remittance of dividend 5,88.00 
Abbott Healthcare Products Ltd., U.K.
Remittance of dividend 14,97.98 !

136 ANNUAL REPORT 2017-18 137

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

vi) Reimbursements to and from fellow subsidiaries : ix) Non-Executive, Other Directors’ sitting fees :
Reimbursement to Reimbursement from For the year ended For the year ended
For the For the For the For the March 31, 2018 7K\MR!
year ended year ended year ended year ended 7\7_XS\=RKSUR-RKS\WKX 13.50 
March 31, 2018 7K\MR! March 31, 2018 7K\MR!
Abbott Healthcare Private Ltd., India 7\<KTOXN\K=RKR3XNOZOXNOX^.S\OM^Y\ 17.00 
Shared and support Services 10,52.03   - - 7\<KXTKX5KZ_\3XNOZOXNOX^.S\OM^Y\MOK]ON^YLO^RO
<OX^ObZOX]O] .S\OM^Y\OPPOM^S`O4KX_K\c!"N_O^YNOWS]O 10.50 
32,93.22 " - -
7K\UO^\O]OK\MRKXNY^RO\ObZOX]O] -  # 16.42 - 7\5\S]RXK7YRKX=KRXS3XNOZOXNOX^.S\OM^Y\ 15.00 
/bMS]ON_^cZKcWOX^MOX`K^\OMY`O\cYX
Loan Licensee manufacturing 38.10 ! 1,78.89 # D) Outstanding :
Abbott International LLC, USA As at March 31, 2018 +]K^7K\MR!
/WZVYcOOLOXO ^]ObZOX]O^\K`OVKXN Trade payables to fellow subsidiaries <OPO\8Y^O
Y^RO\ObZOX]O] 36.98 ! -  #
+LLY^^:\YN_M^]9ZO\K^SYX]+1=aS^dO\VKXN 56,34.60 !"
Abbott Manufacturing Pte Ltd.,
Singapore +LLY^^6KLY\K^Y\SO]=SXQKZY\O:^O6^N=SXQKZY\O - 
/WZVYcOOLOXO ^]ObZOX]O^\K`OVKXN +LLY^^3X^O\XK^SYXKV66-?=+ - "
Y^RO\ObZOX]O] - - 22.45 "!
+LLY^^2OKV^RMK\O:\S`K^O6^N3XNSK 16,73.23 !
Abbott Laboratories (Singapore) Pte
Ltd., Singapore 73,07.83 !""
/WZVYcOOLOXO ^]ObZOX]O^\K`OVKXN
Y^RO\ObZOX]O] 24.62 " - -
Other payables to fellow subsidiaries <OPO\8Y^O
Abbott Products Operations AG.,
Switzerland +LLY^^2OKV^RMK\O:\S`K^O6^N3XNSK 44.66 -
/WZVYcOOLOXO ^]ObZOX]O^\K`OVKXN 44.66 -
Y^RO\ObZOX]O] - - 1,77.80 

vii) Income from fellow subsidiaries : Trade receivables from fellow subsidiaries <OPO\8Y^O

For the year ended For the year ended +LLY^^2OKV^RMK\O:\S`K^O6^N3XNSK 22,72.66  ! 
March 31, 2018 7K\MR! 22,72.66  ! 
Abbott Healthcare Private Ltd., India Other receivables from fellow subsidiaries <OPO\8Y^O
=RK\ONKXN]_ZZY\^]O\`SMO]<OPO\8Y^O L 16,27.73  "" +LLY^^3X^O\XK^SYXKV66-?=+ - "
<OX^SXMYWO<OPO\8Y^O! 28.63 -
+LLY^^7KX_PKM^_\SXQ:^O6^N=SXQKZY\O - #
Abbott Products Operations AG., Switzerland
+LLY^^:\YN_M^]9ZO\K^SYX]+1=aS^dO\VKXN 90.39 ""
=RK\ONKXN]_ZZY\^]O\`SMO]<OPO\8Y^O L 5,26.33  "
+LLY^^2OKV^RMK\O:\S`K^O6^N3XNSK 35.92  
viii) Key management personnel remuneration * : +VO\O7ONSMKV:\S`K^O6SWS^ON3XNSK<OPO\8Y^O 4,68.49 -
For the year ended For the year ended 5,94.80 !#
March 31, 2018 7K\MR!
Loan and deposit to fellow subsidiaries
7\+WLK^S@OX_7KXKQSXQ.S\OM^Y\aOP=OZ^OWLO\#  5,85.89  "!
+LLY^^2OKV^RMK\O:\S`K^O6^N3XNSK<OPO\8Y^O "KXN 14,69.86 -
7\<KTS`=YXKVUO\ARYVO^SWO.S\OM^Y\aOP+_Q_]^"! 1,61.64 -
+VO\O7ONSMKV:\S`K^O6SWS^ON3XNSK<OPO\8Y^O 200,00.00 -
7\<ORKX+5RKX7KXKQSXQ.S\OM^Y\^SVV+Z\SV  -  "
* >ROKLY`OVYKXS]Q_K\KX^OONLc+LLY^^6KLY\K^Y\SO]?=+SO^RO?V^SWK^O2YVNSXQ-YWZKXc
._\SXQ^ROcOK\K]KZK\^YP^ROs6YXQ>O\W3XMOX^S`O:\YQ\KWt<O]^\SM^ON=^YMU?XS^]YP+LLY^^6KLY\K^Y\SO]
?=+MK\\cSXQZO\[_S]S^O`KV_OYP` 1,23.72 Lakhs 7K\MR!$836RK`OLOOXQ\KX^ON^Y^ROKLY`OOWZVYcOO] Terms and conditions of transactions with related parties :
+V]Y\OPO\8Y^O#M
  +
 VV^\KX]KM^SYX]aS^R\OVK^ONZK\^SO]K\OWKNOSX^ROY\NSXK\cMY_\]OYPL_]SXO]]KXN^RO]KWOS]K^K\Wt]VOXQ^R9_^]^KXNSXQ
    +
 V]YZ\Y`S]SYXPY\ZY]^OWZVYcWOX^LOXO ^]K]MYX^\SL_^SYX^YQ\K^_S^cP_XNVOK`OOXMK]RWOX^YX\O^S\OWOX^KXN LKVKXMO]K^^ROcOK\OXNK\O_X]OM_\ONKXN]O^^VOWOX^YMM_\]SXMK]R>RO-YWZKXcRK]XY^\OMY\NONKXcSWZKS\WOX^PY\
Y^RO\NO XONLOXO ^]aRSMRK\OWKNOLK]ONYXKM^_K\SKV`KV_K^SYXYXKXY`O\KVVMYWZKXcLK]S]K\OXY^SXMV_NONSX \OMOS`KLVO]>RS]K]]O]]WOX^S]_XNO\^KUOXOKMR XKXMSKVcOK\^R\Y_QRObKWSXSXQ^RO XKXMSKVZY]S^SYXYP^RO\OVK^ONZK\^SO]
\OW_XO\K^SYX^YUOcWKXKQOWOX^ZO\]YXXOV KXN^ROWK\UO^SXaRSMR\OVK^ONZK\^SO]YZO\K^O

138 ANNUAL REPORT 2017-18 139

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

43 DISCLOSURE PURSUANT TO SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) AND SECTION B. =O^Y_^LOVYaS]KMYWZK\S]YXLcMVK]]YP^ROMK\\cSXQKWY_X^]KXNPKS\`KV_OYP^RO -YWZKXct] XKXMSKV K]]O^]
186 (4) OF THE COMPANIES ACT, 2013 : liabilities, other than those with the carrying amounts that are reasonable approximations of fair values :
._\SXQ^ROcOK\OXNON7K\MR"^RO-YWZKXcRKNQ\KX^ONVYKXYP` 200,00.00 Lakhs^Y+VO\O7ONSMKV:\S`K^O6SWS^ON3XNSK Carrying Fair value Fair value hierarchy
KPOVVYa]_L]SNSK\cPY\KZO\SYNYP]SbWYX^R]OPPOM^S`O.OMOWLO\ !K^KXSX^O\O]^\K^OYPZO\KXX_WZ_\]_KX^^Y^RO amount
Z\Y`S]SYX]YP=OM^SYX" YP^RO-YWZKXSO]+M^KXN\OVO`KX^\_VO]WKNO^RO\O_XNO\PY\Z_\ZY]OYPP_XNSXQaY\USXQMKZS^KV As at As at Quoted prices =SQXS MKX^ =SQXS MKX^
\O[_S\OWOX^>RS]VYKXS]Q_K\KX^OONLc+LLY^^6KLY\K^Y\SO]?=+SO^RO?V^SWK^O2YVNSXQ-YWZKXc March 31, 2018 March 31, 2018 in active observable unobservable
markets inputs inputs
Purpose for As at Maximum balance As at 7KbSW_WLKVKXMO Level 1 Level 2 Level 3
which the loan March 31, 2018 outstanding 7K\MR! outstanding during Financial assets at amortised cost
Nature of transaction is proposed to during the the year ended Loans (non-current)
be utilised by year ended 7K\MR!
.OZY]S^]PY\Z\OWS]O]<OPO\8Y^O  1,58.94 1,58.94 - - 1,58.94
recipient March 31, 2018 @
.OZY]S^]QS`OX^YPOVVYa]_LNS]SK\c
Loan given to fellow <OPO\8Y^O  12,12.28 12,12.28 - - 12,12.28
subsidiary :
Deposits against tenders (Refer 1,31.36 1,31.36 - - 1,31.36
+VO\O7ONSMKV:\S`K^O Funding working 8Y^O 
Limited, India MKZS^KV\O[_S\OWOX^ 205,20.55 205,20.55 - - 9^RO\ XKXMSKVK]]O^]<OPO\8Y^O! 22,70.67 22,70.67 - - 22,70.67
 *3XMV_NSXQKMM\_ONSX^O\O]^` 5,20.55 Lakhs, net of TDS ` 4,68.49 Lakhs <OPO\8Y^O. 37,73.25 37,73.25 - - 37,73.25
Financial assets at fair value through
44 FAIR VALUE DISCLOSURE :\Y ^Y\6Y]]
A. >ROMK\\cSXQ`KV_OKXNPKS\`KV_OYP XKXMSKVK]]O^]VSKLSVS^SO]LcMK^O\QY\SO]K\OK]PYVVYa]$ 0Y\aK\NMYX^\KM^\OMOS`KLVO 31.59 31.59 - 31.59 -
31.59 31.59 - 31.59 -
-K\\cSXQ`KV_OYP^RO XKXMSKV 0KS\`KV_OYP^RO XKXMSKV
assets/liabilities assets/liabilities
Carrying 0KS\`KV_O 0KS\`KV_ORSO\K\MRc
As at As at As at As at amount
March 31, 2018 7K\MR! March 31, 2018 7K\MR! As at As at ;_Y^ONZ\SMO] =SQXS MKX^ =SQXS MKX^
Financial assets/liabilities at amortised cost 7K\MR! 7K\MR! in active YL]O\`KLVO _XYL]O\`KLVO
markets inputs inputs
Financial assets at amortised cost (non- 6O`OV 6O`OV 6O`OV
current) :
Financial assets at amortised cost
6YKX]<OPO\8Y^O  15,02.58   15,02.58  
Loans (non-current)
9^RO\ XKXMSKVK]]O^]<OPO\8Y^O! 22,70.67 " # 22,70.67 " # .OZY]S^]PY\Z\OWS]O]<OPO\8Y^O  "" "" - - ""
Financial assets at amortised cost (current) : Deposits against tenders (Refer !# !# - - !#
>\KNOKXNY^RO\\OMOS`KLVO]<OPO\8Y^O ! ## ! ## 8Y^O 
263,44.30 263,44.30
9^RO\ XKXMSKVK]]O^]<OPO\8Y^O! " # " # - - " #
-K]RKXNMK]RO[_S`KVOX^]<OPO\8Y^O 37,67.71 " 37,67.71 "
 !#  !# - -  !#
,KXULKVKXMO]Y^RO\^RKXMK]RKXNMK]R Financial liabilities at fair value
O[_S`KVOX^]<OPO\8Y^O 993,67.32 """ "  993,67.32 """ "  ^R\Y_QR:\Y ^Y\6Y]]
6YKX]<OPO\8Y^O 205,47.81 # 205,47.81 # 0Y\aK\NMYX^\KM^ZKcKLVO !" !" - !" -
9^RO\ XKXMSKVK]]O^]<OPO\8Y^O 40,21.24 "!! 40,21.24 "!! !" !" - !" -
Financial liabilities at amortised cost (current) :   >ROPYVVYaSXQWO^RYN]KXNK]]_WZ^SYX]aO\O_]ON^YO]^SWK^O^ROPKS\`KV_O]$
>\KNOZKcKLVO]<OPO\8Y^O 480,62.48 ! # 480,62.48 ! #   0
 KS\`KV_OYPMK]RKXNLKXULKVKXMO]]RY\^^O\WVYKX]^\KNOKXNY^RO\]RY\^^O\W\OMOS`KLVO]^\KNOZKcKLVO]Y^RO\ XKXMSKV
9^RO\ XKXMSKVVSKLSVS^SO] 48,66.84 "" 48,66.84 "" M_\\OX^VSKLSVS^SO]KZZ\YbSWK^O^ROS\MK\\cSXQKWY_X^]VK\QOVcN_O^Y^RO]RY\^^O\WWK^_\S^SO]YP^RO]OSX]^\_WOX^]7O^RYN]
KXNK]]_WZ^SYX]_]ON^YO]^SWK^O^ROPKS\`KV_O]K\OMYX]S]^OX^aS^R^RY]O_]ONPY\^ROcOK\OXNON7K\MR!
Financial assets/liabilities at fair value   .
 _\SXQ^RO\OZY\^SXQZO\SYNOXNSXQ7K\MR"KXN7K\MR!^RO\OaO\OXY^\KX]PO\]LO^aOOX6O`OVKXN6O`OV
^R\Y_QR:\Y ^Y\6Y]] PKS\`KV_OWOK]_\OWOX^]
0SXKXMSKVK]]O^]K^PKS\`KV_O^R\Y_QR:\Y ^Y\ >RO-YWZKXc_]O]^ROPYVVYaSXQRSO\K\MRcPY\NO^O\WSXSXQKXNNS]MVY]SXQ^ROPKS\`KV_OYP XKXMSKVSX]^\_WOX^]Lc
Loss (current) : valuation technique :
0Y\aK\NMYX^\KM^\OMOS`KLVO 31.59 - 31.59 -   6O`OV$;_Y^ON_XKNT_]^ONZ\SMO]SXKM^S`OWK\UO^]PY\SNOX^SMKVK]]O^]Y\VSKLSVS^SO]
0SXKXMSKVVSKLSVS^SO]K^PKS\`KV_O^R\Y_QR:\Y ^   6
 O`OV$9^RO\^OMRXS[_O]PY\aRSMRKVVSXZ_^]aRSMRRK`OK]SQXS MKX^OPPOM^YX^RO\OMY\NONPKS\`KV_OK\OYL]O\`KLVOOS^RO\
or Loss (current) : NS\OM^VcY\SXNS\OM^Vc
0Y\aK\NMYX^\KM^ZKcKLVO - !" - !"   6
 O`OV$>OMRXS[_O]aRSMR_]OSXZ_^]^RK^RK`OK]SQXS MKX^OPPOM^YX^RO\OMY\NONPKS\`KV_O^RK^K\OXY^LK]ONYXYL]O\`KLVO
market data

140 ANNUAL REPORT 2017-18 141

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

 >ROPKS\`KV_O]YP^ROPY\OSQXObMRKXQOPY\aK\NMYX^\KM^RK]LOOXNO^O\WSXON_]SXQ`KV_K^SYX^OMRXS[_O]aS^RKNO[_K^OYL]O\`KLVO   >RO-YWZKXct]ObZY]_\O^YPY\OSQXM_\\OXMc\S]US]K]PYVVYa]$
SXZ_^]>RS]WYNOVSXMY\ZY\K^O`K\SY_]SXZ_^]SXMV_NSXQ^ROM\ONS^[_KVS^cYPMY_X^O\ZK\^SO]KXNPY\OSQXObMRKXQOPY\aK\N\K^O]
.O]M\SZ^SYXYP]SQXS MKX^_XYL]O\`KLVOSXZ_^]^Y`KV_K^SYX6O`OV$ As at March 31, 2018 +]K^7K\MR!

 >ROPYVVYaSXQ^KLVO]RYa]^RO`KV_K^SYX^OMRXS[_O]KXNSXZ_^]_]ONPY\ XKXMSKVSX]^\_WOX^]^RK^K\OXY^MK\\SONK^PKS\`KV_O$ Particulars (` Lakhs) USD Euro GBP CHF USD Euro
>\KNO\OMOS`KLVO] 7,42.60 - - - #  -
As at March 31, 2018 +]K^7K\MR!
9^RO\ XKXMSKVK]]O^] 92.08 - 0.63 13.64 !! #
(a) Deposits for premises Discounted Discounted
MK]R
YaWO^RYN MK]R
YaWO^RYN >\KNOZKcKLVO] 82,56.89 6.80 - 13.37 #"!  #!
using interest rate using interest rate
9^RO\ XKXMSKVVSKLSVS^SO] - - - - "  -
PY\]SWSVK\ XKXMSKV PY\]SWSVK\ XKXMSKV
instrument instrument Foreign currency sensitivity
(b) 0SXKXMSKVK]]O^]VSKLSVS^SO]Y^RO\^RKXKKLY`O /bZOM^ONMK]R
Ya] /bZOM^ONMK]R
Ya]
PY\^RO XKXMSKV PY\^RO XKXMSKV  RO PYVVYaSXQ ^KLVO NOWYX]^\K^O ^RO ]OX]S^S`S^c ^Y K \OK]YXKLVc ZY]]SLVO MRKXQO SX PY\OSQX ObMRKXQO \K^O] LOSXQ ^RO WY]^
>
instruments instruments ^\KX]KM^ONM_\\OXMSO]aS^RKVVY^RO\`K\SKLVO]ROVNMYX]^KX^>ROObMRKXQO\K^OLO^aOOX<_ZOOKXNY^RO\PY\OSQXM_\\OXMSO]
RK`OMRKXQON]_L]^KX^SKVVcSX^RO\OMOX^cOK\]KXNWKc
_M^_K^O]_L]^KX^SKVVcSX^ROP_^_\O-YX]O[_OX^Vc^RO\O]_V^]YP^RO
 +YXOZO\MOX^KQOZYSX^MRKXQOSX^RO_XYL]O\`KLVOSXZ_^]_]ONSXPKS\`KV_K^SYXYPVO`OVK]]O^]Y\VSKLSVS^SO]NYO]XY^RK`O]SQXS MKX^ -YWZKXct]YZO\K^SYX]MY_VNLOKPPOM^ONK]^RO<_ZOOKZZ\OMSK^O]NOZ\OMSK^O]KQKSX]^^RO]OM_\\OXMSO]
SWZKM^SXS^]`KV_O
As at March 31, 2018 +]K^7K\MR!
45 FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES
Currency 1% Increase 1% Decrease 3XM\OK]O .OM\OK]O
  RO-YWZKXct]KM^S`S^SO]ObZY]OS^^Y`K\SO^cYP XKXMSKV\S]U]XKWOVcWK\UO^\S]UM\ONS^\S]UKXNVS[_SNS^c\S]U>RO-YWZKXcRK]
>
USD (74.22) 74.22    
`K\SY_] XKXMSKVK]]O^]]_MRK]NOZY]S^]^\KNOKXNY^RO\\OMOS`KLVO]KXNMK]RKXNLKXULKVKXMO]NS\OM^Vc\OVK^ON^Y^ROS\L_]SXO]]
YZO\K^SYX]>RO-YWZKXct]Z\SXMSZKV XKXMSKVVSKLSVS^SO]MYWZ\S]OYP^\KNOKXNY^RO\ZKcKLVO] Euro (0.07) 0.07 # #
  RO -YWZKXct] ]OXSY\ WKXKQOWOX^t] PYM_] S] ^Y PY\O]OO ^RO _XZ\ONSM^KLSVS^c KXN WSXSWS]O ZY^OX^SKV KN`O\]O OPPOM^] YX ^RO
> 3XM\OK]O.OM\OK]OSX:\Y ^Y\6Y]] (74.29) 74.29 #! #!
-YWZKXct] XKXMSKVZO\PY\WKXMO>RO-YWZKXct]Y`O\KVV\S]UWKXKQOWOX^Z\YMON_\O]^YWSXSWS]O^ROZY^OX^SKVKN`O\]OOPPOM^]YP
XKXMSKVWK\UO^YX^RO-YWZKXct]ZO\PY\WKXMOK\OK]PYVVYa]$ b) Credit risk

a) Market risk  \ONS^\S]US]^RO\S]U^RK^MY_X^O\ZK\^caSVVXY^WOO^S^]YLVSQK^SYX]_XNO\K XKXMSKVSX]^\_WOX^Y\M_]^YWO\MYX^\KM^VOKNSXQ

-
  7
 K\UO^\S]US]^RO\S]U^RK^^ROPKS\`KV_OYPP_^_\OMK]R
Ya]YPK XKXMSKVSX]^\_WOX^aSVV
_M^_K^OLOMK_]OYPMRKXQO]SX ^YK XKXMSKVVY]]-YXMOX^\K^SYXYPM\ONS^\S]UK\S]O]aROXMY_X^O\ZK\^SO]K\OOXQKQONSX]SWSVK\L_]SXO]]KM^S`S^SO]Y\RK`O
WK\UO^Z\SMO]7K\UO^\S]UMYWZ\S]O]^R\OO^cZO]YP\S]U]XKWOVcSX^O\O]^\K^O\S]UM_\\OXMc\S]UKXNY^RO\Z\SMO\S]U]_MRK] ]SWSVK\ OMYXYWSM POK^_\O] ^RK^ aY_VN MK_]O ^RO KLSVS^c ^Y WOO^ MYX^\KM^_KV YLVSQK^SYX] ^Y LO ]SWSVK\Vc KPPOM^ON Lc MRKXQO]
MYWWYNS^c\S]U>RO-YWZKXcS]XY^ObZY]ON^YY^RO\Z\SMO\S]UaRO\OK]^ROObZY]_\O^YM_\\OXMc\S]UKXNSX^O\O]^\S]US] SX OMYXYWSMKV ZYVS^SMKV Y\ Y^RO\ MYXNS^SYX] -YXMOX^\K^SYX YP M\ONS^ \S]U SXNSMK^O ^RO \OVK^S`O ]OX]S^S`S^c YP ^RO -YWZKXct]
QS`OXLOVYa$ ZO\PY\WKXMO^YNO`OVYZWOX^]KPPOM^SXQKZK\^SM_VK\SXN_]^\c
(i) Interest rate risk   -
 \ONS^\S]UYPMYWZKXcK\S]O]Z\SXMSZKVVcP\YW^RO^\KNONOL^]VYKX]KXNKN`KXMO]^\KNONOZY]S^]Y^RO\\OMSO`KLVO]KXNLKVKXMO
   3 X^O\O]^\K^O\S]US]^RO\S]U^RK^^ROPKS\`KV_OY\P_^_\OMK]R
Ya]YPK XKXMSKVSX]^\_WOX^aSVV
_M^_K^OLOMK_]OYP aS^R LKXU] >RO MK\\cSXQ KWY_X^ YP XKXMSKV K]]O^] \OZ\O]OX^] ^RO WKbSW_W M\ONS^ ObZY]_\O >RO WKbSW_W ObZY]_\O ^Y
MRKXQO]SXWK\UO^SX^O\O]^\K^O]>RO-YWZKXct]ObZY]_\O^Y^RO\S]UYPMRKXQO]SXWK\UO^SX^O\O]^\K^O]\OVK^O]Z\SWK\SVc credit risk was ` 1578,21.18 LakhsK]K^7K\MR"7K\MR!$`  6KUR]-_]^YWO\M\ONS^\S]US]WKXKQON
^Y^RO-YWZKXct]NOZY]S^KMMY_X^]aS^RLKXU] PY\OKMRL_]SXO]]_XS^]_LTOM^^Y^RO-YWZKXct]O]^KLVS]RONZYVSMcZ\YMON_\O]KXNMYX^\YV\OVK^SXQ^YM_]^YWO\M\ONS^\S]U
WKXKQOWOX^ -\ONS^ [_KVS^c YP K M_]^YWO\ S] K]]O]]ON LK]ON YX KX Ob^OX]S`O M\ONS^ \K^SXQ ]MY\OMK\N KXN SXNS`SN_KV M\ONS^
Particulars Carrying Amount
VSWS^]K\ONO XONSXKMMY\NKXMOaS^R^RS]K]]O]]WOX^0_\^RO\]SQXS MKX^]KVO]YP^RO-YWZKXcK\OKQKSX]^KN`KXMOZKcWOX^
As at March 31, 2018 +]K^7K\MR! MYVVOM^SYXYXNOVS`O\c^O\W]9_^]^KXNSXQM_]^YWO\\OMOS`KLVO]K\O\OQ_VK\VcWYXS^Y\ONKXNKXc]RSZWOX^]^YXOaY`O\]OK]
Fixed rate instruments M_]^YWO\]K\OQOXO\KVVcMY`O\ONLcVO^^O\]YPM\ONS^Y\Y^RO\PY\W]YPM\ONS^SX]_\KXMO>ROWKXKQOWOX^MYX^SX_Y_]VcWYXS^Y\]
0SXKXMSKVK]]O^] 987,35.00 !  ^ROM\ONS^ObZY]_\O^YaK\N]^ROM_]^YWO\]KXNWKUO]Z\Y`S]SYXKQKSX]^^RY]OLKVKXMO]MYX]SNO\ONNY_L^P_VYP\OMY`O\c
  >ROKQOSXQYP^\KNO\OMOS`KLVO]KXNKVVYaKXMOPY\M\ONS^VY]]O]S]K]PYVVYa]$
   0KS\`KV_O]OX]S^S`S^cKXKVc]S]PY\ bON\K^OSX]^\_WOX^]$
   >
 RO -YWZKXct] SX`O]^WOX^] K\O Z\SWK\SVc SX bON \K^O SX^O\O]^ LOK\SXQ SX`O]^WOX^] 2OXMO ^RO -YWZKXc S] XY^ As at March 31, 2018 +]K^7K\MR!
]SQXS MKX^VcObZY]ON^YSX^O\O]^\K^O\S]U Gross Allowance for 1\Y]] +VVYaKXMOPY\
Particulars credit losses M\ONS^VY]]O]
(ii) Foreign currency risk
8Y^cO^N_O 229,49.52 - " -
  Y\OSQXM_\\OXMc\S]US]^RO\S]U^RK^^ROPKS\`KV_OY\P_^_\OMK]R
Ya]YPKXObZY]_\OaSVV
_M^_K^OLOMK_]OYPMRKXQO]
0
SXPY\OSQXObMRKXQO\K^O]KXNK\S]O]aRO\O^\KX]KM^SYX]K\ONYXOSXPY\OSQXM_\\OXMc3^K\S]O]WKSXVcaRO\O\OMOS`KLVO] :K]^N_ONKc] 21,30.99 23.75 " !
KXNZKcKLVO]ObS]^N_O^Y^\KX]KM^SYX]OX^O\ONSXPY\OSQXM_\\OXMSO] :K]^N_O NKc] 3,61.20 4.43 !#! "
   >
 RO-YWZKXcO`KV_K^O]ObMRKXQO\K^OObZY]_\OK\S]SXQP\YWPY\OSQXM_\\OXMc^\KX]KM^SYX]KXNPYVVYa]O]^KLVS]RON\S]U :K]^N_O #NKc] 4,33.66 46.45 # "  
WKXKQOWOX^ ZYVSMSO] SXMV_NSXQ _]O YP NO\S`K^S`O] VSUO PY\OSQX ObMRKXQO PY\aK\N MYX^\KM^] ^Y RONQO PY\OSQX M_\\OXMc 9`O\#NKc] 16,07.46 10,63.90 # !"
\S]U>RO-YWZKXcNYO]XY^OX^O\SX^Y XKXMSKVSX]^\_WOX^^\KX]KM^SYX]PY\^\KNSXQY\]ZOM_VK^S`OZ_\ZY]O]?XRONQON
ObZY]_\OK^KXcZYSX^YP^SWON_\SXQ^ROcOK\S]XY^WK^O\SKV 274,82.83 11,38.53 "!### !!

142 ANNUAL REPORT 2017-18 143

 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

(All amounts in ` Lakhs, unless otherwise stated) (All amounts in ` Lakhs, unless otherwise stated)

  7Y`OWOX^SXVY]]KVVYaKXMOYP^\KNO\OMOS`KLVO]KXNY^RO\ XKXMSKVK]]O^]$ YP ^RO -YWZKXc S] O[_S^c LK]ON aS^R XY XKXMSXQ ^R\Y_QR LY\\YaSXQ] >RO -YWZKXc S] XY^ ]_LTOM^ ^Y KXc Ob^O\XKVVc SWZY]ON
MKZS^KV\O[_S\OWOX^]
Particulars As at March 31, 2018 +]K^7K\MR!
,KVKXMOK^^ROLOQSXXSXQYP^ROcOK\ 14,92.33 #   YMRKXQO]aO\OWKNOSX^ROYLTOM^S`O]ZYVSMSO]Y\Z\YMO]]O]PY\WKXKQSXQMKZS^KVN_\SXQ^ROcOK\]OXNON7K\MR"KXN
8
7K\MR!
+VVYaKXMOPY\NY_L^P_VNOL^]KXNKN`KXMO] 1,52.53 #"
Bad debts written off (1,10.21) # 47 STANDARDS ISSUED BUT NOT YET EFFECTIVE
Balance at the end of the year 15,34.65 #  >RO ]^KXNK\N] S]]_ON L_^ XY^ cO^ OPPOM^S`O _Z^Y ^RO NK^O YP S]]_KXMO YP ^RO -YWZKXct] XKXMSKV ]^K^OWOX^] S] NS]MVY]ON LOVYa
>RO-YWZKXc]RKVVKNYZ^^RS]]^KXNK\NaROXS^LOMYWO]OPPOM^S`O
 RO WKXKQOWOX^ LOVSO`O] ^RK^ XY P_\^RO\ Z\Y`S]SYX S] XOMO]]K\c SX \O]ZOM^ YP ^\KNO \OMOS`KLVO] LK]ON YX RS]^Y\SMKV ^\OXN]
>
YP ^RO]O M_]^YWO\] 0_\^RO\ ^RO -YWZKXct] ObZY]_\O ^Y M_]^YWO\] S] NS`O\]S ON KXN XY ]SXQVO M_]^YWO\ RK] ]SQXS MKX^ Ind AS 115 Revenue from Contracts with Customers :
MYX^\SL_^SYX^Y^\KNO\OMOS`KLVO]LKVKXMO]
 X7K\MR""7SXS]^\cYP-Y\ZY\K^O+PPKS\]u7-+vRK]XY^S ON3XN+=<O`OX_OP\YW-YX^\KM^]aS^R-_]^YWO\]3XN+=
9
  >
 ROM\ONS^\S]UYXVS[_SNP_XN]]_MRK]LKVKXMO]aS^RLKXU]SXM_\\OX^KXNNOZY]S^KMMY_X^]S]VSWS^ONLOMK_]O^ROMY_X^O\ O]^KLVS]RO]K `O]^OZWYNOV^YKMMY_X^PY\\O`OX_OK\S]SXQP\YWMYX^\KM^]aS^RM_]^YWO\]KXN\O[_S\O]\O`OX_O^YLO\OMYQXS]ON
ZK\^SO]K\OLKXU]aS^R\OK]YXKLVcRSQRM\ONS^\K^SXQ] aROXZ\YWS]ONQYYN]Y\]O\`SMO]K\O^\KX]PO\\ON^Y^ROM_]^YWO\]SXKWY_X^]^RK^\O
OM^^ROMYX]SNO\K^SYX^YaRSMR^RO-YWZKXc
ObZOM^]^YLOOX^S^VONSXObMRKXQOPY\^RY]OQYYN]Y\]O\`SMO]0_\^RO\^ROXOa]^KXNK\N\O[_S\O]OXRKXMONNS]MVY]_\O]KLY_^^RO
  0SXKXMSKVK]]O^]Y^RO\^RKX^\KNO\OMOS`KLVO]KXNLKXULKVKXMO]K\OXY^ObZY]ON^YKXcWK^O\SKVM\ONS^\S]U XK^_\O^SWSXQKWY_X^KXN_XMO\^KSX^cYP\O`OX_OKXNMK]R
Ya]K\S]SXQP\YW^ROOX^S^ct]MYX^\KM^]aS^R^ROM_]^YWO\]
c) Liquidity risk   RO XOa \O`OX_O ]^KXNK\N ]_ZO\]ONO] KVV M_\\OX^ \O`OX_O \OMYQXS^SYX \O[_S\OWOX^] _XNO\ 3XN += /S^RO\ K P_VV \O^\Y]ZOM^S`O
>
KZZVSMK^SYXY\KWYNS ON\O^\Y]ZOM^S`OKZZVSMK^SYXS]\O[_S\ONPY\KXX_KVZO\SYN]LOQSXXSXQYXY\KP^O\+Z\SV">RO-YWZKXc
  6
 S[_SNS^c\S]US]^RO\S]U^RK^MYWZKXcaSVVXY^LOKLVO^YWOO^S^] XKXMSKVYLVSQK^SYX]K]^ROcPKVVN_O6S[_SNS^c\S]UK\S]O]
aSVVKNYZ^^RO]^KXNK\NYX+Z\SV"Lc_]SXQ^ROWYNS ON\O^\Y]ZOM^S`OKZZ\YKMRKXNKMMY\NSXQVcMYWZK\K^S`O]PY\^ROcOK\
LOMK_]OYP^ROZY]]SLSVS^c^RK^^ROMYWZKXcMY_VNLO\O[_S\ON^YZKcS^]VSKLSVS^SO]OK\VSO\^RKXObZOM^ONY\OXMY_X^O\]NSP M_V^c
OXNSXQ7K\MR#aSVVXY^LO\O^\Y]ZOM^S`OVcKNT_]^ON
SX\KS]SXQP_XN]^YWOO^MYWWS^WOX^]K]]YMSK^ONaS^R XKXMSKVVSKLSVS^SO]K]^ROcPKVVN_O>RO-YWZKXct]KZZ\YKMR^YWKXKQSXQ
VS[_SNS^cS]^YOX]_\OK]PK\K]ZY]]SLVO^RK^S^aSVVKVaKc]RK`O]_P MSOX^VS[_SNS^c^YWOO^S^]VSKLSVS^SO]aROXN_O>RO-YWZKXc   RO-YWZKXcRK]_XNO\^KUOXK\O`SOaYPWKSX^cZO]YPMYWWO\MSKVK\\KXQOWOX^]OX^O\ONSX^YaS^RM_]^YWO\]_XNO\^RS]WYNOV
>
WKXKQO]VS[_SNS^c\S]ULcWKSX^KSXSXQ]_P MSOX^MK]RKXNLKXULKVKXMOKXNK`KSVKLSVS^cYPP_XNSXQ^R\Y_QRKNO[_K^OKWY_X^YP KXNRK]ZO\PY\WONKXKXKVc]S]YP^ROSWZKM^SXMV_NSXQK\OK]]_MRK]`K\SKLVOMYX]SNO\K^SYX\SQR^YP\O^_\XKXNKQOX^\OVK^SYX]RSZ]
MYWWS^^ONM\ONS^PKMSVS^SO] KXNRK]MYXMV_NON^RK^^RO]^KXNK\NaSVVXY^RK`OKWK^O\SKVSWZKM^YX^RO\O`OX_O]^\OKW]P\YW^RO]_ZZVcYPQYYN]S^]K]]YMSK^ON
\OLK^O]KXN\O^_\XZ\Y`S]SYX]>ROZ\O]OX^^SWSXQYP^RO\OMYQXS^SYXYPZ\YN_M^]KVO]KXN^ROLK]S]YPO]^SWK^O]YP]KVO]NON_M^SYX]
  >RONO^KSV]YP^ROMYX^\KM^_KVWK^_\S^SO]YP]SQXS MKX^VSKLSVS^SO]K]K^7K\MR"K\OK]PYVVYa]$ K\OMYX]S]^OX^aS^R^RY]OKNYZ^ON_XNO\3XN+=
Particulars Carrying Less than 1-3 years 3-5 years More than Total   K]ONYX^ROKXKVc]S]S^S]K]]O]]ON^RK^^RO]^KXNK\NaSVVXY^RK`OKXc]SQXS MKX^SWZKM^YX\O`OX_O\OMYQXS^SYXY\WOK]_\OWOX^
,
Amount 1 year 5 years MYWZK\ON^YM_\\OX^Z\KM^SMO
>\KNOZKcKLVO]<OPO\XY^O 480,62.48 480,62.48 - - - 480,62.48
48 RECENT ACCOUNTING PRONOUCEMENTS
9^RO\M_\\OX^ XKXMSKVVSKLSVS^SO]
<OPO\XY^O 48,98.43 48,98.43 - - - 48,98.43 Appendix B to Ind AS 21, Foreign currency transactions and advance consideration :
529,60.91 529,60.91 - - - 529,60.91   X7K\MR""7SXS]^\cYP-Y\ZY\K^O+PPKS\]u7-+vRK]XY^S ON^RO-YWZKXSO]3XNSKX+MMY_X^SXQ=^KXNK\N]+WOXNWOX^
9
<_VO]"MYX^KSXSXQ+ZZOXNSb,^Y3XN+=0Y\OSQXM_\\OXMc^\KX]KM^SYX]KXNKN`KXMOMYX]SNO\K^SYXaRSMRMVK\S O]^RONK^O
YP^RO^\KX]KM^SYXPY\^ROZ_\ZY]OYPNO^O\WSXSXQ^ROObMRKXQO\K^O^Y_]OYXSXS^SKV\OMYQXS^SYXYP^RO\OVK^ONK]]O^ObZOX]OY\
>RONO^KSV]YP^ROMYX^\KM^_KVWK^_\S^SO]YP]SQXS MKX^VSKLSVS^SO]K]K^7K\MR!K\OK]PYVVYa]$ SXMYWOYX^RONO\OMYQXS^SYXYPKXYXWYXO^KcK]]O^Y\XYXWYXO^K\cVSKLSVS^c\OVK^SXQ^YKN`KXMOMYX]SNO\K^SYX>RO+ZZOXNSbS]
OPPOM^S`OPY\KXX_KVZO\SYNLOQSXXSXQYXY\KP^O\+Z\SV"
:K\^SM_VK\] Carrying Less than cOK\] cOK\] More than >Y^KV
Amount cOK\ cOK\] 49 >RO-YWZKXcRK]LKXUY`O\N\KP^K\\KXQOWOX^]OM_\ONLcRcZY^ROMK^SYXYPKVV]^YMU]KXNLYYUNOL^]KQKSX]^aRSMR^RO\OK\OXY
LY\\YaSXQ]
>\KNOZKcKLVO]<OPO\XY^O ! # ! # - - - ! #
50 :\O`SY_]cOK\t] Q_\O]RK`OLOOX\OQ\Y_ZON\OMVK]]S ON^YMYXPY\W^Y^ROM_\\OX^cOK\t]MVK]]S MK^SYX
9^RO\M_\\OX^ XKXMSKVVSKLSVS^SO]
<OPO\XY^O  #  # - - -  #
! ! - - - ! 0Y\KXNYXLORKVPYP^RO,YK\NYP.S\OM^Y\]
As per our report of even date
For S R B C & CO LLP AMBATI VENU R A SHAH
46 CAPITAL MANAGEMENT Chartered Accountants Managing Director Director
3-+30S\W<OQS]^\K^SYX8Y#"// .38$! "# .38$#"
FY\^ROZ_\ZY]OYP^RO-YWZKXct]MKZS^KVWKXKQOWOX^MKZS^KVSXMV_NO]S]]_ONO[_S^cMKZS^KVKXNKVVY^RO\O[_S^c\O]O\`O]K^^\SL_^KLVO
^Y^ROO[_S^cRYVNO\]YP^RO-YWZKXc>ROZ\SWK\cYLTOM^S`OYP^RO-YWZKXct]MKZS^KVWKXKQOWOX^S]^Y]KPOQ_K\N^RO-YWZKXct] per RAVI BANSAL RAJIV SONALKER KRUPA ANANDPARA
KLSVS^c^Y\OWKSXK]KQYSXQMYXMO\XKXNWKbSWS]O^RO]RK\ORYVNO\`KV_O :K\^XO\ -09KXNARYVO^SWO.S\OM^Y\ Company Secretary
7OWLO\]RSZ8Y#  .38$!#!" 7OWLO\]RSZ8Y+-= 
 >RO-YWZKXcWKXKQO]S^]MKZS^KV]^\_M^_\OKXNWKUO]KNT_]^WOX^]SXVSQR^YPMRKXQO]SXOMYXYWSMMYXNS^SYX]KXX_KVYZO\K^SXQ
ZVKX]KXNVYXQ^O\WKXNY^RO\]^\K^OQSMSX`O]^WOX^ZVKX]3XY\NO\^YWKSX^KSXY\KNT_]^^ROMKZS^KV]^\_M^_\O^RO-YWZKXcWKc :VKMO$7_WLKS :VKMO$7_WLKS
KNT_]^^ROKWY_X^YPNS`SNOXN]ZKSN^Y]RK\ORYVNO\]\O^_\XMKZS^KV^Y]RK\ORYVNO\]Y\S]]_OXOa]RK\O]>ROM_\\OX^MKZS^KV]^\_M^_\O .K^O$7Kc" .K^O$7Kc"

144 ANNUAL REPORT 2017-18 145

 ABBOTT
ABBOTT INDIA
INDIA LIMITED
LIMITED
NOTICE
Notice is hereby given that the Seventy-fourth Annual General
Meeting of Abbott India Limited will be held at RAMA WATUMULL
AUDITORIUM, K C College, 124, Dinshaw Wachha Road,
Vidyasagar Prin. K. M. Kundnani Chowk, Churchgate, Mumbai -
400 020 on Wednesday, July 18, 2018 at 3.30 p.m. to transact the
following business :
ORDINARY BUSINESS :
1. To receive, consider and adopt the Audited Financial
  Y MYX]SNO\ KXN SP ^RY_QR^ ^ ^Y ZK]] aS^R Y\ aS^RY_^
=^K^OWOX^] YP ^RO -YWZKXc PY\ ^RO XKXMSKV cOK\ OXNON
March 31, 2018 together with the Reports of Directors and
Auditors thereon.
 >
 Y NOMVK\O K XKV NS`SNOXN YP ` 50/- and special dividend of
`ZO\/[_S^c=RK\OPY\^RO XKXMSKVcOK\OXNON7K\MR"
3. To appoint a Director in place of Mr Kaiyomarz Marfatia
(DIN : 03449627), who retires by rotation and being eligible,
offers himself for re-appointment.
SPECIAL BUSINESS :
 <
 K^S MK^SYX YP \OW_XO\K^SYX ZKcKLVO ^Y 7] 5S]RY\O
,RK^SK  +]]YMSK^O] -Y]^ +_NS^Y\] PY\ ^RO XKXMSKV cOK\
!
2018-19
  Y MYX]SNO\ KXN SP ^RY_QR^ ^ ^Y ZK]] aS^R Y\ aS^RY_^
> 2015 and the Secretarial Standards issued by the Institute of
WYNS MK^SYX] ^RO PYVVYaSXQ \O]YV_^SYX K] KX 9\NSXK\c
Resolution :
</=96@/. >RK^ pursuant to the provisions of Section 148
and all other applicable provisions, if any, of the Companies
Act, 2013 and the Rules framed thereunder (including any
]^K^_^Y\c WYNS MK^SYX] Y\ \OOXKM^WOX^ ^RO\OYP PY\ ^RO
time being in force), remuneration of ` 6.65 Lakhs plus
taxes as applicable and reimbursement of out-of-pocket
expenses (at actuals), as approved by the Board of Directors
of the Company, payable to M/s Kishore Bhatia & Associates,
Cost Accountants (Registration No. 00294) for conducting
^RO-Y]^+_NS^YP^RO-YWZKXcPY\^RO XKXMSKVcOK\"#
" +
LOKXNS]RO\OLc\K^S ON
 +
 ZZYSX^WOX^YP7]+XS]RK7Y^aKXS.38$ ##K]
3XNOZOXNOX^.S\OM^Y\
  Y MYX]SNO\ KXN SP ^RY_QR^ ^ ^Y ZK]] aS^R Y\ aS^RY_^
> Resolution :
WYNS MK^SYX] ^RO PYVVYaSXQ \O]YV_^SYX K] KX 9\NSXK\c
Resolution :
</=96@/. >RK^ pursuant to the provisions of Sections
149, 150, 152 and all other applicable provisions, if any, read
with Schedule IV of the Companies Act, 2013 and the Rules
P\KWON^RO\O_XNO\SXMV_NSXQKXc]^K^_^Y\cWYNS MK^SYX]Y\
re-enactment thereof for the time being in force) (“the Act”)
and applicable provisions of the Securities and Exchange Board
of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended from time to time,
Ms Anisha Motwani (DIN : 06943493), who was appointed as
146 ANNUAL REPORT 2017-18
Additional Director by the Board of Directors effective April 25,
2018 in terms of the provisions of Section 161 of the Act and who
RYVN]YP MO_Z^Y^RONK^OYP^RS]+XX_KV1OXO\KV7OO^SXQLOKXN
is hereby appointed as Independent Director of the Company,
XY^VSKLVO^Y\O^S\OLc\Y^K^SYXKXN^YRYVNYP MOPY\K^O\WYP
3 (three) years effective April 25, 2018.
 +
 ZZYSX^WOX^YP7\4KaONDSK.38$#! K].S\OM^Y\
VSKLVO^Y\O^S\OLc\Y^K^SYX
> to attend the Annual General Meeting pursuant to Section
WYNS MK^SYX] ^RO PYVVYaSXQ \O]YV_^SYX K] KX 9\NSXK\c
Resolution :
</=96@/. >RK^ Mr Jawed Zia (DIN : 00191276), who was
appointed as Additional Director of the Company by the Board
of Directors effective June 1, 2018 as per the provisions of
Section 161 of the Companies Act, 2013 and the Rules framed
^RO\O_XNO\ SXMV_NSXQ KXc ]^K^_^Y\c WYNS MK^SYX] Y\
re-enactment thereof for the time being in force), and who
RYVN] YP MO _Z^Y ^RO NK^O YP ^RS] +XX_KV 1OXO\KV 7OO^SXQ
be and is hereby appointed as Director of the Company, liable
to retire by rotation.
+ZZYSX^WOX^ YP 7\ <KTS` =YXKVUO\ .38 $ !#!" K]
.S\OM^Y\
 Y MYX]SNO\ KXN SP ^RY_QR^ ^ ^Y ZK]] aS^R Y\ aS^RY_^
> .38 $ # ! aRY RK] K^^KSXON ^RO KQO YP =O`OX^c `O
WYNS MK^SYX] ^RO PYVVYaSXQ \O]YV_^SYX K] KX 9\NSXK\c
Resolution :
</=96@/. >RK^ Mr Rajiv Sonalker (DIN : 07900178),
who was appointed as Additional Director of the Company
by the Board of Directors effective August 8, 2017 as per
the provisions of Section 161 of the Companies Act, 2013
and the Rules framed thereunder (including any statutory
WYNS MK^SYX] Y\ \OOXKM^WOX^ ^RO\OYP PY\ ^RO ^SWO LOSXQ
SX PY\MO KXN aRY RYVN] YP MO _Z^Y ^RO NK^O YP ^RS] +XX_KV
General Meeting, be and is hereby appointed as Director of
the Company.
 ZZYSX^WOX^ YP 7\ <KTS` =YXKVUO\ .38 $ !#!" K]
ARYVO^SWO.S\OM^Y\
 Y MYX]SNO\ KXN SP ^RY_QR^ ^ ^Y ZK]] aS^R Y\ aS^RY_^
> Fax : +91-22-6797 8727 / +91-22-3816 2400
WYNS MK^SYX] ^RO PYVVYaSXQ \O]YV_^SYX K] KX 9\NSXK\c
</=96@/. >RK^ in accordance with the provisions of
Sections 196, 197, 203 and all other applicable provisions, if any,
read with Schedule V of the Companies Act, 2013 and the Rules
P\KWON^RO\O_XNO\SXMV_NSXQKXc]^K^_^Y\cWYNS MK^SYX]Y\
re-enactment(s) thereof for the time being in force), consent of
the Company be and is hereby accorded to the appointment of
Mr Rajiv Sonalker (DIN : 07900178) as Whole-time Director,
not liable to retire by rotation, for a period of 2 (two) years
effective August 8, 2017, at a remuneration and upon such
terms and conditions as set out in explanatory statement
annexed hereto.
CORPORATE OVERVIEW
 /=96@/. 0_\^RO\ >RK^ the Board of Directors of the
< A person can act as a proxy on behalf of Members not
Company (hereinafter referred to as “the Board” which term
shall deemed to include any Committee of the Board) shall,
in accordance with the statutory limits/approvals as may
be applicable for the time being in force, be at full liberty to
revise/alter/modify/amend the terms and conditions of the
said appointment and/or remuneration, from time to time,
K]S^WKcNOOW ^
# <
 OKZZYSX^WOX^ YP 7\ 7_XS\ =RKSUR .38 $ # !
aRY RK] K^^KSXON ^RO KQO YP =O`OX^c `O cOK\] KXN aRY
\O^S\O] Lc \Y^K^SYX KXN LOSXQ OVSQSLVO YPPO\] RSW]OVP PY\
\OKZZYSX^WOX^K].S\OM^Y\VSKLVO^Y\O^S\OLc\Y^K^SYX
  Y MYX]SNO\ KXN SP ^RY_QR^ ^ ^Y ZK]] aS^R Y\ aS^RY_^
> authorised to attend and vote on their behalf at the Meeting.
WYNS MK^SYX] ^RO PYVVYaSXQ \O]YV_^SYX K] K =ZOMSKV
Resolution :
  /=96@/. >RK^ pursuant to the provision of Section 152
<
and all other applicable provisions, if any, of the Companies
Act, 2013 and the Rules framed thereunder (including any
]^K^_^Y\c WYNS MK^SYX] Y\ \OOXKM^WOX^ ^RO\OYP PY\ ^RO
time being in force) (“the Act”) and the Securities and
Exchange Board of India (Listing Obligations and Disclosure
Requirements) (Amendment) Regulations, 2018, as amended
from time to time, consent of the Company be and is hereby
accorded to the re-appointment of Mr Munir Shaikh
years and who retires by rotation at this Annual General
Meeting and being eligible, offers himself for re-appointment,
as Director of the Company, liable to retire by rotation.
,c9\NO\YP^RO,YK\N
5\_ZK+XKXNZK\K
Mumbai Company Secretary
June 1, 2018 Membership No.: ACS 16536
<OQS]^O\ON9P MO$
Abbott India Limited
CIN : L24239MH1944PLC007330
3, Corporate Park, Sion-Trombay Road,
Mumbai - 400 071
Telephone No.: +91-22-6797 8888 / +91-22-3816 2000
Email : investorrelations.india@abbott.com
Website : www.abbott.co.in
NOTES:
i.   7/7,/< /8>3>6/. >9 +>>/8. +8. @9>/ +>
+
>2/+88?+61/8/<+67//>381u>2/7//>381v
3=/8>3>6/.>9+::938>+:<9BC>9+>>/8.+8.
@9>/ 38=>/+. 90 237=/602/<=/60 +8. >2/
:<9BC8//.89>,/+7/7,/<90>2/-97:+8C
The instrument appointing the proxy, in order to be effective,
should be duly signed and completed and must be deposited
K^ ^RO <OQS]^O\ON 9P MO YP ^RO -YWZKXc XY^ VO]] ^RKX
forty-eight hours before commencement of the Meeting.
STATUTORY REPORT FINANCIAL STATEMENTS
ObMOONSXQ P^c KXN RYVNSXQ SX ^RO KQQ\OQK^O XY^ WY\O ^RKX
ten percent of the total share capital of the Company carrying
voting rights. A Member holding more than ten percent of the
total share capital of the Company carrying voting rights may
appoint a single person as proxy and such person shall not act
as a proxy for any other person or Member.
ii. Corporate Members intending to send their representatives
113 of the Companies Act, 2013, are requested to send to the
-YWZKXc K MO\^S ON MYZc YP ^RO \OVO`KX^ ,YK\N <O]YV_^SYX
together with the specimen signature of the representative(s)
Proxies submitted on behalf of Corporate Members must be
supported by an appropriate Board Resolution.
iii. A statement pursuant to Section 102(1) of the Companies Act,
2013, relating to the Special Business to be transacted at the
Meeting is annexed hereto.
iv. The additional details of Directors retiring by rotation/
seeking appointment/re-appointment, pursuant to Regulation
36(3) of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations,
Company Secretaries of India, are annexed hereto.
`  RO\O[_S\OWOX^PY\\K^S MK^SYXYPKZZYSX^WOX^YP+_NS^Y\]
>
by Members at each Annual General Meeting has been
omitted as per Section 40 of the Companies (Amendment)
+M^!XY^S ONYX7Kc!"+MMY\NSXQVc\O]YV_^SYXPY\
\K^S MK^SYX YP KZZYSX^WOX^ YP = < , -  -9 66: =^K^_^Y\c
Auditors, who were appointed at the Annual General Meeting
held on August 1, 2014 is not included in this Notice.
`S >
 RO<OQS]^O\YP,OXO MSKV9aXO\]<OQS]^O\YP7OWLO\]KXN
Share Transfer Books of the Company will remain closed from
Thursday, July 12, 2018 to Wednesday, July 18, 2018 (both days
inclusive).
vii. Final dividend of ` 50/- and special dividend of ` 5/- per
Equity Share of ` 10/- each, as recommended by the Board of
Directors, if approved by the Members at the Annual General
Meeting, will be paid on and from July 24, 2018 to the Members
whose names appear on the Register of Members as on
4_Vc""KXN^Y^RO,OXO MSKV9aXO\]YP^RO]RK\O]K]YX
July 11, 2018, as per the details furnished by the Depositories
for this purpose.
viii. The Securities and Exchange Board of India has mandated
submission of Permanent Account Number (PAN) by every
participant in securities market. Accordingly, Members
holding shares in dematerialized form are requested to
submit the PAN to their respective Depository Participants.
Members holding shares in physical form can submit their
PAN to the Company/Registrar & Share Transfer Agent.
147
 ABBOTT INDIA LIMITED
ix. Members holding shares in electronic form may note that
bank particulars registered against their respective depository
account will be used by the Company for payment of dividend.
x. Members holding shares in electronic form are requested to
intimate immediately change, if any, in their registered address
or bank particulars to their Depository Participants with
whom they have Demat accounts. The Company or Registrar
& Share Transfer Agent cannot act on any request received
directly from the Members holding shares in electronic form
in this regard.
Members holding shares in physical form are requested to
intimate change, if any, in their registered address or bank
particulars to the Company/Registrar & Share Transfer Agent.
xi. Members holding shares in physical mode are advised to
register nomination in respect of their shareholding in the
Company. Nomination Form (SH – 13) is made available on
the website of the Company at http://www.abbott.co.in/
investor-relations.html
Members holding shares in electronic form are required to
contact their Depository Participants for registering/changing
their nomination.
xii. The Company has transferred the amount lying in the
following unpaid/unclaimed dividend accounts to the
Investor Education and Protection Fund since the date of last
Annual General Meeting :
=\ :K\^SM_VK\] COK\ .O^KSV]
8Y
1 53rd Unpaid Dividend 2010 Abbott India Limited
2 Unpaid Final Dividend 2010 Erstwhile Solvay
Pharma India Limited
Members whose dividend has remained unpaid/unclaimed
from the year 2011 onwards, are requested to write to the
Company for issue of demand drafts for the same.
In terms of the Investor Education and Protection Fund
(IEPF) (Uploading of Information regarding unpaid and
unclaimed amounts lying with Companies) Rules, 2012, the
Company has uploaded the required information in respect
of dividend remaining unpaid/unclaimed for the last seven
years (as on date of the last Annual General Meeting held on
July 18, 2017) on the Company’s website under the Investor
Section at http://www.abbott.co.in/investor-relations/other-
information/unclaimed-dividend.html
xiii. In terms of requirements of Regulation 39(4) and
Schedule VI of the Securities and Exchange Board of
India (Listing Obligations and Disclosure Requirements)
Regulations, 2015, shares which remained unclaimed in the
custody of the Company are required to be transferred to the
Suspense Account opened by the Company.
148 ANNUAL REPORT 2017-18
Accordingly, 24,671 Equity Shares held by 191 Shareholders
were transferred to “Abbott India Limited - Unclaimed
Suspense Account” in January, 2017. The Company has not
received any claims during the year.
+VV LOXO ^] KMM\_SXQ YX ]_MR ]RK\O] ]RKVV LO M\ONS^ON ^Y
Unclaimed Suspense Account for a period of seven years.
>RO\OKP^O\ ^RO ]KSN ]RK\O] SXMV_NSXQ KVV LOXO ^] KMM\_ON
thereon shall be transferred by the Company to IEPF Authority
in accordance with the provisions of Section 124(5) and (6)
of the Companies Act, 2013 and Rules framed thereunder.
The voting rights in respect of such shares shall remain frozen
till the rightful owner claims such shares.
xiv. In terms of requirements of Section 124(6) of the Companies
Act, 2013 read with the Investor Education and Protection
Fund Authority (Accounting, Audit, Transfer and Refund)
Rules, 2016, all shares in respect of which dividend has not
been paid or claimed for 7 (seven) consecutive years or more
are required to be transferred to the Investor Education and
Protection Fund Authority (“IEPF Authority”).
Accordingly, 51,809 Equity Shares held by 317 Shareholders
were transferred to the IEPF Authority in November, 2017.
No claims have been received till date.
The details of shares so transferred is available on the
Company’s website under the Investor Section at http://
www.abbott.co.in/investor-relations/other-information/
unclaimed-dividend.html
b` 7
 OWLO\] ]OOUSXQ KXc SXPY\WK^SYX Y\ MVK\S MK^SYX] YX ^RO
Annual Report are requested to send their queries in writing
to the Company at least one week prior to the Meeting to
enable the Company to compile the information and provide
replies at the Meeting.
xvi. In case all the joint holders attending the Meeting, the
7OWLO\aRY]OXKWOKZZOK\]K] \]^RYVNO\SX^ROY\NO\YP
names as per Register of Members of the Company will be
entitled to vote.
xvii. Members are requested to bring their copy of the Annual
Report to the Meeting, as the same will not be distributed at
the Meeting.
xviii.+XX_KV <OZY\^ PY\ ^RO XKXMSKV cOK\ !" KVYXQ aS^R ^RO
Notice of Seventy-fourth Annual General Meeting, remote
e-voting form, proxy form and attendance slip will be sent
through electronic mode to the Members whose email
addresses are registered with the Company/Depositories for
communication purpose.
Physical copy of Annual Report along with the aforesaid
documents will be sent by the permitted mode to those
Members whose email ids are not registered with the
Company/Depositories or to those Members who have
requested for the same.
CORPORATE OVERVIEW
Members are requested to register/update their email address
with the Company/Depository Participants for receiving all
future communications from the Company including Annual
Reports, Notices, Circulars, etc. electronically.
The aforesaid documents can also be downloaded from the
Company’s website at http://www.abbott.co.in/investor-
\OVK^SYX] XKXMSKV]R^WV
xix. The relevant documents referred to in the accompanying
Notice and Explanatory Statement will be kept open for
SX]ZOM^SYX Lc ^RO 7OWLO\] K^ ^RO <OQS]^O\ON 9P MO YP ^RO
Company during business hours on all working days (except
Saturdays) upto the date of this Annual General Meeting.
The aforesaid documents will also be available for inspection
by Members at the Meeting.
xx. @Y^SXQ^R\Y_QROVOM^\YXSMWOKX]
Pursuant to the provisions of Section 108 and other applicable
provisions, if any, of the Companies Act, 2013 read with the
Companies (Management and Administration) Rules, 2015,
and Regulation 44 of the Securities and Exchange Board of
India (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended from time to time, the Company
is pleased to provide to its Members the facility to exercise
their vote through electronic means i.e. ‘remote e-voting’ on
resolutions proposed to be passed at this Annual General
Meeting (“the Meeting”).
The facility for voting through Insta Poll shall be provided at
the Meeting. Members attending the Meeting who have not
cast their vote earlier by remote e-voting shall be entitled to
vote at this Meeting. A Member can participate in the Meeting
even after exercising his right to vote through remote e-voting
but shall not be allowed to vote again at this Meeting.
The cut-off date for the purpose of remote e-voting and voting
at the Meeting is July 11, 2018.
The remote e-voting facility will be available during the
following voting period :
Commencement of : From 9 a.m. (IST) on Sunday,
remote e-voting July 15, 2018
End of remote e-voting : Upto 5 p.m. (IST) on Tuesday,
July 17, 2018
Complete instructions on e-voting including details of
login ID, process and manner for generating or receiving the
password and for casting vote in a secure manner is given in
the Remote e-voting Form annexed to this Report and forms
an integral part of this Notice.
Mr Taizoon M. Khumri, Practicing Company Secretary
(CP No. 88) (Membership No. FCS 993) has been appointed
as the Scrutinizer to scrutinize the voting process in a fair and
transparent manner.
STATUTORY REPORT FINANCIAL STATEMENTS
The results shall be declared by the Chairman or any
other person authorised by him in writing within
forty-eight hours from the conclusion of this Meeting.
The results declared along with the consolidated Report of
the Scrutinizer shall be immediately placed on the website
of the Company at www.abbott.co.in and on the website of
Karvy Computershare Private Limited at https://evoting.
karvy.com The voting results shall simultaneously be
forwarded to the BSE Limited, Mumbai.
xxi. Attendance Slip, Proxy Form and the Route Map showing
directions to reach the venue of the Seventy-fourth Annual
General Meeting are annexed herewith.
STATEMENT PURSUANT TO SECTION 102 (1) OF THE
COMPANIES ACT, 2013
3^OW8Y
The Board, based on the recommendation of the Audit Committee,
approved the appointment of M/s Kishore Bhatia & Associates,
Cost Accountants (Registration No. 00294) as the Cost Auditors
PY\MYXN_M^SXQ^RO-Y]^+_NS^YP^RO-YWZKXcPY\^RO XKXMSKVcOK\
2018-19 at a remuneration of ` 6.65 Lakhs plus taxes as applicable
and reimbursement of out-of-pocket expenses (at actuals).
Pursuant to the provisions of Section 148 and all other applicable
provisions, if any, of the Companies Act, 2013 and the Rules
framed thereunder, remuneration payable to M/s Kishore Bhatia
+]]YMSK^O]-Y]^+_NS^Y\]K]]^K^ONKLY`O\O[_S\O]\K^S MK^SYX
by the Members.
None of the Directors and/or Key Managerial Personnel of the
-YWZKXcKXN^ROS\\OVK^S`O]S]MYXMO\XONY\SX^O\O]^ON XKXMSKVVc
or otherwise, in the resolution set out at Item No. 4.
The Board recommends the resolution set forth in Item No. 4 for
the approval of Members as an Ordinary Resolution.
3^OW8Y
The Board, based on the recommendation of the Nomination
and Remuneration Committee, appointed Ms Anisha Motwani
(DIN : 06943493) as Additional Director of the Company
effective April 25, 2018, as per the provisions of Section 161 of the
Companies Act, 2013 and Rules framed thereunder (“the Act”)
read with Article 113 of the Articles of Association of the Company.
=RORYVN]YP MO_Z^Y^RONK^OYP^RS]+XX_KV1OXO\KV7OO^SXQ
Further, the Board as per the applicable provisions of the
Act and the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015,
(“the Regulations”) and based on the recommendations of
the Nomination and Remuneration Committee, appointed
Ms Motwani as an Independent Director of the Company, not
liable to retire by rotation, for a term of (3) three years effective
April 25, 2018, subject to approval of the Members at the Annual
General Meeting of the Company.
149
 ABBOTT INDIA LIMITED
Ms Motwani has given her consent to act as a Director of the
-YWZKXc +V]Y K] ZO\ MYX \WK^SYX] \OMOS`ON P\YW RO\ ]RO S]
XY^ NS][_KVS ON P\YW LOSXQ KZZYSX^ON K] K .S\OM^Y\ SX ^O\W] YP
Section 164 of the Companies Act, 2013 and meets the criteria of
Independence as prescribed under the applicable provisions of the
Act and the Regulations.
In the opinion of the Nomination and Remuneration Committee
and the Board, Ms Motwani is independent of the Management.
Ms Motwani is a seasoned marketing professional with over
28 years of experience in Marketing across diverse industries.
In her last executive role, she was the Chief Marketing & Digital
9P MO\YP7Kb6SPO3X]_\KXMO=ROS]^RO0Y_XNO\KXN:K\^XO\K^
‘Storm The Norm’, an innovation company. She is also an Advisor
to World Bank and the Max Group. She was voted as one of the
50 Most Powerful Women in Indian Business by Business Today
for three consecutive years since 2009. She was also recognised
amongst the Top 50 Women in Media, Marketing and Advertising
by Impact & Colors for 3 consecutive years since 2011. She has
been conferred Women at Work Leadership Award 2011 by Asian
Confederation of Business and the Udyog Ratan by the Institute of
Economic Studies.
Ms Motwani has been in the forefront of behaviour change projects
such as Swacchh Bharat and Clean Ganga Mission. She writes for
^RO/MYXYWSM>SWO],_]SXO]]=^KXNK\N3XNSK>YNKc2_P XQ^YX
Post and Marketingbuzzar.com.
Ms Motwani holds a Bachelor of Science from Sophia College,
New Delhi and a Masters of Business Administration from the
University of Rajasthan.
Ms Motwani serves as Independent Director on the Boards of
Prataap Snacks Limited (listed company), India Shelter Finance
Corporate Limited, L&T Investment Management Limited,
PNB Metlife India Insurance Company Limited and also
a Director on the Board of Quintessentially Lifestyle Services
(India) Private Limited.
The additional details of Ms Motwani as required under
Regulation 36(3) of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations,
2015 and Secretarial Standards issued by the Institute of Company
Secretaries of India are set out in the Annexure forming part of
this Notice. Ms Motwani does not hold any shares in the Company.
The Letter of appointment of Ms Motwani containing terms of
her appointment, will be kept open for inspection by Members at
^RO<OQS]^O\ON9P MOYP^RO-YWZKXcN_\SXQL_]SXO]]RY_\]YXKVV
working days (except Saturdays).
None of the Directors and/or Key Managerial Personnel of the
Company and their relatives, except Ms Motwani, is concerned
Y\SX^O\O]^ON XKXMSKVVcY\Y^RO\aS]OSX^RO\O]YV_^SYX]O^Y_^K^
Item No. 5.
The Board recommends the resolution set forth in Item No. 5 for
the approval of Members as an Ordinary Resolution.
150 ANNUAL REPORT 2017-18
3^OW8Y
The Board, based on the recommendation of the Nomination
and Remuneration Committee, appointed Mr Jawed Zia
(DIN : 00191276) as Additional Director of the Company effective
June 1, 2018, as per the provisions of Section 161 of the Companies
Act, 2013 and Rules framed thereunder (“the Act”) read with
Article 113 of the Articles of Association of the Company. He holds
YP MO_Z^Y^RONK^OYP^RS]+XX_KV1OXO\KV7OO^SXQ
Mr Zia is Vice-President of Established Pharmaceuticals
business of Abbott in India. He has a wealth of experience
gained in various geographies and functions across the globe.
Prior to joining the Company, Mr Zia was the Vice-Chairman and
Managing Director of Novartis India Limited responsible for the
Novartis Group of Companies. He has a successful career history
in Novartis working across Pharmaceuticals, Consumer Health
and Devices in positions of increasing responsibility across various
functions of Market Research, Brand Management, Marketing
Management, Division Management and Area Management in
Ireland, Saudi Arabia, Turkey, Singapore, Canada, Switzerland
and in India.
Mr Zia has a deep knowledge and extensive experience of building
businesses from inception. His innate ability to drive growth of
people and businesses, build brands, transform operations and
scale capabilities has been the hallmark of his success.
Mr Zia is a graduate in Clinical Pharmacology from All India
Institute of Medical Sciences, New Delhi and a Master of Business
Administration from Trinity College, Dublin (Ireland).
Mr Zia has given his consent to act as a Director of the Company.
+V]YK]ZO\MYX \WK^SYX\OMOS`ONP\YWRSWROS]XY^NS][_KVS ON
from being appointed as a Director in terms of Section 164 of the
Companies Act, 2013.
The additional details of Mr Zia as required under Regulation
36(3) of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 and
Secretarial Standards issued by the Institute of Company
Secretaries of India are set out in the Annexure forming part of
this Notice. Mr Zia does not hold any shares in the Company.
None of the Directors and/or Key Managerial Personnel of the
Company and their relatives, except Mr Zia, is concerned or
SX^O\O]^ON XKXMSKVVc Y\ Y^RO\aS]O SX ^RO \O]YV_^SYX ]O^ Y_^ K^
Item No. 6.
The Board recommends the resolution set forth in Item No. 6 for
the approval of Members as an Ordinary Resolution.
3^OW8Y]!KXN"
The Board, based on the recommendation of the Nomination
and Remuneration Committee, appointed Mr Rajiv Sonalker
(DIN : 07900178) as Additional Director of the Company effective
August 8, 2017, as per the provisions of Section 161 of the Companies
CORPORATE OVERVIEW
Act, 2013 and Rules framed thereunder (“the Act”) read with
Article 113 of the Articles of Association of the Company. He holds
YP MO_Z^Y^RONK^OYP^RS]+XX_KV1OXO\KV7OO^SXQ
The Board, based on the recommendation of the Nomination
and Remuneration Committee, also appointed Mr Sonalker as
Whole-time Director, not liable to retire by rotation, for a term of
(2) two years effective August 8, 2017, subject to the approval of the
Members at the Annual General Meeting of the Company.
7\=YXKVUO\RK]LOOX^RO-RSOP0SXKXMSKV9P MO\YP^RO-YWZKXc
since 2006. Besides in-depth knowledge of the Company, he has
Y`O\ # cOK\] YP ]^\YXQ XKXMSKV KXN WKXKQOWOX^ ObZO\SOXMO
having worked in Pharmaceutical, FMCG and Engineering
industries. Prior to joining the Company, he worked with
Bristol-Myers Squibb as Director – Finance and in positions
of increasing responsibility in Voltas, Johnson and Johnson,
=KXY +`OX^S]SX3XNSKKXN1O\WKXc
Mr Sonalker has been awarded the “Best CFO in MNC,
Mid Enterprise Category, by Business World in the year 2016.
Mr Sonalker holds a Bachelor of Science from Elphinston
College, Mumbai and is a fellow Member of the Institute of
Chartered Accountants of India.
>RO ]SQXS MKX^ ^O\W] KXN MYXNS^SYX] YP KZZYSX^WOX^ YP
Mr Sonalker are as under :
1. Period of Appointment is 2 (two) years, commencing from
August 8, 2017;
2. Mr Sonalker shall perform such duties and exercise such
powers as are entrusted to him from time to time by the Board
of Directors (hereinafter called “the Board”), subject to the
superintendence, control and directions of the Board;
 7
 \ =YXKVUO\ ]RKVV NO`Y^O ]_P MSOX^ ^SWO ^Y OXKLVO RSW ^Y
discharge his duties to the Company diligently and to the best
of his abilities and skills. He shall in all respects comply with
the Abbott Code of Business Conduct and other Abbott India
Policies and Procedures;
4. During the period of his employment with the Company,
Mr Sonalker shall, whenever required to by the Board, undertake
to travel in India and elsewhere as the Board may direct;
5. In consideration of the performance of his duties to the
Company, Mr Sonalker shall be entitled to the following
remuneration subject to applicable taxes :
(a) Salary and perquisites : upto a ceiling of ` 2 Crores per
annum; to be paid monthly/annually, as may be approved
by the Board;
(b) Performance Linked Incentive or Bonus : as may be
approved by the Board; upto a ceiling of ` 57 Lakhs per
annum.
STATUTORY REPORT FINANCIAL STATEMENTS
In addition to the above, Mr Sonalker shall be entitled to
Medical Reimbursement, Mobile Phone, Telephone at
\O]SNOXMO YP MSKV MKVV] KXN Y^RO\ ZO\[_S]S^O]LOXO ^] ]_MR
as group insurance and gratuity in accordance with the
Company’s Rules. Mr Sonalker will be entitled to Restricted
Stock Units/any other stock options of Abbott Laboratories,
USA as per his eligibility.
The Company’s contribution to provident fund shall not
be included in the computation of the above ceiling on
\OW_XO\K^SYXKXNKVVYaKXMO]ZO\[_S]S^O]LOXO ^]
6. Within the overall ceiling on managerial remuneration
prescribed under the Companies Act, 2013 and Rules framed
thereunder, the Board shall be entitled to add, alter or vary
KXc YP ^RO PY\OQYSXQ ^O\W] YP \OW_XO\K^SYX LOXO ^] Y\
perquisites to which Mr Sonalker may be entitled as aforesaid;
!  RO\OSXKXc XKXMSKVcOK\N_\SXQ^RO^OX_\OYP7\=YXKVUO\
A
K] ARYVO^SWO .S\OM^Y\ ^RO -YWZKXc RK] XY Z\Y ^] Y\
S^] Z\Y ^] K\O SXKNO[_K^O ^RO \OW_XO\K^SYX ZKcKLVO ^Y
Mr Sonalker shall be subject to the provisions of Section 197
and Section II of Part II of Schedule V to the Companies Act,
2013 or any other law or enactment for the time being or from
time to time in force;
8. Mr Sonalker shall not directly or indirectly, engage himself in
any other business or occupation or employment whatsoever,
without the approval of the Board. PROVIDED HOWEVER,
that it shall be permissible to Mr Sonalker to hold share(s) of
any other company(ies);
9. So long as Mr Sonalker functions as Whole-time Director,
he shall not become interested or otherwise concerned directly
or through any of his relatives, if any, in any selling agency of
the Company, without the prior approval of the Board;
10. Mr Sonalker shall not, during the continuance of his
employment hereunder or at any time thereafter divulge
or disclose to any person whomsoever or make any use
whatsoever for his own purpose or for any purpose other
than that of the Company, of any information or knowledge
obtained by him during his employment as to the business
or affairs of the Company or its methods or as to any trade
secrets or secret processes of the Company and he shall
during the continuance of his employment hereunder also
use his best endeavors to prevent any other person from so
doing. PROVIDED HOWEVER that any such divulgence or
NS]MVY]_\O^YYP MO\]KXNOWZVYcOO]YP^RO-YWZKXc]RKVVXY^
be deemed to be contravention of this Clause;
11. The employment of Mr Sonalker shall forthwith be
determined if he shall become insolvent or make any
composition or arrangement with his creditors or if he is
guilty of any misconduct or otherwise violates the Abbott
Code of Business Conduct;
151
 ABBOTT INDIA LIMITED CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS

:?<=?+8>>9</1?6+>398 90>2/=/-?<3>3/=+8./B-2+81/,9+<.9038.3+63=>3819,631+>398=+8..3=-69=?</
./>+36= 90 .3</->9<= =//5381 +::938>7/8></+::938>7/8> +> >2/ =/@/8>C09?<>2 +88?+6 1/8/<+6 7//>381

</;?3</7/8>=</1?6+>398=+8.=/-</>+<3+6=>+8.+<.=3==?/.,C>2/38=>3>?>/90-97:+8C=/-</>+<3/=9038.3+
12. In case of the demise of Mr Sonalker during the course of his YP=O`OX^c `OcOK\]]RKVVLOKZZYSX^ONY\MYX^SX_OK]K.S\OM^Y\

Institute of Chartered
OX^\OZ\OXO_\SKV
KS\
Mr Shaikh possesses
employment hereunder, the Company will pay to his legal unless a special resolution is passed approving such appointment

team player with an

England and Wales

7\7_XS\=RKSUR

vast knowledge of
personal representatives the salary and other emoluments or continuation. In view of the same, approval of the Members

is a consummate
the industry and

Accountants in
payable hereunder for the then current month and other dues is sought through Special Resolution for re-appointment of

March 2, 2001
March 1, 1943

Fellow of the
together with any such further sum as the Board in its sole and 7\7_XS\=RKSURaRYRK]K^^KSXON^ROKQOYP=O`OX^c `OcOK\]
uncontrolled discretion may determine; as Director of the Company, liable to retire by rotation.

None

None

None
Mr Munir Shaikh has held several management and leadership

NIL
13. Either party shall be entitled to determine this Agreement
by giving not less than three months’ notice in writing positions with Abbott since 1968 in different geographies across
in that behalf to the other party without the necessity of various businesses. In his last role, from June, 2005 until his

College, Mumbai and

Accountants of India
showing any cause. However, the Company shall have the retirement in 2010, he was the Divisional Vice President, South-

industries in Indian

Bachelor of Science
7\<KTS`=YXKVUO\
East Asia/Middle-East/Africa, Abbott Nutrition International

and International

a Fellow Member
having worked in
and management
option to terminate the employment by giving 3 (three)

from Elphinston
Mr Sonalker has

Pharmaceutical,
]^\YXQ XKXMSKV
over 29 years of

of the Institute
based in Singapore.

environments.
August 8, 2017
WYX^R]t\OW_XO\K^SYXSXMV_NSXQ]KVK\cKVVYaKXMO]LOXO ^]

June 19, 1959

of Chartered
Engineering
experience,
perquisites in lieu of notice.

FMCG and
As the Chairman of the Board of the Company since March, 2001,
Mr Sonalker is the Key Managerial Personnel of the Company and Mr Shaikh brings to the Board extensive leadership and industry

None

None

None
ObZO\SOXMOYPY`O\ `ONOMKNO]SXMV_NSXQKNOOZUXYaVONQOKXN

NIL
a Member of Risk Management and Finance Committees.
understanding of the Company’s business operations, strategies
Mr Sonalker has given his consent to act as a Director of the and the business envirionment into which the Company operates.

of building businesses

various functions and

-YWZKXc +V]Y K] ZO\ MYX \WK^SYX \OMOS`ON P\YW RSW RO S] XY^

extensive experience

Administration from
He has over 30 years
2S] ]SQXS MKX^ MYX^\SL_^SYX KXN Q_SNKXMO ^Y ^RO ,YK\N SX

Master’s in Business
of Medical Sciences,
Graduate in Clinical
Pharmacology from
geographies across
NS][_KVS ONP\YWLOSXQKZZYSX^ONK]K.S\OM^Y\SX^O\W]YP=OM^SYX

All India Institute

Mr Zia has a deep
governance matters and strategic direction to the Management in

Dublin (Ireland)
of experience in

Trinity College,
from inception.
 YP^RO-YWZKXSO]+M^2O]K^S] O]KVV^ROMYXNS^SYX]K]]O^

October 3, 1963

knowledge and

New Delhi and

Company’s business over these years have helped the Company

7\4KaONDSK
out under Part I of Schedule V and Section 196 (3) of the Act for his

June 1, 2018
achieve several milestones year-after-year.

the globe.
appointment as Whole-time Director.
Mr Shaikh is a Fellow of the Institute of Chartered Accountants

None

None

None
The additional details of Mr Sonalker as required under of England and Wales.

NIL
Regulation 36(3) of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, The Nomination and Remuneration Committee and the Board is
of the view that his strong knowledge, independent perspective

7]+XS]RK7Y^aKXS
2015 and Secretarial Standards issued by the Institute of Company

from Sophia College,

Masters of Business
Bachelor of Science
KXN MYX^SX_ON K]]YMSK^SYX aSVV MYX^SX_O ^Y SWWOX]OVc LOXO ^

from University of
diverse industries.
Secretaries of India are set out in the Annexure forming part of

Marketing across
Ms Motwani has
the Company and therefore, recommend his re-appointment.

over 28 years of

Administration
this Notice. Mr Sonalker does not hold any shares in the Company.

New Delhi and

April 25, 2018

experience in
Mr Shaikh is not related to the Promoter Companies. He does not

June 21, 1963

A copy of the agreement between Mr Sonalker and the Company hold any shares in the Company.

Rajasthan
containing terms of his appointment referred in this Notice shall
None of the Directors and/or Key Managerial Personnel of the

None
be made available for inspection by the Members at the Registered

NIL
Company and their relatives, except Mr Shaikh, is concerned or
9P MOYP^RO-YWZKXcN_\SXQL_]SXO]]RY_\]YXKVVaY\USXQNKc]

2
5
SX^O\O]^ON XKXMSKVVc Y\ Y^RO\aS]O SX ^RO \O]YV_^SYX ]O^ Y_^ K^
(except Saturdays).
Item No. 9.

and Law degree from

Commerce from Lala
Mr Marfatia has over

Legal and Secretarial

about 22 years have

None of the Directors and/or Key Managerial Personnel of the

November 22, 1956

38 years of diverse

Lajpat Rai College

been with Abbott.
The Board recommends the resolution set forth in Item No. 9 for

streams, of which

Government Law
experience in the

College, Mumbai
7\5KScYWK\d
Company and their relatives, except Mr Sonalker, is concerned or
the approval of Members as a Special Resolution.

March 1, 2011
SX^O\O]^ON XKXMSKVVc Y\ Y^RO\aS]O SX ^RO \O]YV_^SYX] ]O^ Y_^ K^

Bachelor of
Item Nos. 7 and 8. ,c9\NO\YP^RO,YK\N

7K\PK^SK
The Board recommends the resolutions set forth in Item Nos. 7

None

None

None
5\_ZK+XKXNZK\K

NIL
and 8 for the approval of Members as Ordinary Resolutions.
Mumbai Company Secretary
3^OW8Y# June 1, 2018 Membership No.: ACS 16536

7OWLO\]RSZYP-YWWS^^OO]
SXY^RO\3XNSKX-YWZKXSO]
Mr Munir Shaikh (DIN : 00096273), Non-Executive Chairman of <OQS]^O\ON9P MO$

8YYP=RK\O]ROVNSX^RO
Abbott India Limited

.S\OM^Y\]RSZ]SXY^RO\
the Board retires by rotation at this Annual General Meeting of the

<OVK^SYX]RSZLO^aOOX
.K^OYP+ZZYSX^WOX^
CIN : L24239MH1944PLC007330

/bZO\^S]OSX=ZOMS M
Company in terms of provisions of Section 152 of the Companies

.S\OM^Y\]SX^O\]O
3XNSKX-YWZKXSO]
3, Corporate Park,

8KWOYP.S\OM^Y\
Act, 2013 and being eligible, offers himself for re-appointment.

0_XM^SYXKV+\OK
7\=RKSURRK]K^^KSXON^ROKQOYP=O`OX^c `OcOK\] Sion-Trombay Road,

;_KVS MK^SYX]
.K^OYP,S\^R
Mumbai - 400 071
In terms of the provisions of Regulation 17(1A) of the Securities

and Exchange Board of India (Listing Obligations and Disclosure
Requirements) (Amendment) Regulations, 2018, which shall come
into force from April 1, 2019, no person who has attained the age
-YWZKXc
Telephone No.: +91-22-6797 8888 / +91-22-3816 2000
Fax : +91-22-6797 8727 / +91-22-3816 2400
Email : investorrelations.india@abbott.com
Website : www.abbott.co.in

152 ANNUAL REPORT 2017-18 153

 ABBOTT INDIA LIMITED
ABBOTT INDIA LIMITED
-Y\ZY\K^O3NOX^S MK^SYX8_WLO\-38$6#72#:6-!
<OQS]^O\ON9P MO$-Y\ZY\K^O:K\U=SYX>\YWLKc<YKN7_WLKS!
>OV$# !#!""""#" 0Kb$# !#!"!!#" 

R oute M ap /WKSV$SX`O]^Y\\OVK^SYX]SXNSK*KLLY^^MYWAOL]S^O$aaaKLLY^^MYSX

ATTENDANCE SLIP
@OX_O$ RAMA WATUMULL AUDITORIUM, K C College, 124, Dinshaw Wachha Road, Vidyasagar Prin. K. M. Kundnani Chowk,
Churchgate, Mumbai - 400 020 :6/+=/0366+>>/8.+8-/=63:+8.2+8.3>9@/<+>>2//8><+8-/90>2/7//>3812+66
4YSX^=RK\ORYVNO\]WKcYL^KSXKNNS^SYXKV]VSZK^^RO@OX_OYP^RO7OO^SXQ
6KXNWK\U$Next to HR College
.S]^KXMOP\YW-R_\MRQK^O=^K^SYX$1 km 8YYP]RK\O]ROVN$llllllllllllllllllllll0YVSY8Y.:3.-VSOX^3.$llllllllllllllllllllll
3MO\^SPc^RK^3KWK7OWLO\:\YbcPY\^RO7OWLO\YP^RO-YWZKXc
.S]^KXMOP\YW-RRK^\KZK^S=RS`KTS>O\WSX_]$2 kms
3RO\OLc\OMY\NWcZ\O]OXMOK^^RO=O`OX^cPY_\^R+XX_KV1OXO\KV7OO^SXQYP^RO-YWZKXcROVNYXAONXO]NKc4_Vc""K^ZW
K^ <+7+ A+>?7?66 +?.3>9<3?7 5 - -YVVOQO  .SX]RKa AKMRRK <YKN @SNcK]KQK\ :\SX 5 7 5_XNXKXS -RYaU -R_\MRQK^O
7_WLKS
Chhatrapati Shivaji
Terminus
lllllllllllllllll llllllllllllllll
8KWOYP^RO7OWLO\:\Ybc =SQXK^_\OYP^RO7OWLO\:\Ybc
Churchgate SX,69-5VO^^O\]
Station
+ZZVSMKLVOPY\7OWLO\]RYVNSXQ]RK\O]SXOVOM^\YXSMPY\W
Siddharth
College of Law

ABBOTT INDIA LIMITED

-Y\ZY\K^O3NOX^S MK^SYX8_WLO\-38$6#72#:6-!
<OQS]^O\ON9P MO$-Y\ZY\K^O:K\U=SYX>\YWLKc<YKN7_WLKS!
>OV$# !#!""""#" 0Kb$# !#!"!!#" 
/WKSV$SX`O]^Y\\OVK^SYX]SXNSK*KLLY^^MYWAOL]S^O$aaaKLLY^^MYSX
Din

Maharshi Karve Road

09<771>
sha
wW
ach
PROXY FORM
JTS Malani Marg

ha Samrat
Roa E:_\]_KX^ ^Y =OM^SYX   YP ^RO -YWZKXSO] +M^  KXN <_VO # YP ^RO -YWZKXSO] 7KXKQOWOX^ KXN +NWSXS]^\K^SYX <_VO] G
d Restaurant

8KWOYP^RO7OWLO\]$llllllllllllllllllllllll0YVSY8Y.:3.-VSOX^3.$llllllllllllllll
Din <OQS]^O\ONKNN\O]]$lllllllllllllllllllllllllllllllllllllllllllllllllll
sha
ad

wW
Ro

ach
ha /WKSV3N$lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll
a
Tat

Roa
d
dji
she

H R College +ZZVSMKLVOPY\7OWLO\]RYVNSXQ]RK\O]SXOVOM^\YXSMPY\W
Jam

3AOLOSXQ^RO7OWLO\]YPllllllllllllll]RK\O]YP+LLY^^3XNSK6SWS^ONRO\OLcKZZYSX^$
ow i
Ch van

Vidyasagar Prin. K. M. Kundnani Chowk

k
Ad

K.C. 1. 8KWO$lllllllllllllllllllllllllllllllllllllllllllllllllllll

College  +NN\O]]$llllllllllllllllllllllllllllllllllllllllllll

 /WKSV3.$lllllllllllllllllllllllllllllll=SQXK^_\O$llllllllllY\PKSVSXQRSWRO\

 8KWO$llllllllllllllllllllllllllllllllllllllllllllllllllllll

 +NN\O]]$lllllllllllllllllllllllllllllllllllllllllll

 /WKSV3.$lllllllllllllllllllllllllllllll=SQXK^_\O$llllllllllY\PKSVSXQRSWRO\

 8KWO$llllllllllllllllllllllllllllllllllllllllllllllllllllll

 +NN\O]]$lllllllllllllllllllllllllllllllllllllllllll

 /WKSV3.$lllllllllllllllllllllllllllllll=SQXK^_\O$lllllllllll

K]WcY_\Z\Ybc^YKXN`Y^OYXKZYVVPY\WO_]KXNYXWcY_\LORKVPK^^RO=O`OX^cPY_\^R+XX_KV1OXO\KV7OO^SXQYP^RO-YWZKXc^YLO
ROVNYXAONXO]NKc4_Vc""K^$ZWK^<+7+A+>?7?66+?.3>9<3?75--YVVOQO.SX]RKaAKMRRK<YKN@SNcK]KQK\
:\SX575_XNXKXS-RYaU-R_\MRQK^O7_WLKS7KRK\K]R^\KKXNK^KXcKNTY_\XWOX^^RO\OYPSX\O]ZOM^YP]_MR\O]YV_^SYX]K]
SXNSMK^ONY`O\VOKP$
154 ANNUAL REPORT 2017-18
 Resolution Particulars For Against
No.
ORDINARY RESOLUTIONS
 +NYZ^SYX YP +_NS^ON 0SXKXMSKV =^K^OWOX^] YP ^RO -YWZKXc PY\ ^RO XKXMSKV cOK\ OXNON 7K\MR  "
^YQO^RO\aS^R^RO<OZY\^]YP.S\OM^Y\]KXN+_NS^Y\]^RO\OYX
 .OMVK\K^SYXYP XKVNS`SNOXNYP`KXN]ZOMSKVNS`SNOXNYP`ZO\O[_S^c]RK\OPY\^RO XKXMSKVcOK\OXNON
7K\MR"
 +ZZYSX^WOX^YP7\5KScYWK\d7K\PK^SKK].S\OM^Y\VSKLVO^Y\O^S\OLc\Y^K^SYX
 <K^S MK^SYX YP \OW_XO\K^SYX YP `   6KUR] ZKcKLVO ^Y 7] 5S]RY\O ,RK^SK  +]]YMSK^O]
<OQS]^\K^SYX8Y#-Y]^+_NS^Y\]PY\^RO XKXMSKVcOK\"#
 +ZZYSX^WOX^ YP 7] +XS]RK 7Y^aKXS K] 3XNOZOXNOX^ .S\OM^Y\ PY\ K ^O\W YP  ^R\OO cOK\] OPPOM^S`O
+Z\SV"
 +ZZYSX^WOX^YP7\4KaONDSKK].S\OM^Y\VSKLVO^Y\O^S\OLc\Y^K^SYX
! +ZZYSX^WOX^YP7\<KTS`=YXKVUO\K].S\OM^Y\
" +ZZYSX^WOX^ YP 7\ <KTS` =YXKVUO\ K] ARYVO^SWO .S\OM^Y\ PY\ K ZO\SYN YP  ^aY cOK\] OPPOM^S`O
+_Q_]^"!
SPECIAL RESOLUTION
# <OKZZYSX^WOX^YP7\7_XS\=RKSURaRYRK]K^^KSXON^ROKQOYP=O`OX^c `OcOK\]K].S\OM^Y\VSKLVO^Y
\O^S\OLc\Y^K^SYX

=SQXON^RS]llllNKcYPll"
+P b
<O`OX_O
=^KWZ
=SQXK^_\OYP7OWLO\ =SQXK^_\OYP:\Ybc2YVNO\]

Notes:
 >RS]PY\WYPZ\YbcSXY\NO\^YLOOPPOM^S`O]RY_VNLON_Vc]SQXONMYWZVO^ONKXNNOZY]S^ONK^^RO<OQS]^O\ON9P MOYP^RO-YWZKXcXY^
VO]]^RKXPY\^cOSQR^RY_\]LOPY\O^ROMYWWOXMOWOX^YP^RO7OO^SXQ
 +:\YbcXOONXY^LOK7OWLO\YP^RO-YWZKXc
 +ZO\]YXMKXKM^K]KZ\YbcYXLORKVPYP7OWLO\]XY^ObMOONSXQ P^cKXNRYVNSXQSX^ROKQQ\OQK^OXY^WY\O^RKXYP^RO^Y^KV]RK\O
MKZS^KVYP^RO-YWZKXcMK\\cSXQ`Y^SXQ\SQR^]+7OWLO\RYVNSXQWY\O^RKXYP^RO^Y^KV]RK\OMKZS^KVYP^RO-YWZKXcMK\\cSXQ`Y^SXQ
\SQR^]WKcKZZYSX^K]SXQVOZO\]YXK]Z\YbcKXN]_MRZO\]YX]RKVVXY^KM^K]KZ\YbcPY\KXcY^RO\ZO\]YXY\7OWLO\
 +ZZYSX^SXQKZ\YbcNYO]XY^Z\O`OX^K7OWLO\P\YWK^^OXNSXQ^ROWOO^SXQSXZO\]YXSPRO]YaS]RO]
 3X^ROMK]OYPTYSX^RYVNO\]^RO]SQXK^_\OYPKXcYXORYVNO\aSVVLO]_P MSOX^L_^XKWO]YPKVV^ROTYSX^RYVNO\]]RY_VNLO]^K^ON
 :\Ybc]RKVVXY^RK`O\SQR^^Y]ZOKUK^^ROWOO^SXQKXN]RKVVXY^LOOX^S^VON^Y`Y^OObMOZ^YXK:YVV
+,,9>>38.3+6373>/D
CIN : L24239MH1944PLC007330
3, CORPORATE PARK, SION-TROMBAY ROAD,
MUMBAI - 400 071, INDIA
© ABBOTT INDIA LIMITED ALL RIGHTS RESERVED. REPRODUCTION IN WHOLE
OR PART WITHOUT WRITTEN PERMISSION IS STRICTLY PROHIBITED.

concept, content and design at Mindseye creative (www.mecstudio.com) print@parksonsgraphics.com